<SEC-DOCUMENT>0001520138-25-000029.txt : 20250108
<SEC-HEADER>0001520138-25-000029.hdr.sgml : 20250108
<ACCEPTANCE-DATETIME>20250108081423
ACCESSION NUMBER:		0001520138-25-000029
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20241130
FILED AS OF DATE:		20250108
DATE AS OF CHANGE:		20250108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axil Brands, Inc.
		CENTRAL INDEX KEY:			0001718500
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				474125218
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41958
		FILM NUMBER:		25516633

	BUSINESS ADDRESS:	
		STREET 1:		9150 WILSHIRE BOULEVARD
		STREET 2:		UNIT 245
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212
		BUSINESS PHONE:		888-638-8883

	MAIL ADDRESS:	
		STREET 1:		9150 WILSHIRE BOULEVARD
		STREET 2:		UNIT 245
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Reviv3 Procare Co
		DATE OF NAME CHANGE:	20171003
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>axil-20241130_10q.htm
<DESCRIPTION>FORM 10-Q FOR PERIOD ENDING NOVEMBER 30, 2024
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:axil="http://reviv.com/20241130">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_US%2DGAAP%2D2024%2D(with%2DECD)_rempres -->
<!-- Field: Set; Name: xdx; ID: xdx_037_axil_reviv.com_20241130 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20240601_20241130 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentFiscalYearFocus_2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNS0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentFiscalPeriodFocus_Q2 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001718500 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000004" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000005" name="dei:CurrentFiscalYearEndDate">--05-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000006" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000007" name="dei:EntityCentralIndexKey">0001718500</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-05-31" id="xdx2ixbrl0125" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-11-30" id="xdx2ixbrl0136" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-05-31" id="xdx2ixbrl0137" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:GainOnDebtSettlement" contextRef="From2024-09-012024-11-30" id="xdx2ixbrl0247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:GainOnDebtSettlement" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl0249" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-09-012024-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-09-012024-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-09-012024-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0342" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-09-012023-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-09-012023-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-09-012023-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-09-012023-11-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:PreferredStockConvertedToCommonStock" contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:PreferredStockConvertedToCommonStock" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-06-012023-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-06-012023-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-06-012023-11-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30_us-gaap_CommonStockMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:GainOnDebtSettlement" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:GainOnForgivenessOfAccountPayable" contextRef="From2023-06-012023-11-30" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-06-012023-11-30" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-06-012023-11-30" id="xdx2ixbrl0526" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:RepaymentOfEquipmentFinancing" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-06-012023-11-30" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" contextRef="From2023-06-012023-11-30" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:RestrictedStockAwards" contextRef="From2023-09-012023-11-30" id="xdx2ixbrl0733" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:RestrictedStockAwards" contextRef="From2023-06-012023-11-30" id="xdx2ixbrl0735" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-05-31_custom_ProductCertificationTestingMember" id="xdx2ixbrl0921" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="axil:RoyaltyPaymentAccrual" contextRef="AsOf2024-11-30" id="xdx2ixbrl0948" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl1077" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl1091" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-06-01to2024-11-30" id="xdx2ixbrl1093" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-05-31" id="xdx2ixbrl1179" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember" id="xdx2ixbrl1358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember" id="xdx2ixbrl1360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember" id="xdx2ixbrl1362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember" id="xdx2ixbrl1364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="axil-20241130.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-06-01to2024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_PromotionalRisplayRacksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">axil:PromotionalRisplayRacksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_PromotionalRisplayRacksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">axil:PromotionalRisplayRacksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_srt_MinimumMember_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_srt_MaximumMember_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_AutomobilesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_AutomobilesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_LicensingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:LicensingRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_LicensingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:LicensingRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_WebsiteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:WebsiteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_WebsiteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:WebsiteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_ProductCertificationTestingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:ProductCertificationTestingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_ProductCertificationTestingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:ProductCertificationTestingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-31_custom_EconomicInjuryDisasterLoanProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-012020-05-18_custom_EconomicInjuryDisasterLoanProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012022-05-31_custom_EconomicInjuryDisasterLoanProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2022-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_EconomicInjuryDisasterLoanProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_EconomicInjuryDisasterLoanProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_EIDLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EIDLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_EIDLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EIDLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-012023-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-01</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-03-05_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-03-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_PreferredStockMember105062531">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_CommonStockMember105062546">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-13_custom_OneConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:OneConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-14_custom_OfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:OfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-012024-02-14_custom_ThreeBoardMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">axil:ThreeBoardMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-02-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-13_custom_OneConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:OneConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_custom_RestrictedStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">axil:RestrictedStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_custom_RestrictedStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">axil:RestrictedStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_custom_IntrepidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:IntrepidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_IntrepidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:IntrepidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_IntrepidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:IntrepidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_custom_BZCapitalStrategiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">axil:BZCapitalStrategiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_HairCareAndSkinCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_custom_HairCareAndSkinCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_HearingEnhancementAndProtectionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_custom_HearingEnhancementAndProtectionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718500</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 3pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 12pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 12pt"><b>SECURITIES AND EXCHANGE
COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 12pt"><b>WASHINGTON, DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20240601__20241130_zrpxX1DvMENb"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000013" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--DocumentQuarterlyReport_c20240601__20241130_z4m6EQtUSSBc"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span></span>
<b>QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the quarterly period ended <span id="xdx_907_edei--DocumentPeriodEndDate_c20240601__20241130_z82r093r1Lf7"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate">November 30, 2024</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">OR</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_edei--DocumentTransitionReport_c20240601__20241130_zGTCINinYbkd"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt:booleanfalse" id="Fact000016" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span>&#160;<b>TRANSITION
REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the transition period from _____________ to _____________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Commission File Number: <span id="xdx_90D_edei--EntityFileNumber_c20240601__20241130_z9mIC14XpbQd"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000017" name="dei:EntityFileNumber">001-41958</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="image_01.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_905_edei--EntityRegistrantName_c20240601__20241130_zqqPOHoN06tf"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000018" name="dei:EntityRegistrantName">AXIL Brands, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20240601__20241130_zCFAGgI2uyOb"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:stateprovnameen" id="Fact000019" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20240601__20241130_zXfeiMVtK1N5"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000020" name="dei:EntityTaxIdentificationNumber">47-4125218</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or Other Jurisdiction of<br/>
Incorporation or Organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer<br/>
Identification No.)</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20240601__20241130_zzfYYZ8cQZ2h"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000021" name="dei:EntityAddressAddressLine1">9150 Wilshire Boulevard</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20240601__20241130_zVoxw8aiQwe3"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000022" name="dei:EntityAddressAddressLine2">Suite 245</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCityOrTown_c20240601__20241130_zgm5X9Rmwoab"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000023" name="dei:EntityAddressCityOrTown">Beverly Hills</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20240601__20241130_zJNRidjEm49e"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:stateprovnameen" id="Fact000024" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><b><span id="xdx_909_edei--EntityAddressPostalZipCode_c20240601__20241130_zdg6ZFWr7Yef"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000025" name="dei:EntityAddressPostalZipCode">90212</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(Address of Principal Executive Offices)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">(<span id="xdx_905_edei--CityAreaCode_c20240601__20241130_zGDTZvLxBDQh"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000026" name="dei:CityAreaCode">888</ix:nonNumeric></span>) <span id="xdx_908_edei--LocalPhoneNumber_c20240601__20241130_zrPEoi4bOKN4"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000027" name="dei:LocalPhoneNumber">638-8883</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&#8217;s Telephone Number, Including Area
Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; width: 40%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"><b>Trading symbol(s)</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 38%; text-align: center"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20240601__20241130_zxGMzRkiJR4b"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000028" name="dei:Security12bTitle">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_900_edei--TradingSymbol_c20240601__20241130_zKanyWSTTGnc"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000029" name="dei:TradingSymbol">AXIL</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center">The <span id="xdx_903_edei--SecurityExchangeName_c20240601__20241130_zR4mFTYc3LPl"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric></span> American LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
<span id="xdx_90E_edei--EntityCurrentReportingStatus_c20240601__20241130_zYW76L0ELcWa"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000031" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;No&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_90E_edei--EntityInteractiveDataCurrent_c20240601__20241130_zv2LO0798n9a"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000032" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;No&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large
accelerated filer,&#8221; accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221;
in Rule 12b-2 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%">Large accelerated filer</td>
    <td style="width: 48%"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="width: 25%">Accelerated filer</td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_903_edei--EntityFilerCategory_c20240601__20241130_zOcoDdPM1Ogc"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:entityfilercategoryen" id="Fact000033" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td>Smaller reporting company&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--EntitySmallBusiness_c20240601__20241130_zJtO1H5FWZm1"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt:booleantrue" id="Fact000034" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Emerging growth company</td>
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20240601__20241130_zxgrmuFSJUg1"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt:booleanfalse" id="Fact000035" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). Yes&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;<span id="xdx_903_edei--EntityShellCompany_c20240601__20241130_zr3kKghEYuy"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt:booleanfalse" id="Fact000036" name="dei:EntityShellCompany">No</ix:nonNumeric></span>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of January 3, 2025, there were <span id="xdx_90C_edei--EntityCommonStockSharesOutstanding_c20250103_pdd" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-01-03" id="Fact000038" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,466,852</ix:nonFraction></span> shares of the registrant&#8217;s
common stock, $0.0001 par value, outstanding.&#160;</p><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 3pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 8%">&#160;</td>
    <td style="width: 84%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 8%; text-align: center"><b>Page</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="2"><a href="#a_001">Cautionary Note Regarding Forward Looking Statements</a></td>
    <td style="text-align: center"><a href="#a_001">ii&#160;</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="2" style="text-align: center"><a href="#a_002"><b>PART I - FINANCIAL INFORMATION</b></a></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_003">Item 1.</a></td>
    <td><a href="#a_003">Financial Statements (Unaudited)</a></td>
    <td style="text-align: center"><a href="#a_003">1</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_009">Item 2.</a></td>
    <td><a href="#a_009">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></td>
    <td style="text-align: center"><a href="#a_009">2</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_010">Item 3.</a></td>
    <td><a href="#a_010">Quantitative and Qualitative Disclosures About Market Risk</a></td>
    <td style="text-align: center"><a href="#a_010">7</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_011">Item 4.</a></td>
    <td><a href="#a_011">Controls and Procedures</a></td>
    <td style="text-align: center"><a href="#a_011">7</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="2" style="text-align: center"><a href="#a_012"><b>PART II - OTHER INFORMATION</b></a></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_013">Item 1.</a></td>
    <td><a href="#a_013">Legal Proceedings</a></td>
    <td style="text-align: center"><a href="#a_013">8</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_014">Item 1A.</a></td>
    <td><a href="#a_014">Risk Factors</a></td>
    <td style="text-align: center"><a href="#a_014">8</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_015">Item 2.</a></td>
    <td><a href="#a_015">Unregistered Sales of Equity Securities and Use of Proceeds</a></td>
    <td style="text-align: center"><a href="#a_015">8</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_016">Item 3.</a></td>
    <td><a href="#a_016">Defaults Upon Senior Securities</a></td>
    <td style="text-align: center"><a href="#a_016">8</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_017">Item 4.</a></td>
    <td><a href="#a_017">Mine Safety Disclosures</a></td>
    <td style="text-align: center"><a href="#a_017">8</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_018">Item 5.</a></td>
    <td><a href="#a_018">Other Information</a></td>
    <td style="text-align: center"><a href="#a_018">8</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a_019">Item 6.</a></td>
    <td><a href="#a_019">Exhibits</a></td>
    <td style="text-align: center"><a href="#a_019">9</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="2"><a href="#a_020">Signatures</a></td>
    <td style="text-align: center"><a href="#a_020">10</a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_001"></span><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Quarterly Report on Form 10-Q, and in particular
Part I, Item 2 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; contains certain
&#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These forward-looking
statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any
statements regarding our assumptions about financial performance; the continuation of historical trends; the sufficiency of our cash balances
for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial
condition or cash flows; anticipated problems and our plans for future operations, including expected growth; and the economy in general
or the future of the beauty and hair care industry and the hearing protection and ear bud business, all of which are subject to various
risks and uncertainties. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are a number of factors that could cause
our actual results to differ from those indicated in the forward-looking statements, many of which are outside of our control. They
include: the impact of unstable market and general economic conditions on our business, financial condition and stock price,
including inflationary cost pressures, interest rate changes, decreased discretionary consumer spending, supply chain disruptions
and constraints, labor shortages, ongoing economic disruption, the possibility of an economic recession and other macroeconomic
factors, geopolitical events and uncertainty, including the effects of the Ukraine-Russia conflict and the Israel-Hamas conflict,
and other downturns in the business cycle or the economy; our financial performance and liquidity, including our ability to
successfully generate sufficient revenue to support our operations; our expectations regarding our financing arrangements and our
ability to obtain additional capital if and as needed, including potential difficulties of obtaining financing due to market
conditions resulting from geopolitical conditions and other economic factors; risks related to our operations and international
markets, such as fluctuations in currency exchange rates, different regulatory environments, trade barriers and sanctions, exchange
controls, and social and political instability; changes in the regulatory environment in which we operate, including environmental,
health and safety regulations, including those related to climate change; our ability to protect and defend our intellectual
property; continuity and security of information technology infrastructure and the potential impact of cybersecurity breaches or
disruptions to our management information systems; widespread outages, interruptions or other failures of operational,
communication, and other systems; competition; our ability to retain our management and employees and the potential impact of
ongoing labor shortages; demands on management resources; availability and cost of the raw materials we use to manufacture our
products, including the impacts of inflationary cost pressures and ongoing supply chain disruptions and constraints, which have
been, and may continue to be, exacerbated by the Russia-Ukraine conflict, the Israel-Hamas conflict and other geopolitical
conflicts; additional tax expenses or exposures; product liability claims; the potential outcome of any legal or regulatory
proceedings, including ongoing litigation, the disposition of which may have an adverse effect upon our business, financial
condition, or results of operations; our ability to engage in acquisitions, investments, partnerships, strategic alliances or
dispositions when desired; global or regional catastrophic events, including the effects of natural disasters, which may be worsened
by the impact of climate change; effectiveness of our marketing strategy, demand for and market acceptance of our products, as well
as our ability to successfully anticipate consumer trends and to realize anticipated benefits from our efforts to expand into new geographic markets and product lines; labor relations; the potential impact of environmental, social and
governance matters; implementation of environmental remediation matters; our ability to maintain effective internal control over
financial reporting; and risks related to our common stock, including our ability to maintain our stock exchange listing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When used in this Quarterly Report on Form 10-Q and
other reports, statements, and information we have filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), in our press
releases, presentations to securities analysts or investors, in oral statements made by or with the approval of an executive officer,
the words or phrases &#8220;believes,&#8221; &#8220;may,&#8221; &#8220;can,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221;
&#8220;could,&#8221; &#8220;would,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;likely,&#8221;
&#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;design,&#8221; &#8220;potential,&#8221; &#8220;focus&#8221;
or similar expressions and variations thereof are intended to identify such forward-looking statements. However, any statements contained
in this Quarterly Report on Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Furthermore,
such forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. We caution that these statements by their
nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on
a variety of important factors. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties,
estimates and assumptions that are difficult to predict.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We do not assume the obligation to update any forward-looking
statement, except as required by applicable law. You should carefully evaluate such statements in light of factors described in this Quarterly
Report on Form 10-Q. In this Quarterly Report on Form 10-Q, AXIL Brands, Inc. (&#8220;AXIL Brands, Inc.,&#8221; &#8220;AXIL Brands,&#8221;
the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) has identified material factors that could cause
actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such
factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_002"></span><b>PART I &#8211; FINANCIAL INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="a_003"></span><b>ITEM 1. FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Financial Statements:</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 95%"><a href="#a_004">Consolidated Balance Sheets - As of November 30, 2024 (Unaudited) and May 31, 2024</a></td>
    <td style="width: 5%; text-align: center"><a href="#a_004">F-1</a></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#a_005">Consolidated Statements of Operations - For the three and six months ended November 30, 2024 and 2023 (Unaudited)</a></td>
    <td style="text-align: center"><a href="#a_005">F-2</a></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#a_006">Consolidated Statements of Changes in Stockholders&#8217; Equity - For the three and six months ended November 30, 2024 and 2023 (Unaudited)</a></td>
    <td style="text-align: center"><a href="#a_006">F-3</a></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#a_007">Consolidated Statements of Cash Flows &#8211; For the six months ended November 30, 2024 and 2023 (Unaudited)</a></td>
    <td style="text-align: center"><a href="#a_007">F-4</a></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><a href="#a_008">Condensed Notes to Unaudited Consolidated Financial Statements</a></td>
    <td style="text-align: center"><a href="#a_008">F-5</a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="a_004"></span>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)" id="xdx_303_111_zDwWSpvlHJr" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20241130" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20240531" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>(Unaudited)</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsAbstract_iB_zg28YMWYk878" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrentAbstract_i01B_z5q5UMvZtuJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CURRENT ASSETS:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCz1NT_z64cppCqlkt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; padding-left: 10pt">Cash</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-11-30" id="Fact000046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,213,897</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-05-31" id="Fact000047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,253,876</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsReceivableNet_i02I_maCz1NT_zSSiSPmhJR02" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-11-30" id="Fact000049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,444,218</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-05-31" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,835</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InventoryNet_i02I_maCz1NT_zqGolqOg4P5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Inventory, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-11-30" id="Fact000052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,664,489</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-05-31" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,394,023</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCz1NT_zd1U5CLGTUcd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-11-30" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">724,778</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-05-31" id="Fact000056" format="ixt:numdotdecimal" decimals="0" unitRef="USD">809,126</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsCurrent_i02TI_mtCz1NT_maCzL6n_zKeNEyp5i473" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total Current Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-11-30" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,047,382</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-05-31" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,966,860</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsNoncurrentAbstract_i01B_zKkkUrFEXaBb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">OTHER ASSETS:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maCzi7Q_zgn6g7AiYm63" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-11-30" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">305,433</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-05-31" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,948</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsNet_i02I_maCzi7Q_z7SE0TcyMnrg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-11-30" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">324,907</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-05-31" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">309,104</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maCzi7Q_zxz0C9okjW48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-11-30" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">737,251</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-05-31" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,752</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxAsset_i02I_maCzi7Q_zY4cV4kPp1Na" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:DeferredTaxAsset" contextRef="AsOf2024-11-30" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,791</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:DeferredTaxAsset" contextRef="AsOf2024-05-31" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">231,587</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherAssets_i02I_maCzi7Q_z8fYO6WxNn2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2024-11-30" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,720</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2024-05-31" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,895</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Goodwill_i02I_maCzi7Q_zQRZIW7XXIge" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-11-30" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,152,215</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-05-31" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,152,215</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsNoncurrent_i02TI_mtCzi7Q_maCzL6n_zAcE3e5lPFi4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total Other Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-11-30" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,662,317</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-05-31" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,007,501</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Assets_i01TI_mtCzL6n_zr1Eqk2jtg1h" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 0pt">TOTAL ASSETS</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-11-30" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,709,699</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-05-31" id="Fact000086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,974,361</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zaPCUBmNLE5k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrentAbstract_i01B_zHx7gwE1Tdjc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CURRENT LIABILITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccountsPayableCurrent_i02I_maCz0RZ_z0pe0PYOjut4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-11-30" id="Fact000094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,619,252</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-05-31" id="Fact000095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">967,596</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--CustomerDepositCurrent_i02I_maCz0RZ_zkDM2RmoizRa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:CustomerDepositCurrent" contextRef="AsOf2024-11-30" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">496,404</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:CustomerDepositCurrent" contextRef="AsOf2024-05-31" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,762</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maCz0RZ_zf3gCHfNdjP4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Contract liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-11-30" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">956,022</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-05-31" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">905,311</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NotesPayableCurrent_i02I_maCz0RZ_zXHfRrdTpADl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-11-30" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,342</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-05-31" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,594</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DueToRelatedParty_i02I_maCz0RZ_zqRg1jWK1mAe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:DueToRelatedParty" contextRef="AsOf2024-11-30" id="Fact000106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">178,520</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:DueToRelatedParty" contextRef="AsOf2024-05-31" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,798</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCz0RZ_zZ3QrKl2hHt8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Lease liability, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-11-30" id="Fact000109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,077</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-05-31" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,752</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxLiability_i02I_maCz0RZ_zijpq9oAfly5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Income tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:IncomeTaxLiability" contextRef="AsOf2024-11-30" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,250</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:IncomeTaxLiability" contextRef="AsOf2024-05-31" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">242,296</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_i02I_maCz0RZ_z4fb1blGtZFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-11-30" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">331,395</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-05-31" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,936</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrent_i01TI_mtCz0RZ_maCzxGV_zkrGSA46wzG5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total Current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-11-30" id="Fact000118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,999,262</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-05-31" id="Fact000119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,798,045</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zbSYhgNY2Vl8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LONG TERM LIABILITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maCztZO_zBTYlqHeyp4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-11-30" id="Fact000124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">531,081</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0125">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ContractWithCustomerLiabilityNoncurrent_i02I_maCztZO_zL2EaDcvMjH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Contract liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2024-11-30" id="Fact000127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,205</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2024-05-31" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">480,530</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrent_i02TI_mtCztZO_maCzxGV_zDG93JFU2mVj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total Long Term Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-11-30" id="Fact000130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">888,286</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-05-31" id="Fact000131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">480,530</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Liabilities_i01TI_mtCzxGV_maCzSTq_zel7yaTKD3G4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-11-30" id="Fact000133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,887,548</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-05-31" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,278,575</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommitmentsAndContingencies_i01I_zXQl26fpr6u8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Commitments and contingencies (see Note 10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0136">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0137">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockholdersEquityAbstract_i01B_zUBbF4RypKud" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">STOCKHOLDERS' EQUITY:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PreferredStockValue_i02I_maCzgXP_zrp8Cz2a2Zqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 20pt">Preferred stock, $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20241130_pdd" title="Preferred stock, par value"><span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_c20240531_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-11-30" id="Fact000145" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-05-31" id="Fact000147" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20241130_pdd" title="Preferred stock, shares authorized"><span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_c20240531_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-11-30" id="Fact000149" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-05-31" id="Fact000151" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_c20241130_pdd" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_c20241130_pdd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-11-30" id="Fact000153" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-11-30" id="Fact000155" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,133,500</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_c20240531_pdd" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20240531_pdd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-05-31" id="Fact000157" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-05-31" id="Fact000159" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,251,750</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of November 30, 2024 and May 31, 2024, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-11-30" id="Fact000142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,113</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-05-31" id="Fact000143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,225</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CommonStockValue_i02I_maCzgXP_zHb0YKAFGsoc" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt">Common stock, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20241130_pdd" title="Common stock, par value"><span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20240531_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-11-30" id="Fact000164" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-05-31" id="Fact000166" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value: <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_c20241130_pdd" title="Common stock, shares authorized"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20240531_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-11-30" id="Fact000168" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-05-31" id="Fact000170" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_906_eus-gaap--CommonStockSharesIssued_c20241130_pdd" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_c20241130_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-11-30" id="Fact000172" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-11-30" id="Fact000174" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,466,852</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_c20240531_pdd" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_c20240531_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-05-31" id="Fact000176" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-05-31" id="Fact000178" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,908,939</ix:nonFraction></ix:nonFraction></span></span> shares issued, issuable and outstanding as of November 30, 2024 and May 31, 2024, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-11-30" id="Fact000161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-05-31" id="Fact000162" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_i02I_maCzgXP_zyqkweiqqfid" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-11-30" id="Fact000180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,428,760</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-05-31" id="Fact000181" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,825,240</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzgXP_zeq8ik8Mljt3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Retained earnings/(Accumulated deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-11-30" id="Fact000183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">389,631</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-05-31" id="Fact000184" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,270</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_i02TI_mtCzgXP_maCzSTq_zKIxKiBqPYYg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Stockholders' Equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30" id="Fact000186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,822,151</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31" id="Fact000187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,695,786</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzSTq_zDslir0EpTul" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 0pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-11-30" id="Fact000189" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,709,699</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-05-31" id="Fact000190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,974,361</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes to these unaudited consolidated
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_005"></span><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FOR THE THREE AND SIX MONTHS ENDED NOVEMBER 30,
2024 AND 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_113_zOAT7Py99Smk" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240901__20241130_zJfcptIDK4Ce" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230901__20231130_zbcLs5BhkPu9" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20240601_20241130" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230601_20231130" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">November 30,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">November 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_maCz5oT_z2jqA6UCf4jk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sales, net</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-09-012024-11-30" id="Fact000192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,732,574</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-09-012023-11-30" id="Fact000193" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,421,677</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-06-01to2024-11-30" id="Fact000194" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,583,846</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-06-012023-11-30" id="Fact000195" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,527,946</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CostOfGoodsAndServicesSold_msCz5oT_zkNBwiSuMGTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2024-09-012024-11-30" id="Fact000197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,234,527</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-09-012023-11-30" id="Fact000198" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,163,738</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2024-06-01to2024-11-30" id="Fact000199" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,932,151</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-06-012023-11-30" id="Fact000200" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,622,441</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GrossProfit_iT_mtCz5oT_maCzUHn_zV6b8QjpBXGl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-09-012024-11-30" id="Fact000202" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,498,047</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-09-012023-11-30" id="Fact000203" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,257,939</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-06-01to2024-11-30" id="Fact000204" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,651,695</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-06-012023-11-30" id="Fact000205" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,905,505</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpensesAbstract_iB_zqTeWKoKj3fl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">OPERATING EXPENSES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--SellingAndMarketingExpense_i01_maCzz5J_zOSqMFfvzHuj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-09-012024-11-30" id="Fact000212" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,377,760</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-09-012023-11-30" id="Fact000213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,672,780</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-06-01to2024-11-30" id="Fact000214" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,047,231</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-06-012023-11-30" id="Fact000215" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,879,621</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_i01_maCzz5J_zFa4A2V3Feaf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Compensation and related taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-09-012024-11-30" id="Fact000217" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,674</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-09-012023-11-30" id="Fact000218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,646</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-06-01to2024-11-30" id="Fact000219" format="ixt:numdotdecimal" decimals="0" unitRef="USD">467,322</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-06-012023-11-30" id="Fact000220" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,635</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfessionalFees_i01_maCzz5J_zCR1lqiVrLVd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Professional and consulting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-09-012024-11-30" id="Fact000222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">736,169</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-09-012023-11-30" id="Fact000223" format="ixt:numdotdecimal" decimals="0" unitRef="USD">694,258</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-06-01to2024-11-30" id="Fact000224" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,684,018</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-06-012023-11-30" id="Fact000225" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,303,288</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzz5J_zJnb2rvhBwYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-09-012024-11-30" id="Fact000227" format="ixt:numdotdecimal" decimals="0" unitRef="USD">434,573</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-09-012023-11-30" id="Fact000228" format="ixt:numdotdecimal" decimals="0" unitRef="USD">422,343</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-06-01to2024-11-30" id="Fact000229" format="ixt:numdotdecimal" decimals="0" unitRef="USD">920,955</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-06-012023-11-30" id="Fact000230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,292</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingExpenses_i01T_mtCzz5J_msCzUHn_zI2V8C5LBLO" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total Operating Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-09-012024-11-30" id="Fact000232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,825,176</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-09-012023-11-30" id="Fact000233" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,994,027</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-06-01to2024-11-30" id="Fact000234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,119,526</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-06-012023-11-30" id="Fact000235" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,467,836</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iT_mtCzUHn_maCzikl_zSg4jmqO3WR5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">INCOME FROM OPERATIONS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-09-012024-11-30" id="Fact000237" format="ixt:numdotdecimal" decimals="0" unitRef="USD">672,871</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-09-012023-11-30" id="Fact000238" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,263,912</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-06-01to2024-11-30" id="Fact000239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">532,169</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-06-012023-11-30" id="Fact000240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,437,669</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zMU17VuXEfF4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">OTHER INCOME (EXPENSE):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--GainOnDebtSettlement_i01_maCz7GB_zLN3mo42FPek" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Gain on settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0247">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:GainOnDebtSettlement" contextRef="From2023-09-012023-11-30" id="Fact000248" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,182</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0249">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:GainOnDebtSettlement" contextRef="From2023-06-012023-11-30" id="Fact000250" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,182</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncome_i01_maCz7GB_zH7PDzWRJDP8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2024-09-012024-11-30" id="Fact000252" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,041</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2023-09-012023-11-30" id="Fact000253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,189</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2024-06-01to2024-11-30" id="Fact000254" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,307</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2023-06-012023-11-30" id="Fact000255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,024</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InterestIncomeOther_i01_maCz7GB_zzeBXugwcu94" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2024-09-012024-11-30" id="Fact000257" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,340</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2023-09-012023-11-30" id="Fact000258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,825</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2024-06-01to2024-11-30" id="Fact000259" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,971</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2023-06-012023-11-30" id="Fact000260" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,318</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InterestExpenseNonoperating_i01N_di_msCz7GB_zSISFov0AgJl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Interest expense and other finance charges</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-09-012024-11-30" id="Fact000262" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-09-012023-11-30" id="Fact000263" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,640</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-06-01to2024-11-30" id="Fact000264" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-06-012023-11-30" id="Fact000265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,284</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_i01T_mtCz7GB_maCzikl_zhfLWJuENW6l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-09-012024-11-30" id="Fact000267" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,085</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-09-012023-11-30" id="Fact000268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,556</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-06-01to2024-11-30" id="Fact000269" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,982</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-06-012023-11-30" id="Fact000270" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,240</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzikl_maCzvxI_zdn3PstjRjke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">INCOME BEFORE PROVISION FOR INCOME TAXES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-09-012024-11-30" id="Fact000272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700,956</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-09-012023-11-30" id="Fact000273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,382,468</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-06-01to2024-11-30" id="Fact000274" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591,151</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-06-012023-11-30" id="Fact000275" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,602,909</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_msCzvxI_z2ENqKWp3x1g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Provision for income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-09-012024-11-30" id="Fact000277" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,250</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-09-012023-11-30" id="Fact000278" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,393</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-06-01to2024-11-30" id="Fact000279" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,250</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-06-012023-11-30" id="Fact000280" format="ixt:numdotdecimal" decimals="0" unitRef="USD">430,382</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_iT_mtCzvxI_z7risHYp2XFj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 0pt">NET INCOME</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-09-012024-11-30" id="Fact000282" format="ixt:numdotdecimal" decimals="0" unitRef="USD">633,706</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-09-012023-11-30" id="Fact000283" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018,075</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-01to2024-11-30" id="Fact000284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,901</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30" id="Fact000285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,172,527</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract_iB_zhNp8zXsMNl5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>NET INCOME PER COMMON SHARE:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_i01_ztAQTVLOIKE5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 0pt; padding-left: 10pt; vertical-align: middle">Basic</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-09-012024-11-30" id="Fact000292" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-09-012023-11-30" id="Fact000293" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.17</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-06-01to2024-11-30" id="Fact000294" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-06-012023-11-30" id="Fact000295" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_i01_zMePaJCWyLa3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 0pt; padding-left: 10pt; vertical-align: middle">Diluted</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-09-012024-11-30" id="Fact000297" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-09-012023-11-30" id="Fact000298" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-06-01to2024-11-30" id="Fact000299" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-06-012023-11-30" id="Fact000300" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasicAbstract_iB_z8cAFj8nXvhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 0pt; padding-left: 10pt; vertical-align: middle">Basic</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-09-012024-11-30" id="Fact000307" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,226</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-09-012023-11-30" id="Fact000308" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-06-01to2024-11-30" id="Fact000309" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,303,002</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-06-012023-11-30" id="Fact000310" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 0pt; padding-left: 10pt; vertical-align: middle">Diluted</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-09-012024-11-30" id="Fact000312" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,168,657</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-09-012023-11-30" id="Fact000313" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,632,689</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-06-01to2024-11-30" id="Fact000314" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,194,882</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-06-012023-11-30" id="Fact000315" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,632,689</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes to these unaudited consolidated
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="a_006"></span>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'
EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FOR THE THREE AND SIX MONTHS ENDED NOVEMBER 30,
2024 AND 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>For the three months ended November 30, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)" id="xdx_30B_114_zhym7n6owLie" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zhxKOKlmlack" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zzWmSaMS99F" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zFKVkZAWxHFe" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zcOrLKPNuP1j" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B3_zbrsJrzZgswc" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional Paid-in</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Retained Earnings/<br/> (Accumulated</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<br/> Stockholders'</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td></tr>
  <tr id="xdx_433_c20240901__20241130_eus-gaap--StockholdersEquity_iS_zifoYM8DpdH2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">Balance, August 31, 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20240901__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrSB4AUJlaY2" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember" id="Fact000323" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,133,500</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember" id="Fact000317" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,113</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20240901__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTr6Z2pMhrcg" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31_us-gaap_CommonStockMember" id="Fact000325" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,464,852</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_CommonStockMember" id="Fact000318" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000319" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,124,160</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_RetainedEarningsMember" id="Fact000320" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">244,075</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31" id="Fact000321" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,883,845</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockOptionPlanExpense_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock options expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0327">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0328">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,423</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0330">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-09-012024-11-30" id="Fact000331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,423</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_c20240901__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbyuxVLrYqE9" title="Stock-based compensation, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000339" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0334">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">166,177</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0336">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-09-012024-11-30" id="Fact000337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">166,177</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net income for the three months ended November 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0341">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0342">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember" id="Fact000344" format="ixt:numdotdecimal" decimals="0" unitRef="USD">633,706</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-09-012024-11-30" id="Fact000345" format="ixt:numdotdecimal" decimals="0" unitRef="USD">633,706</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20240901__20241130_eus-gaap--StockholdersEquity_iE_zkYy6zCYgbff" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, November 30, 2024</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20240901__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zOIgijuGYhC8" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember" id="Fact000353" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,133,500</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember" id="Fact000347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,113</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_c20240901__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zon7wBExLcCd" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-11-30_us-gaap_CommonStockMember" id="Fact000355" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,466,852</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_CommonStockMember" id="Fact000348" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,428,760</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember" id="Fact000350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">389,631</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30" id="Fact000351" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,822,151</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>For the three months ended November 30, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional Paid-in</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<br/> Stockholders'</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td></tr>
  <tr id="xdx_431_c20230901__20231130_eus-gaap--StockholdersEquity_iS_zqVjLjXR77fk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">Balance, August 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20230901__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zfej45CWBKFf" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="Fact000363" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="Fact000357" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20230901__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSPs9UEoNbCd" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact000365" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact000358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">586</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,164,472</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember" id="Fact000360" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,312,540</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31" id="Fact000361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,877,518</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockOptionPlanExpense_zt9lPzCQLcX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock options expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0367">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0368">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-09-012023-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000369" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,108</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0370">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-09-012023-11-30" id="Fact000371" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,108</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zDwb1oB321" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net income for the three months ended November 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0373">&#8212;</span></td><td style="white-space: nowrap; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0374">&#8212;</span></td><td style="white-space: nowrap; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0375">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-09-012023-11-30_us-gaap_RetainedEarningsMember" id="Fact000376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018,075</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-09-012023-11-30" id="Fact000377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018,075</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20230901__20231130_eus-gaap--StockholdersEquity_iE_zICgaNW4ICje" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, November 30, 2023</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20230901__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z0XpVTxoptDh" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember" id="Fact000385" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember" id="Fact000379" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20230901__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUG0skw82m39" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-11-30_us-gaap_CommonStockMember" id="Fact000387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_CommonStockMember" id="Fact000380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">586</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,215,580</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_RetainedEarningsMember" id="Fact000382" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,294,465</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30" id="Fact000383" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,946,701</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>For the six months ended November 30, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock<br/> Issued/Issuable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional Paid-in</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Retained Earnings/<br/> (Accumulated</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<br/> Stockholders'</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td></tr>
  <tr id="xdx_434_c20240601__20241130_eus-gaap--StockholdersEquity_iS_zQ6Y5Yj2gBm" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">Balance, May 31, 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zjQiOyZVWTLk" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember" id="Fact000395" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,251,750</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember" id="Fact000389" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,225</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1IZPQVkq8Nk" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-05-31_us-gaap_CommonStockMember" id="Fact000397" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,908,939</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_CommonStockMember" id="Fact000390" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000391" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,825,240</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_RetainedEarningsMember" id="Fact000392" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,270</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31" id="Fact000393" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,695,786</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockOptionPlanExpense_zrza6xXMezb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock options expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0400">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000401" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,055</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0402">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-06-01to2024-11-30" id="Fact000403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,055</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_zuEFjjJ1EFv7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb7lZug9N6Z8" title="Stock-based compensation, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember" id="Fact000411" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0406">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000407" format="ixt:numdotdecimal" decimals="0" unitRef="USD">391,409</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-06-01to2024-11-30" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">391,409</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--PreferredStockConvertedToCommonStock_iP3us-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_zcwP9QHGGuH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Preferred shares converted to common</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--PreferredStockConvertedToCommonStockShares_iP3custom--PreferredStockConvertedToCommonStock_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zbXZdtINlila" title="Preferred shares converted to common, shares" style="text-align: right">(<ix:nonFraction name="axil:PreferredStockConvertedToCommonStockShares" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember" id="Fact000419" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">11,118,250</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="axil:PreferredStockConvertedToCommonStock" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember" id="Fact000413" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,112</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--PreferredStockConvertedToCommonStockShares_iP3custom--PreferredStockConvertedToCommonStockShares_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKSBq4sIGWgi" title="Preferred shares converted to common, shares" style="text-align: right"><ix:nonFraction name="axil:PreferredStockConvertedToCommonStockShares" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember" id="Fact000421" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">555,913</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:PreferredStockConvertedToCommonStock" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember" id="Fact000414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:PreferredStockConvertedToCommonStock" contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,056</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_zx2Qhz3ayNye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net income for the six months ended November 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0424">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember" id="Fact000426" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,901</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-01to2024-11-30" id="Fact000427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,901</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20240601__20241130_eus-gaap--StockholdersEquity_iE_zLJSYkgDRzR2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, November 30, 2024</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z94zhYJJDTuj" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember" id="Fact000435" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,133,500</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember" id="Fact000429" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,113</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20240601__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6NcfMnbD1ul" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-11-30_us-gaap_CommonStockMember" id="Fact000437" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,466,852</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_CommonStockMember" id="Fact000430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000431" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,428,760</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember" id="Fact000432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">389,631</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-11-30" id="Fact000433" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,822,151</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>For the six months ended November 30, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional Paid-in</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<br/> Stockholders'</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td></tr>
  <tr id="xdx_433_c20230601__20231130_eus-gaap--StockholdersEquity_iS_zAqouOObZVk5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">Balance, May 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230601__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zqoQ5Nsy8pf4" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember" id="Fact000445" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember" id="Fact000439" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230601__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfzQreg85lba" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-05-31_us-gaap_CommonStockMember" id="Fact000447" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_CommonStockMember" id="Fact000440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">586</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000441" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,113,365</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_RetainedEarningsMember" id="Fact000442" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,466,992</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31" id="Fact000443" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,671,959</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockOptionPlanExpense_z4Ca3cpn2Wt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock options expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0449">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-06-012023-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000451" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,215</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-06-012023-11-30" id="Fact000453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,215</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_zdZmYO4M4OO2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net income for the six months ended November 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30_us-gaap_RetainedEarningsMember" id="Fact000458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,172,527</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30" id="Fact000459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,172,527</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230601__20231130_eus-gaap--StockholdersEquity_iE_zocSdXZsI0m2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, November 30, 2023</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20230601__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zSJTR3CtkJIi" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember" id="Fact000467" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember" id="Fact000461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20230601__20231130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMChU8sGR3Mc" title="Ending balance, shares" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-11-30_us-gaap_CommonStockMember" id="Fact000469" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_CommonStockMember" id="Fact000462" format="ixt:numdotdecimal" decimals="0" unitRef="USD">586</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,215,580</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30_us-gaap_RetainedEarningsMember" id="Fact000464" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,294,465</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-11-30" id="Fact000465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,946,701</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes to these unaudited consolidated
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_007"></span><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FOR THE SIX MONTHS ENDED NOVEMBER 30, 2024 AND 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" id="xdx_308_112_zArHxeljedkh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240601__20241130_zAw1i9nvr6R6" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20230601__20231130_zGap4sZvXT25" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">November 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zgQjQug7CRx7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_i01_maCzmjp_zsQMibfMA9sg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-left: 10pt">Net income</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-01to2024-11-30" id="Fact000474" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,901</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-11-30" id="Fact000475" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,172,527</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z5yCUGMd2Wm" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Adjustments to reconcile net income to net cash provided by operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationAndAmortization_i02_maCzmjp_zhb749TYR9se" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-06-01to2024-11-30" id="Fact000480" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,335</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-06-012023-11-30" id="Fact000481" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,022</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--ProvisionForDoubtfulAccounts_i02_maCzmjp_zl8DdoFvn4Jb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Bad debts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2024-06-01to2024-11-30" id="Fact000483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,954</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-06-012023-11-30" id="Fact000484" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,327</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i02_maCzmjp_zUYlG8oABJ34" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-06-01to2024-11-30" id="Fact000486" format="ixt:numdotdecimal" decimals="0" unitRef="USD">602,464</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-06-012023-11-30" id="Fact000487" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,215</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--GainOnDebtSettlement_i02N_di_msCzmjp_zFiCCIQWGWjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Gain on settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="axil:GainOnDebtSettlement" contextRef="From2023-06-012023-11-30" id="Fact000490" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,182</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--GainOnForgivenessOfAccountPayable_i02N_di_msCzmjp_zEmqBcGNNCc6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Gain on forgiveness of account payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="axil:GainOnForgivenessOfAccountPayable" contextRef="From2024-06-01to2024-11-30" id="Fact000492" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,699</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_maCzmjp_zcbUyHBaUte3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2024-06-01to2024-11-30" id="Fact000495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,796</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zZUK16x9s42a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msCzmjp_zl2Twcg2hTu2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-06-01to2024-11-30" id="Fact000501" format="ixt:numdotdecimal" decimals="0" unitRef="USD">962,337</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-06-012023-11-30" id="Fact000502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,626</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msCzmjp_z5mBwYqv0dud" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2024-06-01to2024-11-30" id="Fact000504" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">729,534</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-06-012023-11-30" id="Fact000505" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,040,351</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msCzmjp_zz8IF7N5ChQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2024-06-01to2024-11-30" id="Fact000507" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">80,524</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-06-012023-11-30" id="Fact000508" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,407</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_maCzmjp_zHBFCNMHypAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2024-06-01to2024-11-30" id="Fact000510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">870,357</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-06-012023-11-30" id="Fact000511" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,735</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i03_maCzmjp_zm04tvjvC8ik" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2024-06-01to2024-11-30" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,959</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-06-012023-11-30" id="Fact000514" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,718</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_maCzmjp_z6RXrks8oRzl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Contract liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2024-06-01to2024-11-30" id="Fact000516" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">72,614</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2023-06-012023-11-30" id="Fact000517" format="ixt:numdotdecimal" decimals="0" unitRef="USD">175,135</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtCzmjp_maCzYlE_zcORaJuXfM5l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">NET CASH PROVIDED BY OPERATING ACTIVITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-06-01to2024-11-30" id="Fact000519" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,904,174</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-06-012023-11-30" id="Fact000520" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,252,113</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z8kPrxrJpxub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCzZk6_zaW5sL3Xyhb4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Purchase of intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2024-06-01to2024-11-30" id="Fact000525" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,840</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0526">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzZk6_zaZKL7O6cr48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Purchase of property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-06-01to2024-11-30" id="Fact000528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,783</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-06-012023-11-30" id="Fact000529" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,845</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzZk6_maCzYlE_zm3WvfZK4hwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">NET CASH USED IN INVESTING ACTIVITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-06-01to2024-11-30" id="Fact000531" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">107,623</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-06-012023-11-30" id="Fact000532" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">70,845</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zUYu4Bicr7n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--RepaymentOfEquipmentFinancing_i01_maCzD6t_zubbnyhBRzRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Repayment of equipment financing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="axil:RepaymentOfEquipmentFinancing" contextRef="From2023-06-012023-11-30" id="Fact000538" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,650</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzD6t_zbVnFjCNb1Vc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Repayment of note payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2024-06-01to2024-11-30" id="Fact000540" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,252</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-06-012023-11-30" id="Fact000541" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,657</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_maCzD6t_zGT0p8bik95e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Advances (payments) from a related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2024-06-01to2024-11-30" id="Fact000543" format="ixt:numdotdecimal" decimals="0" unitRef="USD">166,722</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2023-06-012023-11-30" id="Fact000544" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,212</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzD6t_maCzYlE_z8sWFPcLer6k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-06-01to2024-11-30" id="Fact000546" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,470</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-06-012023-11-30" id="Fact000547" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,519</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCzYlE_zCvyKyjGsiPg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NET INCREASE IN CASH</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2024-06-01to2024-11-30" id="Fact000549" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,960,021</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-06-012023-11-30" id="Fact000550" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,129,749</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zDplMMkYQSQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">CASH - Beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-05-31" id="Fact000552" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,253,876</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-05-31" id="Fact000553" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,832,682</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zLw0rsZqlrS3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 0pt; vertical-align: middle">CASH - End of period</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-11-30" id="Fact000555" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,213,897</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-11-30" id="Fact000556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,962,431</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zlHpQODK4Hz1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--CashPaidDuringPeriodForAbstract_i01B_zRIn42PrF1Y7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash paid during the period for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPaidNet_i01_zM9pBJpEqcei" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 0pt; padding-left: 10pt; vertical-align: middle">Interest</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-06-01to2024-11-30" id="Fact000564" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,908</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-06-012023-11-30" id="Fact000565" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,284</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxesPaid_i01_zHNhM4Wl8OU5" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 0pt; padding-left: 10pt">Income taxes</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2024-06-01to2024-11-30" id="Fact000567" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,500</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0568">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_i01B_z487jlFbU7j9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 0pt">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability_i02_z3xL8MPjlxx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 0pt; padding-left: 10pt">Initial recognition of right of use assets recognized as lease liability</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="axil:InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" contextRef="From2024-06-01to2024-11-30" id="Fact000573" format="ixt:numdotdecimal" decimals="0" unitRef="USD">767,269</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes to these unaudited consolidated
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_008"></span><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000576" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z3iC3pT4Djd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 1 &#8211; <span id="xdx_828_ziUXIm3aPqad">Organization</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of AXIL Brands, Inc.&#8217;s (together with
its subsidiary, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) ongoing rebranding efforts, the Company
changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of
Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company&#8217;s corporate
headquarters are located at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. Its phone number is (888) 638-8883. In
March 2022, the Company incorporated a subsidiary &#8220;Reviv3 Acquisition Corporation&#8221; (now known as &#8220;AXIL Distribution
Company&#8221;) and in June 2022, completed the acquisition of certain assets of Axil &amp; Associated Brands Corp. (&#8220;A&amp;A&#8221;).
The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection
products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality
hair and skin care products. These products lines are both sold throughout the United States, Canada, Europe and Asia. On February 14,
2024, the Company successfully completed efforts to uplist from the over-the-counter, (OTC), markets to the NYSE American stock exchange
(&#8220;NYSE American&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000578" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zvpE3JCN6Ai3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; <span id="xdx_82F_zlTCelBBy6zh">Basis of Presentation and Summary of Significant Accounting
Policies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000580" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1KiO5NbTmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_868_zre0insn4Rnk">Basis of Presentation and Principles of Consolidation</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial
statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).
In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash
flows as of November 30, 2024 and 2023, and for the periods then ended, have been made. Those adjustments consist of normal and recurring
adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance
with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction
with the consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended
May 31, 2024. The results of operations for the six months ended November 30, 2024 are not necessarily indicative of the results to be
expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned
subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000582" name="axil:ReverseStockSplitPolicyTextBlock"><p id="xdx_84D_ecustom--ReverseStockSplitPolicyTextBlock_zZ955FgpuPp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_zHsRGnbhVt3c">Reverse Stock Split</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#8220;Reverse Stock Split&#8221;) of the Company&#8217;s issued shares of common stock at a ratio of <span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130" title="Stockholders' Equity, Reverse Stock Split"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000584" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-20</ix:nonNumeric></span>
as approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). The Reverse Stock Split did not affect the total number
of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were
rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial
statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.</p>

<ix:exclude><p id="xdx_23F_zpT82cNkvSSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zqo4CPjNcL4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zpqDUTonB0wa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><i>&#160;</i><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zF8TPsk0eac5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zoekQy5ASGsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zDtQ4LKkt0L" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_z7GMz8qqPDPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and
Summary of Significant Accounting Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000593" name="us-gaap:UseOfEstimates"><p id="xdx_84C_eus-gaap--UseOfEstimates_zvidfFHySl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_867_zwgvJGhyzFW">Use of estimates</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the unaudited consolidated financial
statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures
at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.
Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and
classifications,&#160;the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation,
contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash
Common Stock issuances.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000595" name="us-gaap:Reclassifications"><p id="xdx_84B_eus-gaap--Reclassifications_zkT14GvCz1na" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zeSUlziXWNw4">Reclassifications</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to
prior periods to conform with the current year reporting.&#160;For the three and six months ended November 30, 2023, $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20230901__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zD2WgXf4u6J9" title="Professional and consulting"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-09-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact000597" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,930</ix:nonFraction></span>
and $<span id="xdx_907_eus-gaap--ProfessionalFees_pp0p0_c20230601__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zh6QZyGTvdzg" title="Professional and consulting"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-06-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact000599" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">385,185</ix:nonFraction></span>,
respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited
Consolidated Statements of Operations. There was no change to total operating expenses for the three and six months ended November
30, 2023 as a result of this reclassification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000601" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zTw4gLbOoMo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zEBkDwESyMa8">Cash and cash equivalents</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid debt instruments
and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents.&#160;The Company maintains
cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note
12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000603" name="us-gaap:ReceivablesPolicyTextBlock"><p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zv3GKsDdrzn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zVMaV74m9D62">Accounts receivable and allowance for doubtful
accounts</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2023, the Company adopted ASC 326, "<i>Financial
Instruments - Credit Losses</i>". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting
from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined
principally on the basis of past collection experience and known financial factors regarding specific customers.</p>

<ix:exclude><p id="xdx_230_zb8Zm2yoGLae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zZdBsZsk27Uf" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zTg9eti9aJS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zcC1VfV1DCP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zdig9dydMvNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_z9IP56Z2EMgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_znb6Gt25OX9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Significant Accounting
Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivables comprise of receivables from
customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on
its best estimate of the amount of probable credit losses in its existing accounts receivable.&#160;The Company periodically reviews its
accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may
indicate that the realization of an account may be in doubt.&#160;Account balances deemed to be uncollectible are charged to bad debt
expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000612" name="axil:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"><p id="xdx_849_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIjBX1hxhYf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_864_zlAoCORSDUE6">Prepaid expenses and other current assets</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets consist
primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within
a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns
for products sold. Prepayments to vendors for inventory was $<span id="xdx_905_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20241130_zUGxXAqETkN8" title="Prepaid expenses"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" contextRef="AsOf2024-11-30" id="Fact000614" format="ixt:numdotdecimal" decimals="0" unitRef="USD">498,832</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20240531_zH7SPyxxTLP8" title="Prepaid expenses"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" contextRef="AsOf2024-05-31" id="Fact000616" format="ixt:numdotdecimal" decimals="0" unitRef="USD">472,904</ix:nonFraction></span> as of November 30, 2024 and May 31, 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000618" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zkpbuOtLVgLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zTHtq9eun4S8">Inventory</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company values inventory, consisting of finished
goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces
inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the
difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering
historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component
of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions,
customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory
held above the expected level of sales in the next 12 months is classified as non-current inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000620" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zKXkFLAkaayk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_zIQ8TP5SN98e">Property and Equipment</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost less accumulated
depreciation.&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized.&#160;When assets are retired or
disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000622" name="us-gaap:ExtendedProductWarrantyPolicy"><p id="xdx_84C_eus-gaap--ExtendedProductWarrantyPolicy_zEOXcIiOWQel" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zqbachsHvpt1">Product warranty</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides a one-year, two-year or three-year
limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements,
as they are incurred, to the cost of sales.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000624" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_z6vByfkhiAR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_865_zzxf2Lkpk1cb">Revenue recognition</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 606, &#8220;<i>Revenue from Contracts with Customers.</i>&#8221; This revenue recognition standard (new guidance)
has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction
price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.</p>

<ix:exclude><p id="xdx_238_zGrMZJaozjDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zSABt1K4Vha2" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zYEDzRgh4vMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zxMR7ozQ2wC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zf0mEEIFkhub" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_z0WKggEpaY99" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_z05KjeIHNdFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Critical Accounting
Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company sells a variety of electronic hearing
and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase
order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation.
Consideration paid to the customer to promote and sell the Company&#8217;s products is typically recorded as a reduction in revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The five steps for the revenue recognition are
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Identify the contract with a customer.&#160;</i>The
Company generally considers completion of a sales order (which requires customer acceptance of the Company&#8217;s click-through terms
and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone)
or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that
are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other
circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts
prior to shipping the product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Identify the performance obligations in the contract</i>.
Product performance obligations include shipment of products and related accessories, and service performance obligations include extended
warranty coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">However, as the historical redemption rate under our
warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether
promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Determine the transaction price and allocation
to performance obligations</i>. The transaction price in the Company&#8217;s customer contracts consists of both fixed and variable consideration.
Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and
60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate
product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this
information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction
price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Allocate the transaction price to the performance
obligations in the contract</i>. For contracts that contain multiple performance obligations, the Company allocates the transaction price
to the performance obligations on a relative standalone selling price basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Recognize revenue when or as the Company satisfies
a performance obligation</i>. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services
(extended warranty) is recognized over time on a ratable basis over the warranty period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, and May 31, 2024, contract
liabilities amounted to $<span id="xdx_90D_eus-gaap--ContractWithCustomerLiability_c20241130_pp0p0" title="Contract liabilities"><ix:nonFraction name="us-gaap:ContractWithCustomerLiability" contextRef="AsOf2024-11-30" id="Fact000633" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,313,227</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--ContractWithCustomerLiability_c20240531_pp0p0" title="Contract liabilities"><ix:nonFraction name="us-gaap:ContractWithCustomerLiability" contextRef="AsOf2024-05-31" id="Fact000635" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,385,841</ix:nonFraction></span>, respectively. As of November 30, 2024, and May 31, 2024, <span id="xdx_90B_ecustom--ContractLiabilitiesDescription_c20240601__20241130" title="Contract Liabilities Description"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact000637" name="axil:ContractLiabilitiesDescription">contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#8217; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.</ix:nonNumeric></span></p>

<ix:exclude><p id="xdx_234_zx6g2cl3u9d9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zfkSsn88SOQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zcSHiIDjkwOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_z99HB7nU1kdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z0GNwCSBe9l7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zEU0YewPDFnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zEoLwkYMtRg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Critical Accounting
Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000646" name="us-gaap:CostOfSalesPolicyTextBlock"><p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_z57l9uMigz14" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zqvxiBZJ3ZZk">Cost of Sales</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The primary components of cost of sales include the
cost of the product and shipping fees related to product procurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000648" name="axil:ShippingAndHandlingCostsPolicyTextBlock"><p id="xdx_840_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z8ymXoEuSYog" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_862_zXaYynZ5eZMf">Shipping and Handling Costs</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for shipping and handling fees
in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping
products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses
were $<span id="xdx_901_eus-gaap--SellingAndMarketingExpense_c20240901__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-09-012024-11-30_custom_CustomerMember" id="Fact000650" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">265,138</ix:nonFraction></span>&#160;and $<span id="xdx_90E_eus-gaap--SellingAndMarketingExpense_c20230901__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-09-012023-11-30_custom_CustomerMember" id="Fact000652" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">308,081</ix:nonFraction></span>&#160;for the three months ended November 30, 2024 and 2023, respectively. Shipping costs included in marketing
and selling expense were $<span id="xdx_90D_eus-gaap--SellingAndMarketingExpense_c20240601__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-06-012024-11-30_custom_CustomerMember" id="Fact000654" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">515,052</ix:nonFraction></span>&#160;and $<span id="xdx_90B_eus-gaap--SellingAndMarketingExpense_c20230601__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-06-012023-11-30_custom_CustomerMember" id="Fact000656" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">561,533</ix:nonFraction></span>&#160;for the six months ended November 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000658" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zzLHVS0EGpJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zjmE6fshcDsl">Sales, Marketing and Advertising</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales, marketing and advertising costs are expensed
as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000660" name="axil:CustomerDepositPolicytextBlock"><p id="xdx_848_ecustom--CustomerDepositPolicytextBlock_zWEJWL9qWZP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_869_z92X6qG6e9Ni">Customer Deposits</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer deposits consisted of prepayments from customers
to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition
policy.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000662" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDkszICzqQik" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_zqmYKLPadtkd">Fair value measurements and fair value of financial instruments</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASC 820, &#8220;<i>Fair Value
Measurements and Disclosures</i>,&#8221; for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a
common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value
measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption
of ASC&#160;820 did not have an impact on the Company&#8217;s financial position or operating results, but did expand certain disclosures.
ASC&#160;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, ASC&#160;820 requires the use of valuation
techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%">Level 1:</td>
    <td style="width: 95%; text-align: justify">Observable inputs such as quoted market prices in active markets for identical assets or liabilities.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">Level 2:</td>
    <td style="text-align: justify">Observable market-based inputs or unobservable inputs that are corroborated by market data.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">Level 3:</td>
    <td style="text-align: justify">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity&#8217;s own assumptions.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with
features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of certain financial instruments,
including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their
fair values because of the short-term nature of these instruments.</p>

<ix:exclude><p id="xdx_238_zfn7fLNN2Hwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zVCnXPGuncn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zSnHv737AeW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zv6woIZegvTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_z2JeCyRwmDT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zQVsuySjlDVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zBbmEbPTaxl2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Significant Accounting
Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000671" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_840_eus-gaap--BusinessCombinationsPolicy_zqCnndI63M7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zAntM9YjzNYh">Business Combinations</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For all business combinations (whether partial, full
or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair
values.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the excess purchase price over
the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized
separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration,
the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration
resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is
classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or
(2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings.
The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes
in assumed discount periods and rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000673" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zmPsBrPQdk6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_860_zCsbnrLRtgr4">Goodwill</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill is comprised of the purchase price of business
combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill
is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances
indicate the fair value of a reporting unit is below its carrying value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs its annual goodwill impairment
assessment on May 31st&#160;of each year or as impairment indicators dictate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When evaluating the potential impairment of goodwill,
management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions,
the competitive environment, changes in the market for the Company&#8217;s products and services, regulatory and political developments,
entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company&#8217;s
reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting
unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach
(discounted cash flow method).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the quantitative method&#160;we compare the
carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If
the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the
carrying amount exceeds the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When required, we arrive at our estimates of fair
value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified
assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows
requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital
requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or
estimates for future cash flows could produce different results.&#160;</p>

<ix:exclude><p id="xdx_239_zamVUqUexbMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zi8cBJT8bITg" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zKzTLLWiv1Ti" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zJ3Z24xEWYmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zqygDxK3Wjcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zSocQo0LQsgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zNK3qPqDoYY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Critical Accounting
Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000682" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zABWBX4W2Vn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_zfLedypeYAJj">Income Taxes</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes pursuant to
the provision of ASC 740-10, &#8220;<i>Accounting for Income Taxes</i>,&#8221; which requires, among other things, an asset and liability
approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.
A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that
the net deferred asset will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows the provision of ASC 740-10 related
to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken
or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax
position is recognized in the financial statements in the period during which, based on all available evidence, management believes it
is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,
if any. Tax positions taken are not offset or aggregated with other positions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax positions that meet the more likely than not recognition
threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with
the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described
above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated
interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all
more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has adopted ASC 740-10-25, &#8220;<i>Definition
of Settlement</i>&#8221;, which provides guidance on how an entity should determine whether a tax position is effectively settled for
the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion
and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity
would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based
solely on the basis of its technical merits and the statute of limitations remains open.&#160;The federal and state income tax returns
of the Company are subject to examination by the Internal Revenue Service (&#8220;IRS&#8221;) and state taxing authorities, generally
for three years after they are filed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000684" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zANewW9YtlE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zNFy0f3NlU12">Impairment of long-lived assets</span></span></i>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least
annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying
amount of the asset. The amount of impairment is measured as the difference between the asset&#8217;s estimated fair value and its book
value. The Company did <span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240901__20241130_zxh0P51ZO9bg" title="Impairment loss"><span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230901__20231130_zKyUaTSGtFMd" title="Impairment loss"><span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240601__20241130_zRwo5Ux687G9" title="Impairment loss"><span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230601__20231130_zNLPD1gh5YXl" title="Impairment loss"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2024-09-012024-11-30" id="Fact000686" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-09-012023-11-30" id="Fact000688" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2024-06-01to2024-11-30" id="Fact000690" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-06-012023-11-30" id="Fact000692" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span>t record any impairment loss during the three and six months ended November 30, 2024 and 2023.</p>

<ix:exclude><p id="xdx_236_z5h2AdcCCHnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zM5rvrHvJLKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zBhw36751Xnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zRk2QvEldh79" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_z3rdazzgLA6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zXlbo1azcatb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zRrZg7sinqTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Critical Accounting
Policies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000701" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHiOPClhqeG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zPgmegPTfds8">Stock-based compensation</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation is accounted for based on
the requirements of the Share-Based Payment Topic of ASC 718, &#8220;<i>Compensation &#8212; Stock Compensation</i>,&#8221; which requires
recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments
over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period).
ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date
fair value of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For non-employee stock option based awards, the Company
follows Accounting Standards Update (&#8220;ASU&#8221;) 2018-7, which substantially aligns share based compensation for employees and
non-employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000703" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zh4HBO8Z7JEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_866_zjck7fpzF5Yk">Net income per share of Common Stock</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net income per share is computed by dividing
the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted
average number of common shares and potentially dilutive securities outstanding during the period. For the three and six months ended
November 30, 2024 and 2023, certain stock options, preferred shares and restricted stock awards were excluded from the computation of
diluted common shares outstanding as they would have an anti-dilutive impact on the Company&#8217;s net income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The dilutive common stock equivalent shares consist
of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market
price during the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the computations of basic and diluted net
income per common share:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000705" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;<span id="xdx_8B0_zQdgvg0HpIRa" style="display: none">Schedule of net loss per share</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Three Months Ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Six Months Ended</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-09-012024-11-30" id="Fact000707" format="ixt:numdotdecimal" decimals="0" unitRef="USD">633,706</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-09-012023-11-30" id="Fact000708" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018,075</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-06-01to2024-11-30" id="Fact000709" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,901</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-06-012023-11-30" id="Fact000710" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,172,527</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average basic shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-09-012024-11-30" id="Fact000712" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,226</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-09-012023-11-30" id="Fact000713" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-06-01to2024-11-30" id="Fact000714" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,303,002</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-06-012023-11-30" id="Fact000715" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,863,939</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2024-09-012024-11-30" id="Fact000722" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,556,675</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-09-012023-11-30" id="Fact000723" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2024-06-01to2024-11-30" id="Fact000724" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,702,912</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-06-012023-11-30" id="Fact000725" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2024-09-012024-11-30" id="Fact000727" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,033</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2023-09-012023-11-30" id="Fact000728" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">268,750</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2024-06-01to2024-11-30" id="Fact000729" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,394</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2023-06-012023-11-30" id="Fact000730" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">268,750</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted stock awards</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="axil:RestrictedStockAwards" contextRef="From2024-09-012024-11-30" id="Fact000732" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,723</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="axil:RestrictedStockAwards" contextRef="From2024-06-01to2024-11-30" id="Fact000734" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,574</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Weighted average dilutive shares</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-09-012024-11-30" id="Fact000737" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,168,657</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-09-012023-11-30" id="Fact000738" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,632,689</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-06-01to2024-11-30" id="Fact000739" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,194,882</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-06-012023-11-30" id="Fact000740" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,632,689</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Basic</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-09-012024-11-30" id="Fact000747" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-09-012023-11-30" id="Fact000748" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.17</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-06-01to2024-11-30" id="Fact000749" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-06-012023-11-30" id="Fact000750" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Diluted</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-09-012024-11-30" id="Fact000752" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-09-012023-11-30" id="Fact000753" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-06-01to2024-11-30" id="Fact000754" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-06-012023-11-30" id="Fact000755" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<ix:exclude><p id="xdx_232_zhtiMuGl1n" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zADdqKoWONE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z7iva4XqVF3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zSsIGVqlV0P3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zGYstH3x98f8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zaeuOr1Dkdej" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z2KwzmbLhp7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; Basis of Presentation and Summary of Critical Accounting
Policies (continued)</b>&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000764" name="us-gaap:LoansAndLeasesReceivableLeaseFinancingPolicy"><p id="xdx_84D_eus-gaap--LoansAndLeasesReceivableLeaseFinancingPolicy_zXziGyZdOB9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_ziKHWCY2NGyf">Lease Accounting</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,&#160;&#8220;<i>Leases</i>,&#8221;
which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements
classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must
be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must
be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that
leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally
flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new
standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted
ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company renewed its lease for its previous corporate
headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expires on December 1, 2024.
The Company also signed a lease agreement in September 2024 for a warehouse and new corporate headquarters commencing October 1, 2024
and November 1, 2024, respectively. Please see Note 10 &#8211; &#8220;Commitments and Contingencies&#8221; under &#8220;Leases&#8221;
below for more information about the Company&#8217;s leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000766" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zV08KEVJvGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_860_z6ScJV7UD9Jf">Segment Reporting</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 280,&#160;&#8220;<i>Segment
Reporting</i>.&#8221; The Company&#8217;s management reviews the Company&#8217;s consolidated financial results when making decisions
about allocating resources and assessing the performance of the Company as a whole and has determined that the Company&#8217;s reportable
segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products.
See Note 13 &#8211; &#8220;Business Segment and Geographic Area Information&#8221; for more information about the Company&#8217;s reportable
segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000768" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zksyCEYMxJQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_862_z28abXgGfUld">Recently Issued Accounting Pronouncements</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, the FASB issued ASU No. 2020-06,&#160;<i>Debt
&#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity</i>&#160;(ASU
2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion
features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted
for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use
of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted
the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the
accompanying consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, the FASB issued ASU No. 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures
for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments
are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15,
2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form
10-K for the year ended May 31, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other accounting standards that have been issued or
proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements
upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its
financial condition, results of operations, cash flows or disclosures.</p>

<ix:exclude><p id="xdx_237_z9JsQ8y9pVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_z2ForlDI3QP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zB10bgR6HMz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zJwIwfAAq6p3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zDdiB6y4drmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000775" name="us-gaap:AccountsAndNontradeReceivableTextBlock"><p id="xdx_807_eus-gaap--AccountsAndNontradeReceivableTextBlock_zkiuoBzzx8X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 3 &#8211; <span id="xdx_821_zrgaOMtjwVr8">Accounts Receivable, net</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts receivable, net consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000777" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Accounts Receivable, net (Details)" id="xdx_88F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zfEglMtFdYA8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_zCvvhfMaCLn7" style="display: none">Schedule of accounts receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20241130_zcGXqv9QmlHd" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20240531_zyvXupzbXfHf" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_40A_ecustom--CustomersReceivable_iI_pp0p0_maARNzFhC_zsZjx66yhui9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customers receivable</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="axil:CustomersReceivable" contextRef="AsOf2024-11-30" id="Fact000779" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">794,275</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="axil:CustomersReceivable" contextRef="AsOf2024-05-31" id="Fact000780" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">524,730</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--MerchantProcessorReceivable_iI_pp0p0_maARNzFhC_znk95gqsVRB8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Merchant processor receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:MerchantProcessorReceivable" contextRef="AsOf2024-11-30" id="Fact000782" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">746,123</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:MerchantProcessorReceivable" contextRef="AsOf2024-05-31" id="Fact000783" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,417</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0p0_di_msARNzFhC_zcNpiXOHUmd2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Allowance for credit losses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-11-30" id="Fact000785" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">96,180</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-05-31" id="Fact000786" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,312</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNet_iTI_pp0p0_mtARNzFhC_zMBgqu5MXpae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Accounts receivables, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-11-30" id="Fact000788" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,444,218</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-05-31" id="Fact000789" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,835</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded bad debt expense of $<span id="xdx_908_eus-gaap--ProvisionForDoubtfulAccounts_c20240901__20241130_pp0p0" title="Bad debt expense"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2024-09-012024-11-30" id="Fact000791" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,169</ix:nonFraction></span>&#160;and
$<span id="xdx_906_eus-gaap--ProvisionForDoubtfulAccounts_c20230901__20231130_pp0p0" title="Bad debt expense"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-09-012023-11-30" id="Fact000793" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,461</ix:nonFraction></span>&#160;during the three months ended November 30, 2024 and 2023, respectively. The Company recorded bad debt expense of $<span id="xdx_907_eus-gaap--ProvisionForDoubtfulAccounts_c20240601__20241130_pp0p0" title="Bad debt expense"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2024-06-01to2024-11-30" id="Fact000795" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,954</ix:nonFraction></span>&#160;and
$<span id="xdx_905_eus-gaap--ProvisionForDoubtfulAccounts_c20230601__20231130_pp0p0" title="Bad debt expense"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-06-012023-11-30" id="Fact000797" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,327</ix:nonFraction></span>&#160;during the six months ended November 30, 2024 and 2023, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000799" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_zQaOJ1D34cO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 4 &#8211; <span id="xdx_827_zwuKjPLzs3b">Inventory, net</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000801" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Inventory, net (Details)" id="xdx_882_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQPmoAn3C74g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_8B8_zt6fxJlr2iU6" style="display: none">Schedule of inventory</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20241130_zVQ9PDDXWHsg" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240531_zFCk6573cjn7" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzXX2_zCFXMLNXsqt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Finished Goods</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2024-11-30" id="Fact000803" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,543,218</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2024-05-31" id="Fact000804" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,190,344</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzXX2_zQYeEbXnk2M7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Raw Materials</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2024-11-30" id="Fact000806" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">121,271</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2024-05-31" id="Fact000807" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">203,679</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pp0p0_mtINzXX2_zHSkA94FCv8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-11-30" id="Fact000809" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,664,489</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-05-31" id="Fact000810" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,394,023</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At November 30, 2024 and May 31, 2024, inventory held
at third party locations amounted to $<span id="xdx_90C_ecustom--InventoryHeldAtThirdPartyLocation_c20241130_pp0p0" title="Inventory held at third party location"><ix:nonFraction name="axil:InventoryHeldAtThirdPartyLocation" contextRef="AsOf2024-11-30" id="Fact000812" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">88,869</ix:nonFraction></span> and $<span id="xdx_900_ecustom--InventoryHeldAtThirdPartyLocation_c20240531_pp0p0" title="Inventory held at third party location"><ix:nonFraction name="axil:InventoryHeldAtThirdPartyLocation" contextRef="AsOf2024-05-31" id="Fact000814" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,242</ix:nonFraction></span>, respectively. At November 30, 2024 and May 31, 2024, inventory in-transit amounted
to $<span id="xdx_906_eus-gaap--OtherInventoryInTransit_c20241130_pp0p0" title="Inventory in-transit"><ix:nonFraction name="us-gaap:OtherInventoryInTransit" contextRef="AsOf2024-11-30" id="Fact000816" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,500</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--OtherInventoryInTransit_c20240531_pp0p0" title="Inventory in-transit"><ix:nonFraction name="us-gaap:OtherInventoryInTransit" contextRef="AsOf2024-05-31" id="Fact000818" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,738</ix:nonFraction></span>, respectively. At November 30, 2024 and May 31, 2024, the Company had provided $<span id="xdx_909_eus-gaap--InventoryValuationReserves_c20241130_pp0p0" title="Inventory valuation reserves"><span id="xdx_90E_eus-gaap--InventoryValuationReserves_iI_pp0p0_c20240531_zuTHFYTWiI83" title="Inventory valuation reserves"><ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2024-11-30" id="Fact000820" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2024-05-31" id="Fact000822" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">46,895</ix:nonFraction></ix:nonFraction></span></span> as obsolescence reserve
on some slow-moving inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000824" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zH8HGPS6khpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 5 &#8211; <span id="xdx_825_zFDZ8BsSTeM1">Property and Equipment</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Property and equipment, stated at cost, consisted of the following:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000826" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Property and Equipment (Details)" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2GWsdOhehEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zZM4bkJ0CW5e" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Estimated Life</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">Promotional display racks</td><td style="width: 5%">&#160;</td>
    <td style="width: 14%; text-align: center"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_zmVtSEqBtMz6" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_custom_PromotionalRisplayRacksMember" format="ixt-sec:duryear" id="Fact000828" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">2</ix:nonNumeric></span> years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" title="Plant Equipment" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-11-30_custom_PromotionalRisplayRacksMember" id="Fact000830" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,709</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" title="Plant Equipment" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-05-31_custom_PromotionalRisplayRacksMember" id="Fact000832" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,709</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and Fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zI7ZmzqIurm8" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000834" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-11-30_us-gaap_FurnitureAndFixturesMember" id="Fact000836" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,475</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-05-31_us-gaap_FurnitureAndFixturesMember" id="Fact000838" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,759</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer Equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGfbB5qho1zj" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_us-gaap_ComputerEquipmentMember" format="ixt-sec:duryear" id="Fact000840" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-11-30_us-gaap_ComputerEquipmentMember" id="Fact000842" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,496</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-05-31_us-gaap_ComputerEquipmentMember" id="Fact000844" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,130</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plant Equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFCguvgvnSK3" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentMember" format="ixt-sec:duryear" id="Fact000846" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zQ7XKIpAh0Fe" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentMember" format="ixt-sec:duryear" id="Fact000848" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-11-30_us-gaap_PropertyPlantAndEquipmentMember" id="Fact000850" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">309,868</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-05-31_us-gaap_PropertyPlantAndEquipmentMember" id="Fact000852" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,168</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zd1mvCVj4Lvk" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_srt_MinimumMember_us-gaap_OfficeEquipmentMember" format="ixt-sec:duryear" id="Fact000854" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zIXFa8EAw6gh" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_srt_MaximumMember_us-gaap_OfficeEquipmentMember" format="ixt-sec:duryear" id="Fact000856" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-11-30_us-gaap_OfficeEquipmentMember" id="Fact000858" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,838</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-05-31_us-gaap_OfficeEquipmentMember" id="Fact000860" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,838</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Automobile</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zHxqfhoHalJg" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2024-11-30_us-gaap_AutomobilesMember" format="ixt-sec:duryear" id="Fact000862" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-11-30_us-gaap_AutomobilesMember" id="Fact000864" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,347</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" title="Plant Equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-05-31_us-gaap_AutomobilesMember" id="Fact000866" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,347</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241130_zwUMtgha9WF6" title="Less:Accumulated Depreciation" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-11-30" id="Fact000868" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,300</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20240531_z000zixLNiMc" title="Less:Accumulated Depreciation" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-05-31" id="Fact000870" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,003</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Property, plant and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20241130_pp0p0" title="Property and equipment, net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-11-30" id="Fact000872" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">305,433</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20240531_pp0p0" title="Property and equipment, net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-05-31" id="Fact000874" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">260,948</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense amounted to $<span id="xdx_905_eus-gaap--Depreciation_c20240901__20241130_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-09-012024-11-30" id="Fact000876" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,405</ix:nonFraction></span>&#160;and
$<span id="xdx_907_eus-gaap--Depreciation_c20230901__20231130_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-09-012023-11-30" id="Fact000878" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,410</ix:nonFraction></span>&#160;for the three months ended November 30, 2024 and 2023, respectively.&#160; Depreciation expense amounted to $<span id="xdx_906_eus-gaap--Depreciation_c20240601__20241130_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-06-01to2024-11-30" id="Fact000880" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,298</ix:nonFraction></span>&#160;and
$<span id="xdx_908_eus-gaap--Depreciation_c20230601__20231130_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-06-012023-11-30" id="Fact000882" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,272</ix:nonFraction></span>&#160;for the six months ended November 30, 2024 and 2023, respectively.&#160;</p>

<ix:exclude><p id="xdx_23D_zzI2HCwhTGFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zgr2IfGdJzoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_ztGUj8zRpE7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zFS7rfL1Jby1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zmN4n63wCGV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000889" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zguFpp5uxYUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 6 &#8211; <span id="xdx_823_z6Uhh7kgwgN3">Intangible Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The intangible assets consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000891" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Intangible Assets (Details)" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zyaYPM7537Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_z8At2VUSQIMi" style="display: none">Schedule of intangible assets</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Estimated Life</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">Licensing Rights</td><td style="width: 5%">&#160;</td>
    <td style="width: 14%; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_zi7HW1fuLJpe" title="Estimated Life"><ix:nonNumeric contextRef="AsOf2024-11-30_custom_LicensingRightsMember" format="ixt-sec:duryear" id="Fact000893" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3</ix:nonNumeric></span> years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-11-30_custom_LicensingRightsMember" id="Fact000895" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,080</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-05-31_custom_LicensingRightsMember" id="Fact000897" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,024</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer Relationships</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSLHkNU7bBH9" title="Estimated Life"><ix:nonNumeric contextRef="AsOf2024-11-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact000899" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-11-30_us-gaap_CustomerRelationshipsMember" id="Fact000901" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-05-31_us-gaap_CustomerRelationshipsMember" id="Fact000903" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade Names</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zZRpwtenzfMd" title="Estimated Life"><ix:nonNumeric contextRef="AsOf2024-11-30_us-gaap_TradeNamesMember" format="ixt-sec:duryear" id="Fact000905" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-11-30_us-gaap_TradeNamesMember" id="Fact000907" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">275,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-05-31_us-gaap_TradeNamesMember" id="Fact000909" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">275,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Website</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_zXcB2ZTexEoc" title="Estimated Life"><ix:nonNumeric contextRef="AsOf2024-11-30_custom_WebsiteMember" format="ixt-sec:duryear" id="Fact000911" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-11-30_custom_WebsiteMember" id="Fact000913" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-05-31_custom_WebsiteMember" id="Fact000915" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Product Certification Testing</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_zM5fUUFl9c5b" title="Estimated Life"><ix:nonNumeric contextRef="AsOf2024-11-30_custom_ProductCertificationTestingMember" format="ixt-sec:duryear" id="Fact000917" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3</ix:nonNumeric></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-11-30_custom_ProductCertificationTestingMember" id="Fact000919" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,840</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" title="Finite-lived Intangible Assets, Gross" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0921">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20241130_zSBR5ODyoqX9" title="Less: Accumulated Amortization" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-11-30" id="Fact000923" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">184,013</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20240531_zpUHuV4qQNRg" title="Less: Accumulated Amortization" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-05-31" id="Fact000925" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,920</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="padding-bottom: 4.5pt">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20241130_pp0p0" title="Finite-lived Intangible Assets, Net" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-11-30" id="Fact000927" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">324,907</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20240531_pp0p0" title="Finite-lived Intangible Assets, Net" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-05-31" id="Fact000929" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">309,104</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Goodwill arising through the business combination in June 2022 was $<span id="xdx_903_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c20241130_pp0p0" title="Goodwill"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="AsOf2024-11-30" id="Fact000931" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,152,215</ix:nonFraction></span>
at November 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization expense amounted to $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20240901__20241130_pp0p0" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-09-012024-11-30" id="Fact000933" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,035</ix:nonFraction></span>&#160;and
$<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230901__20231130_pp0p0" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-09-012023-11-30" id="Fact000935" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,375</ix:nonFraction></span>&#160;for the three months ended November 30, 2024 and 2023, respectively. Amortization expense amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20240601__20241130_pp0p0" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-06-01to2024-11-30" id="Fact000937" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,037</ix:nonFraction></span>&#160;and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230601__20231130_pp0p0" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-06-012023-11-30" id="Fact000939" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,522</ix:nonFraction></span>&#160;for
the six months ended November 30, 2024 and 2023, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000941" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_805_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zoJ3xIbBI4wi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 7 &#8211; <span id="xdx_82A_zi7twkN03lb3">Other Current Liabilities</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Other current liabilities comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000943" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Other Current Liabilities (Details)" id="xdx_882_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zCoQczWtSoEk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_z4FtypkJUlch" style="display: none">Schedule of other current liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20241130_zAEYbhTpI7E1" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240531_zD9zWNpuHOP8" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_400_ecustom--CreditCards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Credit Cards</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="axil:CreditCards" contextRef="AsOf2024-11-30" id="Fact000945" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,631</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="axil:CreditCards" contextRef="AsOf2024-05-31" id="Fact000946" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,734</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--RoyaltyPaymentAccrual_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Royalty Payment Accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="axil:RoyaltyPaymentAccrual" contextRef="AsOf2024-05-31" id="Fact000949" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,376</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales Tax Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2024-11-30" id="Fact000951" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">315,377</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2024-05-31" id="Fact000952" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">231,283</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-11-30" id="Fact000954" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,387</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-05-31" id="Fact000955" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">92,543</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pp0p0_z91toXAqLkcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other current liabilities</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-11-30" id="Fact000957" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">331,395</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-05-31" id="Fact000958" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">332,936</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000960" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zbx6fxUSAZWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8 &#8211; <span id="xdx_828_zta7KHKnUwZh">Notes Payable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended May 31, 2020, a commercial bank
granted to the Company a loan (the &#8220;Loan&#8221;) in the amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20200531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Face Amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-05-31_custom_EconomicInjuryDisasterLoanProgramMember" id="Fact000962" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction></span>, which is administered under the authority and regulations
of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the &#8220;EIDL&#8221;) of the Coronavirus
Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;). The Loan, which is evidenced by a note dated May 18, 2020,&#160;bears
interest at an annual rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20200501__20200518__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pdd" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-05-012020-05-18_custom_EconomicInjuryDisasterLoanProgramMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.75</ix:nonFraction>%</span> and&#160;is payable in installments of principal and interest of $731 per month, beginning May 18,
2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all
items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to
be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively,
&#8220;qualifying expenses&#8221;). The Company used the loan proceeds for qualifying expenses. During the year ended May 31, 2022, the
Company received additional $<span id="xdx_902_ecustom--LoanForgiveness_c20210601__20220531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Loan forgiveness"><ix:nonFraction name="axil:LoanForgiveness" contextRef="From2021-06-012022-05-31_custom_EconomicInjuryDisasterLoanProgramMember" id="Fact000966" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> of borrowings under the program. The Company received a loan forgiveness for $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfDebt_c20210601__20220531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Additional borrowings"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2021-06-012022-05-31_custom_EconomicInjuryDisasterLoanProgramMember" id="Fact000968" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> during the year
ended May 31, 2022. The Company recorded, on the accompanying unaudited consolidated financial statements, and paid interest of $<span id="xdx_90D_eus-gaap--InterestPayableCurrent_c20241130__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2024-11-30_custom_EconomicInjuryDisasterLoanProgramMember" id="Fact000970" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,296</ix:nonFraction></span>,
and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_c20240531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2024-05-31_custom_EconomicInjuryDisasterLoanProgramMember" id="Fact000972" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">562</ix:nonFraction></span>, during the three months ended November 30, 2024 and 2023, respectively.</p>

<ix:exclude><p id="xdx_232_zYDMZUGUXdNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_z4c8eh7bHPzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zAWb7weg6kUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zUxWXmVZOFm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_z8TunMzqC84l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zgIZZXmbjBMa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zYmOtRAcNYX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8 &#8211; Notes Payable (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024 and May 31, 2024, the outstanding
balance of the loan amounted to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20241130__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Face Amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-11-30_custom_EIDLMember" id="Fact000981" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">143,342</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20240531__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Face Amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-05-31_custom_EIDLMember" id="Fact000983" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,594</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The amounts of loan payments due in the next 12 months ended November 30,
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000985" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Notes Payable (Details)" id="xdx_883_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zREqc0YqAEMh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_z5kRlsW8vI45" style="display: none">Schedule of notes payments due in the next twelve months</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" id="xdx_49B_20241130_z90Ho0QES69i" style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDziXa_zntJ4gzaSQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: left; padding-bottom: 1.5pt">2025</td><td style="width: 5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2024-11-30" id="Fact000987" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">143,342</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDziXa_zdkhvG0hOYh7" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2024-11-30" id="Fact000989" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">143,342</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact000991" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlTCg739clH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 &#8211; <span id="xdx_823_zV2iCKBitmnd">Stockholders&#8217; Equity</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Shares Authorized</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, the authorized capital of
the Company consists of <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20241130_zhm3Oq1APjji" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-11-30" id="Fact000993" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,000,000</ix:nonFraction></span> shares of common stock, par value $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241130_zxuzCyArBJ6h" title="Common stock, par or stated value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-11-30" id="Fact000995" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share and <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20241130_zHNxxCP5jpS5" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-11-30" id="Fact000997" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></span> shares of preferred stock, par
value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241130_ziRoz8uRXUyc" title="Preferred stock, par or stated value per share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-11-30" id="Fact000999" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#8220;Reverse Stock Split&#8221;) of the Company&#8217;s issued shares of common stock at a ratio of <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130_zeAM3IL2B7Ik" title="Reverse stock split"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" id="Fact001001" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-20</ix:nonNumeric></span>,
as approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). The Reverse Stock Split did not change the par value
of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the
Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to
the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the financial statements give retroactive
effect to the Reverse Stock Split for all periods presented, unless otherwise specified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Preferred Stock</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preferred stock may be issued from time to time
in one or more series. The Board is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock
in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited,
or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications,
limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board providing the issuance of
such shares. The Board is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue
of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status
that they had prior to the adoption of the resolution originally fixing the number of shares of such series.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal year ended May 31, 2023, the Company
issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220601__20230531_pdd" title="Shares issued during the period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-06-012023-05-31" id="Fact001003" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span> shares of non-voting Series A Preferred Stock, which, following the Reverse Stock Split of the Company&#8217;s common
stock, are convertible into shares of the Company&#8217;s common stock on a twenty-to-one ratio. These 250,000,000 shares of non-voting
Series A Preferred Stock were valued at the fair market value of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220601__20230531_pp0p0" title="Shares issued value during the period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-06-012023-05-31" id="Fact001005" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,100,000</ix:nonFraction></span> at issuance.</p>

<ix:exclude><p id="xdx_23C_zSUhGIA13iD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zwnUMjDECsX5" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zfoludykZpoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zWlXHXbHnYO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zCJYYwZH7Bw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zX0zUBS9oaRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_za0RB6Itxk2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 &#8211; Stockholders&#8217; Equity (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The holders of shares of Series A Preferred Stock
have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the common stock
unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon
the number of shares of common stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation,
or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out
of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of common stock.
The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Company or any holder or holders
of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time
after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock into one fully paid and nonassessable
share of common stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of
shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company&#8217;s
common stock as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The conversion provisions of the Company&#8217;s Series
A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split, and the number of shares of Series A Preferred
Stock issued and outstanding was not affected by the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2024, the Company entered into repurchase
agreements with certain stockholders of the Company to purchase in the aggregate&#160;<span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20240301__20240305__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Number of share purchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-03-012024-03-05_us-gaap_PreferredStockMember" id="Fact001014" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">207,748,250</ix:nonFraction></span>&#160;shares of Series A Preferred Stock
of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company&#8217;s common stock on an as converted basis) for the aggregate
cash consideration of $<span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodValue_c20240301__20240305__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pp0p0" title="Cash consideration"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-03-012024-03-05_us-gaap_PreferredStockMember" id="Fact001016" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,246,490</ix:nonFraction></span>. Such repurchase was approved by the Company&#8217;s Board of Directors. Following the repurchase,&#160;<span id="xdx_90F_ecustom--RemainingOutstanding_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Remaining outstanding"><ix:nonFraction name="axil:RemainingOutstanding" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember105062531" id="Fact001018" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,251,750</ix:nonFraction></span>&#160;shares
of Series A Preferred Stock remained outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the fiscal
year 2024, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024, certain
stockholders of <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember105062531" id="Fact001020" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,118,250</ix:nonFraction></span> preferred shares converted their preferred stock into <span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember105062546" id="Fact001022" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">555,913</ix:nonFraction></span> shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024 and May 31, 2024,&#160;<span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_c20241130_zU0cwAGJs4o6" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20241130_zvp8hnNuFDnc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-11-30" id="Fact001024" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-11-30" id="Fact001026" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,133,500</ix:nonFraction></ix:nonFraction></span></span>
and <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20240531_zC9U5G14uGf1" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20240531_zp5HJZn6QMkc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-05-31" id="Fact001028" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-05-31" id="Fact001030" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,251,750</ix:nonFraction></ix:nonFraction></span></span> shares of Series A Preferred Stock, respectively, were issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Common Stock</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20241130_zQ5NE3DnsbDl" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20241130_zHhfv5SnU4al" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-11-30" id="Fact001032" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-11-30" id="Fact001034" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,466,852</ix:nonFraction></ix:nonFraction></span></span> shares of common
stock were issued and outstanding.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Reverse Stock Split as more fully discussed in
Note 2, did not change the par value of the common stock, modify any voting rights or other terms of the common stock, or change the number
of authorized shares of the Company. Any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole
share.</p>

<ix:exclude><p id="xdx_230_zFnCckSV7p5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zU7GmqOwTtwa" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zztR3fhHO3Y5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zEGTZ51cViG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zBJCpLeKQYV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_z9wyL7JKjNwg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zeOrxD16k9Pk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Stockholders&#8217; Equity (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">Stock Options</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective February 14, 2024, the Board amended the
Company&#8217;s original 2022 Equity Incentive Plan (as amended the &#8220;Plan&#8221;), which was originally approved on March 21, 2022.
The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors,
non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i)&#160;Incentive Stock
Options (to eligible employees only); (ii)&#160;Nonqualified Stock Options; (iii)&#160;Restricted Stock; (iv)&#160;Stock Awards; (v)&#160;Performance
Shares; or (vi)&#160;any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March
21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend
or terminate the Plan without stockholder approval, subject to certain exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 8, 2024, the Board of Directors approved
the amendment and restatement of the Plan in order to increase the number of shares authorized for issuance under the Plan by 800,000
shares, any or all of which may be issued pursuant to grants of &#8220;incentive stock options&#8221; (within the meaning of Section 422
of the Internal Revenue Code). The amendment and restatement of the Plan became effective December 18, 2024, following shareholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of shares initially authorized for
issuance under the Plan was 500,000 shares. The Plan has since been amended to increase the number of shares authorized for issuance under
the Plan to 2,050,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in
2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of
the total number of shares of the Company&#8217;s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii)
such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change
unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable
year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be
added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance
or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including
a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option,
or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares
available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease
in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision
or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure
of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued
shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Two types of options may be granted under the Plan:
(1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of
the option not less than the fair market value of the common stock on the grant date, or,&#160;in the case of an Incentive Stock Option
granted to a Ten Percent Stockholder, 110%&#160;of the fair market value of the common stock on the grant date; and (2) Non-qualified
Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value
of the common stock on the grant date, but not less than par value of the stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board may grant or sell restricted stock to participants
(i.e., shares that are subject to a subject to restrictions or limitations as to the participant&#8217;s ability to sell, transfer, pledge
or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted
stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction
period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant
awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout
is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each equity-based award granted under the Plan will
be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the
Board may determine, consistent with the provisions of the Plan.</p>

<ix:exclude><p id="xdx_238_zr4JozRFo6jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zMirftiU4XF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z6Suy300YVee" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zxV8zgA8ysmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zeBGdBhPDase" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_z2jNNACox66k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zlJ5K4Z1fuJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 &#8211; Stockholders&#8217; Equity (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subject to the Plan&#8217;s terms, the Board has full
power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled,
forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will
be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of share-based
compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term,
expected volatility of the Company&#8217;s stock price over the expected term, expected risk-free interest rate over the expected option
term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for
estimating the fair value of stock options granted to employees and directors which are subject to ASC 718 requirements. These amounts
are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants.
The Company recognizes compensation on a straight-line basis over the requisite service period for each award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the simplified method to estimate
the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical
data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based
on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield
is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase
if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 13, 2024, the Company issued stock options
to one consultant to purchase, in aggregate, up to&#160;<span id="xdx_905_ecustom--NumberOfOptionIssued_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Number of option issued"><ix:nonFraction name="axil:NumberOfOptionIssued" contextRef="AsOf2024-11-13_custom_OneConsultantMember" id="Fact001050" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000</ix:nonFraction></span>&#160;shares of its common stock, at an exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-11-13_custom_OneConsultantMember" id="Fact001052" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per share
valued at $<span id="xdx_900_ecustom--ValueOfOptionIssued_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pp0p0" title="Value of option issued"><ix:nonFraction name="axil:ValueOfOptionIssued" contextRef="AsOf2024-11-13_custom_OneConsultantMember" id="Fact001054" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></span> and expiring on October 31, 2034. The options vest quarterly over a year beginning on February 28, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 14, 2024, the Company issued to two Company
officers stock options to purchase, in the aggregate, up to&#160;<span id="xdx_904_ecustom--NumberOfOptionIssued_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pdd" title="Number of option issued"><ix:nonFraction name="axil:NumberOfOptionIssued" contextRef="AsOf2024-10-14_custom_OfficersMember" id="Fact001056" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></span>&#160;shares of its common stock, at an exercise price of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pdd" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-10-14_custom_OfficersMember" id="Fact001058" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.01</ix:nonFraction></span>
per share valued at $<span id="xdx_908_ecustom--ValueOfOptionIssued_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pp0p0" title="Value of option issued"><ix:nonFraction name="axil:ValueOfOptionIssued" contextRef="AsOf2024-10-14_custom_OfficersMember" id="Fact001060" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,406,000</ix:nonFraction></span> and expiring in ten years from the date of grant. The options vest over forty-eight equal monthly installments
starting on the grant date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended August 31, 2024, the
Company issued stock options, to two consultants, to purchase, in the aggregate, up to 24,000 shares of its common stock, at an exercise
price equal to the Company&#8217;s closing price on the NYSE American on the date of grant. The options are valued at approximately $195,960
and expire in ten years from the date of grant.</p>

<ix:exclude><p id="xdx_23E_zSvMA9syWvP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zbvIlqaom9O4" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zhrBC8MEDYSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zRqmujwKNYg6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zK61DnMpNM6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_z46L0dN9QLC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zNBT2NBDc698" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 &#8211; Stockholders&#8217; Equity (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the weighted-average
assumptions used to estimate the fair value of the stock options granted during the six months ended November 30, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001069" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Stockholders' Equity (Details)" id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4m0elWfo1i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: white">
    <td><span id="xdx_8B0_zu3zfXyKET7i" style="display: none">Schedule of stock option assumptions</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Risk free interest rate</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20240601__20241130_pdd" title="Risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-06-01to2024-11-30" id="Fact001071" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.95</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Expected life</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240601__20241130_zeXIQ76XcgFg" title="Expected life"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:duryear" id="Fact001073" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">7</ix:nonNumeric></span> years</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%">Expected volatility</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: center"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20240601__20241130_pdd" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-06-01to2024-11-30" id="Fact001075" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">464</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Expected dividend</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20240601__20241130_pdd" title="Expected dividend"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_z9Zi8GQwDbO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the activities for
the Company&#8217;s stock options for the&#160;six months ended November 30, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001079" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcf8H5MW7gj" summary="xdx: Disclosure - Stockholders' Equity (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B3_zO4GfUn4yHef" style="display: none">Schedule of stock options activities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Term</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 49%">Outstanding as of May 31, 2024</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240531_zmDANmVyPacd" title="Number of Options Outstanding, Beginning" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-05-31" id="Fact001081" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">268,750</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240531_zk70Sqto5p5l" title="Weighted Average  Exercise Price, Beginning" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-05-31" id="Fact001083" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.84</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220601__20230531_zHQzQR79BUvi" title="Weighted Average  Remaining Term"><ix:nonNumeric contextRef="From2022-06-012023-05-31" format="ixt-sec:duryear" id="Fact001085" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.9</ix:nonNumeric></span></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240601__20241130_pdd" title="Number of Options Outstanding, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-06-01to2024-11-30" id="Fact001087" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">629,000</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240601__20241130_pdd" title="Weighted Average  Exercise Price, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-06-01to2024-11-30" id="Fact001089" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.17</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240601__20241130_zFC9aO68cFB4" title="Number of Options Outstanding, Exercised/Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1091">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240601__20241130_z6mNOLm5jdrc" title="Weighted Average  Exercise Price, Exercised/Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1093">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Less: Unvested at November 30, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNI_di_c20241130_zrASSeGiVmr5" title="Number of Options Outstanding, Ending" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-11-30" id="Fact001095" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">650,500</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241130_pdd" title="Number of Options Outstanding, Ending" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-11-30" id="Fact001097" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.11</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240601__20241130_z9TzsyXY4sU2" title="Weighted Average  Remaining Term" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:duryear" id="Fact001099" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.7</ix:nonNumeric></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Vested at November 30, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c20241130_pdd" title="Number of Options Outstanding, Vested" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2024-11-30" id="Fact001101" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">247,250</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20241130_pdd" title="Weighted Average  Exercise Price, Vested" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-11-30" id="Fact001103" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.13</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240601__20241130_z2H6GyxahMn7" title="Weighted Average  Remaining Term, Vested" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" format="ixt-sec:duryear" id="Fact001105" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.6</ix:nonNumeric></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zEyF8TTRe7ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024,
the Company expensed $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20240601__20241130_pp0p0" title="Stock options expense"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-06-01to2024-11-30" id="Fact001107" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">211,055</ix:nonFraction></span>
with respect to options, of which $130,208 was included in General and administrative, and $80,847 in Sales and marketing,
respectively, in the accompanying Consolidated Statements of Operations. During the six months ended November 30, 2023, the Company
expensed $<span id="xdx_905_eus-gaap--StockOptionPlanExpense_c20230601__20231130_pp0p0" title="Stock options expense"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-06-012023-11-30" id="Fact001109" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">102,215</ix:nonFraction></span>
with respect to stock options, which was included in General and administrative in the accompanying Consolidated Statements of
Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Restricted Stock Awards and Restricted Shares Issued </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s non-employee directors participate
in the Company&#8217;s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan,
on February 14, 2024, the Company granted each of its three non-employee directors Board members <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20240201__20240214__srt--TitleOfIndividualAxis__custom--ThreeBoardMembersMember_pdd" title="Number of restricted stock awards issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2024-02-012024-02-14_custom_ThreeBoardMembersMember" id="Fact001111" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000</ix:nonFraction></span> restricted stock awards for an
aggregate of 15,000 shares of the Company&#8217;s common stock that will vest on the one-year anniversary of the grant, subject to the
respective director&#8217;s continued service as a member of the Board, with a total grant date fair value of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20240201__20240214__srt--TitleOfIndividualAxis__custom--ThreeBoardMembersMember_pp0p0" title="Fair value of restricted stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-02-012024-02-14_custom_ThreeBoardMembersMember" id="Fact001113" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,000</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Effective May
28, 2024, a former officer entered into a Separation Agreement and Release (the &#8220;Release&#8221;), which includes a standard release
of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting
Agreement, dated May 28, 2024, with the former officer (the &#8220;Consulting Agreement&#8221;), pursuant to which the former officer
agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier.
Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted
common stock valued at $298,800, which vested upon grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Effective November
13, 2024, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241101__20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Stock issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-11-012024-11-13_custom_OneConsultantMember" id="Fact001115" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000</ix:nonFraction></span> shares of restricted common stock to a consultant for services relating to expansion of the Company
into new markets<span style="background-color: white">. The shares were valued at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20241101__20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_zHbzROlYoNGk" title="Stock issued for valued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-11-012024-11-13_custom_OneConsultantMember" id="Fact001117" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,000</ix:nonFraction></span>
based on the </span>Company&#8217;s closing price on the NYSE American on the date of grant<span style="background-color: white">. The
shares</span> vested upon grant and will be expensed over the six month service period of the consultant beginning
from the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the stock grants is being recorded
over the term of the service related to each grant. During the six months ended November 30, 2024, the Company expensed $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20240601__20241130__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p0" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-06-012024-11-30_custom_RestrictedStockAwardsMember" id="Fact001119" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">97,500</ix:nonFraction></span> related
to restricted stock awards included in General and administrative in the accompanying Consolidated Statements of Operations, and $293,909
related to restricted stock expenses of which $293,054 was included in General and administrative and $855 in Sales and marketing, respectively,
in the accompanying Consolidated Statements of Operations. During the six months ended November 30, 2023, the Company expensed $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20230601__20231130__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p0" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-06-012023-11-30_custom_RestrictedStockAwardsMember" id="Fact001121" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> related
to restricted stock awards and restricted stock expense.</p>

<ix:exclude><p id="xdx_233_znaG6JlFWhdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zekJqY8B28fd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zyxYYQuzYoM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zzAv4pHO0mK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zpYfhv6vpiKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001128" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znaBUnwxGuB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 10 &#8211; <span id="xdx_824_zW8EEHrSqLm9">Commitments and Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Leases</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in Note 2 above, the Company adopted
ASU 2016-02, &#8220;Leases<i>&#8221; </i>on June 1, 2019, which require lessees to report on their balance sheets a right-of-use asset
and a lease liability in connection with most lease agreements classified as operating leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company treats a contract as a lease when the
contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or if the Company directs
the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (&#8220;ROU&#8221;)
assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company&#8217;s right to
use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company&#8217;s obligation to make payments
over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of
the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease.
In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services,
which are considered non-lease components for accounting purposes. For our real estate leases, the Company applies a practical expedient
to include these non-lease components in calculating the ROU asset and lease liability. For variable costs that may change during the
lifetime of the lease, the Company expenses as incurred.&#160;Since the interest rate implicit in a lease is generally not readily determinable
for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental
borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease
term to obtain an asset of similar value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews the impairment of ROU assets consistent
with the approach applied for the Company&#8217;s other long-lived assets. The Company reviews the recoverability of long-lived assets
when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment
of possible impairment is based on the Company&#8217;s ability to recover the carrying value of the asset from the expected undiscounted
future pre-tax cash flows of the related operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lease expense is recognized on a straight-line basis
over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring
after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024, the
Company entered into two new lease agreements. The Company&#8217;s lease agreements do not contain any residual value guarantees or restrictive
covenants. The Company&#8217;s lease agreements do not have an explicit renewal option, and the termination options are available in the
event of material breaches. The expiration dates of the leases are on various dates between December 1, 2024 and January 31, 2029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computed an initial lease liability of
$<span id="xdx_90A_ecustom--InitialLeaseLiability_c20241130_pp0p0" title="Initial lease liability"><ix:nonFraction name="axil:InitialLeaseLiability" contextRef="AsOf2024-11-30" id="Fact001130" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">767,269</ix:nonFraction></span>&#160;for the two new lease agreements and an initial ROU asset in the same amount which was recorded on the books at the commencement
of the leases. During the three months ended November 30, 2024 and 2023, the Company recorded operating lease costs in the amount of $<span id="xdx_901_eus-gaap--OperatingLeaseCost_c20240901__20241130_pp0p0" title="Operating lease cost"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2024-09-012024-11-30" id="Fact001132" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,080</ix:nonFraction></span>&#160;and
$<span id="xdx_908_eus-gaap--OperatingLeaseCost_c20230901__20231130_pp0p0" title="Operating lease cost"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-09-012023-11-30" id="Fact001134" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,659</ix:nonFraction></span>, respectively. During the six months ended November 30, 2024 and 2023, the Company recorded operating lease costs in the amount
of $<span id="xdx_90B_eus-gaap--OperatingLeaseCost_c20240601__20241130_pp0p0" title="Operating lease cost"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2024-06-01to2024-11-30" id="Fact001136" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,739</ix:nonFraction></span>&#160;and $<span id="xdx_90D_eus-gaap--OperatingLeaseCost_c20230601__20231130_pp0p0" title="Operating lease cost"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-06-012023-11-30" id="Fact001138" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,317</ix:nonFraction></span>, respectively. Operating lease and short-term lease expenses are included in General and administrative expenses
on the accompanying Consolidated Statements of Operations.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average remaining term and discount
rate for the Company&#8217;s operating leases as of November 30, 2024&#160;was&#160;<span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241130_zv7Wkco6HRAe"><ix:nonNumeric contextRef="AsOf2024-11-30" format="ixt-sec:duryear" id="Fact001139" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">3.8</ix:nonNumeric></span>&#160;years
and&#160;<span id="xdx_902_eus-gaap--LesseeOperatingLeaseDiscountRate_c20241130_pdd"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2024-11-30" id="Fact001140" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.0</ix:nonFraction>%</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23C_z3XDLDyP2Aq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zd095CKsDG1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zOk2sWjmXGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z2JNSCAmJu8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z31DwsUyFWU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zWMZ7nOEH8Vh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zJlRT96hh0ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 10 &#8211; Commitments and Contingencies (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Supplemental balance sheet information related to leases was as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001149" name="axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Commitments and Contingencies (Details)" id="xdx_89B_ecustom--ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_zAcrHm0htup8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span id="xdx_8B2_z15bIRVPzzG" style="display: none">Schedule of supplemental balance sheet information</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20241130_zdjHzwYHe515" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20240531_z5EzBjvpJgff" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_402_ecustom--RightOfUseAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-left: 9pt">Right of use assets</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="axil:RightOfUseAssets" contextRef="AsOf2024-11-30" id="Fact001154" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">899,239</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="axil:RightOfUseAssets" contextRef="AsOf2024-05-31" id="Fact001155" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,970</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Accumulated reduction</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="axil:OperatingLeaseRightOfUseAssetAccumulatedAmortization" contextRef="AsOf2024-11-30" id="Fact001157" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">161,988</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="axil:OperatingLeaseRightOfUseAssetAccumulatedAmortization" contextRef="AsOf2024-05-31" id="Fact001158" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">95,218</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Operating lease assets, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-11-30" id="Fact001160" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">737,251</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-05-31" id="Fact001161" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,752</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="axil:LeaseLiability" contextRef="AsOf2024-11-30" id="Fact001166" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">899,239</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="axil:LeaseLiability" contextRef="AsOf2024-05-31" id="Fact001167" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,970</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AccumulatedReduction_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Accumulated reduction</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="axil:AccumulatedReduction" contextRef="AsOf2024-11-30" id="Fact001169" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">161,081</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="axil:AccumulatedReduction" contextRef="AsOf2024-05-31" id="Fact001170" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">95,218</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease liability, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-11-30" id="Fact001172" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">738,158</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-05-31" id="Fact001173" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,752</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--OperatingLeaseLiabilityCurrentPortion_iNI_pp0p0_di_zt6NgcuV3QU8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="axil:OperatingLeaseLiabilityCurrentPortion" contextRef="AsOf2024-11-30" id="Fact001175" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">207,077</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="axil:OperatingLeaseLiabilityCurrentPortion" contextRef="AsOf2024-05-31" id="Fact001176" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,752</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Non-current portion</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-11-30" id="Fact001178" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">531,081</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_z4tmRNVK2rdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Maturities of operating lease liabilities were as follows as of November
30, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001181" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4BZ0rSSOCh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_z4FOsnbl7Pd2" style="display: none">Schedule of maturities of operating lease liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20241130_zbzsam2y0Xal" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Operating Lease (fiscal year-end)</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz3IL_z87XRggIyeae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 81%">2025 (six months remaining)</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-11-30" id="Fact001183" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">94,651</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz3IL_zEiMUpr53XD6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-11-30" id="Fact001185" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258,005</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz3IL_zwm8rKEk30a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-11-30" id="Fact001187" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">269,437</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz3IL_zWnpCyRufoUb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2024-11-30" id="Fact001189" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">218,420</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz3IL_zg63Cy6ZHG2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2029</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2024-11-30" id="Fact001191" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,040</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz3IL_zCE6kpDMo5Wi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-11-30" id="Fact001193" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">968,553</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zOI7bPagT1s4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2024-11-30" id="Fact001195" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">230,395</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zN4FhJcJ6L6a" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-11-30" id="Fact001197" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">738,158</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zmCeY9ct0J87" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Accounts Payable</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended November 30, 2024, the
Company renewed its relationship with an entity, and as a result of the agreement, $<span id="xdx_90E_eus-gaap--AccruedRoyaltiesCurrent_c20241130_pp0p0" title="Due in royalties"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="AsOf2024-11-30" id="Fact001199" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">218,699</ix:nonFraction></span> previously due in relation to royalties, was
forgiven and included in Sales and marketing in the accompanying Consolidated Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, we become involved in various lawsuits
and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of
the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure
purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and
circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate
and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments
on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent
with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with
certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of
operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings
are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution
of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As
a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular
period, depending upon the size of the loss or our income for that particular period.</p>

<ix:exclude><p id="xdx_231_zAqMjPw6VnNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zztUYjDq3Xwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z0kuKsucyxU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z2PIggw2yjxb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zf8TFrwl8B28" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001206" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zY7tVSnUtwI5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 11 &#8211; <span id="xdx_820_zDsw2jZNwHch">Related Party Transactions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s Chairman and Chief Executive
Officer (&#8220;CEO&#8221;), Jeff Toghraie, is the managing director of Intrepid Global Advisors (&#8220;Intrepid&#8221;). Intrepid
has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the
year. Intrepid was paid approximately $<span id="xdx_900_ecustom--ConsultingFee_c20240601__20241130__srt--CounterpartyNameAxis__custom--IntrepidMember_pp0p0" title="Consulting fee"><ix:nonFraction name="axil:ConsultingFee" contextRef="From2024-06-012024-11-30_custom_IntrepidMember" id="Fact001208" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,000</ix:nonFraction></span>
in consulting fees for the six months ended November 30, 2024. As of November 30, 2024 and May 31, 2024, the Company had amounts
payable to Intrepid of $<span id="xdx_90E_ecustom--PayableToRelatedParty_c20241130__srt--CounterpartyNameAxis__custom--IntrepidMember_pp0p0" title="Payable to related party"><ix:nonFraction name="axil:PayableToRelatedParty" contextRef="AsOf2024-11-30_custom_IntrepidMember" id="Fact001210" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,520</ix:nonFraction></span>
and $<span id="xdx_909_ecustom--PayableToRelatedParty_iI_pp0p0_c20240531__srt--CounterpartyNameAxis__custom--IntrepidMember_z6sDuFaoVwxi" title="Payable to related party"><ix:nonFraction name="axil:PayableToRelatedParty" contextRef="AsOf2024-05-31_custom_IntrepidMember" id="Fact001212" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,798</ix:nonFraction></span>,
respectively. These advances were short-term in nature and non-interest bearing. The Company's Board Member, Chief Financial Officer
("CFO"), and Chief Operating Officer ("COO") has a controlling interest in BZ Capital Strategies. BZ Capital
Strategies was&#160;paid $<span id="xdx_904_ecustom--ConsultingFee_c20240601__20241130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BZCapitalStrategiesMember_pp0p0" title="Consulting fee"><ix:nonFraction name="axil:ConsultingFee" contextRef="From2024-06-012024-11-30_custom_BZCapitalStrategiesMember" id="Fact001214" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span>
in consulting fees&#160;for the six months ended November 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001216" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_zCKNLGKmQ1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 12 &#8211; <span id="xdx_82C_zMt8WgS5RPJ8">Concentrations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Concentration of Credit Risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the
Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents
instruments. The Company maintains its cash in bank deposits accounts. The Company&#8217;s account at this institution is insured by the
Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20241130_pp0p0" title="Cash, FDIC insured amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2024-11-30" id="Fact001218" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>. At November 30, 2024 and May 31, 2024, the Company held cash
of approximately $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20241130_pp0p0" title="Cash, uninsured amount"><ix:nonFraction name="us-gaap:CashUninsuredAmount" contextRef="AsOf2024-11-30" id="Fact001220" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,463,897</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_c20240531_pp0p0" title="Cash, uninsured amount"><ix:nonFraction name="us-gaap:CashUninsuredAmount" contextRef="AsOf2024-05-31" id="Fact001222" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,003,876</ix:nonFraction></span>, respectively, in excess of federally insured limits. The Company has not experienced any losses
in such accounts through November 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Concentration of Revenue, Accounts Receivable,
Product Line, and Supplier</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company predominantly sells the products direct-to-consumer.
There was no single customer that accounted for greater than 10% of consolidated net sales for the three and six months ended November
30, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended November 30, 2024, approximately&#160;<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-09-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90.2</ix:nonFraction>%</span>&#160;of
our consolidated net sales were to customers located in the U.S. (based on the customer&#8217;s shipping address). During the three months
ended November 30, 2023, approximately&#160;<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20230901__20231130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-09-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001226" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">94.6</ix:nonFraction>%</span>&#160;of our consolidated net sales were to customers located in the U.S. (based on the
customer&#8217;s shipping address). All Company assets are located in the U.S.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024, approximately&#160;<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001228" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">91.2</ix:nonFraction>%</span>&#160;of
our consolidated net sales were to customers located in the U.S. (based on the customer&#8217;s shipping address). During the six months
ended November 30, 2023, approximately&#160;<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_c20230601__20231130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-06-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001230" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">93.9</ix:nonFraction>%</span>&#160;of our consolidated net sales were to customers located in the U.S. (based on the
customer&#8217;s shipping address).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, accounts receivable from
customers that accounted for more than&#160;10%&#160;of sales transactions were from one customer amounting to <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" id="Fact001232" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.5</ix:nonFraction>%</span>. As of May 31, 2024,
no single customer accounted for more than&#160;10%&#160;of accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Manufacturing is outsourced primarily overseas via
a number of third-party vendors. The two largest vendors accounted for&#160;<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember" id="Fact001234" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">73.2</ix:nonFraction>%</span>&#160;and&#160;<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorOneMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember" id="Fact001236" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.9</ix:nonFraction>%</span>, respectively,&#160;of all purchases
for the three months ended November 30, 2024. For the three months ended November 30, 2023, the largest vendor accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20230901__20231130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-09-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember" id="Fact001238" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82.7</ix:nonFraction>%</span> of
all purchases. For the six months ended November 30, 2024, the two largest vendors accounted for&#160;<span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember" id="Fact001240" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">61.8</ix:nonFraction>%</span>&#160;and&#160;<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorOneMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember" id="Fact001242" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">26.0</ix:nonFraction>%</span>, respectively,&#160;of
all purchases. For the six months ended November 30, 2023, the largest vendor accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20230601__20231130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-06-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember" id="Fact001244" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">86.7</ix:nonFraction>%</span> of all purchases.</p>

<ix:exclude><p id="xdx_23D_zAbw1LMmn8Qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zygzlh0PGgE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zdOPpVovsbz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zA7uybAujeS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_z87cKoVmPa3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001251" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_805_eus-gaap--SegmentReportingDisclosureTextBlock_zmPxQC5GHzWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 13 &#8211; <span id="xdx_82A_zLtLMcALAsfg">Business Segment and Geographic Area Information</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Business Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company, directly or through its subsidiaries,
markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing
enhancement and hearing protection business. The Company&#8217;s determination of its reportable segments is based on how its chief operating
decision makers manage the business.&#160;</p>

<ix:exclude><p id="xdx_23F_z9g674DKogx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zkANVLsxS7sd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_z5OlDl4pbmah" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zELhEM3sDwz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zAsDVQS44zR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_z3xQrQCPooJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zjktTUjYTwWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 13 &#8211; Business Segment and Geographic Area Information (continued)</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company&#8217;s segment information is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001260" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_za2t9Oc9lZTg" summary="xdx: Disclosure - Business Segment and Geographic Area Information (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;<span id="xdx_8B2_zdNxLoyJPpM9" style="display: none">Schedule of segment information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended November 30,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months ended November 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember" id="Fact001262" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">284,545</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember" id="Fact001264" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">230,741</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember" id="Fact001266" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">836,054</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember" id="Fact001268" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">545,594</ix:nonFraction></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total net sales" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001270" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,448,029</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total net sales" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001272" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,190,936</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total net sales" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001274" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,747,792</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total net sales" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001276" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,982,352</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Total net sales</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20240901__20241130_pp0p0" title="Total net sales" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-09-012024-11-30" id="Fact001278" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,732,574</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230901__20231130_pp0p0" title="Total net sales" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-09-012023-11-30" id="Fact001280" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,421,677</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20240601__20241130_pp0p0" title="Total net sales" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-06-01to2024-11-30" id="Fact001282" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,583,846</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20230601__20231130_pp0p0" title="Total net sales" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-06-012023-11-30" id="Fact001284" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,527,946</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Segment gross profit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember" id="Fact001286" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,507</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember" id="Fact001288" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,583</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember" id="Fact001290" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">429,996</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember" id="Fact001292" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,107</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total segment gross profit" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001294" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,324,540</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total segment gross profit" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001296" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,085,356</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total segment gross profit" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001298" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,221,699</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Total segment gross profit" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001300" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,511,398</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total segment gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-09-012024-11-30" id="Fact001302" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,498,047</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GrossProfit_c20230901__20231130_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-09-012023-11-30" id="Fact001304" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,257,939</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GrossProfit_c20240601__20241130_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-06-01to2024-11-30" id="Fact001306" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,651,695</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GrossProfit_c20230601__20231130_pp0p0" title="Total segment gross profit" style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-06-012023-11-30" id="Fact001308" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,905,505</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and Marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SellingAndMarketingExpense_c20240901__20241130_pp0p0" title="Selling and Marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-09-012024-11-30" id="Fact001310" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,377,760</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SellingAndMarketingExpense_c20230901__20231130_pp0p0" title="Selling and Marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-09-012023-11-30" id="Fact001312" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,672,780</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SellingAndMarketingExpense_c20240601__20241130_pp0p0" title="Selling and Marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-06-01to2024-11-30" id="Fact001314" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,047,231</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SellingAndMarketingExpense_c20230601__20231130_pp0p0" title="Selling and Marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-06-012023-11-30" id="Fact001316" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,879,621</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240901__20241130_pp0p0" title="General and Administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2024-09-012024-11-30" id="Fact001318" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,447,416</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230901__20231130_pp0p0" title="General and Administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2023-09-012023-11-30" id="Fact001320" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,321,247</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240601__20241130_pp0p0" title="General and Administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2024-06-01to2024-11-30" id="Fact001322" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,072,295</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230601__20231130_pp0p0" title="General and Administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2023-06-012023-11-30" id="Fact001324" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,588,215</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated operating income</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ConsolidatedOperatingIncomeLoss_c20240901__20241130_pp0p0" title="Consolidated operating income (loss)" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="axil:ConsolidatedOperatingIncomeLoss" contextRef="From2024-09-012024-11-30" id="Fact001326" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">672,871</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ConsolidatedOperatingIncomeLoss_c20230901__20231130_pp0p0" title="Consolidated operating income (loss)" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="axil:ConsolidatedOperatingIncomeLoss" contextRef="From2023-09-012023-11-30" id="Fact001328" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,263,912</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--ConsolidatedOperatingIncomeLoss_c20240601__20241130_pp0p0" title="Consolidated operating income (loss)" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="axil:ConsolidatedOperatingIncomeLoss" contextRef="From2024-06-01to2024-11-30" id="Fact001330" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">532,169</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ConsolidatedOperatingIncomeLoss_c20230601__20231130_pp0p0" title="Consolidated operating income (loss)" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="axil:ConsolidatedOperatingIncomeLoss" contextRef="From2023-06-012023-11-30" id="Fact001332" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,437,669</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-11-30_custom_HairCareAndSkinCareMember" id="Fact001334" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,039,069</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-11-30_custom_HairCareAndSkinCareMember" id="Fact001336" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,439,289</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zSd1tXeKzgJb" title="Consolidated total assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-11-30_custom_HairCareAndSkinCareMember" id="Fact001338" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,039,069</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zgJkAQWpELv2" title="Consolidated total assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-11-30_custom_HairCareAndSkinCareMember" id="Fact001340" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,439,289</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001342" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,670,630</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001344" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,686,720</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z1wRJEG4eV49" title="Consolidated total assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001346" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,670,630</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z50CV28EbXtj" title="Consolidated total assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001348" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,686,720</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total assets</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20241130_pp0p0" title="Consolidated total assets" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-11-30" id="Fact001350" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,709,699</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20231130_pp0p0" title="Consolidated total assets" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-11-30" id="Fact001352" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,126,009</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130_zWjVhJ4qa31b" title="Consolidated total assets" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-11-30" id="Fact001354" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,709,699</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20231130_ztQM5MICcI22" title="Consolidated total assets" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-11-30" id="Fact001356" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,126,009</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments for property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total payments for property and equipment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total payments for property and equipment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1360">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total payments for property and equipment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total payments for property and equipment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1364">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001366" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,783</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001368" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,885</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001370" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,623</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001372" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,845</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total payments for property and equipment</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-09-012024-11-30" id="Fact001374" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,783</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-09-012023-11-30" id="Fact001376" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,885</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-06-01to2024-11-30" id="Fact001378" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,623</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130_pp0p0" title="Consolidated total payments for property and equipment" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-06-012023-11-30" id="Fact001380" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,845</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember" id="Fact001382" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">839</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember" id="Fact001384" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,417</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember" id="Fact001386" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,678</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" title="Consolidated total depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember" id="Fact001388" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,835</ix:nonFraction></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001390" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,601</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001392" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,368</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001394" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,657</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember" id="Fact001396" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,187</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total depreciation and amortization</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-09-012024-11-30" id="Fact001398" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,440</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-09-012023-11-30" id="Fact001400" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,785</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-06-01to2024-11-30" id="Fact001402" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,335</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130_pp0p0" title="Consolidated total depreciation and amortization" style="border-bottom: Black 4.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-06-012023-11-30" id="Fact001404" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,022</ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p id="xdx_8A1_zrmtTLXO59qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Geographic Area Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For geographic area information of sales for the three
and six months ended November 30, 2024, see Note 12 &#8211; Concentrations.</p>

<ix:exclude><p id="xdx_236_z9ItFo9s1igk" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zLOE5OIbuo9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zg1M0TcQVxYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>AXIL BRANDS, INC. AND SUBSIDIARY</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zpeT8Je1avi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zY9II4FQRks9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2024</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-06-01to2024-11-30" escape="true" id="Fact001411" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zuG215MeHdzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 14 &#8211; <span id="xdx_823_zZPYnc6cMxJ6">Income Taxes</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We calculated our interim tax provision in accordance
with ASC 270, &#8220;<i>Interim Reporting</i>,&#8221; and ASC 740, &#8220;<i>Accounting for Income Taxes</i>.&#8221; As the end of each
interim quarterly period, we estimate our annual effective tax rate and apply that rate to our ordinary quarterly earnings to calculate
the tax related to ordinary income. The tax effects of other items that are excluded from ordinary income are discretely calculated and
recognized in the period in which they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recorded an income tax expense of $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20240901__20241130_zHVgCTFNkh4" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-09-012024-11-30" id="Fact001413" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,250</ix:nonFraction></span> for the
three months ended November 30, 2024 and an income tax expense of $<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230901__20231130_zbV5EC57EQea" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-09-012023-11-30" id="Fact001415" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">364,393</ix:nonFraction></span> for the three months ended November 30, 2023. We recorded an
income tax expense of $<span id="xdx_903_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20240601__20241130_zE13RdFSUPu3" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-06-01to2024-11-30" id="Fact001417" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,250</ix:nonFraction></span> for the six months ended November 30, 2024 and an income tax expense of $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230601__20231130_zVLhqALjhiW2" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-06-012023-11-30" id="Fact001419" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">430,382</ix:nonFraction></span> for the six months ended
November 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any uncertain tax positions
or events leading to uncertainty in a tax position. The Company&#8217;s 2020, 2021, 2022 and 2023 Corporate Income Tax Returns are subject
to IRS examination.&#160;</p>

</ix:nonNumeric><p id="xdx_81A_zHNymTrV2zab" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_009"></span>ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>The following Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations should be read in conjunction with, and is qualified in its entirety by, the
unaudited consolidated financial statements and related notes thereto included in Item 1 in this Quarterly Report on Form 10-Q and with
our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended May 31,
2024 filed with the SEC on August 15, 2024. Our Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
contains not only statements that are historical facts, but also statements that are forward-looking.&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Although the forward-looking statements in this
Quarterly Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors
currently known by them.&#160;Consequently, and because forward-looking statements are inherently subject to risks and uncertainties,
the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are
urged to carefully review and consider the various disclosures made by us in herein and in our other reports as we attempt to advise interested
parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects. Please see
&#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; in this Quarterly Report on Form 10-Q for additional information.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Overview</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is engaged in the manufacturing, marketing,
sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions
for people with varied applications across many industries and professional quality hair and skin care products under various trademarks
and brands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company has two reportable
segments: hair care and skin care, and hearing enhancement and protection.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Through our hearing enhancement and protection segment,
we design, innovate, engineer, manufacture, market and service specialized systems in hearing enhancement, hearing protection, wireless
audio, and communication. Through our hair care and skin care segment, we manufacture, market, sell, and distribute professional quality
hair and skin care products.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s overall business strategy is to
establish market awareness of our products through our direct-to-consumer campaigns. The Company's strategy centers on driving growth
by expanding market share within existing channels and developing new ones through both online and traditional platforms. The Company&#8217;s
primary focus is optimizing its e-commerce strategies, building sales teams to meet the needs of distribution channels, and enhancing
value through strategic partnerships. We believe the increase in awareness will allow the Company to increase distribution and gain customers
through our distribution partners&#8217; retail establishments, with the goal of helping us achieve growth in market share and diversify
our sales channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Results of Operations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Our results of operations are summarized below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Six months ended</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">November 30,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">November 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sales, net</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">7,732,574</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">8,421,677</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">13,583,846</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">14,527,946</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,234,527</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,163,738</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,932,151</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,622,441</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,498,047</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,257,939</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,651,695</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,905,505</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,825,176</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,994,027</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,119,526</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,467,836</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">672,871</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,263,912</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,169</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,437,669</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income after tax</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">633,706</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">1,018,075</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">523,901</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">1,172,527</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We calculate EBITDA by taking net income calculated
in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;), and adjusting for income taxes,
interest income or expense, and depreciation and amortization. We calculate adjusted EBITDA as EBITDA, further adjusted for stock-based
compensation. Adjusted EBITDA is also presented as a percentage of revenue, which is calculated by dividing the non-GAAP Adjusted EBITDA
for a period by revenue for the same period. Other companies may calculate EBITDA and adjusted EBITDA differently, limiting the usefulness
of these measures for comparative purposes. We believe that these non-GAAP measures of financial results provide useful information regarding
certain financial and business trends relating to our financial condition and results of operations, and management considers EBITDA and
adjusted EBITDA important indicators in evaluating our business on a consistent basis across various periods for trend analyses. These
non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our financial statements
and are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded
or included in determining these non-GAAP financial measures. Investors should review the reconciliation of these non-GAAP financial measures
to the comparable GAAP financial measure included below. Investors should not rely on any single financial measure to evaluate our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center"><b>For the Three Months Ended</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center"><b>For the Six Months Ended</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="7" style="text-align: center"><b>November 30,</b></td>
    <td>&#160;</td>
    <td colspan="7" style="text-align: center"><b>November 30,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center">2024</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center">2023</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center">2024</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%">Net income (GAAP)</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 10%; text-align: right">633,706</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 10%; text-align: right">1,018,075</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 10%; text-align: right">523,901</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 10%; text-align: right">1,172,527</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 13.5pt">Income taxes</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">67,250</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">364,393</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">67,250</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">430,382</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 13.5pt">Interest (income) expense, net</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(26,044</td>
    <td style="white-space: nowrap">)&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(36,185</td>
    <td style="white-space: nowrap">)&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(54,675</td>
    <td style="white-space: nowrap">)&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(73,034</td>
    <td style="white-space: nowrap">)&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 13.5pt">Depreciation and amortization</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">34,440</td>
    <td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">27,785</td>
    <td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">47,335</td>
    <td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">56,022</td>
    <td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><b>Total EBITDA (Non-GAAP)</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">709,352</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">1,374,068</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">583,811</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">1,585,897</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><b>Adjustments:</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Stock-based compensation</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">304,600</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">51,108</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">602,464</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">102,215</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><b>Total Adjusted EBITDA (Non-GAAP)</b></td>
    <td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: black 4.5pt double">$</td>
    <td style="border-bottom: black 4.5pt double; text-align: right">1,013,952</td>
    <td style="white-space: nowrap; padding-bottom: 4.5pt">&#160;</td>
    <td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: black 4.5pt double">$</td>
    <td style="border-bottom: black 4.5pt double; text-align: right">1,425,176</td>
    <td style="white-space: nowrap; padding-bottom: 4.5pt">&#160;</td>
    <td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: black 4.5pt double">$</td>
    <td style="border-bottom: black 4.5pt double; text-align: right">1,186,275</td>
    <td style="white-space: nowrap; padding-bottom: 4.5pt">&#160;</td>
    <td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: black 4.5pt double">$</td>
    <td style="border-bottom: black 4.5pt double; text-align: right">1,688,112</td>
    <td style="white-space: nowrap; padding-bottom: 4.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Sales, net (GAAP)</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">7,732,574</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">8,421,677</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">13,583,846</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">14,527,946</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><b>Adjusted EBITDA as a percentage of Sales, net (Non-GAAP)</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">13.1</td>
    <td style="white-space: nowrap">%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">16.9</td>
    <td style="white-space: nowrap">%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">8.7</td>
    <td style="white-space: nowrap">%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">11.6</td>
    <td style="white-space: nowrap">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 32; Options: NewSection; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>For the Three Months Ended November 30, 2024 Compared to the Three
Months Ended November 30, 2023</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales for the three months ended November 30,
2024 and 2023 were $7,732,574 and $8,421,677, respectively. Net sales for the three months ended November 30, 2024 decreased by $689,103
or 8%, as compared to the three months ended November 30, 2023. This decrease is primarily due to the timing of post-Thanksgiving sales
events, as a significant portion of these sales will be recognized in the third quarter this fiscal year, whereas sales from post-Thanksgiving
sales events were recognized entirely in the second quarter in the prior fiscal year. Additionally, reduced advertising expenditure adversely
affected direct to consumer sales in the three months ended November 30, 2024, as well as an increase of discounts as a percentage of
revenue, offset by the strength in our distribution channels for AXIL products, and an increase in distributor sales in our hair and skin
care products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended November 30, 2024, the
overall cost of sales increased by $70,789 or 3%, as compared to the three months ended November 30, 2023, which was primarily due to
the relative increase in sales of the Company&#8217;s hair and skin care products. Cost of sales as a percentage of net revenues for the
three months ended November 30, 2024 was 28.9% as compared to 25.7% for the comparable period in 2023. The increase in cost of sales,
as a percentage of sales, was primarily attributable to an increase in sales to distributors in our hair and skin care products bearing
lower margins, and an increase in sales of lower margin products in our hearing enhancement and protection segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Gross profit for the three months ended November 30,
2024 and 2023 was $5,498,047 and $6,257,939, respectively. Gross profit as a percentage of sales for the three months ended November 30,
2024, was 71.1% as compared to 74.3% for the comparable period in 2023. The decrease in the gross profit margin for the three months ended
November 30, 2024 was primarily attributable to an increase in cost of sales as a percentage of revenue, and an increase of discounts
as a percentage of revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Operating expenses consisted of marketing and selling
expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses decreased
by $168,851 or 3% from $4,994,027 in the three months ended November 30, 2023 to $4,825,176 in the three months ended November 30, 2024.
Operating expense as a percentage of revenue for the three months ended November 30, 2024 was 62.4% compared 59.3% for the comparable
period in 2023. Included in operating expenses were non-cash stock-based compensation of $304,600 and $51,111 in the three months ended
November 30, 2024 and 2023, respectively. The decrease in operating expenses related primarily to lower advertising costs, and a forgiveness
of accounts payable of approximately $220,000, partially offset by an increase of stock-based compensation expense and an increase in
salaries and consulting fees. During the three months ended November 30, 2024, we incurred approximately $130,000 in consulting fees to
support our expansion into new geographic markets, compared to $0 for the same period in 2023. Of this amount, approximately $50,000 was
related to stock-based compensation. We have also incurred additional costs related to new product lines. We believe we have not yet realized
the anticipated benefits from our recent efforts to expand into new geographic markets and product lines.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income from operations for the three months ended
November 30, 2024 was $672,871 compared to $1,263,912 for the three months ended November 30, 2023. The decrease in income from operations
of $591,041 or 46.8% was primarily related to the timing of post-Thanksgiving sales events, as a significant portion of these sales will
be recognized in the third quarter this fiscal year, whereas sales from post-Thanksgiving sales events were recognized entirely in the
second quarter in the prior fiscal year. Additionally, there was an increase in our non-cash stock-based compensation and lower gross
profit, partially offset by a forgiveness of accounts payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended November 30, 2024 provision
for income taxes was $67,250. For the three months ended November 30, 2023, provision for income tax expense was $364,393.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the above, and a gain on
settlement of debt of approximately $79,000 in the prior year period that did not recur in the current period, we reported a net
income of $633,706 and a net income of $1,018,075 for the three months ended November 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Adjusted EBITDA for the three months ended November
30, 2024 and 2023 were $1,013,952 and $1,425,176, respectively. The decrease of $411,224 was primarily related to the timing of post-Thanksgiving
sales events, as a significant portion of these sales will be recognized in the third quarter this fiscal year, whereas sales from post-Thanksgiving
sales events were recognized entirely in the second quarter in the prior fiscal year. Adjusted EBITDA as a percentage of sales, net for
the three months ended November 30, 2024 and 2023, were 13.1% and 16.9%, respectively. The decline was primarily due to the decrease in
the gross margin and the increase in costs related to our expansion into new geographic markets and product lines, partially offset by
a forgiveness of accounts payable of approximately $220,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>For the Six Months Ended November 30, 2024 Compared to the Six Months
Ended November 30, 2023</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales for the six months ended November 30, 2024
and 2023 were $13,583,846 and $14,527,946, respectively. Net sales for the six months ended November 30, 2024 decreased by $944,100 or
6%, as compared to the six months ended November 30, 2023. This decrease is primarily due to the timing of post-Thanksgiving sales events,
as a significant portion of these sales will be recognized in the third quarter this fiscal year, whereas sales from post-Thanksgiving
sales events were recognized entirely in the second quarter in the prior fiscal year. Additionally, reduced advertising expenditure adversely
affected direct to consumer sales in the six months ended November 30, 2024, as well as an increase of discounts as a percentage of revenue,
offset by the strength in our distribution channels for AXIL products, and an increase in distributor sales in our hair and skin care
products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six months ended November 30, 2024, the overall
cost of sales increased by $309,710 or 9%, as compared to the six months ended November 30, 2023, which was primarily due to the relative
increase in sales of the Company&#8217;s hair and skin care products. Cost of sales as a percentage of net revenues for the six months
ended November 30, 2024 was 28.9% as compared to 24.9% for the comparable period in 2023. The increase in cost of sales, as a percentage
of sales, was primarily attributable to an increase in sales to distributors in our hair and skin care products bearing lower margins,
and an increase in sales of lower margin products in our hearing enhancement and protection segment.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Gross profit for the six months ended November 30,
2024 and 2023 was $9,651,695 and $10,905,505, respectively. Gross profit as a percentage of sales for the six months ended November 30,
2024, was 71.1% as compared to 75.1% for the comparable period in 2023. The decrease in the gross profit margin for the six months ended
November 30, 2024 was primarily attributable to an increase in cost of sales as a percentage of revenue, and an increase of discounts
as a percentage of revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Operating expenses consisted of marketing and selling
expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses decreased
by $348,310 or 4% from $9,467,836 in the six months ended November 30, 2023 to $9,119,526 in the six months ended November 30, 2024. Operating
expenses as a percentage of net revenues for the six months ended November 30, 2024, were 67.1% compared to 65.2% for the six months ended
November 30, 2023. Included in operating expenses were non-cash stock-based compensation of $602,464 and $102,215 in the six months ended
November 30, 2024 and 2023, respectively. The decrease in operating expenses related primarily to a net decrease in advertising expenses,
and a forgiveness of account payable amounting to approximately $220,000 partially offset by an increase of stock-based compensation of
$500,249 and increased professional and consulting fees. During the six months ended November 30, 2024, we incurred approximately $200,000
in consulting fees to support our expansion into new geographic markets, compared to $0 for the same period in 2023. Of this amount, approximately
$80,000 was related to stock-based compensation. We have also incurred additional costs related to new product lines. We believe we have
not yet realized the anticipated benefits from our recent efforts to expand into new geographic markets and product lines.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income from operations for the six months ended November
30, 2024, was $532,169 compared to income of $1,437,669 for the six months ended November 30, 2023. The decrease in income from operations
of $905,500 or 63.0% was primarily timing of post-Thanksgiving sales events, as a significant portion of these sales will be recognized
in the third quarter this fiscal year, whereas sales from post-Thanksgiving sales events were recognized entirely in the second quarter
in the prior fiscal year. Additionally, there was a decrease related to the increase of our non-cash stock-based compensation and lower
gross profit, partially offset by a forgiveness of accounts payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six months ended November 30, 2024, provision
for income tax expense was $67,250. For the six months ended November 30, 2023, provision for income tax expense was $430,382.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the above, and a gain on settlement
of debt of approximately $79,000 in the prior year period that did not recur in the current period, we reported a net income of $523,901
and $1,172,527 for the six months ended November 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Adjusted EBITDA for the six months ended November
30, 2024 and 2023 were $1,186,275 and $1,688,112 respectively. The decrease of $501,837 was primarily related to the timing of post-Thanksgiving
sales events, as a significant portion of these sales will be recognized in the third quarter this fiscal year, whereas sales from post-Thanksgiving
sales events were recognized entirely in the second quarter in the prior fiscal year. Adjusted EBITDA as a percentage of sales, net for
the six months ended November 30, 2024 and 2023, were 8.7% and 11.6%, respectively. The decline was primarily due to the decrease in the
gross margin and the increase in costs related to our expansion into new geographic markets and product lines, partially offset by a forgiveness
of accounts payable of approximately $220,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Liquidity and Capital Resources</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are currently engaged in product sales and development.
Although we earned net income and have cash provided by operations for the six months ended November 30, 2024, we have incurred operating
losses in the past. We currently expect to earn net income and positive cash flows from operations during the current fiscal year ending
May 31, 2025. We believe our current cash balances, coupled with anticipated cash flow from operating activities, will be sufficient to
meet our working capital requirements for at least one year from the date of issuance of the accompanying unaudited consolidated financial
statements. We intend to continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use
our cash balances in the short-term to invest in revenue growth. As a result of the acquisition of AXIL &amp; Associated Brands&#8217;
assets in June 2022, we have generated and expect we will continue to generate sufficient cash for our operational needs, including any
required debt payments, for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements.
Management is focused on growing the Company&#8217;s existing product lines and introducing new products, as well as expanding its customer
base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption
and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash
utilization at levels greater than recently experienced. The Company cannot provide any assurance that it will be able to raise additional
capital or obtain necessary financing on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has
sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying unaudited
consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Cash Flows</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Operating Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash provided by operating activities for the
six months ended November 30, 2024, was $1,904,174, compared to $1,252,113 for the same period in 2023. This improvement primarily resulted
from our strategic decision to increase inventory levels as of May 31, 2024 to accommodate new product variations and packaging aimed
at expanding into new markets. Inventory sold during the six months ended November 30, 2024, contributed positively to cash flows. We
also negotiated a forgiveness of accounts payable during the six months ended November 30, 2024, resulting in an improvement of operating
cash flows of approximately $220,000 offset by timing of net changes in operating assets and liabilities excluding inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Investing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash flows used in investing activities for the
six months ended November 30, 2024 was $107,623 due to the purchase of intangibles and property and equipment for the Company&#8217;s
business. For the six months ended November 30, 2023, net cash flows used in investing activities were $70,845, attributable to the cash
used in the purchase of property and equipment primarily relating to our expansion into new product lines.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Financing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash flows provided by financing activities for
the six months ended November 30, 2024 was $163,470, and were from advances made from a related party of $166,722 partially offset by
a repayment of the note payable of $3,252. Net cash flows used in financing activities for the six months ended November 30, 2023 were
$51,519 primarily related to the repayment of note payable of $24,657 and payments to our related party of $25,212.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, we had a secured Economic
Injury Disaster Loan outstanding, administered pursuant to the CARES Act in the principal amount of $143,342, with a maturity date of
May 18, 2050. The Company continues to pay interest and principal on the loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are dependent on our product sales to fund our
operations and may require additional capital in the future, such as pursuant to the sale of additional common or preferred stock or of
debt securities or entering into credit agreements or other borrowing arrangements with institutions or private individuals, to maintain
operations, which may not be available on favorable terms, or at all, and could require us to sell certain assets or discontinue or curtail
our operations. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult
to obtain, more costly and more dilutive. Our officers and directors have made no written commitments with respect to providing a source
of liquidity in the form of cash advances, loans, and/or financial guarantees. We do not have any plans to seek additional financing at
this time and anticipate that our existing cash equivalents and cash provided by operations will be sufficient to meet our working capital
requirements. However, if the need arises for additional cash, there can be no assurance that we will be able to raise the capital we
need for our operations on favorable terms, or at all. We may not be able to obtain additional capital or generate sufficient revenues
to fund our operations. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse
effect on our growth strategy, financial performance and stock price and could require us to delay or abandon our business plans. If we
are unsuccessful at raising sufficient funds, for whatever reason, to fund our operations, we may be forced to cease operations. If we
fail to raise funds, we expect that we will be required to seek protection from creditors under applicable bankruptcy laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Off-Balance Sheet Arrangements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, we do not have any off-balance
sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial
condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Critical Accounting Policies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial
statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements. Such estimates and assumptions affect the reported amounts of expenses during the reporting period.
On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances.
We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates
under different future conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe that the estimates and assumptions that
are most important to the portrayal of our financial condition and results of operations, in that they require the most difficult, subjective
or complex judgments, form the basis for the accounting policies deemed to be most critical to us. These critical accounting policies
relate to revenue recognition, impairment of intangible assets and long-lived assets, inventory, stock compensation, and evaluation of
contingencies. We believe estimates and assumptions related to these critical accounting policies are appropriate under the circumstances;
however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial
condition or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See the footnotes to our unaudited consolidated financial
statements for the three and six months ended November 30, 2024, included with this Quarterly Report on Form 10-Q for additional discussion
of our critical accounting policies and use of estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_010"></span>ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">As a smaller reporting company, we are not required to provide the information
required by this Item 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_011"></span>ITEM 4. CONTROLS AND PROCEDURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Disclosure Controls and Procedures</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain &#8220;disclosure controls and procedures,&#8221;
as such term is defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act, that are designed to ensure that information required
to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s
rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (&#8220;CEO&#8221;)
and Principal Executive Officer, and Chief Financial Officer (&#8220;CFO&#8221;) and Principal Financial and Accounting Officer, as appropriate,
to allow timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation
of our CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of November 30, 2024.
Based on this evaluation of disclosure controls and procedures as of November 30, 2024, our CEO and CFO concluded that our disclosure
controls and procedures were effective.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Changes in Internal Control over Financial Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have been no changes in our internal control
over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) under the Exchange Act
that occurred during the fiscal quarter ended November 30, 2024 that has materially affected or are reasonably likely to materially affect
our internal control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_012"></span><b>PART II - OTHER INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_013"></span>ITEM 1. LEGAL PROCEEDINGS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, we become involved in various lawsuits
and legal proceedings which arise in the ordinary course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Where it is probable that we will incur a loss and
the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual
and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific
facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss.
We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant
developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual,
consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be
predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on
our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However,
legal proceedings are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately
result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided
by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations
for a particular period, depending upon the size of the loss or our income for that particular period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_014"></span>ITEM 1A. RISK FACTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a smaller reporting company, we are not required
to provide the information required by this Item 1A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_015"></span>ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_016"></span>ITEM 3. DEFAULTS UPON SENIOR SECURITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_017"></span>ITEM 4. MINE SAFETY DISCLOSURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_018"></span>ITEM 5. OTHER INFORMATION</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the quarter ended November 30, 2024, <span id="xdx_90A_eecd--Rule10b51ArrAdoptedFlag_c20240901__20241130_zBgUnzuyTeN" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_90C_eecd--NonRule10b51ArrAdoptedFlag_c20240901__20241130_z33VDwFZUh45" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_907_eecd--Rule10b51ArrTrmntdFlag_c20240901__20241130_zBasGAWl3obb" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_905_eecd--NonRule10b51ArrTrmntdFlag_c20240901__20241130_ztvUILCwZqA6" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2024-09-012024-11-30" format="ixt:booleanfalse" id="Fact001420" name="ecd:Rule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2024-09-012024-11-30" format="ixt:booleanfalse" id="Fact001421" name="ecd:NonRule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2024-09-012024-11-30" format="ixt:booleanfalse" id="Fact001422" name="ecd:Rule10b51ArrTrmntdFlag"><ix:nonNumeric contextRef="From2024-09-012024-11-30" format="ixt:booleanfalse" id="Fact001423" name="ecd:NonRule10b51ArrTrmntdFlag">no</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span></span> director or officer of the
Company adopted, modified or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221;
as each term is defined in Item 408 of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_019"></span>ITEM 6. EXHIBITS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 10%"><b>Exhibit</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 67%; text-align: justify">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center"><b>Filed&#160;</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center"><b>Furnished</b></td></tr>
  <tr style="vertical-align: top">
    <td><b>Number</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">Exhibit Description</td>
    <td>&#160;</td>
    <td style="text-align: center"><b>herewith</b></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>herewith</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><b>3.1</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1718500/000121390017010353/fs12017ex3-3_reviv3procare.htm">Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.3 to the Company&#8217;s Registration Statement on Form S-1 filed with the SEC on October 6, 2017).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><b>3.2</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1718500/000152013822000375/rviv-20220531_10kex3z3.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.3 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on August 25, 2022).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><b>3.3</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1718500/000152013824000017/rviv-20240116_8kex3z1.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective as of January 16, 2024 (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 16, 2024).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><b>3.4</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1718500/000152013824000067/rviv20240209_8kex3z1.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective as of February 14, 2024 (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 12, 2024).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><b>3.5</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1718500/000121390017010353/fs12017ex3-2_reviv3procare.htm">Bylaws (incorporated herein by reference to Exhibit 3.2 to the Company&#8217;s Registration Statement on Form S-1 filed with the SEC on October 6, 2017).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><b>3.6</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1718500/000152013824000067/rviv20240209_8kex3z2.htm">Amendment to the Bylaws, effective as of February 14, 2024 (incorporated herein by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 12, 2024).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>10.1*</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/0001718500/000152013824000344/axil-20240831_10qex10z1.htm">Form of Stock Option Agreement (2024) (2022 Equity Incentive Plan) (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on October 10, 2024).</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>10.2*</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/0001718500/000152013824000459/axil-20241218_8kex10z1.htm">AXIL Brands, Inc. Amended and Restated 2022 Equity Incentive Plan (effective as of December 18, 2024) (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 18, 2024).</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>10.3*</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="axil-20241130_10qex10z3.htm">Form of Restricted Stock Award Agreement (2024) (2022 Equity Incentive Plan)</a></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>31.1</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="axil-20241130_10qex31z1.htm">Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>31.2</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="axil-20241130_10qex31z2.htm">Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>32.1</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="axil-20241130_10qex32z1.htm">Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>32.2</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="axil-20241130_10qex32z2.htm">Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>99.1</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="axil-20241130_10qex99z1.htm" style="-sec-extract: exhibit">Office Lease Agreement dated October 15, 2024 between New Lion Enterprises LLC and AXIL Brands, Inc.</a></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>101</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">The following unaudited condensed consolidated financial statements from the Quarterly Report on Form 10-Q for the quarter ended November 30, 2024 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Changes in Stockholders&#8217; Equity, (iv) Statements of Cash Flows, and (v) the Notes to Financial Statements.</td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>104</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</td>
    <td>&#160;</td>
    <td style="text-align: center"><b>X</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Management compensatory plan or arrangement.<span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="a_020"></span><span style="text-decoration: underline">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">AXIL BRANDS, INC.</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Date: January 8, 2025</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>By:&#160;&#160;</td>
    <td style="border-bottom: black 1.5pt solid">/s/ Jeff Toghraie</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Jeff Toghraie</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Chief Executive Officer and Chairman of the Board of Directors</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>(Principal Executive Officer)</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>By:</td>
    <td style="border-bottom: black 1.5pt solid">/s/ Jeff Brown</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Jeff Brown</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Chief Financial Officer, Chief Operating Officer and Director</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>(Principal Financial Officer and Principal Accounting Officer)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 39; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>axil-20241130_10qex10z3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AXIL BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2022 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF RESTRICTED STOCK GRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Capitalized but otherwise undefined
terms in this Notice of Restricted Stock Grant and the attached Restricted Stock Grant Agreement shall have the same defined meanings
as in the AXIL Brands, Inc. 2022 Equity Incentive Plan (as amended from time to time)(the &ldquo;<B><U>Plan</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 8%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Participant&rsquo;s Name:&nbsp;</B></FONT></TD>
    <TD STYLE="width: 44%; border-bottom: black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 48%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;(the &ldquo;<U>Participant</U>&rdquo;)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You have been granted Restricted
Stock subject to the terms and conditions of the Plan and the attached Restricted Stock Grant Agreement, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date of Grant:&nbsp;</B></FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting Commencement Date:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price Per Share:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Number of Shares Granted:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Value of Shares Granted:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Purchase Price:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agreement Date:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting Schedule:&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AXIL BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2022 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>RESTRICTED STOCK GRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This&nbsp;<B>RESTRICTED STOCK
GRANT AGREEMENT&nbsp;</B>(&ldquo;<B><U>Agreement</U></B>&rdquo;), dated as of the Agreement Date specified on the Notice of Restricted
Stock Grant is made by and between AXIL Brands, Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and the grantee
named in the Notice of Restricted Stock Grant (the &ldquo;<B><U>Participant,</U></B>&rdquo; which term as used herein shall be deemed
to include any successor to Participant by will or by the laws of descent and distribution, unless the context shall otherwise require).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>BACKGROUND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Plan, the Board
(or an authorized Committee thereof), approved the issuance to the Participant, effective as of the date set forth above, of an award
of the number of shares of Restricted Stock as is set forth in the attached Notice of Restricted Stock Grant (which is expressly incorporated
herein and made a part hereof, the &ldquo;<B><U>Notice of Restricted Stock Grant</U></B>&rdquo;) at the purchase price per share of Restricted
Stock (the &ldquo;<B><U>Purchase Price</U></B>&rdquo;), if any, set forth in the attached Notice of Restricted Stock Grant, upon the terms
and conditions hereinafter set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration
of the mutual premises and undertakings hereinafter set forth, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Grant
and Purchase of Restricted Stock</U></B>. The Company hereby grants to the Participant, and the Participant hereby accepts the Restricted
Stock set forth in the Notice of Restricted Stock Grant, subject to the payment by the Participant of the total purchase price, if any,
set forth in the Notice of Restricted Stock Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Stockholder
Rights</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting
Rights</U>. Until such time as all or any part of the Restricted Stock is forfeited to the Company under this Agreement, if ever, the
Participant (or any successor in interest) has the rights of a stockholder, including voting rights, with respect to the Restricted Stock
subject, however, to the transfer restrictions or any other restrictions set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;<U>Dividends
and Other Distributions</U>. During the period of restriction, the Participant is entitled to all regular cash dividends or other distributions
paid with respect to all shares while they are so held. If any such dividends or distributions are paid in shares, such shares will be
subject to the same restrictions on transferability and forfeitability as the Restricted Stock with respect to which they were paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Vesting
of Restricted Stock</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp; The Restricted
Stock is restricted and subject to forfeiture until vested. The Restricted Stock which has vested and is no longer subject to forfeiture
are referred to as &ldquo;<B><U>Vested Shares.</U></B>&rdquo; All Restricted Stock which has not become Vested Shares are referred to
as &ldquo;<B><U>Nonvested Shares.</U></B>&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp; Restricted Stock
will vest and become nonforfeitable in accordance with the vesting schedule contained in the Notice of Restricted Stock Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp; Any Nonvested
Shares of the Participant will automatically vest and become nonforfeitable if the Participant&rsquo;s service with the Company ceases
owing to the Participant&rsquo;s (a) death, (b) Disability, or (c) Retirement, unless the Board (or an authorized committee thereof) provides
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp; In the event of
a Change of Control, the Board (or an authorized committee thereof), in its discretion, may accelerate the time at which all or any portion
of the Participant&rsquo;s Restricted Stock will vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp; Terms used
in&nbsp;<U>Section 3</U>&nbsp;and&nbsp;<U>Section 4</U>&nbsp;have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(i)&nbsp;&nbsp;&nbsp; &ldquo;<B><U>Cause</U></B>&rdquo;
has the meaning ascribed to such term or words of similar import in the Participant&rsquo;s written employment or service contract with
the Company or its subsidiaries and, in the absence of such agreement or definition, means the Participant&rsquo;s (i) conviction of,
or plea of nolo contendere to, a felony or crime involving moral turpitude; (ii) fraud on or misappropriation of any funds or property
of the Company or its subsidiaries, or any affiliate, customer or vendor; (iii) personal dishonesty, incompetence, willful misconduct,
willful violation of any law, rule or regulation (other than minor traffic violations or similar offenses), or breach of fiduciary duty
which involves personal profit; (iv) willful misconduct in connection with the Participant&rsquo;s duties or willful failure to perform
the Participant&rsquo;s responsibilities in the best interests of the Company or its subsidiaries; (v) illegal use or distribution of
drugs; (vi) violation of any material rule, regulation, procedure or policy of the Company or its subsidiaries, the violation of which
could have a material detriment to the Company; or (vii) material breach of any provision of any employment, non-disclosure, non-competition,
non-solicitation or other similar agreement executed by the Participant for the benefit of the Company or its subsidiaries, all as reasonably
determined by the Board of Directors of the Company, which determination will be conclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii)&nbsp;&nbsp; &ldquo;<B><U>Retirement</U></B>&rdquo;
means the Participant&rsquo;s retirement from Company employ at or above the age 65 as determined in accordance with the policies of the
Company or its subsidiaries, if any, in good faith by the Board of Directors of the Company, which determination will be final and binding
on all parties concerned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp; Nonvested
Shares may not be sold, transferred, assigned, pledged, or otherwise disposed of, directly or indirectly, whether by operation of law
or otherwise. The restrictions set forth in this Section will terminate upon a Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Forfeiture
of Nonvested Shares</U></B>. Except as provided herein, if the Participant&rsquo;s service with the Company ceases for any reason other
than the Participant&rsquo;s (a) death, (b) Disability, or (c) Retirement, any Nonvested Shares will be automatically forfeited to the
Company; provided, however, that the Board (or an authorized committee thereof) may cause any Nonvested Shares immediately to vest and
become nonforfeitable if the Participant&rsquo;s service with the Company is terminated by the Company without Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Legend</U>.
Each certificate representing Restricted Stock granted pursuant to the Notice of Restricted Stock Grant may bear a legend substantially
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&ldquo;THE SALE OR OTHER TRANSFER OF THE SHARES
REPRESENTED BY THIS CERTIFICATE, WHETHER VOLUNTARY, INVOLUNTARY OR BY OPERATION OF LAW, IS SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER
AS SET FORTH IN THE AXIL BRANDS, INC. 2022 EQUITY INCENTIVE PLAN AND IN A RESTRICTED SHARE GRANT AGREEMENT. A COPY OF SUCH PLAN AND SUCH
AGREEMENT MAY BE OBTAINED FROM AXIL BRANDS, INC. &ldquo;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;<U>Escrow
of Nonvested Shares</U>. The Company has the right to retain the certificates representing Nonvested Shares in the Company&rsquo;s possession
until such time as all restrictions applicable to such shares have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Removal
of Restrictions</U>. The Participant is entitled to have the legend removed from certificates representing Vested Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Recapitalizations,
Exchanges, Mergers, Etc.</U></B>&nbsp;The provisions of this Agreement apply to the full extent set forth herein with respect to any and
all shares of capital stock of the Company or successor of the Company which may be issued in respect of, in exchange for, or in substitution
for the Restricted Stock by reason of any stock dividend, split, reverse split, combination, recapitalization, reclassification, merger,
consolidation or otherwise which does not terminate this Agreement. Except as otherwise provided herein, this Agreement is not intended
to confer upon any other person except the parties hereto any rights or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Participant
Representations</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Participant represents to
the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions
on Transfer</U>. The Participant acknowledges that the Restricted Stock to be issued to the Participant must be held indefinitely unless
subsequently registered and qualified under the Securities Act of 1933, as amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo;) or
unless an exemption from registration and qualification is otherwise available. In addition, the Participant understands that the certificate
representing the Restricted Stock will be imprinted with a legend which prohibits the transfer of such Restricted Stock unless it is sold
in a transaction in compliance with the Securities Act or are registered and qualified or such registration and qualification are not
required in the opinion of counsel acceptable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;<U>Relationship
to the Company; Experience</U>. The Participant either has a preexisting business or personal relationship with the Company or any of
its officers, directors or controlling persons or, by reason of the Participant&rsquo;s business or financial experience or the business
or financial experience of the Participant&rsquo;s personal representative(s), if any, who are unaffiliated with and who are not compensated
by the Company or any affiliate or selling agent, directly or indirectly, has the capacity to protect the Participant&rsquo;s own interests
in connection with the Participant&rsquo;s acquisition of the Restricted Stock to be issued to the Participant hereunder. The Participant
and/or the Participant&rsquo;s personal representative(s) have such knowledge and experience in financial, tax and business matters to
enable the Participant and/or them to utilize the information made available to the Participant and/or them in connection with the acquisition
of the Restricted Stock to evaluate the merits and risks of the prospective investment and to make an informed investment decision with
respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Participant&rsquo;s
Liquidity</U>. In reaching the decision to invest in the Restricted Stock, the Participant has carefully evaluated the Participant&rsquo;s
financial resources and investment position and the risks associated with this investment, and the Participant acknowledges that the Participant
is able to bear the economic risks of the investment. the Participant (i) has adequate means of providing for the Participant&rsquo;s
current needs and possible personal contingencies, (ii) has no need for liquidity in the Participant&rsquo;s investment, (iii) is able
to bear the substantial economic risks of an investment in the Restricted Stock for an indefinite period and (iv) at the present time,
can afford a complete loss of such investment. The Participant&rsquo;s commitment to investments which are not readily marketable is not
disproportionate to the Participant&rsquo;s net worth and the Participant&rsquo;s investment in the Restricted Stock will not cause the
Participant&rsquo;s overall commitment to become excessive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;<U>Access
to Data</U>. The Participant acknowledges that during the course of this transaction and before deciding to acquire the Restricted Stock,
the Participant has been provided with financial and other written information about the Company. The Participant has been given the opportunity
by the Company to obtain any information and ask questions concerning the Company, the Restricted Stock, and the Participant&rsquo;s investment
that the Participant felt necessary; and to the extent the Participant availed himself/herself of that opportunity, the Participant has
received satisfactory information and answers concerning the business and financial condition of the Company in response to all inquiries
in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Risks</U>.
The Participant acknowledges and understands that (i) an investment in the Company constitutes a high risk, (ii) the Restricted Stock
is highly speculative, and (iii) there can be no assurance as to what investment return, if any, there may be. The Participant is aware
that the Company may issue additional securities in the future which could result in the dilution of the Participant&rsquo;s ownership
interest in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Valid
Agreement</U>. This Agreement when executed and delivered by the Participant will constitute a valid and legally binding obligation of
the Participant which is enforceable in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;<U>Residence</U>.
The address set forth on the Notice of Restricted Stock Grant is the Participant&rsquo;s current address and accurately sets forth the
Participant&rsquo;s place of residence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;<U>Tax Consequences</U>.
The Participant has reviewed with the Participant&rsquo;s own tax advisors the federal, state, local and foreign tax consequences of this
investment and the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements
or representations of the Company or any of its agents. The Participant understands that the Participant (and not the Company) is responsible
for the Participant&rsquo;s own tax liability that may arise as a result of the transactions contemplated by this Agreement. The Participant
understands that Section 83 of the Internal Revenue Code of 1986, as amended (the &ldquo;<B><U>Code</U></B>&rdquo;), taxes as ordinary
income the difference between the purchase price for the Restricted Stock and the fair market value of the Restricted Stock as of the
date any restrictions on the Restricted Stock lapse. The Participant understands that the Participant may elect to be taxed at the time
the Restricted Stock is purchased rather than when and as the restrictions lapse by filing an election under Section 83(b) of the Code
with the Internal Revenue Service within 30 days from the date of purchase. The form for making this election is attached as&nbsp;<U>Exhibit
A</U>&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">THE PARTICIPANT ACKNOWLEDGES THAT IT IS THE PARTICIPANT&rsquo;S
SOLE RESPONSIBILITY AND NOT THE COMPANY&rsquo;S TO FILE TIMELY ANY ELECTION UNDER SECTION 83(b), EVEN IF THE PARTICIPANT REQUESTS THE
COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON GRANTEE&rsquo;S BEHALF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No
Employment Contract Created</U></B>. The issuance of the Restricted Stock is not to be construed as granting to the Participant any right
with respect to continuance of employment or any service with the Company or any of its subsidiaries. The right of the Company or any
of its subsidiaries to terminate at will the Participant&rsquo;s employment or terminate the Participant&rsquo;s service at any time (whether
by dismissal, discharge or otherwise), with or without cause, is specifically reserved, subject to any other written employment or other
agreement to which the Company and the Participant may be a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Tax
Withholding</U></B>. The Company has the power and the right to deduct or withhold, or require the Participant to remit to the Company,
an amount sufficient to satisfy Federal, state and local taxes (including the Participant&rsquo;s FICA obligation) required by law to
be withheld with respect to the grant and vesting of the Restricted Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Interpretation</U></B>.
The Restricted Stock is being issued pursuant to the terms of the Plan, and are to be interpreted in accordance therewith. The Board (or
an authorized committee thereof) will interpret and construe this Agreement and the Plan, and any action, decision, interpretation or
determination made in good faith by the Board (or an authorized committee thereof) will be final and binding on the Company and the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;<B><U>Notices</U>.</B>&nbsp;All
notices or other communications which are required or permitted hereunder will be in writing and sufficient if (i) personally delivered
or sent by telecopy, (ii) sent by nationally-recognized overnight courier or (iii) sent by registered or certified mail, postage prepaid,
return receipt requested, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp; if to the
Participant, to the address (or telecopy number) set forth on the Notice of Grant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp; if to the Company,
to its principal executive office as specified in any report filed by the Company with the Securities and Exchange Commission or to such
address as the Company may have specified to the Participant in writing, Attention: Corporate Secretary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">or to such other address as the
party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. Any such communication will
be deemed to have been given (i) when delivered, if personally delivered, or when telecopied, if telecopied, (ii) on the first Business
Day (as hereinafter defined) after dispatch, if sent by nationally-recognized overnight courier and (iii) on the fifth Business Day following
the date on which the piece of mail containing such communication is posted, if sent by mail. As used herein, &ldquo;<B><U>Business Day</U></B>&rdquo;
means a day that is not a Saturday, Sunday or a day on which banking institutions in the city to which the notice or communication is
to be sent are not required to be open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;<B><U>Specific
Performance</U></B>. The Participant expressly agrees that the Company will be irreparably damaged if the provisions of this Agreement
and the Plan are not specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Agreement
or the Plan by the Participant, the Company will, in addition to all other remedies, be entitled to a temporary or permanent injunction,
without showing any actual damage, and/or decree for specific performance, in accordance with the provisions hereof and thereof. The Board
(or an authorized committee thereof) has the power to determine what constitutes a breach or threatened breach of this Agreement or the
Plan. Any such determinations will be final and conclusive and binding upon the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;<B><U>No
Waiver</U>.</B>&nbsp;No waiver of any breach or condition of this Agreement will be deemed to be a waiver of any other or subsequent breach
or condition, whether of like or different nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;<B><U>Participant
Undertaking</U>.</B>&nbsp;The Participant hereby agrees to take whatever additional actions and execute whatever additional documents
the Company may in its reasonable judgment deem necessary or advisable in order to carry out or effect one or more of the obligations
or restrictions imposed on the Participant pursuant to the express provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;<B><U>Modification
of Rights</U>.</B>&nbsp;The rights of the Participant are subject to modification and termination in certain events as provided in this
Agreement and the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;<B><U>Governing
Law</U>.</B>&nbsp;This Agreement is governed by, and construed in accordance with, the laws of the State of Nevada, without giving effect
to its conflict or choice of law principles that might otherwise refer construction or interpretation of this Agreement to the substantive
law of another jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;<B><U>Counterparts;
Facsimile Execution</U>.</B>&nbsp;This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original,
but all of which together will constitute one and the same instrument. Facsimile execution and delivery of this Agreement is legal, valid
and binding execution and delivery for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;<B><U>Entire
Agreement</U>.</B>&nbsp;This Agreement (including the Notice of Restricted Stock Grant) and the Plan, constitute the entire agreement
between the parties with respect to the subject matter hereof, and supersedes all previously written or oral negotiations, commitments,
representations and agreements with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.&nbsp;&nbsp;&nbsp;<B><U>Severability</U>.</B>&nbsp;In
the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability will not affect any other provisions of this Agreement, and this Agreement will
be construed as if such invalid, illegal or unenforceable provision had never been contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">19.&nbsp;&nbsp;&nbsp;<B><U>WAIVER
OF JURY TRIAL</U>.</B>&nbsp;THE PARTICIPANT HEREBY EXPRESSLY, IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION
OR PROCEEDING RELATING TO THIS AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the
parties hereto have executed this Restricted Share Grant Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">AXIL BRANDS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">PARTICIPANT:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SPOUSE&rsquo;S CONSENT TO AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Required where Participant resides in a community
property state)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">I acknowledge that I have read
the Agreement and the Plan and that I know and understand the contents of both. I am aware that my spouse has agreed therein to the imposition
of certain forfeiture provisions and restrictions on transferability with respect to the Restricted Stock that are the subject of the
Agreement, including with respect to my community interest therein, if any, on the occurrence of certain events described in the Agreement.
I hereby consent to and approve of the provisions of the Agreement, and agree that I will abide by the Agreement and bequeath any interest
in the Restricted Stock which represents a community interest of mine to my spouse or to a trust subject to my spouse&rsquo;s control
or for my spouse&rsquo;s benefit or the benefit of our children if I predecease my spouse.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ELECTION UNDER SECTION 83(b)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF THE INTERNAL REVENUE CODE OF 1986</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned taxpayer hereby
elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the taxpayer&rsquo;s gross income or
alternative minimum taxable income, as the case may be, for the current taxable year, as compensation for services the excess (if any)
of the fair market value of the shares described below over the amount paid for those shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The name, address, social security number and taxable year of the undersigned are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxpayer Name:</FONT></TD>
    <TD STYLE="width: 69%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social Security Number:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxable Year:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The property with respect to which the election is made is described as follows: __________ shares (the &ldquo;<B><U>Shares</U></B>&rdquo;)
of the Common Stock of AXIL Brands, Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The date on which the property was transferred is:___________________ ,______.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The property is subject to the following restrictions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Shares may not be transferred
and are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the
satisfaction of certain conditions contained in such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The fair market value of the property at the time of transfer (determined without regard to any restriction other than a nonlapse restriction
as defined in &sect; 1.83-3(h) of the Income Tax Regulations) is: $_______ per share x ________ shares = $___________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
For the property transferred, the undersigned paid $______ per share x _________ shares = $______________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The amount to include in gross income is $______________.&nbsp;<B><I>[The result of the amount reported in Item 5 minus the amount reported
in Item 6.]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned taxpayer will
file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than
30 days after the date of transfer of the property. A copy of the election also will be furnished to the person for whom the services
were performed. The undersigned is the person performing the services in connection with which the property was transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>The undersigned understands that the foregoing
election may not be revoked except with the consent of the Commissioner</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ______________________, _____</FONT></TD>
    <TD STYLE="width: 53%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned spouse of taxpayer joins in this election.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ______________________, _____</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxpayer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;_________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;Spouse of Taxpayer</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>axil-20241130_10qex31z1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>CERTIFICATION PURSUANT
TO RULE 13a-14(a)/15d-14(a), AS ADOPTED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">I, Jeff Toghraie, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly Report on Form
    10-Q of Axil Brands, Inc.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 46%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Date:   January 8, 2025</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeff Toghraie</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Title:</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jeff Toghraie</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>axil-20241130_10qex31z2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; background-color: white"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; background-color: white"><B>PURSUANT TO SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">I, Jeff Brown, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly Report on Form 10-Q of Axil Brands, Inc.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 43%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 41%">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Date: January 8, 2025</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeff Brown</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Title:</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jeff Brown</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer and Principal Accounting Officer)<BR>
    <BR>
    </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>axil-20241130_10qex32z1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">In connection with the Quarterly
Report on Form 10-Q of Axil Brands, Inc. (the &ldquo;Company&rdquo;) for the quarter ended November 30, 2024 (the
&ldquo;Report&rdquo;), I, Jeff Toghraie, Chief Executive Officer, certify as follows:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 9pt; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">A)</FONT></TD><TD><FONT STYLE="font-size: 10pt">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 9pt; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">B)</FONT></TD><TD><FONT STYLE="font-size: 10pt">the information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company as of the dates and for the periods covered by the Report.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">This statement is authorized to be attached
as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and
Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Pursuant to Securities and Exchange
Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement
of the Company filed under Securities Act of 1933, as amended, except to the extent that the Company specifically incorporates it by reference.
A signed original of this written statement by Section 906 has been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 43%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 41%">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Date:  January 8, 2025</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeff Toghraie</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Title:</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jeff Toghraie</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>axil-20241130_10qex32z2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">In connection with the Quarterly
Report on Form 10-Q of Axil Brands, Inc. (the &ldquo;Company&rdquo;) for the quarter ended November 30, 2024 (the
&ldquo;Report&rdquo;), I, Jeff Brown, Chief Financial Officer, certify as follows:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 9pt; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">A)</FONT></TD><TD><FONT STYLE="font-size: 10pt">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 9pt; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">B)</FONT></TD><TD><FONT STYLE="font-size: 10pt">the information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company as of the dates and for the periods covered by the Report.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">This statement is authorized to be attached
as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and
Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Pursuant to Securities and Exchange
Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement
of the Company filed under Securities Act of 1933, as amended, except to the extent that the Company specifically incorporates it by reference.
A signed original of this written statement by Section 906 has been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 42%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Date:  January 8, 2025</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeff Brown</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Title:</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jeff Brown</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer and Principal Accounting Officer)</P></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>axil-20241130_10qex99z1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OFFICE LEASE AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FOR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>9150 WILSHIRE BOULEVARD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NEW LION ENTERPRISES LLC,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS LANDLORD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AXIL BRANDS, INC.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS TENANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>The submission of this document for examination
does not constitute an option or offer to lease space. This document shall have no binding effect on the parties unless executed by the
Landlord and the executed copy is delivered to the Tenant.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">9150 Wilshire Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Davidovich</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OFFICE LEASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Office Lease Agreement (the
<B>&ldquo;Lease&rdquo;) </B>is made this 12 day of October 2024 <B>(&ldquo;Effective Date&rdquo;) </B>by and between <B>NEW LION ENTERPRISES
LLC, </B>a California limited liability company <B>(&ldquo;Landlord&rdquo;) </B>and <B>AXIL BRANDS, INC., </B>a Delaware corporation <B>(&ldquo;Tenant&rdquo;).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD><B>BASIC LEASE PROVISIONS:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.1.</TD><TD STYLE="text-align: justify"><U>Building</U>: That certain office building having a street address of 9150 Wilshire Boulevard, Beverly
Hills, California 90212, as more particularly described in <B>Schedule 1, </B>including all parking garages, outside plazas, atria, lobbies,
office and commercial spaces, landscaping, and the real property upon which said office building complex is located.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.2.</TD><TD><U>Unit/Suite No.</U>: 245</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in"><U>Floor</U>: Second (2<SUP>nd</SUP>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.3.</TD><TD><U>Premises</U>: Approximately 2,793 total rentable square feet <B>(&ldquo;RSF&rdquo;) </B>as reflected on the floor plan attached
hereto as <B>Schedule 2.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.4.</TD><TD STYLE="text-align: justify"><U>Commencement Date of Lease</U>: November 1, 2024 (Any possession of the Premises by Tenant prior to
the Commencement Date, shall be subject to the terms and conditions of this Lease; provided, however, Tenant shall not be required to
pay any Base Rent during any such early occupancy period.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.5.</TD><TD><U>Rent Commencement Date</U>: November 1, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.6.</TD><TD><U>Expiration Date of Lease</U>: January 31, 2029.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.7.</TD><TD><U>Tenant&rsquo;s Percentage Share</U>: 3.11 %. Based upon Premises of 2,793 RSF in a Building of 89,651 RSF.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.8.</TD><TD><U>Security Deposit</U>: $12,568.50.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.9.</TD><TD><U>Advance Payment</U>: $11,168.00.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.10.</TD><TD><U>Rent Abatement</U>: The Base Rent shall be abated for months 2, 15, and 30 of the initial Lease Term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.11.</TD><TD><U>Base Rent</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in">Base Rent for the Lease Term shall be according to the following
schedule:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif; margin-left: 1.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Period</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">Monthly Base Rent</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">Annual Base Rent</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%">Months 1-12</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 25%; text-align: right">11,168.00</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 25%; text-align: right">134,016.00</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Months 13.:.24</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,618.88</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">139,426.56</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Months 25-36</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,093.69</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">145,124.28</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Months 37-348</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,568.50</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">150,822.00</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Months 49-52</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,945.56</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">155,346.72</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in"><U>Operating Expense Rent</U>: The total Operating Expense Rent
for the Lease Term shall be according to the following schedule and shall not be modified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif; margin-left: 1.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Period</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">Monthly Operating Expense Rent</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">Annual</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font-weight: normal">Months 1-12</TD><TD STYLE="width: 1%; font-weight: normal">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: normal; text-align: left">$</TD><TD STYLE="width: 25%; font-weight: normal; text-align: right">0.00</TD><TD STYLE="white-space: nowrap; width: 1%; font-weight: normal; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: normal">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: normal; text-align: left">$</TD><TD STYLE="width: 25%; font-weight: normal; text-align: right">0.00</TD><TD STYLE="white-space: nowrap; width: 1%; font-weight: normal; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal">Months 13-24</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">232.28</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">2,788.53</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal">Months 25-36</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">464.56</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">5,574.72</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal">Months 37-348</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">929.12</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">11,149.44</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal">Months 49-52</TD><TD STYLE="font-weight: normal">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: left">$</TD><TD STYLE="font-weight: normal; text-align: right">1,858.24</TD><TD STYLE="white-space: nowrap; font-weight: normal; text-align: left">&nbsp;</TD><TD STYLE="font-weight: normal; font-style: italic">&nbsp;</TD>
    <TD STYLE="font-weight: normal; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="font-weight: normal; font-style: italic; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">N/A</FONT></TD><TD STYLE="white-space: nowrap; font-weight: normal; font-style: italic; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.12.</TD><TD>Intentionally Omitted</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.13.</TD><TD><U>Permitted Use</U>: General Office &amp; storage use and no other purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.14.</TD><TD STYLE="text-align: justify"><U>Parking Spaces</U>: Tenant shall be entitled to use three (3) unreserved parking spaces (the <B>&ldquo;Parking
Spaces&rdquo;) </B>per 1,000 RSF of the Premises. Notwithstanding anything to the contrary contained in this Lease, Tenant, during the
Lease Term, shall be obligated to lease and pay on a &ldquo;must take&rdquo; basis six (6) single reserved Parking Spaces (the <B>&ldquo;Must
Take Parking Spaces&rdquo;) </B>at the rate set forth below, which rate .increase by $10 at the beginning of each year. The charge for
Tenant&rsquo;s Parking Spaces during the Lease Term (the <B>&ldquo;Parking Charges&rdquo;) </B>shall be as follows, which shall increase
by $10 at the beginning of each year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD><B><U>Single Unreserved Spaces</U>: </B>$210.00 plus tax per Single Unreserved Parking Space per month.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD><B><U>Single Reserved Spaces:</U></B> $295.00 plus tax per Single Reserved Parking Space per month.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD><B><U>Tandem Spaces: UNAVAILABLE</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.15.</TD><TD><U>Guarantor(s)</U>: Intentionally Omitted</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.16.</TD><TD><U>Addresses</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>Address for payment of Rent and notices:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Landlord:</TD>
    <TD STYLE="width: 50%">Tenant:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For Notices:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New Lion Enterprises LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">9150 Wilshire Blvd. Suite 104</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Beverly Hills, CA 90212</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attention: Property Manager</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">After Commencement Date:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Axil Brands, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">777 S Auto Mall Drive, Unit 107</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">American Fork, UT 84003</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For Payment of Rent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New Lion Enterprises LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">9150 Wilshire Blvd. Suite 104</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Beverly Hills, CA 90212</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attention: Property Manager</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">1.17.</TD><TD><U>Broker</U>: See <B>Schedule 7. </B>(See <B>Paragraph 41.)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B>DEFINITIONS: </B>Unless the context otherwise specifies or requires, the following terms will have the meanings set forth below:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.1.</TD><TD STYLE="text-align: justify"><U>Common Areas</U>: shall mean all areas and facilities outside the Premises and within the exterior
boundaries of the Building that are not leased to other tenants and that are provided and designated by Landlord, in its sole discretion
from time to time, for the general use and convenience of Tenant and other tenants of the Building and their authorized representatives,
employees, invitees and the general public (such as common entrances, walkways, stairways, elevators, restrooms, and lobbies) as more
particularly set forth in <B>Paragraph 4. </B>Landlord may also designate, from time to time, other areas in the Building, such as pedestrian
walkways, patios, landscaped areas, sidewalks, service corridors, elevators, restrooms, stairways, decorative walls, plazas, loading areas,
parking areas and roads for the non-exclusive use of Tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.2.</TD><TD STYLE="text-align: justify"><U>Operating Expenses</U>: shall mean all costs of operating, servicing, managing, repairing and maintaining
the Building, the landscaping of Common Areas of the Building and the parking lot or garage used as parking for the Building, including
any reasonable and necessary costs of operation, maintenance and repair, computed in accordance with sound accounting principles applied
on a consistent basis, and will include by way of illustration, but not limitation:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all necessary costs of managing, operating, repairing and maintaining the Building, including, without
limitation, wages, salaries, fringe benefits and payroll burden for employees at or below the level of regional manager; employees on-site
utilized in the day to day operation of the Building; public liability, flood, property damage and all other insurance premiums paid by
Landlord with respect to the Building, including any amounts that would be charged as premiums if Landlord self-insures any of the insurance
risks; liability disclaimers; electricity, water, sewer, heating, air conditioning, ventilating and all other utility charges; the cost
of contesting the validity or amount of real estate and personal property taxes; janitorial services; access control; window cleaning;
elevator maintenance; fire detection and security services; gardening and landscape maintenance; all costs of snow and ice removal; trash,
rubbish, garbage and other refuse removal; pest control; painting; facade maintenance; lighting; exterior and partition (demising) wall
repairs; roof repairs; maintenance of all steam, water and other water retention and discharging piping, lakes, culverts, fountains, pumps,
weirs, lift stations, catch basins and other areas and facilities, whether or not on-site; canal embankment and related maintenance; repair
and repainting of sidewalks due to settlement and potholes and general resurfacing and maintenance of parking areas; sanitary control;
depreciation of machinery and equipment used in any of such maintenance and repair activities; repair, maintenance and replacement of
signage located in the Building; management fees; union increases; road sidewalk and driveway maintenance; and all other Building maintenance,
repairs and insurance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT><FONT STYLE="font-size: 10pt">the
costs (amortized together with a reasonable finance charge) of any capital improvements: (A) made to the Building by Landlord primarily
for the purpose of reducing Operating Expenses; or (B) made to the Building by Landlord primarily to comply with any governmental law
or regulation that was not in force at the Commencement Date;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>the costs of supplies, materials, tools and equipment for repairs and maintenance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">all real and personal property taxes, assessments (whether they be general or special), sewer rents, rates
and charges, transit taxes, franchise taxes, and any other federal, state or local government charge, general, special, ordinary or extraordinary
(but not including income taxes), which may now or hereafter be levied or assessed against the land upon which the Building stands or
the Building for such year or the furniture, fixtures, machinery, equipment, apparatus, systems and appurtenances used in connection with
the Building for the operation thereof (the <B>&ldquo;Taxes&rdquo;).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Operating Expenses shall not include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>depreciation on the Building or any Common Areas;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">costs of space planning, tenant improvements, marketing expenses, finders&rsquo; fees and real estate
broker commissions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">any and all expenses for which Landlord is reimbursed (either by an insurer, condemnor, tenant or other
person or entity), but only to the extent of such reimbursement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">that portion of the salaries for on or off-site personnel to the extent any of them work for other projects
owned by Landlord or the Building&rsquo;s managing agent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">costs in connection with services or benefits of a type that are not Building standards and are not available
to Tenant, but are available to another tenant or occupant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">mark-ups on electricity and condenser cooling water for heat pumps in excess of Landlord&rsquo;s costs
therefore;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">Landlord&rsquo;s general overhead and administrative expenses not directly allocable to the operation
of the Building;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">attorneys&rsquo; fees and cost related to negotiating or enforcing any tenant lease, or resolving disputes
with any lender of Landlord;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">cost of capital improvements unless meeting the requirements of <B>Paragraph 2.2(b);</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify">interest on debt or amortization payments on any mortgage/deed of trust, or rent on any ground lease;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(o)</TD><TD>federal and state taxes on income, death, estate or inheritance; or franchise taxes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.3.</TD><TD STYLE="text-align: justify"><U>Environmental Law</U>: shall mean any law, statute, ordinance or regulation pertaining to health, industrial
hygiene or the environment including, without limitation, <B>CERCLA </B>(Comprehensive Environmental Response, Compensation and Liability
Act of 1980), <B>RCRA </B>(Resources Conservation and Recovery Act of 1976), <B>SARA </B>(Superfund Amendments and Reauthorization Act
of 1986), <B>EPCRA </B>(Emergency Planning and Community Right-to-Know Act), and any applicable laws or regulations of the State of California.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.4.</TD><TD STYLE="text-align: justify"><U>Hazardous Substance</U>: shall mean any substance, material or waste which is or becomes designated,
classified or regulated as being &ldquo;toxic&rdquo; or &ldquo;hazardous&rdquo; or a &rsquo;&lsquo;pollutant&rdquo;, which is or becomes
similarly designated, classified or regulated, under any Environmental Law, including asbestos, petroleum and petroleum products, or which
becomes hazardous to the health and welfare of any occupants in the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.5.</TD><TD STYLE="text-align: justify"><U>Building Hours</U>: shall mean Monday through Friday from 8:30 a.m. to 5:30 p.m., excluding federal
and state legal holidays.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.6.</TD><TD STYLE="text-align: justify"><U>Legal Requirements</U>: shall mean any and all statutes, ordinances and requirements of all municipal,
state and federal authorities now in force, or which may hereafter be in force, pertaining to the Premises and/or the Building, including,
but not limited to, the Americans with Disabilities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.7.</TD><TD STYLE="text-align: justify"><U>Schedules</U>: shall mean the Schedules attached hereto and incorporated herein by reference. This
Lease contains the following Schedules:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">Schedule 1</TD>
    <TD STYLE="width: 80%">Description of Building </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Schedule 2</TD>
    <TD>Floor Plan of Premises</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Schedule 3</TD>
    <TD>Work Letter</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Schedule 4</TD>
    <TD>Guaranty of Lease</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Schedule 5</TD>
    <TD>Rules and Regulations</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Schedule 6</TD>
    <TD>Tenant Acceptance Letter</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Schedule 7</TD>
    <TD>Brokerage Commission Agreement</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">2.8.</TD><TD STYLE="text-align: justify"><U>Term/Lease Term</U>: shall mean the initial term of this Lease, namely a period of thirty nine
                                                                 (39) full months. It shall commence as of the Commencement Date and end as of the Expiration Date unless sooner terminated as
                                                                 provided herein or extended pursuant to the terms of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">3.</FONT></TD><TD>PREMISES:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Lease of Premises</U>: Landlord hereby leases to Tenant, and Tenant hereby
leases from Landlord, for the Term and subject to the agreements, covenants, conditions and provisions set forth in this Lease, to which
Landlord and Tenant hereby mutually agree, the premises (the <B>&ldquo;Premises&rdquo;) </B>described in <B>Paragraph 1 </B>above. The
parties hereby stipulate the number of rentable square feet in the Premises and both parties waive the right either may have to re-measure
the same. Upon occupancy of the Premises by Tenant, Tenant shall promptly execute and deliver to Landlord the Tenant Acceptance Letter
attached hereto as <B>Schedule 6. </B>If Landlord is unable to deliver possession of the Premises on the Commencement Date, Landlord shall
not be liable for any damage caused thereby, nor shall this Lease be void or voidable, but Tenant </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>shall not be liable for any Rent and the Commencement Date shall be delayed until possession is delivered, at which
time the Term shall commence and the Expiration Date shall be extended so as to give effect to the full stated Term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">3.2.</TD><TD STYLE="text-align: justify"><U>Building</U>: The Premises are a part of the building (the <B>&ldquo;Building&rdquo;) </B>described
in <B>Paragraph 1. </B>Landlord may increase, reduce or change the number, dimensions or locations of the walks, buildings, mall areas,
parking and other Common Areas and other improvements located in the Building in any manner that Landlord, in its sole discretion, shall
deem proper. Landlord further reserves the right to make alterations and/or additions to and to build or cause to be built additional
stories on the Building in which the Premises are situated and to add any buildings adjoining the Premises or elsewhere in the Building.
Without limiting the generality of the foregoing, Landlord may add additional tenants, retail shops, building and parking facilities anywhere
in the Building. Such alterations and/or additions by Landlord shall not materially impair the Tenant&rsquo;s ability to use the Premises
for its Permitted Use. Landlord reserves the right to install, maintain, use, repair and replace pipes, ducts, conduits and wires leading
through the Premises and serving other parts of the Building in a manner that will not materially interfere with Tenant&rsquo;s use of
the Premises, except temporarily in the case of an emergency. Landlord will also have the right to increase and expand the size of the
Building by adding additional land, buildings and other structures to the Building, provided such expansion does not materially impair
the Tenant&rsquo;s ability to use the Premises for its Intended Use and the Tenant&rsquo;s Percentage Share is equitably adjusted. Landlord
shall have the right to change the Building&rsquo;s name without notice, to change the Building&rsquo;s street address, each upon ninety
(90) days prior notice, and the right to grant to any person or entity the exclusive right to conduct any business or render any service
in or to the Building, provided such exclusive right shall not operate to prohibit Tenant from using the Premises for the purpose set
forth in <B>Paragraph 1, </B>to retain at all times master keys or passkeys to the Premises, and to place such signs, notices or displays
as Landlord reasonably deems necessary or desirable upon the roof and exterior of the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">3.3.</TD><TD STYLE="text-align: justify"><U>Relocation of Tenant</U>: Landlord expressly reserves the right after the execution and during the
Term of this Lease, or any extension or renewal thereof, at its sole cost and expense, to remove the Tenant from the Premises and relocate
the Tenant to some other space of Landlord&rsquo;s choosing of approximately the same size within the Building, which other space shall
be decorated by Landlord at Landlord&rsquo;s expense and Landlord may in its discretion use such decorations and materials from the existing
Premises or other materials, so that the space in which Tenant is relocated is comparable in its interior design and decoration to the
Premises from which Tenant is removed. Tenant, by the execution of this Lease, acknowledges the foregoing right of Landlord, and no rights
granted in this Lease to Tenant, including, but not limited to, the right of peaceful and quiet enjoyment, shall be deemed to have been
breached or interfered with by reason of Landlord&rsquo;s exercise of the right of relocation reserved in this <B>Paragraph 3.3. </B>Landlord&rsquo;s
sole obligation for costs and expenses of removal and relocation shall be the actual cost of relocating and decorating the space in which
Tenant is relocated and the reasonable moving costs of Tenant actually incurred in connection with the same, and Tenant agrees that Landlord&rsquo;s
exercise of its election to remove and relocate Tenant shall not terminate this Lease or release the Tenant, in whole or in part, from
the Tenant&rsquo;s obligation to pay the Rents and perform the covenants and agreements hereunder for the full Term of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">4.</FONT></TD><TD><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>COMMON AREAS:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">4.1.</TD><TD STYLE="text-align: justify"><U>Tenant&rsquo;s Right to Use Common Areas</U>: Landlord grants Tenant and its authorized representatives
and invitees the non-exclusive right to use the Common Areas with others who are entitled to use the Common Areas subject to Landlord&rsquo;s
rights as set forth in this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">4.2.</TD><TD STYLE="text-align: justify"><U>Landlord&rsquo;s Control</U>: Landlord has the right to: (a) establish and enforce reasonable rules
and regulations applicable to all tenants concerning the maintenance, management, use and operation of the Common Areas, the initial rules
and regulations are attached to the Lease as <B>Schedule 5; </B>(b) close, if necessary, any of the Common Areas to prevent dedication
of any of the Common Areas or the accrual of any rights of any person or of the public to the Common Areas; (c) close temporarily any
of the Common Areas for maintenance purposes; (d) select a person, firm or corporation which may be an entity related to Landlord to maintain
and operate any of the Common Areas;. Notwithstanding the provisions of this <B>Paragraph 4.2, </B>in exercising its rights hereunder,
Landlord shall provide Tenant with a means of reasonable access to and from the Premises.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">5.</FONT></TD><TD>RENT:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: right; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.1.</TD><TD STYLE="text-align: justify"><U>Base Rent</U>: Tenant will pay to Landlord as Rent for the use and occupancy of the Premises at the
times and in the manner provided below, Base Rent in the amount specified in <B>Paragraph 1 </B>payable in U.S. funds, in advance starting
on the Rent Commencement Date and on or before the first day of each and every successive calendar month thereafter during the Term without
demand, setoff or deduction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.2.</TD><TD STYLE="text-align: justify"><U>Tenant&rsquo;s Percentage Share</U>. Tenant&rsquo;s Percentage Share of the Operating Expenses is the
proportion that the rentable square footage occupied by Tenant bears to the total rentable square footage of the Building, as determined
by Landlord (said Percentage Share shall be adjusted in the event the rentable area of the Building is increased.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.3.</TD><TD><U>Operating Expense Rent</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Calculation</U>. In addition to Base Rent, Tenant shall pay Tenant&rsquo;s Percentage Share, as specified
in <B>Paragraph 1 </B>of the Operating Expenses paid or incurred by Landlord in such year in excess of the Operating Expenses for the
Base Year <B>(&ldquo;Operating Expense Rent&rdquo;), </B>and such amount have been defined and pre calculated in accordance with Section
1.1 above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Payment</U>:
During December of each calendar year or as soon thereafter as practicable, Landlord shall provide Tenant with a written notice of its
estimate (reasonable line item and detailed support included) of Operating Expense Rent for the ensuing calendar year. On or before the
first day of each month during the ensuing calendar year, Tenant will pay to Landlord I/12th of such estimated amounts, provided that
if such notice is not given in December, Tenant will continue to pay on the basis of the prior year&rsquo;s estimate until the month
after such notice is given. If at any time or times it appears to Landlord that the amounts payable for Operating Expense Rent for the
current calendar year will vary from its estimate by more than ten percent (10%), Landlord, by written notice to Tenant, </FONT>will
revise its estimate for such year, and subsequent payments by Tenant for such year will be in an amount so that by the end of such year
Tenant will have paid a total sum equal to such revised estimate. Landlord will indicate in its notice to Tenant the reasons Landlord
believes its estimate is low by more than ten percent (10%).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Statement</U>: Within ninety (90) days after the close of each calendar year or as soon after such
ninety (90) day period as practicable, Landlord will deliver to Tenant a statement of amounts of Operating Expense Rent payable under
this Lease for such calendar year. If such statement shows an amount owing by Tenant that is more than the estimated payments for such
calendar year previously made by Tenant, Tenant will pay the deficiency to Landlord within thirty (30) days after delivery of the statement.
If the total of the estimated monthly installments paid by Tenant during any calendar year exceeds the actual expense adjustment amount
due from Tenant for such calendar year and provided Tenant is not in default hereunder, such excess shall, at Landlord&rsquo;s option,
be either credited against payments next due hereunder or refunded by Landlord to Tenant. The terms and conditions of this <B>Paragraph
5.3(c) </B>shall survive expiration or other termination of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Audit Rights</U>: Tenant has the right, exercisable no more than once each calendar year on reasonable
notice and at a time reasonably acceptable to Landlord, to cause an audit to be performed at Tenant&rsquo;s sole cost and expense of Landlord&rsquo;s
operations and/or books and records pertaining to Operating Expense Rent for the preceding calendar year. In the event Landlord has overstated
Operating Expense Rent by more than five percent (5%), and provided Tenant is not in default hereunder and that Landlord has reviewed
and agrees with Tenant&rsquo;s findings, then within thirty (30) days after demand therefor by Tenant accompanied by Tenant&rsquo;s verification
of such overcharges and paid invoices, Landlord will reimburse Tenant for such overcharges. In the event that Landlord has overstated
Operating Expenses for the calendar year being reviewed by more than five percent (5%), and provided Tenant is not in default hereunder,
within thirty (30) days after demand therefor by Tenant accompanied .by Tenant&rsquo;s verification of such overcharges and paid invoices,
Landlord shall also reimburse Tenant for the reasonable costs of such audit up to an amount not to exceed the sum of $1,500.00; provided,
however, the person or company performing such audit shall not be compensated, in whole or in part, on a contingency fee basis.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Gross Up</U>. Notwithstanding any provision of this <B>Paragraph 5.3 </B>to the contrary, if the Building
is less than one hundred percent (100%) leased and/or occupied during any calendar year including the Base Year for purposes of determining
Base Year Operating Expense, an adjustment shall be made so that Operating Expense Rent shall be computed for such year as though one
hundred percent (100%) of the Building had been leased and occupied during such year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.4.</TD><TD STYLE="text-align: justify"><U>Sales Tax</U>: Only if and to the extent actually charged by any applicable governmental or quasi-governmental
authority, Tenant agrees to pay to Landlord, concurrently with Tenant&rsquo;s payments under this Lease, all taxes (including, without
limitation, sales tax), or other charges, that are imposed upon any payment to be made by Tenant to Landlord under this Lease (collectively,
<B>&ldquo;Rent Taxes&rdquo;).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.5.</TD><TD STYLE="text-align: justify"><U>Additional Rent</U>: Tenant shall also be responsible for timely payment of sales tax or other taxes,
if any (and for any interest and penalties assessed for untimely payment), on all payments to third parties or performance by Tenant under
the Lease. All sums of money as shall become due and payable by Tenant to Landlord under this Lease, including, without limitation, Rent
Taxes, Operating Expense Rent, electricity costs, and Parking Charges shall be deemed &ldquo;Additional Rent,&rdquo; which Tenant shall
be obligated to pay without offset, charge, deduction or delay. Landlord shall have the same remedies for default in the payment of additional
Rent as are available to Landlord in the case of a default in the payment of Base Rent. All Base Rent, Operating Expense Rent, Additional
Rent and additional sums payable hereunder are sometimes collectively referred to as <B>&ldquo;Rent.&rdquo;</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.6.</TD><TD STYLE="text-align: justify"><U>Late Fee / Default Interest</U>: Any installment of Rent not paid when due and payable shall bear interest
at the rate often percent (10%) per annum. In the event any check, bank draft or negotiable instrument given for any payment under this
Lease shall be dishonored at any time for any reason whatsoever not attributable to Landlord, Landlord shall be entitled, in addition
to any other remedy that may be available, to an administrative charge of two hundred fifty dollars ($250.00).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.7.</TD><TD STYLE="text-align: justify"><U>First Month&rsquo;s Rent</U>: The Base Rent and Operating Expense Rent installment due for the first
full calendar month in which Base Rent is due (plus any partial month occurring at the beginning of the Lease Term) and the Security Deposit,
if any,- shall be delivered to Landlord by Tenant simultaneously with Tenant&rsquo;s delivery to Landlord of its signature(s) to this
Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.8.</TD><TD STYLE="text-align: justify"><U>Proration</U>: If for any reason other than the default of Tenant, this Lease commences on a day other
than the first day of a calendar month or terminates on a day other than the last day of a calendar month or year, the amount of Rent
payable by Tenant for such partial month or year will be prorated on a per diem basis, as applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">5.9.</TD><TD STYLE="text-align: justify"><U>Beverly Hills Gross Receipt Tax</U>. Separately from and in addition to its other Rent obligations
under this Lease, Tenant shall pay monthly, as additional rent hereunder, an amount equal to 1/12 of the Beverly Hills Gross Receipts
Tax (the <B>&ldquo;BHGRT&rdquo;) </B>payable by Landlord with respect to the gross annual Base Rent payable by Tenant under this Lease.
Tenant&rsquo;s obligation to pay monthly the BHGRT shall commence as of the Rent Commencement Date and continue on the first of each month
during the Lease Term. Tenant acknowledges that, as of the date of this Lease, the BHGRT rate is 2.5% of the gross annual Base Rent payable
by Tenant hereunder, but is subject to change by the City of Beverly Hills at any time without notice to Landlord or Tenant. In the event
Landlord receives notice that the City of Beverly Hills has revised the BHGRT, Landlord will promptly deliver written notice thereof to
Tenant and the succeeding monthly BHRGT payments to Landlord by Tenant hereunder shall be revised accordingly, as applicable to comply
with such notice of revision. Notwithstanding the foregoing, in the event the BHGRT rate is revised such that any deficiency is due from
or levied upon Landlord or the Building by the City of Beverly Hills at any time, Tenant shall be obligated to pay on demand such sums,
in addition to and irrespective of having already paid its monthly portions of the BHRGT in accordance herewith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD><B>USE OF PREMISES:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">6.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Quiet
Enjoyment</U>: Tenant shall, and may peacefully have, hold, and enjoy the Premises, subject to the other terms hereof, provided that
Tenant timely pays the Rent within any applicable notice and grace period, and timely performs all of Tenant&rsquo;s covenants and agreements
herein contained. This covenant and all other covenants of Landlord shall be binding upon Landlord and its successors only with respect
to breaches occurring during its or their respective periods of ownership of Landlord&rsquo;s interest hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">6.2.</TD><TD STYLE="text-align: justify"><U>Effect on Insurance</U>: Tenant shall not use any portion of the Premises for purposes other than those
specified in <B>Paragraph 1 </B>and no use shall be made or permitted to be made upon the Premises, nor acts done, which would cause cancellation
of any insurance policies covering the Building. If Landlord&rsquo;s insurance premiums increase due to Tenant&rsquo;s activity, Landlord
may elect to charge Tenant directly for such additional cost as additional Rent hereunder and Tenant shall pay Landlord for the same within
ten (10) days after written demand thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">6.3.</TD><TD STYLE="text-align: justify"><U>Miscellaneous Restrictions</U>: Tenant will not use the Premises for or permit in the Premises any
offensive, noisy, or dangerous trade, business, manufacture or occupation or interfere with the business of any other tenant in the Building.
Tenant agrees not to cause, permit or suffer any waste or damage, disfigurement or injury to the Premises or the fixtures or equipment
thereof or the Common Areas. Tenant will not use the Premises for washing clothes or cooking (except for a small kitchenette customarily
located in an office) and nothing will be prepared, manufactured or mixed in the Premises, which might emit any offensive odor into the
Building. Tenant will not obstruct the Common Areas in the Building or use the same for business operations or advertising. Tenant will
not use the Premises for any purpose which would create unreasonable elevator loads, cause structural loads to be exceeded or adversely
affect the mechanical, electrical, plumbing or other base building systems. Tenant will at all times comply with the rules and regulations
of the Building attached hereto as <B>Schedule 5 </B>and with such additional rules and regulations as may be commercially reasonably
adopted by Landlord from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">6.4.</TD><TD STYLE="text-align: justify"><U>Prohibited Uses</U>: In addition, and not by way of limitation of the restrictions on use set forth
herein, Tenant shall not use or permit the use of the Premises in any manner, nor shall Tenant keep the Premises in such a condition,
which violates any Legal Requirements (as defined in <B>Paragraph 2) </B>now in effect or hereafter promulgated regulating the use, condition
or occupancy of the Premises, or the conduct of Tenant&rsquo;s employees and agents, and Tenant, at its sole expense, shall promptly comply
with all such applicable Legal Requirements and Tenant will indemnify, defend and hold harmless Landlord from any failure to materially
comply with any Legal Requirements and from all fines, suits, proceedings, claims, demands or actions of any kind arising out of or in
connection with the occupancy or use of the Premises by Tenant. The commencement or pendency of any state or federal court proceeding
affecting the use of the Premises shall, at the option of the Landlord, be deemed a breach thereof. Tenant shall not use or permit any
part of the Premises to be used for any unlawful purpose or for any purpose not approved by Landlord, in its sole and absolute discretion.
Tenant shall not use or permit the use of the Premises in any manner, which will tend to create waste or a nuisance or will tend to interfere
with, annoy, or disturb Landlord or any occupants of adjoining premises. Under no circumstances may Tenant use the Premises for any medical
uses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">6.5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Temporary
Closure</U>: Notwithstanding anything contained in this Lease to the contrary, should Landlord determine in its reasonable opinion that
an emergency or force majeure condition exists that threatens the Building or any of the tenants or persons therein, or any of their
property (e.g. an impending hurricane, a bomb threat to the Building), including but not limited to emergencies caused by persons or
natural conditions outside of Landlord&rsquo;s control, Landlord shall have the right to close the Building and require all tenants,
including Tenant, to evacuate the Building until such emergency ceases to exist. Such closure shall not affect Base Rent, any other Rent
or the Lease Term unless such closure exceeds five (5) business days.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">6.6.</TD><TD STYLE="text-align: justify"><U>Compliance by Tenant</U>: Tenant shall, at Tenant&rsquo;s expense, comply with all legal
                                                                 requirements that impose any obligation, order or duty on Landlord or Tenant, arising from or related to (a) Tenant&rsquo;s specific
                                                                 use of the Premises; (b) the conduct of Tenant&rsquo;s business or operation of its installations, equipment or other property
                                                                 therein; (c) any cause or condition created by or at the instance of Tenant to the extent a breach of this Lease; or (d) breach of
                                                                 any of Tenant&rsquo;s obligations hereunder; and Tenant shall pay all costs, expenses, fines, penalties and damages, including
                                                                 attorneys&rsquo; fees and costs, which may be imposed upon Landlord by reason of or arising out of Tenant&rsquo;s failure to fully
                                                                 comply with and observe the provisions of this <B>Paragraph 6.6 </B>within five (5) days after written notice thereof. If at any
                                                                 time Tenant&rsquo;s compliance as required by this <B>Paragraph 6.6 </B>necessitates action by Tenant for which another provision of
                                                                 this Lease requires Landlord&rsquo;s consent, Tenant shall obtain Landlord&rsquo;s consent pursuant to such other provision before
                                                                 taking such action. Tenant will indemnify, defend and hold harmless Landlord from any failure to materially comply with any legal
                                                                 requirements which are expressly applicable to its specific use and occupancy of the Premises and not otherwise the responsibility
                                                                 of Landlord as herein provided and from all fines, suits, proceedings, claims, demands or actions of any kind arising out of or in
                                                                 connection with the occupancy or use of the Premises by Tenant as herein stated.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify">PARKING:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">7.1.</TD><TD STYLE="text-align: justify"><U>Tenant&rsquo;s Parking Rights</U>: Subject to the rules and regulations of the Building, Tenant shall
be entitled to the number of unreserved Parking Spaces set forth in <B>Paragraph 1 </B>above and shall be required to lease the Must Take
Parking Spaces set forth in <B>Paragraph 1. </B>Tenant and its authorized representatives will park their cars only in areas specifically
designated for that purpose by Landlord. Within five (5) days after written request by Landlord or any parking space operator, Tenant
will furnish to Landlord the license numbers assigned to its cars and the cars of all of its authorized representatives. If Tenant or
its authorized representatives fails to park their cars in the designated parking areas, Landlord may charge Tenant as and for liquidated
damages thirty dollars ($30.00) per each day or partial day for each car parked in area other than those designated. Tenant will not park
or permit the parking of any vehicles adjacent to loading areas so as to interfere in any way with the use of such areas. Only automobiles
and pickup trucks will be permitted in the parking areas. Landlord shall have the right, in Landlord&rsquo;s sole discretion, to designate
parking spaces for the exclusive use of a particular tenant or particular tenants or any other third party. Landlord will have the right
to institute reasonable procedures and/or methods to enforce the Terms of this <B>Paragraph </B>7, including but not limited to, a card
access system, the hiring of parking attendants or a management company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">7.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Parking
Charges</U>. Tenant shall pay the Parking Charges to Landlord (or the designated parking facility operator if Landlord so directs) on
the first day of each calendar month. Tenant shall pay the prevailing monthly parking rates charged by Landlord from time to time, plus
applicable parking taxes which are subject to change. The current Parking Charges are set forth in <B>Paragraph 1.9 </B>of the Basic
Lease Provisions. Tenant&rsquo;s obligation to pay the monthly Parking Charges shall be considered an obligation to pay Additional Rent
for all purposes of the Lease. In the event that for any reason whatsoever Landlord is not permitted by governmental law, ordinance,
or otherwise to charge Parking Charges for the Parking Spaces, including but not limited to the Must Take Parking Spaces, as provided
in this <B>Paragraph 7.2, </B>then the Base Rent shall be increased by an amount equal to the total annual Parking Charges otherwise
payable by Tenant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B>SIGNAGE: </B>Landlord, at Tenant&rsquo;s sole cost and expense, will install and maintain all letters
or numerals on the entrance doors for the Premises. All such letters and numerals shall be in the form specified by Landlord, and no other
shall be used or permitted on the Premises. If a Tenant directory exists at the Building, Landlord shall include Tenant&rsquo;s name in
the directory. Tenant shall not place any signs within the Premises that are visible from the outside of the Premises without Landlord&rsquo;s
prior written approval, which may be withheld in Landlord&rsquo;s sole and absolute discretion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">9.</FONT></TD><TD>ASSIGNMENT AND SUBLETTING:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">9.1.</TD><TD STYLE="text-align: justify"><U>Prohibition</U>: Tenant shall not assign this Lease or sublet any portion of the Premises without the
prior written consent of Landlord, which consent shall not be - unreasonably withheld or delayed, provided Tenant is not in default under
the Lease at the time of such request. The parties agree that it shall be reasonable for Landlord to withhold consent if: (i) Landlord
is not satisfied with the financial condition, creditworthiness, identity, reputation, or business character of the proposed assignee
or sublessee, (ii) the proposed assignee or sublessee is an existing tenant of the Building, (iii) the identity of or the use contemplated
by the proposed assignee or sublessee would violate an exclusive use right granted by Landlord to another Tenant, or (iv) the proposed
assignee or sublessee is a governmental subdivision or agency or any person or entity who enjoys diplomatic or sovereign immunity. Notwithstanding
any consent by Landlord, Tenant shall remain jointly and severally liable (along with each approved sublessee, who shall automatically
become liable for all obligations of Tenant hereunder with respect to that portion of the Premises so transferred), and Landlord shall
have the right to enforce the provisions of this Lease directly against Tenant or any sublessee without proceeding in any way against
any other party. In the event of an assignment, Tenant shall only be released from joint liability under this Lease if, at the sole discretion
of Landlord, the proposed assignee: (i) is deemed creditworthy, and (ii) provides a personal guarantee for the Lease, expressly assuming
in writing and agreeing to perform all of the covenants, duties, and obligations of Tenant hereunder. Tenant&rsquo;s obligation shall
cease with such assignment only upon the satisfaction of both these conditions. No use of the Premises different from that provided for
in Paragraph 1 above shall be permitted, and all other terms and provisions of the Lease shall continue to apply following any assignment
or sublease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">9.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Consent Process</U>: If Tenant requests Landlord&rsquo;s consent to an
assignment of this Lease or subletting of all or part of the Premises, Landlord may, at its option: (i) approve such sublease or assignment
(but no approval of an assignment or sublease </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>shall
relieve Tenant of any liability hereunder unless such assignee executes a personal guarantee approved by Landlord as referenced in Paragraph
9.1); (ii) negotiate directly with the proposed subtenant or assignee and, in the event Landlord is able to reach agreement with such
proposed subtenant or assignee, upon execution of a lease with such subtenant or assignee, terminate this Lease (in part or in whole,
as appropriate) upon thirty (30) days&rsquo; notice; (iii) recapture the Premises or applicable portion thereof from Tenant and terminate
this Lease (in part or in whole, as appropriate) upon thirty (30) days&rsquo; notice, in which case Landlord shall be permitted to lease
the Premises to any third party; or (iv) if Landlord should fail to notify Tenant in writing of its decision within a thirty (30) day
period after Landlord is notified in writing of the proposed assignment or sublease, Landlord shall be deemed to have refused to consent
to such assignment or subleasing and to have elected to keep this Lease in full force and effect. If Landlord consents to any assignment
or sublease, Tenant shall pay to Landlord, on demand as Additional Rent, an administrative fee of One Thousand Dollars ($1,000.00) and
will reimburse Landlord for all reasonable attorneys&rsquo; fees and costs associated with Landlord&rsquo;s consent to the assignment
or sublease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">9.3.</TD><TD STYLE="text-align: justify"><U>Excess Profit</U>: Fifty percent (50%) of all cash or other consideration received by Tenant (after
deduction of Tenant&rsquo;s reasonable marketing, remodeling, broker and attorney&rsquo;s fees, costs and expenses, tenant improvements
or other reasonable market standard concessions granted in connection with such assignment or subletting) as the proceeds of any sublease
of Tenant&rsquo;s interest in this Lease and/or the Premises, whether consented to by Landlord or not, shall be paid to Landlord, notwithstanding
the fact that such proceeds shall only be due if the amount the Premises are subleased for exceed the Rent due hereunder, unless Landlord
agrees to the contrary in writing in its sole and absolute discretion, and Tenant hereby assigns all rights it might have or ever acquire
in said 50% of such proceeds to Landlord. This covenant and assignment shall benefit Landlord and its successors in ownership of the Building
and shall bind Tenant and Tenant&rsquo;s members, managers, agents, representatives,&middot; successors and assigns. Any assignee, sublessee
or purchaser of Tenant&rsquo;s interest in this Lease, by occupying the Premises and/or assuming Tenant&rsquo;s obligations hereunder,
shall be deemed to have assumed liability to Landlord for all amounts paid to persons other than Landlord in consideration of any such
sale, assignment or subletting, in violation of the provisions hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">9.4.</TD><TD STYLE="text-align: justify"><U>Affiliated Companies/Restructuring of Business Organization</U>: The assignment or subletting by Tenant
of all or any portion of this Lease or the Premises to any person or entity which controls, is controlled by or is under common control
with Tenant, being sometimes hereinafter referred to individually as an <B>&ldquo;Affiliate&rdquo;, </B>and collectively, as <B>&ldquo;Affiliates&rdquo;)
</B>shall not be deemed a Transfer under this <B>Paragraph 9 </B>(and shall not require Landlord&rsquo;s consent), provided that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any such Affiliate was not formed as a subterfuge to avoid the obligations of this <B>Paragraph 9;</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Tenant gives Landlord at least thirty (30) days prior written notice of any such assignment or sublease
to an Affiliate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any
such Affiliate has, as of the effective date of any such assignment or sublease, a tangible net worth and net income, in the aggregate,
computed in accordance </FONT>with standard commercial real estate accounting practices (but excluding goodwill as an asset), which is
equal to or greater than Tenant as of the effective date of any . such assignment or sublease and sufficient to meet the obligations
of Tenant under this Lease;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">any such assignment or sublease shall be subject to all of the terms and provisions of this Lease, and
such assignee or sublessee shall assume, in a written document reasonably satisfactory to Landlord and delivered to Landlord upon or prior
to the effective date of such assignment or sublease, all the obligations of Tenant under this Lease; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Tenant shall remain fully liable for all obligations to be performed by Tenant under this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD><B>OPTION TERMS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: justify"><U>Option Right</U>. Landlord hereby grants the Tenant named in the Summary (the <B>&ldquo;Original Tenant&rdquo;),
</B>two (2) successive options to extend the Lease Term as to the Premises for a period of two (2) years each (each, an <B>&ldquo;Option
Term&rdquo;), </B>which options shall be exercisable only by written notice delivered by Original Tenant to Landlord as provided below.
Upon the proper exercise of each such option to extend, and provided that, at Landlord&rsquo;s option, as of the end of the initial Lease
Term or the first Option Term, as applicable, Tenant is not in default under this Lease and Original Tenant has not previously been in
default under this Lease more than once in a twelve (12) month period, the Lease Term, as it applies to the Premises, shall be extended,
as to each exercised option, for a period of two (2) years. Except as stated herein, the options are personal to Original Tenant and is
not assignable or transferable. For purposes hereof, however, the term &ldquo;Original Tenant&rdquo; shall also mean an Affiliate (as
such term is defined in <B>Paragraph 9.4 </B>above).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Option
Base Rent</U>. The annual Base Rent payable by Original Tenant during the first year of first Option Term and the first year of the second
Option Term shall be equal to the &ldquo;then prevailing fair market rent&rdquo; for the Premises as of the commencement date of the
subject Option Term; provided, however, the annual Base Rent for the first year of the first Option Term shall in no event be less than
104% of the annual Base Rent payable by Original Tenant under this Lease during the last year of the initial Lease Term, and the annual
Base Rent for the first year of the second Option Term shall in no event be less than 104% of the annual Base Rent payable by Original
Tenant under this Lease during the last year of the first Option Term. The &ldquo;then prevailing fair market rent&rdquo; shall be equal
to the annual rent (including additional rent and considering any &ldquo;base year&rdquo; or &ldquo;expense stop&rdquo; applicable thereto),
including all escalations, at which tenants of the Building, as of the commencement of the subject Option Term, are leasing non-sublease,
non-encumbered space comparable in size, location and quality to the Premises for a term of two (2) years, which comparable space is
located in the Building; provided, however, the following concessions (the <B>&ldquo;Concessions&rdquo;) </B>will not be taken into account:
(a) rental abatement concessions, if any, being granted such tenants in connection with such comparable spaces, and (b) tenant improvements
or allowances provided or to be provided for such comparable renewable space. Base Rent for the 2nd year of the first Option Term and
the second 2nd year of the second Option Term shall be subject to annual increase of 4% over the immediately preceding year. Notwithstanding
anything to the contrary contained in this Lease, Tenant will not be entitled to, and Landlord shall have no obligation to provide </FONT>Tenant,
with any tenant improvement allowance or free or abated Rent in connection with or during the first Option Term or the second Option
Term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify"><U>Exercise of Option</U>. Each of the options contained in this Section 10 shall be exercised only in
the following manner: (i) Original Tenant shall deliver written notice to Landlord not more than twelve (12) months nor less than six
(6) months prior to the expiration of the initial Lease Term or the first Option Term, as applicable, stating that Original Tenant is
interested in exercising the subject option; (ii) Landlord, within thirty (30) days after receipt of Original Tenant&rsquo;s notice, shall
deliver notice (the <B>&ldquo;Option Rent Notice&rdquo;) </B>to Original Tenant setting forth the Base Rent for the first year of the
Option Term or the first year of the second Option Term, as applicable; and (iii) if Original Tenant wishes to exercise such option, Original
Tenant shall, within thirty (30) days after Original Tenant&rsquo;s receipt of the subject Option Rent Notice, exercise the subject option
by delivering written notice thereof to Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">10.4</TD><TD STYLE="text-align: justify"><U>Additional Option Provisions</U>. Except for an option already exercised and except as otherwise stated
in Section 10.2, all of the terms and conditions of the Lease shall apply during each Option Term. Tenant shall have no other right or
option to extend the Lease Term beyond the expiration of the second Option Term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">MAINTENANCE, REPAIRS, ALTERATIONS:</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">11.1.</TD><TD STYLE="text-align: justify"><U>Tenant&rsquo;s Obligations</U>: Tenant has agreed to accept the Premises in its &ldquo;AS IS&rdquo;
condition without any representation or warranty of any kind. Tenant acknowledges that the Premises are in good order and repair, unless
otherwise indicated herein. Tenant shall, at its&rsquo; own expense and at all times, maintain the Premises in good and safe condition.
Tenant, at Tenant&rsquo;s expense, shall be responsible for all maintenance and repairs which are not included in the Operating Expenses
required in the Premises, except any electrical wiring, plumbing and HVAC installations and any other Building systems or Building equipment
located outside the Premises, roof, exterior walls, structural foundations, parking areas and other Common Areas, which shall be maintained
and repaired by Landlord and included in Operating Expenses. Notwithstanding the foregoing, Tenant shall not be responsible for maintaining
and repairing any electrical wiring, telecommunications or computer cabling, supplemental HVAC equipment, flooring, wall surfaces, light
fixtures, plumbing fixtures or the like exclusively serving the Premises.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">11.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Limitations</U>:
Tenant may make any improvements or alterations to the Premises without Landlord&rsquo;s prior written consent, if they are nonstructural,
do not affect any Building system, cost less than five thousand dollars ($5,000.00) in the aggregate during any six (6) month period,
cannot be seen from the exterior of the Premises, and otherwise comply with all Legal Requirements and the following provisions of this
<B>Paragraph 11. </B>All other improvements or alterations to the Premises require Landlord&rsquo;s prior written consent. Prior to the
commencement of any repair, improvement, or alteration, Tenant shall give Landlord at least two (2) business days written notice in order
that Landlord may post appropriate notices to avoid any liability for liens. All repairs, improvements or alterations will be made by
a licensed and insured contractor, consented to by Landlord, and performed in a good and workmanlike manner. All materials used shall
be of a quality comparable to or better than those in the Premises (or such specific materials that Landlord may identify) and shall
be in accordance with plans and specifications approved by Landlord. Tenant </FONT>may, subject to the terms hereof, at Tenant&rsquo;s
sole cost and expense, remove one of the existing rooms in the Premises; provided, however, upon expiration or earlier termination of
this Lease, Tenant shall reconstruct such existing room and associated improvements, which obligation of Tenant shall survive the expiration
or earlier termination of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">11.3.</TD><TD STYLE="text-align: justify"><U>Liens</U>: Tenant will pay all costs of construction done by it or caused to be done by it on the Premises
as permitted by this Lease. Tenant will keep the Building free and clear of all construction, mechanic&rsquo;s, materialman&rsquo;s, laborer&rsquo;s
and supplier&rsquo;s liens, resulting from construction done by or for Tenant. The interest of Landlord in the Premises and the Building
shall not be subject to liens for improvements made by Tenant. Any lien filed by any contractor, materialman, laborer or supplier performing
work for Tenant shall attach only to Tenant&rsquo;s interest in the Premises. Tenant agrees to indemnify, defend and hold harmless Landlord
from and against any and all costs and liabilities (including attorneys&rsquo; fees and expenses) and any and all construction, mechanic&rsquo;s,
materialman&rsquo;s, laborer&rsquo;s or supplier&rsquo;s liens arising out of or pertaining to any improvements or construction done by
Tenant. All persons and entities contracting or otherwise dealing with Tenant relative to the Premises or the Building are hereby placed
on notice of the provisions of this <B>Paragraph 11.3, </B>and Tenant shall further notify in writing such persons or entities of the
provisions of this <B>Paragraph 11.3 </B>prior to commencement of any Tenant work in the Premises. If any construction, mechanic&rsquo;s,
materialman&rsquo;s, laborer&rsquo;s or supplier&rsquo;s lien is ever claimed, fixed or asserted against the Premises or any other portion
of the Building in connection with any such Tenant work, Tenant shall, within ten (10) days after receipt by Tenant of notice of such
lien, discharge same as a lien either by payment or by posting of any bond as permitted by law. If Tenant shall fail to discharge any
such lien, whether valid or not, within ten (10) days after receipt of notice from Landlord, Landlord shall have the right, but not the
obligation, to discharge such lien on behalf of Tenant and all costs and expenses incurred by Landlord associated with the discharge of
the lien, including, without limitation, attorneys&rsquo; fees, shall constitute additional Rent hereunder and shall be immediately due
and payable by Tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">11.4.</TD><TD STYLE="text-align: justify"><U>Surrender of Premises</U>: On the last day of the Term hereof or on any sooner termination, Tenant
shall surrender the Premises to Landlord in the same condition as when received, ordinary wear, tear and casualty excepted, and clear
and free of debris. Tenant shall repair any damage to the Premises occasioned by the installation or removal of Tenant&rsquo;s trade fixtures,
furnishings and equipment. Any of Tenant&rsquo;s property remaining in the Premises after the expiration or earlier termination of this
Lease shall be deemed abandoned by Tenant, and Landlord, in addition to all other rights and remedies it may have, shall have the right
to keep in place and use all of such property in the Premises and/or remove any or all of such property from the Premises, which may then
be disposed of, or stored at the cost of and for the account of Tenant. Landlord shall not be responsible for the care or safekeeping
of any such property and Tenant waives any claim against Landlord relating thereto. The provisions of this subaragraph shall survive the
expiration or earlier termination of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>ENTRY AND INSPECTION: </B>Tenant shall permit Landlord or Landlord&rsquo;s
agents to enter upon the Premises at reasonable times upon verbal &middot; notice for the purpose of inspecting the same, performing any
services required of Landlord hereunder and showing the Premises to potential and existing mortgagees and purchasers and prospective tenants
of other space in the Building. </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>Notwithstanding
the foregoing, Landlord is not required to give notice to Tenant if Landlord must enter the Premises because of an emergency or for the
provision of janitorial services. Tenant will permit Landlord at any time within one hundred eighty (180) days prior to the expiration
or early termination of this Lease, to place upon the Premises any usual &ldquo;To Let&rdquo; or &ldquo;For Lease&rdquo; signs, and permit
potential tenants to inspect the Premises.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">13.</FONT></TD><TD>INDEMNIFICATION:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD><U>Indemnification</U>: Intentionally Omitted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD><B>Survival of Indemnification: </B>Intentionally Omitted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.2.</TD><TD STYLE="text-align: justify"><B>TENANT&rsquo;S INSURANCE: </B>At all times during the Term of this Lease, Tenant shall, at its sole
expense, procure and maintain the following types of insurance coverage:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.3.</TD><TD STYLE="text-align: justify"><U>Commercial General Liability</U>: Commercial General Liability insurance, including Bodily Injury and
Property Damage Liability, Products and Completed Operations, Personal Injury Liability, and Fire Damage Liability against any and all
damages and liability, including attorneys&rsquo; fees and expenses, on account of or arising out of injuries to or the death of any person
or damage to property, however occasioned, in, on or about the Premises in amounts not less than one million dollars ($1,000,000) per
occurrence, two million dollars ($2,000,000) annual aggregate, and one hundred thousand dollars ($100,000) Fire Damage Liability;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.4.</TD><TD STYLE="text-align: justify"><U>Personal Property</U>: Insurance on an all-risks basis covering one hundred percent (100%) of the replacement
cost value of Tenant&rsquo;s property at the Premises including, without limitation, leasehold improvements, trade fixtures, merchandise,
furnishings, equipment, goods and inventory;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.5.</TD><TD STYLE="text-align: justify"><U>Mechanical Equipment</U>: Where applicable, insurance covering central heating, air conditioning and
ventilating systems, generators, refrigeration equipment, machinery and electrical equipment, boilers, and other high pressure piping
and machinery, and other similar apparatus installed in the Premises, including Business Income loss;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.6.</TD><TD STYLE="text-align: justify"><U>Business Income</U>: (a) Business Interruption insurance for a period of not less than twelve (12)
months from the date of fire or casualty; and (b) Loss of Rents insurance to cover rental loss of Landlord for a period of not less than
twelve (12) months from the date of fire or casualty, naming Landlord as Loss Payee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.7.</TD><TD STYLE="text-align: justify"><U>Employer&rsquo;s Liability/Workers&rsquo; Compensation</U>: If and to the extent required by applicable
law, Employer&rsquo;s Liability insurance with limits not less than five hundred thousand dollars ($500,000.00), and Workers&rsquo; Compensation
insurance providing statutory state benefits for all persons employed by Tenant in connection with the Premises;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.8.</TD><TD STYLE="text-align: justify"><U>Sprinkler Leakage</U>: Insurance covering damage from leakage of sprinkler systems now or hereafter
installed in the Premises in an amount not less than the current replacement cost covering Tenant&rsquo;s merchandise, Tenant&rsquo;s
improvements and Tenant&rsquo;s trade fixtures; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">13.9.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT><FONT STYLE="font-size: 10pt"><U>Automobile
Liability</U>: Automobile liability insurance in commercially reasonable amounts, covering company owned vehicles, if any.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.10.</TD><TD STYLE="text-align: justify"><U>Other Insurance</U>: Such other insurance and in such amounts as may be required by Landlord against
other insurable hazards as at the time are commonly insured against by prudent owners of comparable office projects in the area in which
the Building is located.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">13.11.</TD><TD STYLE="text-align: justify"><U>Form of Insurance/Companies</U>: All insurance provided for in <B>Paragraph </B>14 hereof shall be
in a form satisfactory to Landlord and carried with insurance companies reasonably acceptable to Landlord that are licensed or authorized
to do business in the State in which the Building is located, are in good standing with the Department of Insurance in the State in which
the Building is located and have a current rating issued by A.M. Best Company of not less than A-:VII, and/or whose claim paying ability
is rated no lower than A by Standard &amp; Poor&rsquo;s Ratings Service and A2 by Moody&rsquo;s Investors Service. Insurance coverage
shall be written as primary policy coverage and not contributing with or excess of any coverage, which Landlord may carry; Landlord, and
Landlord&rsquo;s managing agent and property manager shall be named as Additional Insureds with respect to Commercial General Liability
and Automobile Liability, including any Umbrella or Excess policies. Tenant shall furnish Landlord at the inception of this Lease (i)
a Certificate of Insurance evidencing that all such insurance is in effect and that Landlord will be given at least thirty (30) days prior
written notice of cancellation or non-renewal, and (ii) proof that premiums have been paid by Tenant. Not later than fifteen (15) days
prior to the expiration of any insurance policy, evidence of renewals or replacements of such policy shall be delivered to Landlord, together
with proof of payment of the associated premiums. In the event Tenant shall fail to procure any contract of insurance required under the
terms hereof or any renewal of or replacement for any contract of insurance that is expiring or has been canceled, Landlord may, but shall
not be obligated to, procure such insurance on behalf of Tenant and the cost thereof shall be payable to Landlord as additional Rent within
ten (10) days following written demand therefor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">14.</FONT></TD><TD STYLE="text-align: justify">LANDLORD&rsquo;S INSURANCE:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">14.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>All Risk</U>: Landlord (or its principals naming Landlord as an additional
insured) shall, as part of the Operating Expenses, maintain fire and extended coverage insurance on the Building and the Premises (which
may include vandalism and malicious mischief coverage) and such endorsements as Landlord may require or is otherwise reasonably consistent
with other similarly situated buildings) in an amount not less than the full replacement value thereof (which may be exclusive of foundations),
or in such amounts as any mortgagee of Landlord shall require, with such deductibles as shall be determined by Landlord from time to time.
Landlord (or its principals naming Landlord as an additional insured) reserves the right to self-insure the Building so long as a financial
institution such as an insurance company, bank, savings and loan association, or pension fund having a net worth of at least one hundred
million dollars ($100,000,000.00) owns an interest in the Building of fifty percent (50%) or more. Landlord (or its principals naming
Landlord as an additional insured) also reserves the right to provide the insurance required hereunder as part of a blanket policy. All
insurance obtained by Landlord in connection with the Building shall be passed through to the tenants of the Building, including Tenant,
as part of the Operating Expenses, and payments for losses thereunder shall be made solely to Landlord or </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>Landlord&rsquo;s mortgagee as their interests shall appear. In the event of self-insurance, the premium cost equivalency
of such policy or policies shall be a part of the Operating Expenses. In the event of blanket insurance, Landlord shall reasonably allocate
the portion of the blanket premium to the Operating Expenses for the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">14.2.</TD><TD STYLE="text-align: justify"><U>Liability</U>: Landlord shall, as part of the Operating Expenses, maintain a policy or policies of
commercial general liability insurance with respect to the Common Areas and the activities thereon in such amounts as Landlord or any
mortgagee of Landlord may require. In the event of self-insurance (as referenced in <B>Paragraph 15.1 </B>above), the premium cost equivalency
of such policy or policies shall be part of the Operating Expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">14.3.</TD><TD STYLE="text-align: justify"><U>Other</U>: Landlord may purchase insurance for windstorm, flood, plate glass, sign, automobile, sinkhole,
business income, Rent loss, liquor liability, terrorism, earthquake and such other insurance that Landlord or any mortgagee of Landlord
may require in their sole discretion and with such deductibles as Landlord may desire. The costs of all such insurance shall be part of
the Operating Expenses. Landlord may hereafter raise or lower such coverage in such amounts as may from time to time be prudent to Landlord
within its sole discretion or as Landlord&rsquo;s mortgagee may require.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><B>SUBROGATION: </B>Landlord and Tenant shall each obtain from their respective insurers under all policies
of property insurance maintained by either of them at any time during the Term hereof insuring or covering the Premises or Building, as
applicable, a waiver of all rights of subrogation which the insurer of one party might otherwise have, if at all, against the other party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">16.</FONT></TD><TD STYLE="text-align: justify">UTILITIES AND SERVICES:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">16.1.</TD><TD STYLE="text-align: justify"><U>Standards</U>: Pursuant to the terms and conditions of this Lease, Landlord shall use all reasonable
efforts to furnish (as part of Operating Expenses) heating, ventilation, and air conditioning <B>(&ldquo;HVAC&rdquo;), </B>electricity
for normal lighting and office machines, cold water for reasonable and normal drinking and lavatory use, replacement light bulbs and/or
fluorescent tubes and ballasts for standard overhead fixtures, exterior window washing, standard trash removal, sewer and waste water
services, and janitorial services five (5) days per week. Said services and utilities shall be provided during Building Hours, except
for janitorial which may be provided after Building Hours. HVAC required at other times shall be subject to a charge of $75.00 per hour
or fraction thereof, with a two (2) hour minimum requirement, for after-hours HVAC by Tenant, as such sum may be reasonably increased
by Landlord from time to time upon written notice to Tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">16.2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Temporary Interruption</U>: Landlord reserves the right, without any
liability to Tenant and without affecting Tenant&rsquo;s covenants and obligations hereunder, to stop or interrupt or reduce any of the
services listed in this <B>Paragraph 17 </B>or to stop or interrupt or reduce any other services, required of Landlord under this Lease,
whenever and for so long as may be reasonably necessary, by reason of (i) accidents, emergencies, strikes or the occurrence of any of
the other events of force majeure, (ii) the making of repairs or changes which Landlord is required by law or is permitted by this Lease
to make or in good faith deems necessary, (iii) difficulty or excessive expense in securing proper supplies of fuel, steam, water, electricity,
or (iv) any other cause beyond Landlord&rsquo;s reasonable control, whether similar or dissimilar to the </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>foregoing. Landlord does not warrant that the services provided for in this Lease will be free from interruption or
stoppage resulting from the above causes, and specifically no reduction, interruption or stoppage of any such services for any reason,
shall ever be construed as an eviction of Tenant nor shall the same cause any abatement of the Rent payable hereunder or in any manner
or for any purpose relieve Tenant from any of Tenant&rsquo;s obligations hereunder, and in any event, Landlord shall not be liable for
any loss, cost or damage, direct or consequential, of any nature arising in connection with interruption or stoppage of any of such services
or for any damage to persons or property resulting therefrom; provided, however, Landlord agrees to use reasonable diligence to resume
the service or to cause the same to be resumed. Furthermore, Landlord shall not be liable under any circumstances for a loss of, or injury
to, property or for injury to, or interference with, Tenant&rsquo;s business, including, without limitation, loss of profits, however
occurring, through or in connection with or incidental to a failure to furnish any of the services or utilities as set forth in this <B>Paragraph
17.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">16.3.</TD><TD STYLE="text-align: justify"><U>Security</U>: Landlord shall have no obligation to provide any security whatsoever for the Building,
the Premises, the Building and/or Tenant&rsquo;s business therein. Tenant does hereby acknowledge and agree that it shall provide and
be solely responsible for its own security, at Tenant&rsquo;s sole cost and expense, as may be required for the operation of Tenant&rsquo;s
business within the Premises. Landlord shall have no liability to any Tenant and its employees, agents or invitees for losses due to theft
or burglary, or for damages done by unauthorized persons in the Premises, the Building, any parking facility, or the Building or for any
injury, trauma or other harm to any person, and neither shall Landlord be required to insure against any such losses. Notwithstanding
the foregoing, Tenant acknowledges and agrees Landlord may, but will not be required to, adopt and provide security services for the Building
from time to time. Tenant shall cooperate fully in any efforts of Landlord to maintain security in the Building and shall follow all rules
and regulations promulgated by Landlord with respect thereto. However, any security services that are voluntarily undertaken by Landlord
may be changed or discontinued from time to time in Landlord&rsquo;s sole and absolute discretion, without liability to any Tenant and
its employees, agents or invitees. Tenant or any of its employees, agents or invitees waive any claims it may have against Landlord arising
out of any security services provided by Landlord, or the inadequacy or absence thereof, specifically including Landlord&rsquo;s negligence
with respect to the providing or failure to provide such services.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">17.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>CONDEMNATION:
</B>If all or substantially all of the Building or Premises should be taken for any public or quasi-:public use, by right of eminent
domain or otherwise or should be sold in lieu of condemnation, then this Lease shall terminate as of the date when physical possession
of the Building and/or Premises is taken by the condemning authority. If less than substantially all of the Building, Premises or Building
is taken or sold, Landlord (whether or not the Premises are affected thereby) may, at its option, terminate this Lease by giving written
notice thereof to Tenant; in which event this Lease shall terminate as of the date when physical possession of such portion of the Building,
the Premises or the Building is taken by condemning authority. If this Lease is not terminated upon any such taking or sale, and if the
Premises are affected, the Base Rent payable hereunder shall be diminished by an equitable amount, and Landlord shall, to the extent
Landlord deems feasible, restore the Building and, if affected, the Premises to substantially their former condition, but such work shall
not exceed the scope of the work done by Landlord in originally constructing the Building , nor shall Landlord in any event be required
to spend for such work an amount in excess of the amount received by Landlord as compensation for such taking. All </FONT>amounts awarded
upon a taking of any part or all of the Building, Building, or Premises shall belong to Landlord, and Tenant shall not be entitled to
any part thereof, provided however, that Tenant shall be entitled to retain any amount separately awarded to it for its trade fixtures
or moving expenses if such award to Tenant does not reduce Landlord&rsquo;s award.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify"><B>TRADE FIXTURES: </B>Any and all improvements made to the Premises during the Term hereof shall, unless
Landlord requests their removal, belong to the Landlord without compensation, allowance or credit to Tenant, except movable trade fixtures
of the Tenant which can be removed without defacing the Premises or any portion of the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">19.</FONT></TD><TD STYLE="text-align: justify">DESTRUCTION OF PREMISES:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">19.1.</TD><TD STYLE="text-align: justify"><U>Termination or Repair</U>: If the Premises or any part thereof shall be damaged by fire or other casualty,
Tenant shall give prompt written notice thereof to Landlord if Landlord does not otherwise have actual knowledge thereof In case the Building
shall be so damaged that substantial alteration or reconstruction of the Building shall be required (whether or not the Premises shall
have been damaged by such casualty), as determined by Landlord in its sole opinion; or in the event any mortgagee of Landlord&rsquo;s
interest in the Building should require that the insurance proceeds payable as a result of a casualty be applied to the payment of the
mortgage debt; or in the event of any material uninsured loss to the Building, Landlord may, at its option, terminate this Lease by notifying
Tenant in writing of such termination within ninety (90) days after the date of such casualty. If Landlord does not elect to terminate
this Lease, Landlord shall commence and proceed with reasonable diligence to restore the Building; except that Landlord&rsquo;s obligation
to restore shall not require Landlord to spend for such work an amount in excess of the insurance proceeds actually received by Landlord
as a result of the casualty. Notwithstanding anything to the contrary contained in this <B>Paragraph 20, </B>Landlord shall not have any
obligation whatsoever to repair, reconstruct, or restore the Premises when the damage resulting from any casualty contained under this
<B>Paragraph 20 </B>occurs during the final twelve (12) months of the Lease Term, and Landlord may terminate this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">19.2.</TD><TD STYLE="text-align: justify"><U>Abatement of Rent</U>: Landlord shall not be liable for any inconvenience or annoyance to Tenant or
injury to the business of Tenant resulting in any way from such casualty damage or the repair thereof; except that, subject to the provisions
of the next sentence, Landlord shall allow Tenant a fair diminution of Rent during the time and to the extent the Premises are unfit for
occupancy. If the Premises or any other portion of the Building be damaged by fire or other casualty resulting from the fault or negligence
of Tenant or any of Tenant&rsquo;s agents, contractors, employees, or invitees, the Rent hereunder shall not be diminished during the
repair of such damage, and Tenant shall be liable to Landlord for the cost of the repair and restoration of the Building caused thereby
to the extent such cost and expense is not covered by insurance proceeds.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">19.3.</TD><TD STYLE="text-align: justify"><U>Last Year of Term</U>: If any material obligation whatsoever to repair, reconstruct, or restore the
Premises when the damage resulting from any casualty contained under this <B>Paragraph 20 </B>occurs during the final twelve (12) months
of the Lease Term, and Landlord or Tenant may terminate the Lease upon written notice to within thirty (30) days after the occurrence
of the damage or destruction, and Tenant shall not responsible for any further payments of rent thirty-one (31) days following written
notice, only if the material obligation belongs to Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">20.</FONT></TD><TD>HAZARDOUS SUBSTANCES:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">20.1.</TD><TD STYLE="text-align: justify"><U>Tenant&rsquo;s Responsibilities</U>: At its own expense, Tenant will procure, maintain in effect and
comply with all conditions of any and all permits, licenses and other governmental and regulatory approvals required for Tenant&rsquo;s
use of the Premises. Tenant will not cause or permit any Hazardous Substance to be brought upon, kept or used in or about the Building
by Tenant, its agents, employees, contractors or invitees without the prior written consent of Landlord except for routine office cleaning
supplies that may be deemed Hazardous Substances, provided such Hazardous Substances are stored, used and removed in compliance with all
Legal Requirements and Environmental Laws. Tenant will cause any and all Hazardous Substances brought upon the Premises by Tenant
to be removed from the Premises and transported solely by duly licensed haulers to duly licensed facilities for final disposal of such
materials and wastes. Tenant will, in all respects, handle, treat, deal with and manage any and all Hazardous Substances in, on, under
or about the Premises in total conformity with all applicable Environmental Laws and prudent industry practices regarding management of
such Hazardous Substances. Upon expiration or earlier termination of the Term of the Lease, Tenant will cause all Hazardous Substances
placed on, under or about the Premises by Tenant or at Tenant&rsquo;s direction to be removed and transported for use, storage or disposal
in accordance and compliance with all applicable Environmental Laws. Tenant will not take any remedial action in response to the presence
of any Hazardous Substances in or about the Premises or the Building, nor enter into any settlement agreement, consent decree or other
compromise in respect to any claims relating to any Hazardous Substances in any way connected with the Premises without first notifying
Landlord of Tenant&rsquo;s intention to do so and affording Landlord ample opportunity to appear, intervene or otherwise appropriately
assert and protect Landlord&rsquo;s interests with respect thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">20.2.</TD><TD STYLE="text-align: justify"><U>Indemnification</U>: If the Premises or the Building become contaminated in any manner for which Tenant
is legally liable, or if the Premises otherwise become affected by any release or discharge of a Hazardous Substance, Tenant shall immediately
notify Landlord of the release or discharge of the Hazardous Substance, and Tenant shall indemnify, defend and hold harmless Landlord
from and against any and all claims, damages, fines, judgments, penalties, costs, liabilities or losses (including, without limitation,
a decrease in value of the Building or the Premises, damages caused by loss or restriction of rentable or usable space, or any damages
caused by adverse impact on marketing of the space, and any and all sums paid for settlement of claims, attorneys&rsquo; fees and expenses
at all levels, consultant fees and expert fees) arising during or after the Term of this Lease and arising as a result of such contamination,
release or discharge. This indemnification includes, without limitation, any and all costs incurred because of any investigation of the
site or any cleanup, removal or restoration mandated by federal, state or local agency or political subdivision. This provision of this
<B>Paragraph 21.2 </B>shall survive termination of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">21.</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>EVENTS OF DEFAULT: </B>If one or more of the following events (each an <B>&ldquo;Event of Default&rdquo;)
</B></FONT>occurs, such occurrence constitutes a breach of this Lease by Tenant:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">21.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abandonment/Vacation</U>: Tenant abandons or vacates the Premises or
removes furniture, fixtures or personal property, except in the normal course of business. Tenant waives any right to notice Tenant may
have under Section 1951.3 of the </FONT>California Civil Code, the terms of this <B>Paragraph 22.1 </B>being deemed such notice to Tenant
as required by said Section 1951.3; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">21.2.</TD><TD STYLE="text-align: justify"><U>Rent</U>: Tenant fails to pay any monthly Base Rent or Operating Expenses Rent, if applicable, as and
when the same becomes due and payable, and such failure continues for more than five (5) days; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">21.3.</TD><TD STYLE="text-align: justify"><U>Other Sums</U>: Tenant fails to pay any other sum or charge payable by Tenant hereunder as and when
the same becomes due and payable, and such failure continues for more than fifteen (15) days after Landlord gives written notice thereof
to Tenant; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">21.4.</TD><TD STYLE="text-align: justify"><U>Other Provisions</U>: Tenant fails to perform or observe any other non-monetary agreement, covenant,
condition or provision of this Lease to be performed or observed by Tenant as and when performance or observance is due (or immediately
if the failure involves a hazardous condition), and such failure continues for more than fifteen (15) days after Landlord gives written
notice thereof to Tenant, or if the default does not involve a hazardous condition and cannot be reasonably cured within said fifteen
(15) day period and Tenant fails promptly to commence with due diligence and dispatch the curing of such default within said fifteen (15)
day period or, having so commenced, thereafter fails to prosecute or complete with due diligence and dispatch the curing of such default;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">21.5.</TD><TD STYLE="text-align: justify"><U>Insolvency</U>: Tenant or Guarantor, if any, (a) files or consents by answer or otherwise to the filing
against it of a petition for relief or reorganization or arrangement or any other petition in bankruptcy or liquidation or to take advantage
of any bankruptcy or insolvency law of any jurisdiction; (b) makes an assignment for the benefit of its creditors; (c) consents to the
appointment of a custodian, receiver, trustee or other officer with similar powers of itself or of any substantial part of its property;
or (d) takes action for the purpose of any of the foregoing; and in the case of Guarantor a replacement for Guarantor acceptable to Landlord
is not provided within thirty (30) days after the filing or occurrence of any matters in <B>Paragraphs 22.1, 21.2, 21.3, and 21.4 </B>above;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">21.6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Receiver</U>: A court or governmental authority of competent jurisdiction,
without consent by Tenant or Guarantor, as applicable, enters an order appointing a custodian, </FONT>receiver, trustee or other officer
with similar powers with respect to Tenant <B><U>or</U></B> Guarantor, if any, or with respect to any substantial power of its property,
or constituting an order for relief or approving a petition for relief or reorganization or any other petition in bankruptcy or insolvency
law of any jurisdiction, or ordering the dissolution, winding up or liquidation of Tenant, or if any such petition is filed against Tenant
or Guarantor and such receivership or petition is not dismissed within sixty (60) days; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">21.7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Attachments</U>: This Lease or any estate of Tenant hereunder is levied
upon under any attachment or execution and such attachment or execution is not vacated within sixty </FONT>(60) days; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">21.8.</TD><TD STYLE="text-align: justify"><U>Assignment/Sublease</U>: Tenant assigns this Lease or subleases all or any portion of the Premises
without Landlord&rsquo;s prior written consent in violation of <B>Paragraph 9 </B>above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">22.</FONT></TD><TD STYLE="text-align: justify">REMEDIES UPON DEFAULT:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">22.1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Termination</U>:
If an Event of Default occurs, Landlord shall have the right, with notice or demand, immediately (after expiration of the applicable
grace periods specified herein) to terminate this Lease, and at any time thereafter recover possession of the Leased Premises or any
part thereof and expel and remove therefrom Tenant and any other person occupying the same, by any lawful means, and again repossess
and enjoy the Leased Premises without prejudice to any of the remedies that Landlord may have under this Lease, or at law or equity by
reason of Tenant&rsquo;s default or of such termination.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">22.2.</TD><TD STYLE="text-align: justify"><U>Continuation After Default</U>: Even though Tenant has breached this Lease and/or abandoned the Leased
Premises, this Lease shall continue in effect for so long as Landlord does not terminate Tenant&rsquo;s right to possession under <B>Paragraph
23.1 </B>hereof, and Landlord may enforce all of its rights and remedies under this Lease, including (but without limitation) the right
to recover Rent as it becomes due. Landlord has the remedy described in Section 1951.4 of the California Civil Code (Landlord may continue
the Lease in effect after Tenant&rsquo;s breach and abandonment and recover rent as it becomes due, if Tenant has the right to sublet
or assign, subject only to reasonable limitations). Acts of maintenance, preservation or efforts to lease the Premises or the appointment
of receiver upon application of Landlord to protect Landlord&rsquo;s interest under this Lease shall not constitute an election to terminate
Tenant&rsquo;s right to possession.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">22.3.</TD><TD STYLE="text-align: justify"><U>Damages Upon Termination</U>: Should Landlord terminate this Lease pursuant to the provisions of <B>Paragraph
23.1 </B>hereof, Landlord shall have all the rights and remedies of a landlord provided by Section 1951.2 of the California Civil Code.
Upon such termination, in addition to any other rights and remedies to which Landlord may be entitled under applicable law, Landlord shall
be entitled to recover from Tenant after reasonably attempting to mitigate all losses: (i) the worth at the time of award of the unpaid
Rent and other amounts which had been earned at the time of termination; (ii) the worth at the time of award of the amount by which the
unpaid Rent which would have been earned after termination until the time of award exceeds the amount_ of such Rent loss that the Tenant
proves could have been reasonably avoided; (iii) the worth at the time of award of the amount by which the unpaid Rent for the balance
of the Term after the time of award exceeds the amount of such Rent loss that the Tenant proves could be reasonably avoided; and (iv)
any other amount necessary to compensate Landlord for all the detriment proximately caused by Tenant&rsquo;s failure to perform its obligations
under this Lease or which, in the ordinary course of things, would be likely to result therefrom, including, without limitation unamortized
brokerae commissions, if any, brokerage commissions for a new lease, and unamortized amount of any tenant improvement allowance. The &ldquo;worth
at the time of award&rdquo; of the amounts referred to in (i) and (ii) shall be computed with interest at twelve percent (12%) per annum
or the highest lawful rate, whichever is lower. The &ldquo;worth at the time of award&rdquo; of the amount referred to in (iii) shall
be computed by discounting such amount at the &ldquo;discount rate&rdquo; of the Federal Reserve Bank of San Francisco in effect as of
time of award plus one percent (1%) and, where rental value is a material issue, shall be based upon competent appraisal evidence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">22.4.</TD><TD STYLE="text-align: justify"><U>Computation of Rent For Purposes of Default</U>: For purposes of computing unpaid Rent that would have
accrued and become payable under this Lease pursuant to the provisions of <B>Paragraph 23.3 </B>hereof, unpaid Rent shall consist of the
sum of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD><FONT STYLE="font-size: 10pt">the
total Base Rent for the balance of the Term, plus</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>a computation of the Operating Expense Rent for the balance of the Term as reasonably determined by Landlord in accordance with any
applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">22.5.</TD><TD STYLE="text-align: justify"><U>Remedies Cumulative</U>. All rights, privileges and elections or remedies of the parties are cumulative
and not alternative to the extent permitted by law and except as otherwise provided herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.</TD><TD STYLE="text-align: justify"><B>SECURITY DEPOSIT: </B>The Security Deposit set forth in <B>Paragraph 1, </B>if any, shall secure the
performance of the Tenant&rsquo;s obligations hereunder and for the payment of any damages incurred by Landlord as a result of an Event
of Default or breach hereunder (including, without limitation, amounts that Landlord may be entitled to recover pursuant to the provisions
of Sections 1951.2 or 1951.4 of the California Civil Code). Landlord may, but shall not be obligated to, apply all or portions of the
Security Deposit on account of Tenant&rsquo;s obligations hereunder. In the event that Landlord applies all or a portion of the Security
Deposit to Tenant&rsquo;s obligations hereunder, Tenant shall be obligated, within ten (10) days after receipt of notice from Landlord,
to deposit cash with Landlord in an amount sufficient to restore the Security Deposit to the full amount stated in <B>Paragraph 1 </B>above.
Failure to deposit such cash shall be a default under the Terms of this Lease. Provided Tenant is not in default, any balance remaining
upon termination shall be returned to Tenant. Tenant shall not have the right to apply the Security Deposit in payment of the last month&rsquo;s
Rent. No interest shall be paid by Landlord on the Security Deposit. In the event of a sale of the Building, Landlord shall have the right
to transfer the Security Deposit to the purchaser, upon such transfer Landlord shall have no further liability with respect thereto, and
Tenant agrees to look solely to such purchaser for the return of the Security Deposit. Landlord shall not be required to keep the Security
Deposit in a segregated account, and the Security Deposit may be commingled with other funds of Landlord. Tenant hereby waives any rights
which it may now or hereafter have under Section 1950.7 of the California Civil Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.</TD><TD STYLE="text-align: justify"><B>LIEN FOR RENT: </B>Tenant hereby grants to Landlord a lien and security interest on all furnishings,
equipment, fixtures, inventory, accounts receivable, and other personal property of any kind of Tenant now or hereafter placed in or upon
the Premises, and such property shall be and remain subject to such lien and security interest of Landlord for payment of all Rent and
other sums agreed to be paid by Tenant herein. The provisions of this <B>Paragraph 25 </B>relating to such lien and security interest
shall constitute a security agreement under and subject to the laws of the State in which the Building is located so that Landlord shall
have and may enforce a security interest on all property of Tenant now or hereafter placed in or on the Premises, in addition to and cumulative
of the Landlord&rsquo;s liens and rights provided by law or by the other Terms and provisions of this Lease. Notwithstanding anything
contained herein to the contrary, Landlord&rsquo;s lien rights granted hereunder shall automatically be subordinate to the rights of any
equipment or personal property lessor with respect to the equipment or personal property leased by it to Tenant. Notwithstanding, any
provision to the contrary in this Lease, any lien for rent or other charges due under this Lease (collectively &ldquo;Rent Liens&rdquo;)
shall be and hereby are expressly made subordinate and inferior to any lien or any other security interest (collectively &ldquo;Credit
Liens&rdquo;) where such Credit Liens are now existing or hereafter created by any lender of credit (collectively, &ldquo;Credit Lenders&rdquo;)
who has provided financing to Tenant. Tenant agrees to execute as debtor such financing statement or statements and other documents as
Landlord may now or hereafter request. Landlord may at its election at any time file a copy of this Lease as a financing statement. Notwithstanding
the above, Landlord shall neither sell nor withhold from Tenant, Tenant&rsquo;s business records and Landlord&rsquo;s lien rights shall
not apply with respect to any property that is leased to Tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">25.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>LIMITATION
ON LANDLORD&rsquo;S PERSONAL LIABILITY: </B>Tenant specifically agrees to look solely to Landlord&rsquo;s interest in the Building for
the recovery of any judgment from Landlord, it being agreed that Landlord (and any officers, shareholders, partners, members, managers,
directors, employees, affiliates, subsidiaries or parents of Landlord) shall never be personally liable for any such judgment. Landlord
shall have the right to transfer and assign, in whole or in part, all its rights and obligations hereunder and in the Building and/or
Premises referred to herein, and in such event and upon such transfer, Landlord shall be released from any further obligations hereunder,
and Tenant agrees to look solely to such successor in interest of Landlord for the performance of such obligations. In no event shall
Landlord be liable for any special, incidental, consequential, loss of profits or punitive damages in connection with any breach or alleged
breach of Landlord&rsquo;s obligations under this Lease.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.</TD><TD STYLE="text-align: justify"><B>ATTORNEYS&rsquo; FEES: </B>In the event there is any legal action or proceeding between Landlord
                                                           and Tenant to enforce any provision of this Lease or to protect or establish any right or remedy of either Landlord or Tenant
                                                           hereunder, the unsuccessful party to such action or proceeding will pay to the prevailing party all costs and expenses, including
                                                           reasonable attorneys&rsquo; fees at all tribunal levels (including allocated costs of Landlord&rsquo;s in-house attorney), incurred
                                                           by such prevailing party in such action or proceeding and in any appearance in connection therewith, and if such prevailing party
                                                           recovers a judgment in any such action, proceeding or appeal, such costs, expenses and attorneys&rsquo; fees will be determined by
                                                           the court handling the proceeding and will be included in and as a part of such judgment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.</TD><TD STYLE="text-align: justify"><B>WAIYER: </B>No failure of Landlord to enforce any term hereof shall be deemed to be a waiver. The failure
of Landlord to insist at any time upon the strict performance of any covenant or agreement contained herein or to exercise any option,
right, power, or remedy contained in this Lease shall not be construed as a waiver or a relinquishment thereof for the future. No payment
by Tenant or receipt by Landlord of a lesser amount than the applicable Rent payment due under this Lease shall be deemed to be other
than on account of the earliest Rent due hereunder, nor shall any endorsement or statement on any check or any letter accompanying any
check or payment as Rent be deemed an accord and satisfaction, and Landlord may accept such check or payment without prejudice to Landlord&rsquo;s
right to recover the balance of such Rent or pursue any other remedy in this Lease provided.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.</TD><TD STYLE="text-align: justify"><B>SEVERABILITY: </B>If any clause or provision of this Lease is illegal, invalid or unenforceable under
present or future laws effective during the Term hereof, then it is the intention of the parties hereto that the remainder of this Lease
shall not be affected thereby, and it is also the intention of both parties that in lieu of each clause or provision that is illegal,
invalid or unenforceable, there shall be added as a part of this Lease, a clause or provision as similar in terms to such illegal, invalid
or unenforceable clause or provision as may be possible and be legal, valid and enforceable. The inadvertent failure to attach any exhibit
(or schedule or addendum) described in this Lease to the fully executed version hereof shall not render this Lease invalid, incomplete,
or ineffective in any way. Upon notice from one party to the other, Landlord and Tenant shall cooperate in good faith to provide any missing
information regarding such missing exhibit, and shall both append the missing exhibit to their respective fully executed original of the
Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">29.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTICES: </B>Unless otherwise set forth in this Lease, any notice, demand,
or request to be given under this Lease (i) may be given by either party or its attorney or agent, (ii) shall be in writing, and <FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)
</FONT>shall be deemed to have been properly given (a) on the date delivered personally (including by courier), (b) one (1) business day
following deposit with a nationally recognized overnight delivery service, (c) three (3) business days following deposit with the United
States Postal Service (designated certified mail, return receipt requested, bearing adequate postage and addressed as </FONT>designated
in <B>Paragraph 1 </B>of the Lease), or (d) upon refusal of delivery by the recipient. Landlord&rsquo;s address for notices may be changed
by ten (10) days prior written notice from time to time. The foregoing notice provisions shall in no way prohibit notices from being given
as provided by statute or in the rules or civil procedure of the state in which the Building is located, as the same may be amended from
time to time (including by posting notice on the door of the Premises) and any notice so given shall constitute notice herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">30.</TD><TD STYLE="text-align: justify"><B>HOLDING OVER: </B>Any holding over after the expiration or termination of this Lease shall be construed
as a tenancy at sufferance at a rental of one hundred fifty percent (150%) of the Base Rent and Operating Expense Rent for the month of
the Lease Term preceding the month in which the expiration or termination occurred. In the event Tenant shall be or become a holdover
tenant, Tenant shall also indemnify Landlord against all claims for damages against Landlord as a result of Tenant&rsquo;s possession
of the Premises, including, without limitation, claims for damages by any tenant to whom Landlord may have leased the Premises, or any
portion thereof, for a Term commencing after the expiration or termination of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.</TD><TD><B>TIME: </B>Time is of the essence with respect to the obligations of any party under this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.</TD><TD STYLE="text-align: justify"><B>HEIRS, ASSIGNS, SUCCESSORS: </B>This Lease is binding upon and inures to the benefit of the assigns
and successors in interest of Landlord and is binding upon and inures to the benefit of Tenant and Tenant&rsquo;s successors and, to the
extent assignment may be approved by Landlord hereunder, Tenant&rsquo;s assigns.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.</TD><TD STYLE="text-align: justify"><B>SUBORDINATION: </B>This Lease is and shall always be subject and subordinate to the lien of any mortgages
or ground leases which are now or shall at any future time be placed upon the Building, the Premises or Landlord&rsquo;s rights hereunder,
and to any renewals, extensions, modifications or consolidations of any such mortgage or ground lease. This clause shall be self-operative
and no further instrument of subordination need be required by any mortgagee or ground lessee. In confirmation of such subordination,
however, Tenant, at Landlord&rsquo;s request, shall execute promptly any appropriate certificate or instrument that Landlord may reasonably
request.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">34.</TD><TD STYLE="text-align: justify"><B>ESTOPPEL CERTIFICATE: </B>Tenant shall at any time upon not less than five (5) days prior written notice
from Landlord execute, acknowledge and deliver to Landlord a statement in writing on the form provided by Landlord: (i) certifying that
this Lease is unmodified and in full force and effect (or, if modified, stating the nature of such modification and certifying that this
Lease, as so modified, is in full force and effect), the amount of any security deposit, and the date to which the Rent and other charges
are paid in advance, if any; and (ii) acknowledging that there are not, to Tenant&rsquo;s knowledge, any uncured defaults on the part
of Landlord hereunder, or specifying such defaults if any are claimed. Any such statement may be conclusively relied upon by a prospective
purchaser or encumbrancer to the Premises. At Landlord&rsquo;s option, Tenant&rsquo;s failure to deliver such statement within such time
shall be an Event of Default under this Lease or shall be conclusive upon Tenant: (i) that this Lease is in full force and effect, without
modification, except as may be represented by Landlord; (ii) that there are no uncured defaults in Landlord&rsquo;s performance; and (iii)
that not more than one month&rsquo;s Rent has been paid in advance or such failure may be considered by Landlord as a default by Tenant
under this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">35.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>FINANCIAL STATEMENTS. </B>Tenant shall furnish Landlord, within ten (10)
business days after Landlord&rsquo;s request therefor, its most recent financial statement of Tenant. Unless: (i) Landlord has reason
to believe there has been a material reduction in the financial worth of any of such parties; or (ii) requested by any current or proposed
lender, investor or purchaser of Landlord or the Building, such financial statement(s) shall not be required to be furnished more than
twice each </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>calendar year. If Tenant
is a publicly traded company and Tenant&rsquo;s financial information is publicly available, Tenant shall not be obligated to deliver
financial statement(s).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">36.</FONT></TD><TD>REPRESENTATIONS; AUTHORITY:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">36.1.</TD><TD STYLE="text-align: justify"><U>Tenant</U>. Tenant represents and warrants that: (i) there are no proceedings pending or, to the knowledge
of Tenant, threatened before any court or administrative agency that would materially adversely affect the ability of Tenant to enter
into this Lease or the validity or enforceability of this Lease; (ii) there is no provision of any existing mortgage, indenture, contract
or agreement binding on Tenant which would conflict with or in any way prevent the execution, delivery or performance of the terms of
this Lease; (iii) if Tenant is a corporation, limited liability company, partnership or other legal entity, the person executing this
Lease on behalf of Tenant represent and warrant that this Lease has been authorized and approved by the appropriate officers, members,
managers, partners, beneficiaries, shareholders or other beneficial owner(s) of Tenant as may be required by law; (iv) Tenant is in good
standing, qualified to do business in the state in which the Building is located; (v) Tenant has full right, power and lawful authority
to execute, deliver and perform its obligations under this Lease, in the manner and upon the terms contained herein, and to grant the
estate herein demised, with no other person needing to join in the execution hereof in order for this Lease to be binding on Tenant; and
(vi) the financial information provided by Tenant to Landlord materially and accurately depicts the financial condition of Tenant as of
the Effective Date of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">36.2.</TD><TD STYLE="text-align: justify"><U>Landlord</U>. Landlord represents and warrants to Tenant that Landlord has full right, power and lawful
authority to execute, deliver and perform its obligations under this Lease, in the manner and upon the terms contained herein, and to
grant the estate herein demised.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.</TD><TD STYLE="text-align: justify"><B>JOINT AND SEVERAL LIABILITY: </B>In the event that more than one person or entity executes the Lease
as Tenant, all such persons and entities shall be jointly and severally liable for all of Tenant&rsquo;s obligations hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.</TD><TD STYLE="text-align: justify"><B>FORCE MAJEURE: </B>Both Landlord and Tenant shall be excused for the period of any delay in the performance
of any obligations hereunder when prevented from doing so by cause or causes beyond the other party&rsquo;s absolute control which shall
include, without limitation, all labor disputes, civil commotion, civil disorder, riot, civil disturbance, war, war-like operations, invasion,
rebellion, hostilities, military or usurped power, sabotage, governmental regulations, orders, moratoriums or controls, fire or other
casualty, inability to obtain any material, services or financing or Acts of God. Tenant shall be excused up to a maximum of 50% rent
during the duration of the Force Majure. By way of example, Tenant shall pay a minimum of 50% rent in such an event.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.</TD><TD STYLE="text-align: justify"><B>RECORDING: </B>Tenant shall not record this Lease, or any memorandum or short form thereof, without
the written consent and joinder of Landlord, which may be given or withheld in Landlord&rsquo;s sole discretion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">40.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>BROKERS.
</B>Landlord and Tenant each represent and warrant one to the other that except as otherwise set forth in <B>Paragraph 1, </B>neither
of them has employed any broker in connection with the negotiations of the Terms of this Lease or the execution thereof. Landlord and
Tenant hereby agree to indemnify and to hold harmless each other against any loss, expense or liability with respect to any claims for
commissions, finder&rsquo;s fees or brokerage fees arising from or out of any </FONT>breach of the foregoing representation and warranty.
Landlord shall be responsible for paying any commission due Tenant&rsquo;s Broker in connection with this transaction pursuant to a separate
written agreement between them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.</TD><TD STYLE="text-align: justify"><B>ENTIRE AGREEMENT: </B>The foregoing, together with all Exhibits and Schedules attached hereto, constitutes
the entire agreement between the parties and may be modified only by a writing signed by both parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.</TD><TD STYLE="text-align: justify"><B>GOVERNING LAW: </B>This Lease shall be construed in accordance with the laws of the State of California.
Exclusive venue in any legal proceeding related to or arising out of this Lease shall be in the county and state where the Premises are
located, and Tenant submits to personal jurisdiction and venue in such forum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">43.</FONT></TD><TD STYLE="text-align: justify">EFFECT OF DELIVERY OF THIS LEASE: LANDLORD HAS DELIVERED A COPY OF THIS LEASE TO TENANT FOR TENANT&rsquo;S
REVIEW ONLY, AND THE DELIVERY HEREOF DOES NOT CONSTITUTE AN OFFER TO TENANT OR OPTION TO LEASE. THIS LEASE SHALL NOT BE EFFECTIVE UNTIL
A FULLY EXECUTED COPY OF THIS LEASE HAS BEEN DELIVERED TO BOTH LANDLORD AND TENANT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.</TD><TD STYLE="text-align: justify"><B>WAIVER OF THE RIGHT TO TRIAL BY JURY: TO THE FULLEST EXTENT PERMITTED BY LAW, WHETHER NOW OR HEREINAFTER
ENACTED, LANDLORD AND TENANT HEREBY KNOWINGLY AND INTENTIONALLY WAIVE THE RIGHT TO TRIAL BY JURY </B>IN <B>ANY ACTION OR PROCEEDING THAT
LANDLORD OR TENANT MAY HEREINAFTER INSTITUTE AGAINST EACH OTHER WITH RESPECT TO ANY MATTER ARISING OUT OF OR RELATED TO THIS LEASE OR
THE LEASED PREMISES WHETHER ARISING IN CONTRACT, TORT OR OTHERWISE</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.</TD><TD STYLE="text-align: justify"><B>BANKRUPTCY: </B>Landlord and Tenant understand that, notwithstanding certain provisions to the contrary
contained herein, a trustee&rdquo; or debtor in possession under the Bankruptcy Code may have certain rights to assume or assign this
Lease. Landlord and Tenant further understand that, in any event, Landlord is entitled under the Bankruptcy Code to adequate assurances
of future performance of the provisions of this Lease. The parties agree that, with respect to any such assumption or assignment, the
term &ldquo;adequate assurance&rdquo; shall include at least the following for all bankruptcy matters:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">In order to assure Landlord that the proposed assignees will have the resources with which to pay all
Base Rent, Operating Expense Rent or other sum payable by Tenant pursuant to the provisions of this Lease, any proposed assignee must
have, as demonstrated to Landlord&rsquo;s satisfaction, a net worth (as defined in accordance with generally accepted accounting principles
consistently applied) of not less than the net worth of Tenant or any guarantor (whichever is greater) on the date this Lease became effective,
increased by seven percent (7%), compounded annually, for each year from the Commencement Date through the date of the proposed assignment.
It is understood and agreed that the financial condition and resources of Tenant were a material inducement to Landlord in entering into
this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any proposed assignee must have been engaged in the conduct of business
for the 5 years prior to any such proposed assignment, which business does not violate the Permitted Use, and such proposed assignee shall
continue to engage in the Permitted Use and will not cause Landlord to be in violation or breach of any </FONT><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>provision in any other lease, financing agreement, operating agreement or other agreement relating to the Building.
It is understood and agreed that Landlord&rsquo;s asset will be substantially impaired if the trustee in bankruptcy or any assignee of
this Lease makes any use of the Premises other than the Permitted Use.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Any proposed assignee of this Lease must assume and agree to be personally bound by the provisions of this Lease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">46.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>SURVIVAL: </B>Anything contained in this Lease to the contrary notwithstanding,
the expiration or termination of the Term of the Lease, whether by lapse of time or otherwise, shall not relieve Tenant from Tenant&rsquo;s
obligations accruing prior to the expiration or termination of the Term, all of which shall survive the same, whether or not same is expressly
stated in the particular paragraph of this Lease, including, without limitation, Tenant&rsquo;s obligations with respect to: (i) the payment
of Rent, </FONT>(ii) any provisions of this Lease with respect to indemnities of Landlord made by Tenant; and (iii) the removal of all
property of Tenant required to be removed hereunder and the repair of all damage to the Premises caused by such removal at the expiration
or termination of this Lease to the extent required hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">47.</TD><TD STYLE="text-align: justify"><B>TELECOM: </B>Tenant understands and agrees that Landlord, in its reasonable discretion, expressly reserves
the right to grant or deny access (to the Building or any portion thereof, including without limitation, any tenant&rsquo;s premises)
to any telecommunications service provider whatsoever, and that Tenant shall not have the right to demand or require Landlord to grant
such access to any such telecommunications service provider. Further, Tenant expressly understands and agrees that notwithstanding anything
to the contrary contained herein, Tenant shall not have the right to use the risers, raceways, conduits, or mechanical rooms in the Building
for telecom purposes without Landlord&rsquo;s express written consent, which consent Landlord may withhold or condition in its reasonable
discretion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">48.</TD><TD STYLE="text-align: justify"><B>CONFIDENTIALITY: </B>Tenant agrees, on behalf of Tenant and Tenant&rsquo;s employees, agents, contractors,
consultants, partners, affiliates, assignees and subtenants, not to disclose the terms of this Lease or the results of any audit of Landlord&rsquo;s
books and records under this Lease to any third party except (i) legal counsel to Tenant, (ii) any assignee of Tenant&rsquo;s interest
in this Lease or any subtenant of Tenant relative to the Premises (or any portion thereof), (iii) as required by applicable law or by
subpoena or other similar legal process, or (iv) for financial reporting purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.</TD><TD STYLE="text-align: justify"><B>DAYS: </B>Unless otherwise specifically indicated to the contrary, the word &ldquo;&lsquo;days&rdquo;
as used in this Lease shall mean and refer to calendar days.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">50.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>OFAC
REPRESENTATION: </B>For purposes hereof, &ldquo;List&rdquo; shall mean the Specially Designated Nationals and Blocked Persons List maintained
by OFAC and/or on any other similar list maintained by OFAC pursuant to any authorizing statute, executive order or regulation, and &ldquo;OFAC&rdquo;
shall mean the Office of Foreign Assets Control, Department of the Treasury. Each party represents and warrants to the other that (i)
each Person owning a ten percent (10%) or greater interest in such party is (A) not currently identified on the List, and (B) is not
a person with whom a citizen of the United States is prohibited to engage in transactions by any trade embargo, economic sanction, or
other prohibition of United States law, regulation, or Executive Order of the President of the United States and (ii) each party has
implemented procedures, and will consistently apply those procedures, to ensure the foregoing representations and warranties remain
true and correct at all times. Each party shall comply with all requirements of law relating to money laundering, anti-terrorism, trade
embargos and economic sanctions, now or hereafter in effect and shall use reasonable efforts to notify the other in writing if any of
the forgoing representations, </FONT>warranties or covenants are no longer true or have been breached or if such party has a reasonable
basis to believe that they may no longer be true or have been breached. In addition, at the request of a party, the other party shall
provide such information as may be requested by the requesting to determine the other party&rsquo;s compliance with the terms hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.</TD><TD STYLE="text-align: justify"><B>TENANT REQUESTS: </B>Landlord shall accept or reject any request by Tenant to sign any agreement that
is ancillary to this Lease in Landlord&rsquo;s sole and absolute discretion (including without limitation, an agreement to subordinate
a lien held by Landlord in favor of a third-party lender, an agreement relating to an assignee or subtenant of Tenant, or an estoppel
letter request by Tenant). Tenant shall promptly reimburse Landlord, as Additional Rent, for any costs incurred by Landlord in connection
with the negotiation, preparation, review, or execution any such agreement, including without limitation, Landlord&rsquo;s attorneys&rsquo;
fees or the allocated costs of Landlord&rsquo;s in-house counsel.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">52.</TD><TD STYLE="text-align: justify"><B>ACCESSIBILITY DISCLOSURE: </B>The Premises have not undergone an inspection by a Certified Access Specialist
(CASp). [Note: A Certified Access Specialist (CASp) can inspect the Premises and determine whether the Premises comply with all of the
applicable constructionrelated accessibility standards under state law. Although state law does not require a CASp inspection of the Premises,
Landlord may not prohibit Tenant from obtaining a CASp inspection of the Premises for the occupancy or potential occupancy of the Tenant,
if requested by the Tenant. If Tenant makes such request, Landlord and Tenant shall mutually agree on the arrangement for the time and
manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct
any violations of construction-related accessibility standards within the Premises.] In furtherance of the foregoing, Landlord and Tenant
hereby agree as follows: (i) any CASp inspection requested by Tenant shall be conducted at Tenant&rsquo;s sole cost and expense by a CASp
mutually agreed upon by Landlord and Tenant in writing; and (ii) any violations of construction-related accessibility standards revealed
by such CASp inspection with respect to the Premises shall be made by Tenant, at Tenant&rsquo;s sole cost and expense.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">IN WITNESS WHEREOF,
Landlord and Tenant have executed this Lease as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> LANDLORD:</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>NEW LION ENTERPRISES
LLC,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>a California
limited liability company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>By:&nbsp;&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Armand Newman</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-size: 10pt"><B>Name:&nbsp;&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-size: 10pt">Armand Newman</FONT></TD>
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Its:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Manager 10/16/2024</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>TENANT:</B></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>AXIL BRANDS,
INC.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>a Delaware corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>By:&nbsp;&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Jeff Toghraie</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-size: 10pt"><B>Name:&nbsp;&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-size: 10pt">Jeff Toghraie</FONT></TD>
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Its:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer 10/16/2024</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right; text-indent: -0.5in">9150 Wilshire Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 33; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B><U>SCHEDULE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B><U>LEGAL DESCRIPTION
OF BUILDING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE LAND REFERRED TO HEREIN BELOW IS SITUATED IN
THE COUNTY OF LOS ANGELES, STATE OF CALIFORNIA, AND IS DESCRIBED AS FOLLOWS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LOTS 958, 959, 960, 961 AND 962 OF TRACT 6380,
IN THE CITY OF BEVERLY HILLS, COUNTY OF LOS ANGELES, STATE OF CALIFORNIA, AS PER MAP RECORDED IN BOOK 69, PAGES 11 THROUGH 20, INCLUSIVE
OF MAPS, IN THE OFFICE OF THE COUNTY RECORDER OF SAID COUNTY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COMMONLY KNOWN AS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9150 WILSHIRE BOULEVARD, BEVERLY HILLS, CALIFORNIA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">APN: 4331-018-001, 4331-018-003, 4331-018-002,
4331-018-004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: center; font-size: 10pt">SCHEDULE 1</TD>
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">9150 Wilshire Boulevard</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 34; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FLOOR PLAN OF PREMISES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE 2&nbsp;</P>


<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%"><B><U>PREPARED FOR:</U></B></TD>
    <TD STYLE="vertical-align: bottom; width: 50%; text-align: center"><B><U>LEASE PLAN</U></B></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 25%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>9150 WILSHIRE BLVD<BR>
    BEVERLY HILLS, CA<BR>
    <BR>
    </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SECOND FLOOR</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(As Measured: November 2015)<BR>
    (Last Updated: December 2020)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_02.jpg" ALT=""><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WORK LETTER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Landlord, at Landlord&rsquo;s cost, shall re-paint
the entire premises and replace the carpet to a LVT flooring, which shall be limited to Landlord&rsquo;s selection of flooring.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[NO FURTHER TEXT ON THIS PAGE]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: center; font-size: 10pt">SCHEDULE 3</TD>
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">9150 Wilshire Boulevard</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 4</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INTENTIONALLY LEFT BLANK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: center; font-size: 10pt">SCHEDULE 4</TD>
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">9150 Wilshire Boulevard</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 5</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RULES AND REGULATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">The rights of each tenant in entrances, corridors, parking ramps and areas, elevators and other public
areas servicing the Building are limited to ingress to and egress from such tenant&rsquo;s premises for the tenant and its employees,
licensees and invitees, and no tenant shall use, or permit the use of, the entrances, corridors or elevators for any other purpose. No
tenant shall invite to the tenant&rsquo;s premises, or permit the visit of, persons in such numbers or under such conditions as to interfere
with the use and enjoyment of any of the entrances, corridors, elevators and other facilities of the Building by any other tenant. Fire
exits and stairways are for emergency use only, and they shall not be used for any other purpose by any tenant or its employees, licensees
or invitees. No tenant shall encumber or obstruct, or permit the encumbrance or obstruction of, any of the sidewalks, entrances, corridors,
doorways, elevators, fire exits or stairways of the Building. Landlord reserves the right to control and operate the public portions of
the Building and the public facilities, as well as facilities furnished for the common use of the tenants, in such manner as it in its
reasonable judgment deems best for the benefit of the tenants generally. No tenant and no invitee or employee of any tenant shall be allowed
on the roof of the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">Landlord may refuse admission to the Building during the days and hours specified in Rule 30 to any person
not known to the watchman in charge or not having a pass issued by Landlord and/or the tenant whose premises are to be entered or not
otherwise properly identified, and Landlord may require all persons admitted to or leaving the Building outside of Building Hours on Business
Days to provide appropriate identification and to register. Tenant shall be responsible for all persons to whom it issues any such pass
and shall be liable to Landlord for all acts or omissions of such persons. Any person whose presence in the Building at any time shall,
in the judgment of Landlord or its representatives, be prejudicial to the safety, character or reputation of the Building or its tenants
may be denied access to the Building or may be ejected therefrom. During any invasion, riot, public excitement or other commotion, Landlord
may prevent all access to the Building for the safety of the tenants and protection of property in the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">Tenants shall obtain ice, drinking water, food, beverage, linen, barbering, shoe-polishing, floor-polishing,
cleaning, janitorial, plant-care or other similar services only from vendors who have registered with the Building office and who have
been reasonably approved by Landlord for provision of such services in the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">No awnings, projections or other items shall be attached to the outside walls of the Building. No curtains,
blinds, shades or screens which are different from the standards adopted by Landlord for the Building shall be attached to or hung in,
or used in connection with, any exterior window or door of the premises of any tenant without the prior written consent of Landlord. Such
curtains, blinds, shades or screens must be of a quality, type, design and color, and attached in the manner approved by Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">No lettering, sign, advertisement, notice or object shall be displayed in or on the exterior windows or
doors, or on the outside of any tenant&rsquo;s premises, or at any point inside any tenant&rsquo;s premises where the same might be visible
outside of such premises, without the prior written consent of Landlord, which consent may be withheld in the sole and absolute discretion
of Landlord. Interior signs, elevator cab designations and lettering on doors or the Building directory shall, if and when approved by
Landlord, be inscribed, painted or affixed for each tenant by Landlord at the expense of such tenant, and shall be of size, color and
style acceptable to Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: center; font-size: 10pt">SCHEDULE 5</TD>
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">9150 Wilshire Boulevard</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 39; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">The skylights, windows and doors that reflect or admit light and air into the halls, passageways or other
public places in the Building shall not be covered or obstructed by any tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">No showcases or other articles shall be put in front of or affixed to any part of the exterior of the
Building, nor placed in the halls, corridors or vestibules except as may be licensed by Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">No bicycles, vehicles or animals of any kind shall be brought into or kept in or about the premises of
any tenant of the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">Tenants and their contractors, employees, agents, visitors and licensees shall not at any time bring into
the Building or keep upon the premises of any tenant any foul or noxious gas or substance or any inflammable, combustible, explosive or
otherwise hazardous fluid, chemical or substance. No acids, vapors or other materials which may cause damage shall be discharged or permitted
to be discharged into the waste lines, vents or flues of the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify">Subject to Tenant&rsquo;s obligations to protect patient privacy or otherwise as agreed between Landlord
and Tenant, no locks or bolts of any kind which are not operable by the grand master key for the Building shall be placed upon any of
the doors by any tenant, nor shall any changes be made in locks or the mechanism thereof which would make such locks inoperable by the
grand master key. Additional keys for a tenant&rsquo;s premises and toilet rooms shall be procured only from Landlord, who may impose
a reasonable charge therefor. Each tenant shall, upon the termination of its tenancy, turn over to Landlord all keys of stores, offices
and toilet rooms, either furnished to or otherwise procured by such tenant, and in the event of the loss of any key furnished by Landlord,
such tenant shall pay to Landlord the replacement cost thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">All removals, or the carrying in or out of any safe, freight, furniture, crate or comparable object or
matter of any description, must take place during such hours, in such elevators and in such manner as Landlord or its agent may determine
from time to time. Persons employed to move safes and other heavy objects must be acceptable to Landlord. Before moving large quantities
of furniture and equipment into or out of the Building, tenants shall notify Landlord and shall comply with Landlord&rsquo;s requirements
concerning the time and manner in which the work may be performed. All labor and engineering costs incurred by Landlord in connection
with any moving, including a reasonable charge for overhead and profit, shall be paid by tenant to Landlord, on demand.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">Landlord reserves the right to inspect all objects and matter to be brought into the Building and to exclude
from the Building any object or matter which violates any of these Rules and Regulations or the lease of which this <B>Schedule 5 </B>is
a part. Landlord may require any person leaving the Building with any package or other object or matter to submit a pass issued by the
tenant from whose premises the item is being removed, listing the item. This rule shall not be deemed to impose any responsibility or
liability on Landlord for the protection of any tenant against the removal of property from the premises of such tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">No tenant shall occupy or permit any portion of its premises to be occupied as an office for a public
stenographer or public typist, or for the storage, manufacture, or sale of food, liquor, drugs or tobacco in any form, or for lodging
or as a barber, beauty or manicure shop, or as a school or classroom, unless such use has been specifically approved by Landlord. No tenant
shall use or permit its premises or any part thereof to be used for manufacturing, storage or the sale at retail or auction of merchandise,
goods or property of any kind. These prohibitions supplement the prohibited uses specified in the lease of which this <B>Schedule 5 </B>is
a part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt; width: 34%">SCHEDULE 5</TD>
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">9150 Wilshire Boulevard</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">Landlord shall have the right to prohibit any advertising or identifying sign by any tenant which, in
Landlord&rsquo;s sole and absolute judgment, tends to impair the reputation of the Building or its desirability as a building for others,
and upon written notice from Landlord, such tenant shall refrain from and discontinue such advertising or identifying sign.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">Landlord shall have the right to prescribe the weight, size and position of safes and other objects of
excessive weight, and no safe or other object whose weight exceeds the lawful load for the area upon which it would stand shall be brought
into or kept upon any tenant&rsquo;s premises. If, in the judgment of Landlord, it is necessary to distribute the concentrated weight
of any heavy object, the work involved in such distribution shall be done at the expense of the tenant and in such manner as Landlord
shall determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify">No machinery or mechanical equipment other than ordinary portable business machines may be installed or
operated in any tenant&rsquo;s premises without Landlord&rsquo;s prior written consent, which consent shall not be unreasonably withheld
or delayed, and in no event shall any machine or mechanical equipment be so placed or operated as to disturb other tenants. Machines and
mechanical equipment that Landlord permits a tenant to install and use shall be so equipped, installed and maintained by the tenant as
to prevent any noise, vibration or electrical or other interference from being transmitted from the tenant&rsquo;s premises to any other
area of the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">Landlord, its contractors, and their respective employees shall have the right to use, without charge
therefor, all light, power and water in the premises of any tenant while cleaning or making permitted repairs or alterations in the premises
of such tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify">Those maintenance requirements of tenants which are the responsibility of Landlord will be attended to
only upon application at the office of the Building. Tenant shall have no right to request employees of Landlord to perform any work or
do anything outside of their regular duties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.</TD><TD STYLE="text-align: justify">Canvassing, soliciting and peddling in the Building are prohibited and each tenant shall cooperate to
prevent the same.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.</TD><TD STYLE="text-align: justify">Nothing shall be done or permitted in any tenant&rsquo;s premises, and nothing shall be brought into or
kept in any tenant&rsquo;s premises, which would impair or interfere with any of the Building&rsquo;s services or the proper and economic
heating, ventilating, air conditioning, cleaning or other servicing of the Building or the premises, or the use or enjoyment by any other
tenant of any other premises, nor shall there be installed by any tenant any ventilating, air conditioning, electrical or other equipment
of any kind which, in the reasonable judgment of Landlord, might cause any such impairment or interference.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.</TD><TD STYLE="text-align: justify">The sinks and toilets and other plumbing fixtures in or serving any tenant&rsquo;s premises shall not
be used for any purpose other than the purposes for which they were designed or constructed, and no sweepings, rubbish, rags, acids or
other foreign substances shall be deposited therein. All garbage receptacles used in the premises of any tenant shall be emptied, cared
for and cleaned by and at the expense of the tenant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.</TD><TD STYLE="text-align: justify">All entrance doors in a tenant&rsquo;s premises shall be left locked by the tenant when the tenant&rsquo;s
premises are not in use. Entrance doors shall not be left open at any time. Each tenant, before closing and leaving its premises at any
time, shall turn out all lights and entirely shut off all water faucets.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt; width: 34%">SCHEDULE 5</TD>
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">9150 Wilshire Boulevard</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.</TD><TD STYLE="text-align: justify">Hand trucks shall not be used in the Building unless they are equipped with rubber tires and side guards.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.</TD><TD STYLE="text-align: justify">Tenants shall cooperate with Landlord in obtaining maximum efficiency of the Building air conditioning
system by lowering and partially closing window blinds when the sun&rsquo;s rays fall directly on windows of the premises. Tenant shall
not obstruct, alter or in any way impair the efficient operation of the Building heating, ventilating and air-conditioning systems and
shall not place furniture, equipment or other objects where they would interfere with air flow. Tenant shall not tamper with or change
the setting of any thermostat or temperature control valve.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.</TD><TD STYLE="text-align: justify">Landlord will have the sole authority to direct electricians as to where and how telephone and telegraph
wires are to be introduced. No boring or cutting for wires or stringing of wires will be allowed without the prior written consent of
Landlord. The location of telephones, call boxes and other office equipment affixed to the premises shall be subject to the approval of
Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.</TD><TD STYLE="text-align: justify">Linoleum, tile, carpet and other floor coverings shall be affixed to the floor of the premises only in
a manner previously approved in writing by Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.</TD><TD STYLE="text-align: justify">No person shall be allowed to transport or carry beverages, food, food containers, etc. on any passenger
elevators. The transportation of such items shall be via the freight elevator in such manner as prescribed by Landlord.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.</TD><TD STYLE="text-align: justify">The bulletin board or directory of the Building shall be provided exclusively for the display of the name
and location of tenants only and Landlord reserves the right to exclude all other names therefrom and to limit the number of listings
thereon.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.</TD><TD STYLE="text-align: justify">Tenant shall not overload the floor of the premises or mark, drive nails, screw or drill into the partitions,
woodwork or plaster or in any way deface the premises or any part thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">30.</TD><TD STYLE="text-align: justify">Landlord reserves the right to close and keep locked all entrance and exit doors and otherwise
                                                           regulate access of all persons to the halls, corridors, elevators and stairways in the Building on Sundays and legal holidays and on
                                                           other days between the hours of 7:00 P.M. and 7:00 A.M., and at such other times as Landlord may deem advisable for the adequate
                                                           protection and safety of the Building, its tenants and property in the Building.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.</TD><TD STYLE="text-align: justify">Landlord reserves the right to rescind, alter or waive any rule or regulation with respect to any one
or more tenants at any time when, in its reasonable judgment, it deems it necessary, desirable or proper for its best interest or for
the best interests of the tenants generally, and no alteration or waiver of any rule or regulation in favor of one or more tenants shall
operate as an alteration or waiver in favor of any other tenant not specifically included in such alteration or waiver.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt; width: 34%">SCHEDULE 5</TD>
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">9150 Wilshire Boulevard</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B><U>SCHEDULE 6</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B><U>TENANT ACCEPTANCE
LETTER</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This declaration is
hereby attached to and made part of the Lease, dated October&nbsp;____, 2024, entered into by and between New Lion Enterprises LLC, as
&ldquo;Landlord&rdquo; and AXIL BRANDS, INC., as &ldquo;Tenant.&rdquo; Tenant, hereby confirms as of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
2024, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
has accepted possession of the Premises on</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><FONT STYLE="font-size: 10pt">,
2024 and is currently able to occupy the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Commencement Date as defined in the Lease is</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><FONT STYLE="font-size: 10pt">,
2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Rent Commencement Date as defined in the Lease is</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><FONT STYLE="font-size: 10pt">,
2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Expiration Date of the Lease is</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><FONT STYLE="font-size: 10pt">,
2031.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date hereof, Landlord has fulfilled all of its obligations under the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Lease is in full force and effect and has not been modified, altered, or amended, except pursuant to any instruments described above,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no offsets or credits against Base Rent or additional Rent, nor has any Base Rent or additional Rent been prepaid except as provided
pursuant to the terms of the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
has no notice of any prior assignment, hypothecation, or pledge of the Lease or any Rents due under the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">TENANT:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">AXIL BRANDS, INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 45%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt; width: 34%">SCHEDULE 6</TD>
    <TD STYLE="text-align: right; font-size: 10pt; width: 33%">9150 Wilshire Boulevard</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 43; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 7</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>BROKERAGE COMMISSION AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INTENTIONALLY OMITTED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE 7</P>


<!-- Field: Page; Sequence: 44; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>axil-20241130.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Qpo7xRiXgOn8uPaXcsSaSIebP9xpJ7aZkhtGlzfblq3y4iKAuebCnT7acWkaQH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:axil="http://reviv.com/20241130" elementFormDefault="qualified" targetNamespace="http://reviv.com/20241130">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://reviv.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
          <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" id="ConsolidatedStatementsOfChangesInStockholdersEquity">
          <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
          <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/Organization" id="Organization">
          <link:definition>995612 - Disclosure - Organization</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" id="BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
          <link:definition>995613 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/AccountsReceivableNet" id="AccountsReceivableNet">
          <link:definition>995614 - Disclosure - Accounts Receivable, net</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/InventoryNet" id="InventoryNet">
          <link:definition>995615 - Disclosure - Inventory, net</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>995616 - Disclosure - Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>995617 - Disclosure - Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
          <link:definition>995618 - Disclosure - Other Current Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/NotesPayable" id="NotesPayable">
          <link:definition>995619 - Disclosure - Notes Payable</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>995620 - Disclosure - Stockholders&#8217; Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>995621 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>995622 - Disclosure - Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/Concentrations" id="Concentrations">
          <link:definition>995623 - Disclosure - Concentrations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" id="BusinessSegmentAndGeographicAreaInformation">
          <link:definition>995624 - Disclosure - Business Segment and Geographic Area Information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>995625 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>995626 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables">
          <link:definition>995627 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/AccountsReceivableNetTables" id="AccountsReceivableNetTables">
          <link:definition>995628 - Disclosure - Accounts Receivable, net (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/InventoryNetTables" id="InventoryNetTables">
          <link:definition>995629 - Disclosure - Inventory, net (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>995630 - Disclosure - Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>995631 - Disclosure - Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
          <link:definition>995632 - Disclosure - Other Current Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/NotesPayableTables" id="NotesPayableTables">
          <link:definition>995633 - Disclosure - Notes Payable (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
          <link:definition>995634 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
          <link:definition>995635 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" id="BusinessSegmentAndGeographicAreaInformationTables">
          <link:definition>995636 - Disclosure - Business Segment and Geographic Area Information (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails">
          <link:definition>995637 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>995638 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/AccountsReceivableNetDetails" id="AccountsReceivableNetDetails">
          <link:definition>995639 - Disclosure - Accounts Receivable, net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" id="AccountsReceivableNetDetailsNarrative">
          <link:definition>995640 - Disclosure - Accounts Receivable, net (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/InventoryNetDetails" id="InventoryNetDetails">
          <link:definition>995641 - Disclosure - Inventory, net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/InventoryNetDetailsNarrative" id="InventoryNetDetailsNarrative">
          <link:definition>995642 - Disclosure - Inventory, net (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
          <link:definition>995643 - Disclosure - Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>995644 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
          <link:definition>995645 - Disclosure - Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
          <link:definition>995646 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/OtherCurrentLiabilitiesDetails" id="OtherCurrentLiabilitiesDetails">
          <link:definition>995647 - Disclosure - Other Current Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/NotesPayableDetails" id="NotesPayableDetails">
          <link:definition>995648 - Disclosure - Notes Payable (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
          <link:definition>995649 - Disclosure - Notes Payable (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
          <link:definition>995650 - Disclosure - Stockholders' Equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/StockholdersEquityDetails1" id="StockholdersEquityDetails1">
          <link:definition>995651 - Disclosure - Stockholders' Equity (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>995652 - Disclosure - Stockholders&#8217; Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
          <link:definition>995653 - Disclosure - Commitments and Contingencies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails1" id="CommitmentsAndContingenciesDetails1">
          <link:definition>995654 - Disclosure - Commitments and Contingencies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>995655 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>995656 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/ConcentrationsDetailsNarrative" id="ConcentrationsDetailsNarrative">
          <link:definition>995657 - Disclosure - Concentrations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" id="BusinessSegmentAndGeographicAreaInformationDetails">
          <link:definition>995658 - Disclosure - Business Segment and Geographic Area Information (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://reviv.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>995659 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="axil-20241130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="axil-20241130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="axil-20241130_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="axil-20241130_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="axil_CustomerMember" name="CustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_PromotionalRisplayRacksMember" name="PromotionalRisplayRacksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_LicensingRightsMember" name="LicensingRightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_WebsiteMember" name="WebsiteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ProductCertificationTestingMember" name="ProductCertificationTestingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_EconomicInjuryDisasterLoanProgramMember" name="EconomicInjuryDisasterLoanProgramMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_EIDLMember" name="EIDLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_OneConsultantMember" name="OneConsultantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_OfficersMember" name="OfficersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ThreeBoardMembersMember" name="ThreeBoardMembersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_RestrictedStockAwardsMember" name="RestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_IntrepidMember" name="IntrepidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_BZCapitalStrategiesMember" name="BZCapitalStrategiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_PurchasesMember" name="PurchasesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_VendorsMember" name="VendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_VendorOneMember" name="VendorOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_HairCareAndSkinCareMember" name="HairCareAndSkinCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_HearingEnhancementAndProtectionMember" name="HearingEnhancementAndProtectionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="axil_DeferredTaxAsset" name="DeferredTaxAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_CustomerDepositCurrent" name="CustomerDepositCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_DueToRelatedParty" name="DueToRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_IncomeTaxLiability" name="IncomeTaxLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_GainOnDebtSettlement" name="GainOnDebtSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_PreferredStockConvertedToCommonStock" name="PreferredStockConvertedToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_PreferredStockConvertedToCommonStockShares" name="PreferredStockConvertedToCommonStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="axil_GainOnForgivenessOfAccountPayable" name="GainOnForgivenessOfAccountPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_RepaymentOfEquipmentFinancing" name="RepaymentOfEquipmentFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_CashPaidDuringPeriodForAbstract" name="CashPaidDuringPeriodForAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" name="InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ShippingAndHandlingCostsPolicyTextBlock" name="ShippingAndHandlingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="axil_CustomerDepositPolicytextBlock" name="CustomerDepositPolicytextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" name="ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="axil_RestrictedStockAwards" name="RestrictedStockAwards" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ContractLiabilitiesDescription" name="ContractLiabilitiesDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="axil_CustomersReceivable" name="CustomersReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_MerchantProcessorReceivable" name="MerchantProcessorReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_InventoryHeldAtThirdPartyLocation" name="InventoryHeldAtThirdPartyLocation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_CreditCards" name="CreditCards" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_RoyaltyPaymentAccrual" name="RoyaltyPaymentAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_LoanForgiveness" name="LoanForgiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_RemainingOutstanding" name="RemainingOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="axil_NumberOfOptionIssued" name="NumberOfOptionIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ValueOfOptionIssued" name="ValueOfOptionIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_RightOfUseAssets" name="RightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization" name="OperatingLeaseRightOfUseAssetAccumulatedAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_LeaseLiability" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_AccumulatedReduction" name="AccumulatedReduction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_OperatingLeaseLiabilityCurrentPortion" name="OperatingLeaseLiabilityCurrentPortion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_InitialLeaseLiability" name="InitialLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ConsultingFee" name="ConsultingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_PayableToRelatedParty" name="PayableToRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="axil_ConsolidatedOperatingIncomeLoss" name="ConsolidatedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>axil-20241130_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://reviv.com/role/Cover" xlink:href="axil-20241130.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedBalanceSheets" xlink:href="axil-20241130.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="axil-20241130.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfOperations" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/Organization" xlink:href="axil-20241130.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNet" xlink:href="axil-20241130.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNet" xlink:href="axil-20241130.xsd#InventoryNet" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipment" xlink:href="axil-20241130.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssets" xlink:href="axil-20241130.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilities" xlink:href="axil-20241130.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayable" xlink:href="axil-20241130.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquity" xlink:href="axil-20241130.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingencies" xlink:href="axil-20241130.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/RelatedPartyTransactions" xlink:href="axil-20241130.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/Concentrations" xlink:href="axil-20241130.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IncomeTaxes" xlink:href="axil-20241130.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetTables" xlink:href="axil-20241130.xsd#AccountsReceivableNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetTables" xlink:href="axil-20241130.xsd#InventoryNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentTables" xlink:href="axil-20241130.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsTables" xlink:href="axil-20241130.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilitiesTables" xlink:href="axil-20241130.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableTables" xlink:href="axil-20241130.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityTables" xlink:href="axil-20241130.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesTables" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetDetails" xlink:href="axil-20241130.xsd#AccountsReceivableNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" xlink:href="axil-20241130.xsd#AccountsReceivableNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetDetails" xlink:href="axil-20241130.xsd#InventoryNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetDetailsNarrative" xlink:href="axil-20241130.xsd#InventoryNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentDetails" xlink:href="axil-20241130.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="axil-20241130.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsDetails" xlink:href="axil-20241130.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsDetailsNarrative" xlink:href="axil-20241130.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilitiesDetails" xlink:href="axil-20241130.xsd#OtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableDetails" xlink:href="axil-20241130.xsd#NotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableDetailsNarrative" xlink:href="axil-20241130.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetails" xlink:href="axil-20241130.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetails1" xlink:href="axil-20241130.xsd#StockholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetailsNarrative" xlink:href="axil-20241130.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails1" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="axil-20241130.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConcentrationsDetailsNarrative" xlink:href="axil-20241130.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IncomeTaxesDetailsNarrative" xlink:href="axil-20241130.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_DeferredTaxAsset" xlink:label="loc_axilDeferredTaxAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_axilDeferredTaxAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerDepositCurrent" xlink:label="loc_axilCustomerDepositCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_axilCustomerDepositCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_DueToRelatedParty" xlink:label="loc_axilDueToRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_axilDueToRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_IncomeTaxLiability" xlink:label="loc_axilIncomeTaxLiability" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_axilIncomeTaxLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnDebtSettlement" xlink:label="loc_axilGainOnDebtSettlement" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_axilGainOnDebtSettlement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnDebtSettlement" xlink:label="loc_axilGainOnDebtSettlement" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_axilGainOnDebtSettlement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnForgivenessOfAccountPayable" xlink:label="loc_axilGainOnForgivenessOfAccountPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_axilGainOnForgivenessOfAccountPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RepaymentOfEquipmentFinancing" xlink:label="loc_axilRepaymentOfEquipmentFinancing" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_axilRepaymentOfEquipmentFinancing" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/Organization" xlink:title="995612 - Disclosure - Organization" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNet" xlink:title="995614 - Disclosure - Accounts Receivable, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNet" xlink:title="995615 - Disclosure - Inventory, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipment" xlink:title="995616 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssets" xlink:title="995617 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilities" xlink:title="995618 - Disclosure - Other Current Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayable" xlink:title="995619 - Disclosure - Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquity" xlink:title="995620 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingencies" xlink:title="995621 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/RelatedPartyTransactions" xlink:title="995622 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/Concentrations" xlink:title="995623 - Disclosure - Concentrations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" xlink:title="995624 - Disclosure - Business Segment and Geographic Area Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/IncomeTaxes" xlink:title="995625 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995626 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="995627 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetTables" xlink:title="995628 - Disclosure - Accounts Receivable, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetTables" xlink:title="995629 - Disclosure - Inventory, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentTables" xlink:title="995630 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsTables" xlink:title="995631 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilitiesTables" xlink:title="995632 - Disclosure - Other Current Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableTables" xlink:title="995633 - Disclosure - Notes Payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityTables" xlink:title="995634 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesTables" xlink:title="995635 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" xlink:title="995636 - Disclosure - Business Segment and Geographic Area Information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:title="995637 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995638 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetDetails" xlink:title="995639 - Disclosure - Accounts Receivable, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomersReceivable" xlink:label="loc_axilCustomersReceivable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableNet" xlink:to="loc_axilCustomersReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_MerchantProcessorReceivable" xlink:label="loc_axilMerchantProcessorReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableNet" xlink:to="loc_axilMerchantProcessorReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableNet" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" xlink:title="995640 - Disclosure - Accounts Receivable, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetDetails" xlink:title="995641 - Disclosure - Inventory, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetDetailsNarrative" xlink:title="995642 - Disclosure - Inventory, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentDetails" xlink:title="995643 - Disclosure - Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="995644 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsDetails" xlink:title="995645 - Disclosure - Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsDetailsNarrative" xlink:title="995646 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilitiesDetails" xlink:title="995647 - Disclosure - Other Current Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableDetails" xlink:title="995648 - Disclosure - Notes Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableDetailsNarrative" xlink:title="995649 - Disclosure - Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetails" xlink:title="995650 - Disclosure - Stockholders&apos; Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetails1" xlink:title="995651 - Disclosure - Stockholders&apos; Equity (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetailsNarrative" xlink:title="995652 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetails" xlink:title="995653 - Disclosure - Commitments and Contingencies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetails1" xlink:title="995654 - Disclosure - Commitments and Contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995655 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995656 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConcentrationsDetailsNarrative" xlink:title="995657 - Disclosure - Concentrations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" xlink:title="995658 - Disclosure - Business Segment and Geographic Area Information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://reviv.com/role/IncomeTaxesDetailsNarrative" xlink:title="995659 - Disclosure - Income Taxes (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>axil-20241130_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://reviv.com/role/Cover" xlink:href="axil-20241130.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedBalanceSheets" xlink:href="axil-20241130.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="axil-20241130.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfOperations" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/Organization" xlink:href="axil-20241130.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNet" xlink:href="axil-20241130.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNet" xlink:href="axil-20241130.xsd#InventoryNet" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipment" xlink:href="axil-20241130.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssets" xlink:href="axil-20241130.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilities" xlink:href="axil-20241130.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayable" xlink:href="axil-20241130.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquity" xlink:href="axil-20241130.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingencies" xlink:href="axil-20241130.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/RelatedPartyTransactions" xlink:href="axil-20241130.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/Concentrations" xlink:href="axil-20241130.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IncomeTaxes" xlink:href="axil-20241130.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetTables" xlink:href="axil-20241130.xsd#AccountsReceivableNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetTables" xlink:href="axil-20241130.xsd#InventoryNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentTables" xlink:href="axil-20241130.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsTables" xlink:href="axil-20241130.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilitiesTables" xlink:href="axil-20241130.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableTables" xlink:href="axil-20241130.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityTables" xlink:href="axil-20241130.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesTables" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetDetails" xlink:href="axil-20241130.xsd#AccountsReceivableNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" xlink:href="axil-20241130.xsd#AccountsReceivableNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetDetails" xlink:href="axil-20241130.xsd#InventoryNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetDetailsNarrative" xlink:href="axil-20241130.xsd#InventoryNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentDetails" xlink:href="axil-20241130.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="axil-20241130.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsDetails" xlink:href="axil-20241130.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsDetailsNarrative" xlink:href="axil-20241130.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilitiesDetails" xlink:href="axil-20241130.xsd#OtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableDetails" xlink:href="axil-20241130.xsd#NotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableDetailsNarrative" xlink:href="axil-20241130.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetails" xlink:href="axil-20241130.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetails1" xlink:href="axil-20241130.xsd#StockholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetailsNarrative" xlink:href="axil-20241130.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails1" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="axil-20241130.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConcentrationsDetailsNarrative" xlink:href="axil-20241130.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IncomeTaxesDetailsNarrative" xlink:href="axil-20241130.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapAdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapSharesPaidForTaxWithholdingForShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesPaidForTaxWithholdingForShareBasedCompensation_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PreferredStockConvertedToCommonStock" xlink:label="loc_axilPreferredStockConvertedToCommonStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_axilPreferredStockConvertedToCommonStock_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PreferredStockConvertedToCommonStockShares" xlink:label="loc_axilPreferredStockConvertedToCommonStockShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_axilPreferredStockConvertedToCommonStockShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/Organization" xlink:title="995612 - Disclosure - Organization" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNet" xlink:title="995614 - Disclosure - Accounts Receivable, net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNet" xlink:title="995615 - Disclosure - Inventory, net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipment" xlink:title="995616 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssets" xlink:title="995617 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilities" xlink:title="995618 - Disclosure - Other Current Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayable" xlink:title="995619 - Disclosure - Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquity" xlink:title="995620 - Disclosure - Stockholders&#8217; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingencies" xlink:title="995621 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/RelatedPartyTransactions" xlink:title="995622 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/Concentrations" xlink:title="995623 - Disclosure - Concentrations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" xlink:title="995624 - Disclosure - Business Segment and Geographic Area Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/IncomeTaxes" xlink:title="995625 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995626 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="995627 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetTables" xlink:title="995628 - Disclosure - Accounts Receivable, net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetTables" xlink:title="995629 - Disclosure - Inventory, net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentTables" xlink:title="995630 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsTables" xlink:title="995631 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilitiesTables" xlink:title="995632 - Disclosure - Other Current Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableTables" xlink:title="995633 - Disclosure - Notes Payable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityTables" xlink:title="995634 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesTables" xlink:title="995635 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" xlink:title="995636 - Disclosure - Business Segment and Geographic Area Information (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:title="995637 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995638 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerMember" xlink:label="loc_axilCustomerMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilCustomerMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaapContractWithCustomerLiability_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiability_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ContractLiabilitiesDescription" xlink:label="loc_axilContractLiabilitiesDescription_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_axilContractLiabilitiesDescription_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetDetails" xlink:title="995639 - Disclosure - Accounts Receivable, net (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" xlink:title="995640 - Disclosure - Accounts Receivable, net (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetDetails" xlink:title="995641 - Disclosure - Inventory, net (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetDetailsNarrative" xlink:title="995642 - Disclosure - Inventory, net (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentDetails" xlink:title="995643 - Disclosure - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PromotionalRisplayRacksMember" xlink:label="loc_axilPromotionalRisplayRacksMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_axilPromotionalRisplayRacksMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AutomobilesMember" xlink:label="loc_us-gaapAutomobilesMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAutomobilesMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_190" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="995644 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsDetails" xlink:title="995645 - Disclosure - Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LicensingRightsMember" xlink:label="loc_axilLicensingRightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_axilLicensingRightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_WebsiteMember" xlink:label="loc_axilWebsiteMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_axilWebsiteMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ProductCertificationTestingMember" xlink:label="loc_axilProductCertificationTestingMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_axilProductCertificationTestingMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsDetailsNarrative" xlink:title="995646 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilitiesDetails" xlink:title="995647 - Disclosure - Other Current Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableDetails" xlink:title="995648 - Disclosure - Notes Payable (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableDetailsNarrative" xlink:title="995649 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_EconomicInjuryDisasterLoanProgramMember" xlink:label="loc_axilEconomicInjuryDisasterLoanProgramMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_axilEconomicInjuryDisasterLoanProgramMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_EIDLMember" xlink:label="loc_axilEIDLMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_axilEIDLMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LoanForgiveness" xlink:label="loc_axilLoanForgiveness_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_axilLoanForgiveness_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInterestPayableCurrent_80" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetails" xlink:title="995650 - Disclosure - Stockholders&apos; Equity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetails1" xlink:title="995651 - Disclosure - Stockholders&apos; Equity (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetailsNarrative" xlink:title="995652 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OneConsultantMember" xlink:label="loc_axilOneConsultantMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_axilOneConsultantMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OfficersMember" xlink:label="loc_axilOfficersMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_axilOfficersMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ThreeBoardMembersMember" xlink:label="loc_axilThreeBoardMembersMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_axilThreeBoardMembersMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RestrictedStockAwardsMember" xlink:label="loc_axilRestrictedStockAwardsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_axilRestrictedStockAwardsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RemainingOutstanding" xlink:label="loc_axilRemainingOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_axilRemainingOutstanding_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_NumberOfOptionIssued" xlink:label="loc_axilNumberOfOptionIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_axilNumberOfOptionIssued_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ValueOfOptionIssued" xlink:label="loc_axilValueOfOptionIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_axilValueOfOptionIssued_150" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_150" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_150" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_150" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_150" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_150" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation_150" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetails" xlink:title="995653 - Disclosure - Commitments and Contingencies (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetails1" xlink:title="995654 - Disclosure - Commitments and Contingencies (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995655 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995656 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_IntrepidMember" xlink:label="loc_axilIntrepidMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_axilIntrepidMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_BZCapitalStrategiesMember" xlink:label="loc_axilBZCapitalStrategiesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_axilBZCapitalStrategiesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ConsultingFee" xlink:label="loc_axilConsultingFee_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_axilConsultingFee_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PayableToRelatedParty" xlink:label="loc_axilPayableToRelatedParty_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_axilPayableToRelatedParty_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/ConcentrationsDetailsNarrative" xlink:title="995657 - Disclosure - Concentrations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PurchasesMember" xlink:label="loc_axilPurchasesMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_axilPurchasesMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerMember" xlink:label="loc_axilCustomerMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilCustomerMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OneCustomerMember" xlink:label="loc_axilOneCustomerMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilOneCustomerMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_VendorsMember" xlink:label="loc_axilVendorsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilVendorsMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_VendorOneMember" xlink:label="loc_axilVendorOneMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilVendorOneMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapCashUninsuredAmount_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_140" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" xlink:title="995658 - Disclosure - Business Segment and Geographic Area Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_HairCareAndSkinCareMember" xlink:label="loc_axilHairCareAndSkinCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_axilHairCareAndSkinCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_HearingEnhancementAndProtectionMember" xlink:label="loc_axilHearingEnhancementAndProtectionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_axilHearingEnhancementAndProtectionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenues_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapGrossProfit_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ConsolidatedOperatingIncomeLoss" xlink:label="loc_axilConsolidatedOperatingIncomeLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_axilConsolidatedOperatingIncomeLoss_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapAssetsNet_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_190" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://reviv.com/role/IncomeTaxesDetailsNarrative" xlink:title="995659 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RestrictedStockAwardsMember" xlink:label="loc_axilRestrictedStockAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_axilRestrictedStockAwardsMember" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>axil-20241130_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerMember" xlink:label="axil_CustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_CustomerMember" xlink:to="axil_CustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_CustomerMember_lbl" xml:lang="en-US">Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PromotionalRisplayRacksMember" xlink:label="axil_PromotionalRisplayRacksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PromotionalRisplayRacksMember" xlink:to="axil_PromotionalRisplayRacksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_PromotionalRisplayRacksMember_lbl" xml:lang="en-US">Promotional Risplay Racks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AutomobilesMember" xlink:label="us-gaap_AutomobilesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AutomobilesMember_lbl" xml:lang="en-US">Automobiles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LicensingRightsMember" xlink:label="axil_LicensingRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_LicensingRightsMember" xlink:to="axil_LicensingRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_LicensingRightsMember_lbl" xml:lang="en-US">Licensing Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember" xlink:label="us-gaap_TradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_WebsiteMember" xlink:label="axil_WebsiteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_WebsiteMember" xlink:to="axil_WebsiteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_WebsiteMember_lbl" xml:lang="en-US">Website [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ProductCertificationTestingMember" xlink:label="axil_ProductCertificationTestingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ProductCertificationTestingMember" xlink:to="axil_ProductCertificationTestingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ProductCertificationTestingMember_lbl" xml:lang="en-US">Product Certification Testing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_EconomicInjuryDisasterLoanProgramMember" xlink:label="axil_EconomicInjuryDisasterLoanProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_EconomicInjuryDisasterLoanProgramMember" xlink:to="axil_EconomicInjuryDisasterLoanProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_EconomicInjuryDisasterLoanProgramMember_lbl" xml:lang="en-US">Economic Injury Disaster Loan Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_EIDLMember" xlink:label="axil_EIDLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_EIDLMember" xlink:to="axil_EIDLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_EIDLMember_lbl" xml:lang="en-US">EIDL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OneConsultantMember" xlink:label="axil_OneConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_OneConsultantMember" xlink:to="axil_OneConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_OneConsultantMember_lbl" xml:lang="en-US">One Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OfficersMember" xlink:label="axil_OfficersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_OfficersMember" xlink:to="axil_OfficersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_OfficersMember_lbl" xml:lang="en-US">Officers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ThreeBoardMembersMember" xlink:label="axil_ThreeBoardMembersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ThreeBoardMembersMember" xlink:to="axil_ThreeBoardMembersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ThreeBoardMembersMember_lbl" xml:lang="en-US">Three Board Members [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RestrictedStockAwardsMember" xlink:label="axil_RestrictedStockAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_RestrictedStockAwardsMember" xlink:to="axil_RestrictedStockAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_RestrictedStockAwardsMember_lbl" xml:lang="en-US">Restricted Stock Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_IntrepidMember" xlink:label="axil_IntrepidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_IntrepidMember" xlink:to="axil_IntrepidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_IntrepidMember_lbl" xml:lang="en-US">Intrepid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_BZCapitalStrategiesMember" xlink:label="axil_BZCapitalStrategiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_BZCapitalStrategiesMember" xlink:to="axil_BZCapitalStrategiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_BZCapitalStrategiesMember_lbl" xml:lang="en-US">BZ Capital Strategies [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OneCustomerMember" xlink:label="axil_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_OneCustomerMember" xlink:to="axil_OneCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_OneCustomerMember_lbl" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="us-gaap_ProductConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductConcentrationRiskMember" xlink:to="us-gaap_ProductConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductConcentrationRiskMember_lbl" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PurchasesMember" xlink:label="axil_PurchasesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PurchasesMember" xlink:to="axil_PurchasesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_PurchasesMember_lbl" xml:lang="en-US">Purchases [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_VendorsMember" xlink:label="axil_VendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_VendorsMember" xlink:to="axil_VendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_VendorsMember_lbl" xml:lang="en-US">Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_VendorOneMember" xlink:label="axil_VendorOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_VendorOneMember" xlink:to="axil_VendorOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_VendorOneMember_lbl" xml:lang="en-US">Vendors One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_HairCareAndSkinCareMember" xlink:label="axil_HairCareAndSkinCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_HairCareAndSkinCareMember" xlink:to="axil_HairCareAndSkinCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_HairCareAndSkinCareMember_lbl" xml:lang="en-US">Hair care and skin care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_HearingEnhancementAndProtectionMember" xlink:label="axil_HearingEnhancementAndProtectionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_HearingEnhancementAndProtectionMember" xlink:to="axil_HearingEnhancementAndProtectionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_HearingEnhancementAndProtectionMember_lbl" xml:lang="en-US">Hearing enhancement and protection [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">OTHER ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_DeferredTaxAsset" xlink:label="axil_DeferredTaxAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_DeferredTaxAsset" xlink:to="axil_DeferredTaxAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_DeferredTaxAsset_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerDepositCurrent" xlink:label="axil_CustomerDepositCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_CustomerDepositCurrent" xlink:to="axil_CustomerDepositCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_CustomerDepositCurrent_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Contract liabilities, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_DueToRelatedParty" xlink:label="axil_DueToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_DueToRelatedParty" xlink:to="axil_DueToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_DueToRelatedParty_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Lease liability, current</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_IncomeTaxLiability" xlink:label="axil_IncomeTaxLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_IncomeTaxLiability" xlink:to="axil_IncomeTaxLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_IncomeTaxLiability_lbl" xml:lang="en-US">Income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">LONG TERM LIABILITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (see Note 10)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 31,133,500 and 42,251,750 shares issued and outstanding as of November 30, 2024 and May 31, 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.0001 par value: 450,000,000 shares authorized; 6,466,852 and 5,908,939 shares issued, issuable and outstanding as of November 30, 2024 and May 31, 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings/(Accumulated deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Sales, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">OPERATING EXPENSES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Compensation and related taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional and consulting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER INCOME (EXPENSE):</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnDebtSettlement" xlink:label="axil_GainOnDebtSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_GainOnDebtSettlement" xlink:to="axil_GainOnDebtSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_GainOnDebtSettlement_lbl" xml:lang="en-US">Gain on settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense and other finance charges</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">INCOME BEFORE PROVISION FOR INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract_lbl" xml:lang="en-US">NET INCOME PER COMMON SHARE:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xml:lang="en-US">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock options expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PreferredStockConvertedToCommonStock" xlink:label="axil_PreferredStockConvertedToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PreferredStockConvertedToCommonStock" xlink:to="axil_PreferredStockConvertedToCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_PreferredStockConvertedToCommonStock_lbl" xml:lang="en-US">Preferred shares converted to common</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PreferredStockConvertedToCommonStockShares" xlink:label="axil_PreferredStockConvertedToCommonStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PreferredStockConvertedToCommonStockShares" xlink:to="axil_PreferredStockConvertedToCommonStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_PreferredStockConvertedToCommonStockShares_lbl" xml:lang="en-US">Preferred shares converted to common, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_GainOnDebtSettlement" xlink:to="axil_GainOnDebtSettlement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="axil_GainOnDebtSettlement_2_lbl" xml:lang="en-US">Gain on settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnForgivenessOfAccountPayable" xlink:label="axil_GainOnForgivenessOfAccountPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_GainOnForgivenessOfAccountPayable" xlink:to="axil_GainOnForgivenessOfAccountPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="axil_GainOnForgivenessOfAccountPayable_lbl" xml:lang="en-US">Gain on forgiveness of account payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase of intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RepaymentOfEquipmentFinancing" xlink:label="axil_RepaymentOfEquipmentFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_RepaymentOfEquipmentFinancing" xlink:to="axil_RepaymentOfEquipmentFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_RepaymentOfEquipmentFinancing_lbl" xml:lang="en-US">Repayment of equipment financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Advances (payments) from a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE IN CASH</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH - Beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">CASH - End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CashPaidDuringPeriodForAbstract" xlink:label="axil_CashPaidDuringPeriodForAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_CashPaidDuringPeriodForAbstract" xlink:to="axil_CashPaidDuringPeriodForAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_CashPaidDuringPeriodForAbstract_lbl" xml:lang="en-US">Cash paid during the period for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" xlink:label="axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" xlink:to="axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability_lbl" xml:lang="en-US">Initial recognition of right of use assets recognized as lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="us-gaap_CreditLossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditLossAbstract" xlink:to="us-gaap_CreditLossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditLossAbstract_lbl" xml:lang="en-US">Credit Loss [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="us-gaap_AccountsAndNontradeReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:to="us-gaap_AccountsAndNontradeReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndNontradeReceivableTextBlock_lbl" xml:lang="en-US">Accounts Receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Business Segment and Geographic Area Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ReverseStockSplitPolicyTextBlock" xlink:label="axil_ReverseStockSplitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ReverseStockSplitPolicyTextBlock" xlink:to="axil_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ReverseStockSplitPolicyTextBlock_lbl" xml:lang="en-US">Reverse Stock Split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Reclassifications" xlink:label="us-gaap_Reclassifications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Reclassifications" xlink:to="us-gaap_Reclassifications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Reclassifications_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts receivable and allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:to="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtendedProductWarrantyPolicy" xlink:label="us-gaap_ExtendedProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedProductWarrantyPolicy" xlink:to="us-gaap_ExtendedProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedProductWarrantyPolicy_lbl" xml:lang="en-US">Product warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ShippingAndHandlingCostsPolicyTextBlock" xlink:label="axil_ShippingAndHandlingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ShippingAndHandlingCostsPolicyTextBlock" xlink:to="axil_ShippingAndHandlingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ShippingAndHandlingCostsPolicyTextBlock_lbl" xml:lang="en-US">Shipping and Handling Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Sales, Marketing and Advertising</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerDepositPolicytextBlock" xlink:label="axil_CustomerDepositPolicytextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_CustomerDepositPolicytextBlock" xlink:to="axil_CustomerDepositPolicytextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_CustomerDepositPolicytextBlock_lbl" xml:lang="en-US">Customer Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value measurements and fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net income per share of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy" xlink:label="us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy" xlink:to="us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy_lbl" xml:lang="en-US">Lease Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">Schedule of accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of notes payments due in the next twelve months</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock options activities</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" xlink:label="axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" xlink:to="axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_lbl" xml:lang="en-US">Schedule of supplemental balance sheet information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of maturities of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of segment information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average basic shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="us-gaap_DilutiveSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_DilutiveSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecuritiesAbstract_lbl" xml:lang="en-US">&#160;Dilutive securities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RestrictedStockAwards" xlink:label="axil_RestrictedStockAwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_RestrictedStockAwards" xlink:to="axil_RestrictedStockAwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_RestrictedStockAwards_lbl" xml:lang="en-US">Restricted stock awards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted average dilutive shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings per share:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Stockholders' Equity, Reverse Stock Split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ContractLiabilitiesDescription" xlink:label="axil_ContractLiabilitiesDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ContractLiabilitiesDescription" xlink:to="axil_ContractLiabilitiesDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ContractLiabilitiesDescription_lbl" xml:lang="en-US">Contract Liabilities Description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_2_lbl" xml:lang="en-US">Selling and marketing expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomersReceivable" xlink:label="axil_CustomersReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_CustomersReceivable" xlink:to="axil_CustomersReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_CustomersReceivable_lbl" xml:lang="en-US">Customers receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_MerchantProcessorReceivable" xlink:label="axil_MerchantProcessorReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_MerchantProcessorReceivable" xlink:to="axil_MerchantProcessorReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_MerchantProcessorReceivable_lbl" xml:lang="en-US">Merchant processor receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Less: Allowance for credit losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsReceivableNet_2_lbl" xml:lang="en-US">Accounts receivables, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xml:lang="en-US">Bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished Goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw Materials</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_InventoryHeldAtThirdPartyLocation" xlink:label="axil_InventoryHeldAtThirdPartyLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_InventoryHeldAtThirdPartyLocation" xlink:to="axil_InventoryHeldAtThirdPartyLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_InventoryHeldAtThirdPartyLocation_lbl" xml:lang="en-US">Inventory held at third party location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventoryInTransit" xlink:label="us-gaap_OtherInventoryInTransit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryInTransit" xlink:to="us-gaap_OtherInventoryInTransit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventoryInTransit_lbl" xml:lang="en-US">Inventory in-transit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Inventory valuation reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Plant Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less:Accumulated Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Finite-lived Intangible Assets, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-lived Intangible Assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CreditCards" xlink:label="axil_CreditCards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_CreditCards" xlink:to="axil_CreditCards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_CreditCards_lbl" xml:lang="en-US">Credit Cards</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RoyaltyPaymentAccrual" xlink:label="axil_RoyaltyPaymentAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_RoyaltyPaymentAccrual" xlink:to="axil_RoyaltyPaymentAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_RoyaltyPaymentAccrual_lbl" xml:lang="en-US">Royalty Payment Accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales Tax Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Total other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LoanForgiveness" xlink:label="axil_LoanForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_LoanForgiveness" xlink:to="axil_LoanForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_LoanForgiveness_lbl" xml:lang="en-US">Loan forgiveness</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Additional borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Options Outstanding, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Options Outstanding, Exercised/Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised/Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options Outstanding, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Number of Options Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Number of Options Outstanding, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Term, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock, par or stated value per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred stock, par or stated value per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_2_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Shares issued during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Shares issued value during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Number of share purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Cash consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RemainingOutstanding" xlink:label="axil_RemainingOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_RemainingOutstanding" xlink:to="axil_RemainingOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_RemainingOutstanding_lbl" xml:lang="en-US">Remaining outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Number of shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_NumberOfOptionIssued" xlink:label="axil_NumberOfOptionIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_NumberOfOptionIssued" xlink:to="axil_NumberOfOptionIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_NumberOfOptionIssued_lbl" xml:lang="en-US">Number of option issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ValueOfOptionIssued" xlink:label="axil_ValueOfOptionIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ValueOfOptionIssued" xlink:to="axil_ValueOfOptionIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ValueOfOptionIssued_lbl" xml:lang="en-US">Value of option issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Number of restricted stock awards issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Fair value of restricted stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock issued for valued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RightOfUseAssets" xlink:label="axil_RightOfUseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_RightOfUseAssets" xlink:to="axil_RightOfUseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_RightOfUseAssets_lbl" xml:lang="en-US">Right of use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:label="axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated reduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Operating lease assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LeaseLiability" xlink:label="axil_LeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_LeaseLiability" xlink:to="axil_LeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="axil_LeaseLiability_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_AccumulatedReduction" xlink:label="axil_AccumulatedReduction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_AccumulatedReduction" xlink:to="axil_AccumulatedReduction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="axil_AccumulatedReduction_lbl" xml:lang="en-US">Accumulated reduction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability, net</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OperatingLeaseLiabilityCurrentPortion" xlink:label="axil_OperatingLeaseLiabilityCurrentPortion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_OperatingLeaseLiabilityCurrentPortion" xlink:to="axil_OperatingLeaseLiabilityCurrentPortion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="axil_OperatingLeaseLiabilityCurrentPortion_lbl" xml:lang="en-US">Current portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Non-current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025 (six months remaining)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: Imputed interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Present value of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_InitialLeaseLiability" xlink:label="axil_InitialLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_InitialLeaseLiability" xlink:to="axil_InitialLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_InitialLeaseLiability_lbl" xml:lang="en-US">Initial lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrent" xlink:to="us-gaap_AccruedRoyaltiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xml:lang="en-US">Due in royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ConsultingFee" xlink:label="axil_ConsultingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ConsultingFee" xlink:to="axil_ConsultingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ConsultingFee_lbl" xml:lang="en-US">Consulting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PayableToRelatedParty" xlink:label="axil_PayableToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PayableToRelatedParty" xlink:to="axil_PayableToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_PayableToRelatedParty_lbl" xml:lang="en-US">Payable to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash, FDIC insured amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Cash, uninsured amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total net sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Total segment gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_3_lbl" xml:lang="en-US">Selling and Marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and Administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ConsolidatedOperatingIncomeLoss" xlink:label="axil_ConsolidatedOperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_ConsolidatedOperatingIncomeLoss" xlink:to="axil_ConsolidatedOperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_ConsolidatedOperatingIncomeLoss_lbl" xml:lang="en-US">Consolidated operating income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Consolidated total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Consolidated total payments for property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Consolidated total depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_2_lbl" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_GainOnForgivenessOfAccountPayable" xlink:to="axil_GainOnForgivenessOfAccountPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_GainOnForgivenessOfAccountPayable_2_lbl" xml:lang="en-US">GainOnForgivenessOfAccountPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:to="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiability_2_lbl" xml:lang="en-US">Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_LeaseLiability" xlink:to="axil_LeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_LeaseLiability_2_lbl" xml:lang="en-US">LeaseLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_AccumulatedReduction" xlink:to="axil_AccumulatedReduction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_AccumulatedReduction_2_lbl" xml:lang="en-US">AccumulatedReduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axil_OperatingLeaseLiabilityCurrentPortion" xlink:to="axil_OperatingLeaseLiabilityCurrentPortion_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="axil_OperatingLeaseLiabilityCurrentPortion_2_lbl" xml:lang="en-US">OperatingLeaseLiabilityCurrentPortion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>axil-20241130_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://reviv.com/role/Cover" xlink:href="axil-20241130.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedBalanceSheets" xlink:href="axil-20241130.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="axil-20241130.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfOperations" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="axil-20241130.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/Organization" xlink:href="axil-20241130.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNet" xlink:href="axil-20241130.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNet" xlink:href="axil-20241130.xsd#InventoryNet" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipment" xlink:href="axil-20241130.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssets" xlink:href="axil-20241130.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilities" xlink:href="axil-20241130.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayable" xlink:href="axil-20241130.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquity" xlink:href="axil-20241130.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingencies" xlink:href="axil-20241130.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/RelatedPartyTransactions" xlink:href="axil-20241130.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/Concentrations" xlink:href="axil-20241130.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IncomeTaxes" xlink:href="axil-20241130.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetTables" xlink:href="axil-20241130.xsd#AccountsReceivableNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetTables" xlink:href="axil-20241130.xsd#InventoryNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentTables" xlink:href="axil-20241130.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsTables" xlink:href="axil-20241130.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilitiesTables" xlink:href="axil-20241130.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableTables" xlink:href="axil-20241130.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityTables" xlink:href="axil-20241130.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesTables" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="axil-20241130.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetDetails" xlink:href="axil-20241130.xsd#AccountsReceivableNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" xlink:href="axil-20241130.xsd#AccountsReceivableNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetDetails" xlink:href="axil-20241130.xsd#InventoryNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/InventoryNetDetailsNarrative" xlink:href="axil-20241130.xsd#InventoryNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentDetails" xlink:href="axil-20241130.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="axil-20241130.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsDetails" xlink:href="axil-20241130.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IntangibleAssetsDetailsNarrative" xlink:href="axil-20241130.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/OtherCurrentLiabilitiesDetails" xlink:href="axil-20241130.xsd#OtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableDetails" xlink:href="axil-20241130.xsd#NotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/NotesPayableDetailsNarrative" xlink:href="axil-20241130.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetails" xlink:href="axil-20241130.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetails1" xlink:href="axil-20241130.xsd#StockholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/StockholdersEquityDetailsNarrative" xlink:href="axil-20241130.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetails1" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="axil-20241130.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="axil-20241130.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/ConcentrationsDetailsNarrative" xlink:href="axil-20241130.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" xlink:href="axil-20241130.xsd#BusinessSegmentAndGeographicAreaInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://reviv.com/role/IncomeTaxesDetailsNarrative" xlink:href="axil-20241130.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_DeferredTaxAsset" xlink:label="loc_axilDeferredTaxAsset" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_axilDeferredTaxAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerDepositCurrent" xlink:label="loc_axilCustomerDepositCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_axilCustomerDepositCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_DueToRelatedParty" xlink:label="loc_axilDueToRelatedParty" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_axilDueToRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_IncomeTaxLiability" xlink:label="loc_axilIncomeTaxLiability" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_axilIncomeTaxLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnDebtSettlement" xlink:label="loc_axilGainOnDebtSettlement" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_axilGainOnDebtSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasicAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapAdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapSharesPaidForTaxWithholdingForShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PreferredStockConvertedToCommonStock" xlink:label="loc_axilPreferredStockConvertedToCommonStock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_axilPreferredStockConvertedToCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PreferredStockConvertedToCommonStockShares" xlink:label="loc_axilPreferredStockConvertedToCommonStockShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_axilPreferredStockConvertedToCommonStockShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnDebtSettlement" xlink:label="loc_axilGainOnDebtSettlement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_axilGainOnDebtSettlement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_GainOnForgivenessOfAccountPayable" xlink:label="loc_axilGainOnForgivenessOfAccountPayable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_axilGainOnForgivenessOfAccountPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RepaymentOfEquipmentFinancing" xlink:label="loc_axilRepaymentOfEquipmentFinancing" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_axilRepaymentOfEquipmentFinancing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CashPaidDuringPeriodForAbstract" xlink:label="loc_axilCashPaidDuringPeriodForAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_axilCashPaidDuringPeriodForAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" xlink:label="loc_axilInitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_axilInitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/Organization" xlink:title="995612 - Disclosure - Organization">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNet" xlink:title="995614 - Disclosure - Accounts Receivable, net">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="loc_us-gaapAccountsAndNontradeReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAccountsAndNontradeReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNet" xlink:title="995615 - Disclosure - Inventory, net">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipment" xlink:title="995616 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssets" xlink:title="995617 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilities" xlink:title="995618 - Disclosure - Other Current Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayable" xlink:title="995619 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquity" xlink:title="995620 - Disclosure - Stockholders&#8217; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingencies" xlink:title="995621 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/RelatedPartyTransactions" xlink:title="995622 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/Concentrations" xlink:title="995623 - Disclosure - Concentrations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation" xlink:title="995624 - Disclosure - Business Segment and Geographic Area Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/IncomeTaxes" xlink:title="995625 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995626 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ReverseStockSplitPolicyTextBlock" xlink:label="loc_axilReverseStockSplitPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_axilReverseStockSplitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Reclassifications" xlink:label="loc_us-gaapReclassifications" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReclassifications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="loc_axilPrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_axilPrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtendedProductWarrantyPolicy" xlink:label="loc_us-gaapExtendedProductWarrantyPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapExtendedProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ShippingAndHandlingCostsPolicyTextBlock" xlink:label="loc_axilShippingAndHandlingCostsPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_axilShippingAndHandlingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerDepositPolicytextBlock" xlink:label="loc_axilCustomerDepositPolicytextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_axilCustomerDepositPolicytextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy" xlink:label="loc_us-gaapLoansAndLeasesReceivableLeaseFinancingPolicy" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLoansAndLeasesReceivableLeaseFinancingPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="995627 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetTables" xlink:title="995628 - Disclosure - Accounts Receivable, net (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetTables" xlink:title="995629 - Disclosure - Inventory, net (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentTables" xlink:title="995630 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsTables" xlink:title="995631 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilitiesTables" xlink:title="995632 - Disclosure - Other Current Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaapOtherCurrentLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableTables" xlink:title="995633 - Disclosure - Notes Payable (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityTables" xlink:title="995634 - Disclosure - Stockholders&#8217; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesTables" xlink:title="995635 - Disclosure - Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_axilScheduleOfSupplementalBalanceSheetInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilScheduleOfSupplementalBalanceSheetInformationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables" xlink:title="995636 - Disclosure - Business Segment and Geographic Area Information (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" xlink:title="995637 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="loc_us-gaapDilutiveSecuritiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDilutiveSecuritiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDilutiveSecuritiesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDilutiveSecuritiesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RestrictedStockAwards" xlink:label="loc_axilRestrictedStockAwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDilutiveSecuritiesAbstract" xlink:to="loc_axilRestrictedStockAwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDilutiveSecuritiesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995638 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerMember" xlink:label="loc_axilCustomerMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaapContractWithCustomerLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ContractLiabilitiesDescription" xlink:label="loc_axilContractLiabilitiesDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_axilContractLiabilitiesDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetDetails" xlink:title="995639 - Disclosure - Accounts Receivable, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomersReceivable" xlink:label="loc_axilCustomersReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_axilCustomersReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_MerchantProcessorReceivable" xlink:label="loc_axilMerchantProcessorReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_axilMerchantProcessorReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/AccountsReceivableNetDetailsNarrative" xlink:title="995640 - Disclosure - Accounts Receivable, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetDetails" xlink:title="995641 - Disclosure - Inventory, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/InventoryNetDetailsNarrative" xlink:title="995642 - Disclosure - Inventory, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_InventoryHeldAtThirdPartyLocation" xlink:label="loc_axilInventoryHeldAtThirdPartyLocation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_axilInventoryHeldAtThirdPartyLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventoryInTransit" xlink:label="loc_us-gaapOtherInventoryInTransit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventoryInTransit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentDetails" xlink:title="995643 - Disclosure - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PromotionalRisplayRacksMember" xlink:label="loc_axilPromotionalRisplayRacksMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_axilPromotionalRisplayRacksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AutomobilesMember" xlink:label="loc_us-gaapAutomobilesMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAutomobilesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="995644 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsDetails" xlink:title="995645 - Disclosure - Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LicensingRightsMember" xlink:label="loc_axilLicensingRightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_axilLicensingRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_WebsiteMember" xlink:label="loc_axilWebsiteMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_axilWebsiteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ProductCertificationTestingMember" xlink:label="loc_axilProductCertificationTestingMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_axilProductCertificationTestingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/IntangibleAssetsDetailsNarrative" xlink:title="995646 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/OtherCurrentLiabilitiesDetails" xlink:title="995647 - Disclosure - Other Current Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CreditCards" xlink:label="loc_axilCreditCards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_axilCreditCards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RoyaltyPaymentAccrual" xlink:label="loc_axilRoyaltyPaymentAccrual" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_axilRoyaltyPaymentAccrual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableDetails" xlink:title="995648 - Disclosure - Notes Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/NotesPayableDetailsNarrative" xlink:title="995649 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_EconomicInjuryDisasterLoanProgramMember" xlink:label="loc_axilEconomicInjuryDisasterLoanProgramMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_axilEconomicInjuryDisasterLoanProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_EIDLMember" xlink:label="loc_axilEIDLMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_axilEIDLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LoanForgiveness" xlink:label="loc_axilLoanForgiveness" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_axilLoanForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetails" xlink:title="995650 - Disclosure - Stockholders&apos; Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetails1" xlink:title="995651 - Disclosure - Stockholders&apos; Equity (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/StockholdersEquityDetailsNarrative" xlink:title="995652 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OneConsultantMember" xlink:label="loc_axilOneConsultantMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_axilOneConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OfficersMember" xlink:label="loc_axilOfficersMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_axilOfficersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ThreeBoardMembersMember" xlink:label="loc_axilThreeBoardMembersMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_axilThreeBoardMembersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RestrictedStockAwardsMember" xlink:label="loc_axilRestrictedStockAwardsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_axilRestrictedStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RemainingOutstanding" xlink:label="loc_axilRemainingOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_axilRemainingOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_NumberOfOptionIssued" xlink:label="loc_axilNumberOfOptionIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_axilNumberOfOptionIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ValueOfOptionIssued" xlink:label="loc_axilValueOfOptionIssued" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_axilValueOfOptionIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetails" xlink:title="995653 - Disclosure - Commitments and Contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_RightOfUseAssets" xlink:label="loc_axilRightOfUseAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilRightOfUseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:label="loc_axilOperatingLeaseRightOfUseAssetAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilOperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_LeaseLiability" xlink:label="loc_axilLeaseLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_AccumulatedReduction" xlink:label="loc_axilAccumulatedReduction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilAccumulatedReduction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OperatingLeaseLiabilityCurrentPortion" xlink:label="loc_axilOperatingLeaseLiabilityCurrentPortion" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilOperatingLeaseLiabilityCurrentPortion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetails1" xlink:title="995654 - Disclosure - Commitments and Contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995655 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_InitialLeaseLiability" xlink:label="loc_axilInitialLeaseLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_axilInitialLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="loc_us-gaapLesseeOperatingLeaseDiscountRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseDiscountRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995656 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_IntrepidMember" xlink:label="loc_axilIntrepidMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_axilIntrepidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_BZCapitalStrategiesMember" xlink:label="loc_axilBZCapitalStrategiesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_axilBZCapitalStrategiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ConsultingFee" xlink:label="loc_axilConsultingFee" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_axilConsultingFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PayableToRelatedParty" xlink:label="loc_axilPayableToRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_axilPayableToRelatedParty" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/ConcentrationsDetailsNarrative" xlink:title="995657 - Disclosure - Concentrations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_PurchasesMember" xlink:label="loc_axilPurchasesMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_axilPurchasesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_CustomerMember" xlink:label="loc_axilCustomerMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_OneCustomerMember" xlink:label="loc_axilOneCustomerMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilOneCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_VendorsMember" xlink:label="loc_axilVendorsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_VendorOneMember" xlink:label="loc_axilVendorOneMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_axilVendorOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapCashUninsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails" xlink:title="995658 - Disclosure - Business Segment and Geographic Area Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_HairCareAndSkinCareMember" xlink:label="loc_axilHairCareAndSkinCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_axilHairCareAndSkinCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_HearingEnhancementAndProtectionMember" xlink:label="loc_axilHearingEnhancementAndProtectionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_axilHearingEnhancementAndProtectionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="axil-20241130.xsd#axil_ConsolidatedOperatingIncomeLoss" xlink:label="loc_axilConsolidatedOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_axilConsolidatedOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://reviv.com/role/IncomeTaxesDetailsNarrative" xlink:title="995659 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_01.jpg
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M 0,1 ?_$ (,   (# 0$  P$           H+  @)!@<" P4$ 0$
M            $   !@$# P,#  4'"@<    ! @,$!08'  @)$1(3%!4*(3$6
M02(7&!DC)-676'@Y8=$RDE,UMG>W.$(TU"4V5K@1 0
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MSCE2?85G'V-*V]LUEFI)V@S:MVC;L2;MP<.#$2]5)/UT6S<G43*KK$(4!,8
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=?9__ *#B#S>/W_[]/VE=/6>7Z=/MZ?Z_?Z:#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_02.jpg
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M P,# P,# P/_P  1" &? M # 1$  A$! Q$!_\0 C0   0,$ P$
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MYM_;&UI,:U(C7(>Y\@[89&0RPM6-6HB)Z!Q1L)1K!;A19;'5[6"ULT3)Z+-
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M>!?D)=V$6-H]KG]7L;JMX$_3V]CD+'>]&K=>;E-$ET38CO7G#6I'(Z24Z?\
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M>R(GU^B(GU7W7Z?\5_U7T%?0:4OV9<KJNJ=KX23;VFU_^TYIO%_K^>R>3L0
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M(UE!8#2/(%BO1"XHHVD03_;*EEC1$CB>X%+I;". 4-UG%8S55=-(4ZRMYUE
M%2N52HS#K ^DK63U % /)(/+9(C"_P =)7OFD5C6A'OK_2S^;Y7:; "M.,H*
M4*XL+;++JXIDK)*/)%'5Q4VD,LJ(]+?6"M).6NB:=(/^?'&0L[$BBB"*'%KK
MJWDYS#C';-G4T''>?2$X#K6+\?Z'9@[W8[&>$L':\MT70>D7^*R]2!GA-$8
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M*Y2KV'/&A8"U ZI_':6Q"S6J_P <E#&NLOE,KM!*BZD'G]Z^[L2QXOR6RJQ
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M4!G8BK.EL[<TSDFFJ3I*S[L=A-)^4D<D7VEE4$N)^K#L:9A.=:'S"SNCP_\
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MO"%^;(4^\L4["7@6F'TP>G%G$TN6=6GP2P@%VU)=&$)=DT8AU;7U%G)IQ8J
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M(X&P\*J7>5?A_P"&$+]/G)A%\=>'W\5U#0VD(5P4/@![>KHW)23H%3PCC9B
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MK>%Q%..RNC&?&(K8!B%6*)KH)$G>$4#Z[^)$,L'HI'WY3",Z(?7D(.;5@&M
MMSHB&&1?QA<4U6K71*LZ*QZL5SG.8YP<I]@$52_QKQVQ5\(D9V8((IYZZ.8E
M+"6O/>D3K02LLA2XY4EE+DB**']D9[HD<DC@[=$56/?3?PU4<><2?!,4'+=5
M\D(PO\FR*FJ'Q35[C+:59PED4F)\$D+9V1(C%8DD@9B,<>?.)7SA5LD T%\X
M"A)+S^=O'F#YXZ(BRMBRIS2:X'-2(AT04_X\AI1KEC?*U6.0/JQ^&V[S_3O
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M1#QE#PA@BP6/N_[1BU\+Y@9HX'@)\(4:3,^)%B<LK4D:URJ&PWQ%--R..MW
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MI@ J:,-]?)>7M9H;>T-:0 LT)]G*V&:>&3[+&H0#4Y?R!SHO6^XY+KW2,ES
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M_$_&!KQ6GOA;*P<L,@R=)!$'8R;[D,L#OFQ4>J^@33R%B<L@0T4C08AX%/;
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MJQI,1/".H_LYC9(U!+_XT&[/V5O38_"VCKW9UT(%@%S^FL[];FJ]X+2O@H;
M9*RBM*J[KI&A)$]7V:^Q7WHTC8Y@0:Y=Y<^/?  >GXW=Z)<IM*CR"Z+=5.)$
MP&R.I,_66&G+DM\^7:U-&95PBUA#8;"NB ^\T551BN1B?:>#\7?[*?$J\+'.
MA[P;1 E9PT8(^KS73&Z;"F7# Z>T^U!98^S;HK%PM%%)&C880VP)!)[H_P#\
MK&#9VW[*?'(2LNK"BZ-''>KGM5G*FN%QG1Y0<^21&+7Y"U%(N\"]AE (;$ZZ
MD"*^,\Y3DB=\9?8E@,ES[SFXG@\[1U-AT.*4>6+1S:*0*/86\#I3;C07 (]#
M6R5!]@-<B71C7H;:-*B*%6/XO#;$V&8,];>:WC-"W\YW2+^S-K[TJ%,Y'AM)
M4U!@DT=C8SU6D8+G4&SWYEXU?D7G8)"XA&M>KUE^44@.9N_-3B-Z$'+8=;^+
M+-R'5L=+G=1+88H8X9L9+K6HJJ*8S82N/C4EK+!TQ55-(J3BR?+Y0A/'@W+^
MH>6.$JNC>/\ @-KU_BA%_H1&V^IO<S2U=K,+6YT'H5K6!;9,=O\ *T];1N^;
M7BD.JQY3)I87-6 9K@B2N6 &ILI%A?%GR+DLJDB(X'55/CIU8X0$:&P8(>-5
MGAXQ*9:K0->D[2*Y9FI]N-Z->R58%#"765)RYQ9NF\:/(D.FK^>NL<S':>-?
M;0Q67, I=YL3_P NWJ# [;150B&6L-B8\)L9,"I*C7QL>@,45Y,^(^EK_P"2
MCS6VU]A>ZK3R''!YQ(_OY06WI1\]+N*T\=:,X35(-72'JP-L[)VL9 *X9TS6
MAC _+7A=%N(9:4C8Y93LC:Q,LP\5/+9B$4]O;@'&#QD12N#34T0\<!$9+YG(
MZ&6">%8'A1# [>)\CLITVRC;C!&7(6?D LQX[2J)Y_'0WETMQ=+HJ1(HBWST
M30ZLT@UEA"L$4E>QS&P$&33J'#Y?'2Y_#L#,2XR><W/7LG7;J^/T^F%*K\;H
M=O91:&O@A@N(TKL/?5$=9-9QACK&<YT:*D31XVS!%.LOM%FK#(UN8ZV[!XU+
M032:%A^SHK(JXL(OR%UEJR[YS5C,)Q5HHHRP.<D,\2/8B_;FDE^X&<S&OZ+=
M/Q]M;=RN2#-'E;0NZ$K.H#CZ4XC2:C-0D\_S<>T=#'D-1-D,].4Z=T<H8$CD
M@@F'?-&YP/%GMU;[(G=5VWTFRTT%=SJSJ(JVUVE/LZP&.CH*NM=J#K*E)<5<
M;VH*")9,9^*CB3/S/D2Z%\K)0]I'ZN]7(5^O[PV;$,[+DA>-/*ZVN6%T<MJ2
M718\2VFA,PM@'6-/?<2A'NF6*65APX@\GS^^/$B!/"WKLO9 WYK*[6Z::EK?
MO6,=,(>D5HM./^2)5S&6)CH)7E"P?C+..DQQ9'VU;[?CC-<'5"KB";,<Z)M4
MDU?HJ0BEHSK@.0J>M!K"((+"(8V96:2LL9[6*.5@BL:(0J3-2&:&5Z!IC[E8
M^3?0?V38;Q>YUYA=,X;S6T\6-)WN[BY+7<XLW:#<Y3H/.,/'_,0=4RMV"*(5
MB;=#(9D9\'2MC,@'28S[:A/SQR\>-?P[-=?I+SIG3>U;C3[2TN=/T'?@Y]=Q
MJA*-U75T%67GJ*LS><D(S^:K18!HPTE::.K?MD1S2*] @'R?]6?_ &!?I\GP
M?SF\KN?\^Z1L8MNW&UP_";0&6\O3"28'$6=]S^_DL11#3R!1(YI_^F.Y%E<Z
M.-)) D+A_!3L\A@X87[,O.T/.?AG7FF4#/<*S=I7*0 2P.O$JTXRMD"=>)4_
M".1T#D:- R/ZO2&/T&+L?"[K \<<Z?LJ_8K9QE6-P!;63MOPJ*XI2PR6FUMC
M<OM.2#2/9>6%"Y4:-*0XN-J3._L<Y?09K3^"O7/FD5;^S+]A5C10V,-//]NW
MX72R?R7M92_@K=OY(\$X^GSP1'R(B28B6.6*%B-1(XO0=K]4]/I< OF/E='J
M-QT2>C\T-W61]2VY=1IMOHB*^DK W6'19J*"IJ'Z6O8-+6ASB"CUH<)*2(U)
MHD9Z!X/V>3VU_P#KH\U9J6&PTQ6I\>>NG10/- K0Z]\U5=&VY1>@C.1!:ZNK
M*8Z2))FS..@=)$L8\4<$T@?*12QLWN488) +<BM+ ,M)#_FXP=AY[;-P[5:J
M.^Y Y!Y$C=*^2.!R^[W.7T"8+((;'-! 22^*5D#;A(E8T(@R">=87/\ Q'N@
M+8SW]V2O5SGO5SD_KZ!^N*UQ W0Z\*QK['15UMEZYMF13"A75@+4V54'9 C5
MT%C]^JB.!E%9"U\R.<-,.GP:U\?VW!.&RH/^S;>LI=\5K]B UE;_ "TU)HAG
M2D5ER>A5*#;3C9P]TRVS['[QOYQ9(I8U=]Y&N@="QX=3%VU-8%!D5?C]D@*Z
M3H*9:T+EUN>926@@@D\1XJ7]%1EUHF7)/N8XU+K20Z][5&A9#+ DJ>@4\M:[
M!:[D6AHZ,N2LT=*!66>;:+5#1Z&Q$!!!U5>3%/005#W4>?&&98&/@C*E4>0@
MAK4G=)Z!_P!Z6.)J;.9&:B33!BV8,/X]G:4\5S=V:A7,>5CH1\Q:K9)H*( >
MMJDG'+(9,U\J2#,2*-X+7-&'58UW"]FTK0HT)UEX:=3[]@U7G@\$736H<LS"
MF17A+;*P>)/&UA+&E$C%,^#/FB@SM9D+;3D4+-?L;6AU+:F"TSL(.ES $6+N
M4(K"*Z0N]?%4AW\10MI]N!UB=,S\[W1HHL'LC@R%I@+"LH0(I*'17LU@R?I&
M9F5ME]S2Z=UW63+=.@@-4H.9X@L<3VR(_P"PZS0>"/[Z/D>"5YG@.AZ*MVUS
MB:"KT]%-NM:"'<6.\K:F62JGT2V!24P4A3A&_8.K)JZ*0= &32&%3+(GR;/Z
M!V:+$=+,;G3K:GL%L)<A(ZM/C+MMY8%V=ZE1)H74]?8)=JM);R3# QD2S'CP
M'0M)E9"+/]Y0Z7)8NF6E4;(8929V>C#M6YFN O[*@GT@.6V:YF^;?U=FEP:"
MY:,M6I$X1DEK(K)W?EB_V>@]L7Z"HGC\)\)XB*>.BE<%^R=\%//"P&QI6)VW
MQ\^]5$!3N(/>4/-[M*EDE1[YF?-Z/^XUWH/4)Z ]!1K6M3V:B(GU^B?T^JJJ
M_P#Q5?04<]K58CE]ED=\&?\ ZSOBY_LG_/XM5?\ W>@N] >@/0"_^WV_YI_I
M_P _K[IZ"C45&HBN5RHB(KG>WR<J)[?)?BC6^Z_\D1/05] >@M9\_@W[GQ^Y
M\4^?P]_A\O;^[X_+^[X^_P#3W^OH!_S^/_3^/R]V_P#C]_C\?DGS_P##]??X
M>_M_S]!=Z ] >@/0'H#T!Z ] >@/0>>/_<8=LZ-P/PRZ+L< W $BZ?AG7.-[
MD'=#ZC[[\AVV]Y?S0RPQEIFK^CBJ-93RZ%I$,A["PGL8K9(VM^3T#YN58'FP
MZF?1VEG'/IP8[7/.ET.5"+KZE&#53Z^;6* =.%94Q]?J$D#-F^90\R#->U/C
M%\@24_\ %48%-=Y"WH*B?*5(P FAM:BS6?02'0L9,5B*LG.NTP12A.BA&M1D
M;(L,SR?NHJ22*&"M:^H3/" D/GSD4=W-.N?)*_",I=-4\ZA#S.O8EX;)6WT9
M;A9PPY!Y%'D8-*]OS_Z*1@C+D1\EK14CH<M:4P6AJ6 GEL6"ZTD-D+5 UP5>
M:@X!ME2QM<@WN;".. 2]\(S(51ZN!6]<+@99_P 5->_GNKYLK3Z(L"6=#<\<
M%O6S&4L!CR!Q-/;T/\@K'-KI1@@X?LQM?+(V<A0<:AC(&S-G:64V7'!L:<$Q
MV:O[*LS-O;LOLM:B0[T.)Z4HA.CLY8&_A?D?&:*VBA9+*I/XR/#J)O*BMABE
MT&KJH[@<=S<^,7G;^QT?0I*NUCL"8C8@:4:ANB=()&+!)_-/F^;47X*I+OJ&
M;K]]GR#1[,779G1V])/264!M]CI0@!2)LWI,W'DBJW,U%57"TLI<]>*-7236
M#)2Z:5WS9&L23 T?:B*J[YC<.2)13:@Q AA;"..FNZXZMO(IM$1<"FG,L3%T
MY!WW)%^,OW;6!S'M22#_ *(15>VMIR;^$RP"N/X8"QIJ(B*@A$K+1CY9JQQ@
ML!U0KG/^[*YZD3QPDQ2,1S7_ '/[F!T9CJ,9U@? $ DL;$IPAH7(;'*D]--6
MGJV.2(>*2"-DSI6FJUT_Y*QJUJ^ZRM#ZNOZK%/$_6=X1"#7L][^=XV<X "O@
MV&W LV?M@31WC6*A*^IA@H!8!VI"3)'9*5 ]GM[J])0BY^^EC:?QLY=;TT0E
MK9R^30K:[)0OKLV29=@^-7?" <K&<?%2$#SZ DA!XC8U8+\_NL>WZS>X>2C7
M.ZIIIB;"V\*L)66)K9BVV978.12ZD.UTED<X=UA.)G1;2:I;'(2IL9J?2Q^<
MTA2N?(B@K,=A+9_3>>?R/A)DL1EY9RWTUA%T#D6QBRA5#4H?#T.6FI :Z6R.
M,<(8H[E,,6>%D3(I'R#/E4+-5TT+G?GWR:+563,UBL_Q/J#8]F9HQ46W9:R$
M70@/V:ZP#G(E9>@P5BHR=\)*$R'#K#$[_H@YQ')>"=OUYVWZUDNF$B6M;G*7
M/89O^7Y2OJ<*-]B5EIKZ+/["A/!?T/4WTS8&68LY9@HL*_BRES(CPI8>!?C@
MWF^EF)%VM=>_X3IS<KB)^F;J.@?>8[!; JA %,'O9@_X!T=,\EB/>(URO2-C
MFQJL'H%9SCH(@/BGSX6QZ707S'<6S]2=ISF5->T.QML-!GIN>054QAT;]&_0
M6:U[YAOS)#X[-SHEC:UD# A>_JG(NJG745(8G+R^F\_H>-\QM\V=0 P:[4WI
M4L>NUW3W00"S#4^0O,H&%#02*D?\+.2Z-9W'_;]!B\1<6,?5\_L"NS9>]QU5
M84PV/S69"TV8R; %S:Q?G9$>_= *#SNFAREF0)'"J@P75J]!UCFB_(A#8MH;
M?$0://7!/4,'C[LZ_;8YZOW2V4\'0;[5Y@"*TRE)%E"@HJ[/Z#/7PC_RJA__
M )EUG'-+(A1+O8(?V76*+@7E_I>@]7L,EB"-'RV;*5N:S$>NVE'9P V=FDEY
M:1MJ<PO\JN,1TPZEO$;&UL,<<J0R,5 F?5^07);T@[^-V5OMP^2/(!?"#A]2
M=:RZ-M=?LC8*"/3VNQVUAE:#&61[G-%]G1C2S(4]GW7/!-M\B>&-?)HK/9ZI
M_P#$RYH,?*ID.A6@^>T,>FQ]A2T@=0.E;86'Y=CH!_RXY GC!GQ3*C((22!'
M!Y_=YLZ&X['T?<YV^,T(]KTCJ%T#(#4&6%V'S:_,NF6$NJP5S55P4Q8%82GY
MB+-*:*W_ *ZK)&-%*T(^7Q@ Y&Q?82!5M[#+9M <(21!*621_%V(EE^(4/-.
M6ZQ@EG5BR-#8+[M6-$D56^@PU9+2LGO(67RUH;*JE :*P6JEBN&0,A(M8CXY
M21@K!HY;E>/,1_U'RMC<U6/C:U XX[]Y,3A&OSP@TPP!4J5-,&I2 9:HOJR.
M=DMV0QSC)0Y%<D;YFSS2.:YK?FR+Y LZ^5H)M3+ICQ!)7S#TD%_4%%3G#!6+
MC;4>(457DAN!GKWQCLD@206,0Y621S-E?\0I9(^S!H<I/5J#J[:GHI*^RHJZ
M*&&:F%@MWH984L;1TFG/KBVR26+61&.8)]Q[/B]\D@>_[]+'//([5_J[Y%S'
M.R8_GG.^@"DK+VRNW59:[EF/L"JRJMZ'G^" 6S?4]'E.$F>V\NI:T6N@:-(/
M!:M2#[0>@C)T.:S%?FZ*EB"SV9S^=K/\1!.MR;6XH\_3U$(M.'&6XFQ=/%+:
MC1-6>>-(%9-#(PC[CO[P2OD+#8G>,_9I9]!/0$W?-.FU%;:0:7[U<-!)SHVK
MKK NNJ99HR8O\COAXY@$E)82R1[IVOA^7W@^1-,KX,Z^!=!_)?PD+CP[7*./
MIDN0SPJBN?#%(;#2RP!YZ(F=K&%5@TBH0^!LOQGA=("5M9,KECZPFDT,I,C<
M[3BZVC&;?1K:VQCR1]&!)*<(*,@C818B)%2:1KWSQI%\7->L(;$_":_YO-T7
MJT&FT(,-M8\FS-3F8;0PT=-164X%:980W<1, 0ULR288>* ,GV));%$Q\,L;
ME1P/?W2ORU?H\EW3H3X0-<5Y <?G'L[N2PE@P%!1GU$YE%?Y.QFMLQ6FD541
M!]C6V'V8P;)"&+,Z9%'8$K,IY:\-IA*ZQAZ]CGEV),ZSK9V4&SMZ^N(ISB#-
M$"!=V-57C04FZ'!0.$LR<HOYDQQQME7[L@.M5>7G$8[3/::+R.YY;:(O',H;
M(0W:2S@$R5E]525Y@0%?-'8_E0P*9 1]^820>N:L+72@MB5 ;#LGDEQRRQMN
M51]=PUO5$9ZQ#N\UC+%);0#4-H-U.1#BVG-KYHIZ>;1A!+ ,^W(^R^69KF"O
M8[T'K&_6A>EP>!?B6 '43D7@/CYS2?1U,PMF:S74YU#CT/O[6GLSX1)]$ZBC
M +AG((_($:*U?LPN>X5H+G>>5O,>76CZR\ISQQF=-I.'4.KOM'QJ@K.A]"0
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M''"PB" DM?\ KNC&:K4#(5&ES?<^J9N@JR<9LA*_B=Z7??XY@]W+#GC#-]S
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MG3V6?<^*"$.PE:]KVRMCD?+\XW.!P?YC.E.@-MC_ ,8:OEKQVU<9*QPWGXS
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M97ME1%1RAC::I#KBJS0&EZ2MK[<Z$HN,QH<X$RB26<#(IR+< NPD8!<SR%$
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M #LQ@ND<]T#O\6JDQ@]?:ZN*BQ=Q[AF_;C-+B!'@^:L1$#WFB?O+\1[2[3+
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ME?:BIR6'\7K)<MI$D!B'._B:P?;16AS; =\,@CU;%]J-(E^TSV>GH% 'YGY
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M/'ZF*B $#>0Z#R8X6HD%A91P36MO'7C3)^'^8^.1L#FM^VQJ-1H>JCT!Z ]
M>@/0'H#T%$<CO?V5%]E5J^RHOLJ?U1?;^BIZ"OH**Y$5J>SE^3OBGLU51%^+
MG>[E1%1K?9O]5^GO[)_KZ"OH#T!Z ] >@/0'H#T!Z ] >@/0'H-,'[A?(>'Q
MJQG/-=998[2TNXE"XS)/57H-'8Y^_P"G]MX)29BY5I$4AEO5P6+%_,$%_P"L
M^#W5&O\ _#Z"2.^Z57<ZPNXWNO/FS^2Y_FKO<;R6<JUIJT2ARU4;?6)KZXBW
MG&/D&>*,OR#F<CB"?L(UJL>R((/:K]H?$<9HL]A='3]?Y]M-FL%N/1]?R%SB
M9I 64 6U'.% O;\,V]%N8V$-HQ*R68HU\)42B^X<TGH*8_\ :[XX])N<WFN?
MB=CZ'J=]EJ_7<XS./IF:N\UXH\.ML[DJGK,Y>:ZJEFS8V!T,]M7SD2D-8&L:
M(B/6-0<+AGFMR_O'4.E\BQMU>8_H?, 2CM+57=;35\U$LA61*DKXLK/=V-Q3
MV,Z6_L;#8UX$<DT;_@R5_P!I7@S'[>8#[C]<_F]'4PN=&3Q2_'I:>K%28@X]
MYF>:M*>$C(AS(GS7SC'RN<LDBQ2,<LJ-1J ZHGG'P7!T]7E=->]#!K>;463P
MMSHJ?DW5[W%MZG6UN!JJGEE5JLMF2*BSWYMGMZ^N@ID4D@D@Z.*!L\T4L0X)
MK0_LW\3Z6YW%/H.L:++7W.*S/:KH6+TW,^F4^USE7H.R+QBM#ASEW0#6;KLC
MH-6\ JE26%U74316/V/P)6+,"MT/[)_&"@X_SCN6KW.S$Q/6]$?FL3*736\A
MM@34YBXV-E(QI(CRLE3AY;+&*UR3!Q%/#=$Y?RY%%]!D.:_L)\;^O;7G^ P_
M3;>SV_2^B]DI.=U1V*T&;.DTGC]@*[6](*(?<TM;)1YZBH+E20II?MPW*+)#
M!+.^*6.$(S=+T]=R?]JO7.I=5J'T^!QOZHPM,?LJZMCTH4,IWFK=S%AO B1'
M: N64))HJQPZ$.2-6HV![HFH$C@/V!>*E[>I)EM^,?\ PF:TNJT5M/S?8U63
MY?68PKI&:MEZC?W@C68Z>BON87[7CN6"2%*UT36,D=$^8&![3Y0<;N=AB>B8
M_5[7)=^R&'UYE>-N^'=;-HF<2)TU1)N\OVL(;/5]AA\N+H:,2V&*A);85QT+
M"49,,\B"0->?7]S7]4BXCL/LU&B7I/[R_'+JMG0Y-EV0N&!T_A+64%!7[_/]
M2YURHX>]V> RO^0BP"U;PE MA50^9R_/T"[[A^P,?C;=_9S\<)W.3XUOQN37
MNIR.@YZMY'UZGY^G9SL[79&9MK:@9<&GU2H[1P1N-C>GXL@,Z,^40.'R?S(U
M_D'M]?S^'QTL>;DXO+*%TS?&6FITXM;/J\C8ZNOS(^0TW,,W$:5>Y@]CCAC7
MP6C6HPL8<AC19?01D\*^J"\>\%/UCRS9JPW?0>D\XT@V2J[32Y[!4,8F1R.S
MZIH@'VEVZ&CQUBW+DR0B^P!)LG_TICONQJ1""WQ?[8!M_7".POB!>7V$-[$)
MP+'K>[ VB&T>V946%_))29S/\LOPX8J.NHRX9"JHNU2)RBD2I/$.CV C=_Y6
M<_\ &/\ 9IY"[/8B=!H<_P!#\0_#.JH*SG.<ET>L@&*UW?;P\FREJ8HK&VBS
MT%8?3,M)!8VQ"S*A,:_%C_0/)SS]F7C+I<=M-O7UW02,M@.?]-O;:QT?(B7/
M;%F-)+6V]3GI8K(>GEW![[;^*S]2',]O\W91LACD^$SU"$_['/*7GOE5QW,B
M\CG.U.<Y)Y"<H"Z 3-G:W/54M=TSGN]M<W7UMT2ZKJ#!'T!]21.CF!U S#OQ
MH"Y)E)'A"9GE#/SCQ/Y;6UVBZ16\?\6>HYZ;FVHBZQ;:??5? -5H+ G0XN/F
MVBKM.=L<?1CU)-L)/05MQ"!264X$]?' U\C" UW5/>_US44:TV?_ &9^-*5M
M?#T^DN7Z?G.MU M[F.R7<>EZ8(R0>ZD@K9==HZ"O+=("YLT,L/VQ84B?] RM
M9W7]<0%M4$A?L*\:R0!^A!=6N<#@L)LLOS274S;N^ZF/,F.JM,,!%'0;S16U
MB*T>0:($*8D1\4PD[Q%#:%P7RJX3Y=?L*YMK^#=\QW:*_,>&/6@-'=T8UXRI
M0E.P<56&CMLV57,]Y:X"&.T685"(VRQSO8L7][XPW-F9H>Q+"B!&$;&3_)QQ
MJHU;:?Q\4MBM:[[:I[26%:9':CE?:%0HED04K/DO_2?Z#0AJ<5?Y_P >_%/+
MP:ZD(A?YF>?@ Q><A@V=[2!"[;RH22'546JRG3HI:QE/<"RV$3@DCBD@163@
MOD290P^MSEA??KW\KP:+J.Z_B<MR#M &3OL$%Q[$\CZ@>7R^_*NCZOBFL\>J
M#IK:XJPG3/O#CL3XK8@A'C'O:V=HH;;?$30];SW$9!NUWW&J+05Q86;RO/<(
M;FLC 'SD&DJ*_(5&ES>?T-A@J/H(V.K56U ST\52+*.R*"2%(9"W M=#K\4/
MGC"NG=!YIHLMDL_065GJ-#I\O5X8*A U1<]7<7_\YH#ZUL-& ?&__P ZV8*6
M1\A,BND^!#@= C,#S 4#<Y3Y_.4XP(!6>BK#\JVD=2TQ<IF2;&960!Q25%]7
M&PI%."VP%9*C'NC8/ GL$#?,3$]KV5?P?)<AVM7A-->]6TU=0W2SC4L:4F9Y
ML<4VM_R2$*PN:];6EKC8!B01FN'(LGE!P.DCC(0(%WU1Y:[G$6_COS#F#.V]
MB\8?-;@?8.D=8LK/G/+>'SXG*]/T4<)5E=F[@'I[&WHV"M22&Y_)6AY-;*T5
M5^[(D40;"8_"C<;NV3M6MZE6M\H,^+-=<?Z_D\78P\QXV+\;._M<EDL3<Z.:
MRU>5V5U;L?J)M):2%WI3PW#R!L!!:,$$--G/(_E?:O,KHO?.6U-/SKR2"\:^
M+<]ZYS:^QI=1-?.,MRK!;#";_8B]5Q=/#L]Q-3A , M?L+]A[I)!VN8H2M\2
M.-=3Y?Y'=+R76>Q']XUFEX9RXROMFR:^,7*ST'3.JM/OC;2RL8[H8N^T]843
M)7!DBU&=25M;7M007X-#8/85<A:'0:#.135Y [H!;36B,,A.O;*PK+W.068D
M$\#:PMI;CZ^='BE/5LHLDCG-^:QAK;\CKSQFV7B_Y&87,;;A./CZSE>S\I9J
M,[TSFM UEW>Y2TH3G9^8S78@B\NL%'L8;8A'3K'#"<,Z"2%OM(H:,(O'Y:SI
MV#Z'K^N<@Z/55UIC-,5@=7VGP^8"/5X;+!\NY,RYJ=%V'K&:J3\7S"ESHTI+
M:V,\[\"4E\\));V>@?/PR\9N-PU/=.>=V[YQ:FYUMN('\]SC8O(+QZ'N<&FD
M[GJ^M[6*IGSO7]D[6<NN;Z[5:ZGNP)6"M*,$E:\ D@=H3C\$_(/'Y;J_EC0=
MA[OXB!W&=+\=,C7:CG/2>/4_+NAYF@YIMPJC8TU30:H&"I=<T\HX=G2N6TEJ
MBY'MCE8$\8B4-3/^X9\A.[],R?<L;S7KN;V_BN[_ +#N$I.:;/QPZ?AK2Q'N
M>AR;PVV6NNKWM(6VJ+V'*M856M5!1FD,B:Q7/8H></P%$B9YC>*K[*>>8&#S
M3\<9BP\X&U]<X(?LU+2EDV%?2U\D\5-67MO7-#4M1%;\GC0"Q/BC^T'U$8AZ
MR.P(GNR\[#H(<Y(P4MUH1; '5A%E9&42!$S5U&I1<U@"17&?BP^Z,]VD-1SD
MF4/&?^_2NS--YV9VNC#M[EAO(N#SY[&YK%T6HMQ"J[5>2<I5M6!&7>:>)6N#
M!-)2-)_D5*4PB!8I8F12!JO/[M66L]D;+A>NK!>%5.6A)3F^6H1ABAZX/-A4
M<<<.K/R@MS&E@6V."&LL"&_DI]YWLSW%!O=QT.HZ!3;''+Q_K=?/*,455'_]
MBL,59@U9.M,GJS[U'ZUU1F"_Y"HG"A,(F#+%(FE_']VRE,D!D*P\(\)F;"Q'
M=[O%&U%33T->WB6!NM=>$U<5G;!WJT[K>RK2J.M",)C8X9\8=?*<B_"?[?VV
M!RF 3!UU=9297K0CJ#?:$>RF*\=.1VSQB(**OK,)2#EOTCI K(."MD.(*%CG
M@138Y'D*_P"1*!D3L':=!'.WFZCTZU(N@N"]"7J>58D?7C5MA8:BS&J[.TL2
M8OLV(MQ$Q[G6!1K2S)9&)(BR-BD!X_&.SSMA1!7V6S?XU258K8YB"PI<@'85
M_P!@X2GUD(\<"3&:*>4VOGD2+V_BF02,'8D;DA#4)459X5Q/&NZI=2N?M;.2
MWC!S-LV4NK'+T=A>U^>JMI$X735PUE2U2FH8%*7\X+%$'>\>&;T"3GKJ^++_
M &38ZO';1 0(":V[KG'V=J!88?4F9]@!A=)*)4BNKZ%GWFBQ(>1!7+^/+&R9
M"%!(:S*6*[W6RR:P%TQ%L1_(WQM054J)4AV<MA54=G;@68=H%;G9!TE5 8GV
MYD!';(/$C58^(%!O:NDMKO"$E]*S4=N#E0[>55_-@_F"Z8Y\91LAY><-"O8K
MNNKXJQ'$2F21),KT= ]T$<H,[9T.6TT^UL#R?RJPRK@HZ("P$UT9#*]*W-$I
M84Y(MJ7)4U=1:TQ,;[&X^Y.LBB(GY+&P?;"/_&[0@:_ZS6:?<09"@Q6K"Q=&
MVO(M S+@.[UC+IU!G3,NR"T*B9+3_=F%6>!+?\QK/E"<Z%LX.@'S+_N)=0['
M97>FN<NFFAL[3GNAJ+"/-YW6 #Z&3!X2TK[*"NCN:ZLRK60%QP-F0))F,.<X
M:!SD!Y ?Q*"7%T_Y]P315IA4%&*@^.76#S25D8.K)LBI1*\ O/O'":$C2*QL
M*$/2))61DP2J"9V>)QEC3Z)L<&RLL[87581<Q/SQ453NCKBSJQ*]UJ%_F53;
MVQ%(2UA!A%B6@RO>UKH8)DB8@8/AEN$WC]*996&LM:G/Z.UR9"(&+<MEI0K7
M2T%"!8&/<P\F.*K#B%%8/ KHF&,614:L;T!X;%^7(H\" EC>ZB4E!*(D,_"F
MT%I9'F6="5F@X<^'N!#J@9%S=?-8).! J"NA@GG:]TZS@J[K&9X6 N,C5FV-
M?J/N5DAAA]M%'#5W)%E)7U==**134(=I1WM?.^&K!(=70,469)?DZ*6((<\[
M[3FLN1#GV4+'%%=2NH'YRZ6#,34%KL+I!VYW,S .!)V%QGJ\^%+6 \9'!33J
ML8L\Y;)XP4HW8^E[$2NQXU/4G"G8R]F(-L:"9[8*S+ZBB6KTPMP5+FH@VUI%
MJME):%BSOA;&R.6"&&2,;T%E)WJYS7\Y.W_MZ(9>7-/,<9;D_F&UF0ES9T8X
MEV!!,+ILIDZNXL_OT1K9@9)R; ?\J8J"5KXP]I7^W(\AS>W9#QHHW!T5?GN3
MB^>7/Z.6O<4V[U%E96?AQU^]U-M_''KF6UWSZE'7!"-AF*AB!25Y3UGDC:'K
M^?\ /XK]M6H_Z>RO17-_JGO[HUS5_P##[^WU_KZ"[T OT^O_ .+T%$7W1%]E
M3W1%]E3V5/=/?V5/]%3T%?0'H#T%$1$]_9$3W7W7V3V]U7^JK_S]!7T!Z ]
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M0B!XYLD<\D\3@=']M\@17ZZO.02@?*,01P?7_D3PDE2VK'&1UT#WB53;3\0
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M+]/05] >@/0'H#T!Z ] >@/04:YKO=6N1R(JM56JB^SFJK7-7V_HK53V5/\
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M5]9IXZ7^,L8W!$C*2Q!!WBEHV17JCI/016Q-]5>$I'0.]2^&WD-S'CSN$\N
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MXC"5PTGXPXK1_@U'I(YZ/]!Z@_0'H**B+[>Z(OLONGO_ *+_ ,4_Y^@KZ ]
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MM.-7PD3--?,RP$?\6) /]R8% P0>.*7^:Y58I9U6E$E0\BB(O;<"E:Z<SVJ
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MM.;:P2P?+[:PRS@N^.?L7I_*GN]CR'D')[+38;-V6BK;OI#M#^1"/4YF&Y0
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M/)3;VDI)K*8&W.N2+.!11HJH4Z<<R=WXTKI7+&T,^;M>>G43R3MQGJ<EIO\
M&OH1]ID7/"IRY)(:O!Z]*K0M2R4B]+FC_BYF?_,T9\3G#C0QRPE!T*P"#'^0
M-?%:!5^@%T?#J>#44HH%:Q\OVNDB55AE)<C7:&NJ6:0:B<L8T 93B'O!^"N_
M+FBF&!PJ^JT>'SE'EQPZW_%M!8W\Q&OS3[@X2<*0D*0UIU3,454UNK9*7$82
M+%+,9$USI/QXS8$C&!I-EV6?[B9[69K>V85,+19RGL[&0B*ST]K0FX[-Z.O
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MYK[&?\!;73=-E^-6X*6RB 8^>&%\B,>4"!7R3\80\W5&\C\0]F=5Y28^JO;
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M?:<JS&IO*O7/O?'JEGO;O:="O;9.FT^C'OKO_/KS7U5A?4]KDC"0QB=#N[(
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MH+_0'H#T!Z"UKE<BJK',]G.:B.5BJJ-<J(]/@YR?%Z)[I[^R^R_5$7Z>@N]
M>@/0'H**BJGT7V^J+[^R+]$5%5/K_P#1)]/05] >@Z=C[?QYWO\ T_#*]_Z+
M]/L/_P!%^GH-.7BZ#06]5O8+"KJR!JW,>*SIW3U8LGX^4C\/. E%CQCLKSD/
MEKWSNF&"8LD"R2_V1N>U50)&D8K)$F"!PYJJ )MYK62OLDKZY8W" N? #$0?
M45@,BK,$^$]OVWL8B/8Z.)JJV3T&7M\+@9!BOY#/CS*Z,%X\C:FD=$1<NL9X
MR["(5U66VO0B<I7M9&0OSA-25ZN7YL0"/&4U&00+%C,T0,V85UB\L$5(88XH
MG7CSH32(9)HC0BT2+\>9T<44D+HF?^)R>@UW]FQG9>=<-VGC('R;7]GR5ATO
MGE+R/9<HIJR[O:O!:/R!R/4CZCI>?M3LP3D@N0YV4\6*SK5LJV3/" .>^,UQ
M,,00O,(TW.O]P5T??4O NC=,H:[]=G-<V^YYO5TJ50-UHNL:ZYIW:8@RTRH>
M:K+I,Q8#QD?9)CE*#:DD3V/6?T&W'D/,='266RV?7 :.36=KV%3=7%$- +I:
M_FN0RE2%C.:<\ OG4@,]C_A-'4$36)Q<"16F@M[&<89L+HFJ#RALS(MA>W)%
M+C!3[%TXD,BT+%C(',ED*D&1]L <X%(ZT-[5:P=H\3"?L-]G.1K0T,>"&>S%
MUDO)"[TN<SMH>SSA[B+6W*+4WR9:L(Y#P.MKJFQJ)(%FEJ9:>T)CA9-%-!)(
MT5!HXIY8IXPGYKN4\RUE3T#'[/FF*+H-T(S/'V=3#E:^8.M922I-:4F@'K);
MI$;6VK;".,MKX&I%$JRN?).U0TU?M[%[PGZ\>A\6U7-M'OS,GI>5:N#M>"FJ
M9,-KN6X>WRHT&FZ16 7C+3ENNLH#_MW=9^!,$3=R-D!>Z*?W@"?W)JG>]5R?
MBMA=-S$OD/)>4XOEI>D ZXM _9;;:\UYZ\"BPL6>K)M/7Y:LSEXZ<XDRYE%,
M*EJ@DJX48R:1@2\#Y'F:PRM8W*<QG#BIGE09$+$96L$A@>2IP%F<CBR" QE-
M<P4MSQ9Y887?-K$'+]WA"OMN3IA/V%>%L%(-14-UH:3J\ME_C.8PZV9MF-S'
MH+JNU(L1HZ9U>97/OEK1HE$DDG9! UL<*PRD>@9/NG?.W<O[;WG(\YWES3V^
M$F#GY_F\]@,I:9,WF3,ECB>B;[0[ZYT(>GVW9Z'2OL*<3$E%L,FA&9 P)K&*
M6X(OWGF?YHYG/=,V>0A-Z+B0L%@Y, 5=\HI,=U^?67NOVT,/6VY.JTXA-;DX
MJ+*-KKBFA"&-_P#FM67""-1)820>RR\A/-S/>./,_P#$NA\[TOD-N]'L=3T.
MO&U6'K"!>9T_.I[:PJ"MV5P2NH,I8P[02O49A.>*N4*E) 6Q6'XDH$;>,ZKR
M[\B?(S/TVOVUESJ+I=QVC#=GZ9SZER&+GW?&+/#DYWE/*;[G^FALJ^UZ%E^C
MY&XL*B]>*/(#67M1"+9-;-]IP.3^Q$<_(^7'A'F:Z8BACH/%KKM#07TVF$H[
MBS&B&S&"EF98R Z!U)8*-+$>B2QSEK+)//$BM1WW09O3T@N=OLVM_)>30C1#
MR_<E@6>F)HJL4!EI'F]*%9WE7$K)CGEK71ACQ)]F(B5LD[VP$AR0EZ>,HT4H
MJQ/*)NA%;4"Q%'9_39\1[! X80(CK6;%'VKH1GQN9^0TT:*,>%\K7/2((B>:
M%7729'+C'%3VL==W3AAM81^766ACZ:+4@->-7YQ)OO:T[3VUK$3^3(]BU[1O
M=D3/DZ-X.5VFRZSCL&5;@6>QPQ53K^97MMI;6&?H]UCL3$>:!;:&QP9VD?)T
MO5YEX+%05P)T#!3896C$#I-%Z"*C/(;S8O\ //4:IIVI2WF3YP)G[+%TU(2;
M)N[GD]"3H9:V_P 65>Y>2SI]%9%2%I8'BUL[?C,+[C-EC"S0]4Z326'^,:^#
M6UDO-.E6,!NFR',0^B5FZU,N.YV>1C;0_/V&2HLYSV8C26\C+L5\+QVD1P(U
MC1&"(#M^&/5[;R P^KU>VZ$HY%+_  %=I*F;.!54>/LML33GWT30R<YS^UMY
M!;1B"5J$V1SAY)91H9RW*DC LYQ>7\&Q\TKG&V%CJ="+O\V55%U]_D@_S;6A
MX)3V8%"46^*T&" -T5*#'\YDC#=&4Z%7(L<_XP,5FNX=NO+"M)S&PE*Y!6V^
MI/MMMJ,=E.:;"<2KR&5,TU5K\OJ:>;\*QJ[N6RRU(^@+&/*@<Z1GP^S]PP,S
MW/2=$W_A#L;?I!F=,W,W,C+G0UH69"K9+(0FOI+5M*&M539ZGBE-BEAL&-F'
M@)$^VB/*(>.B^@ET\2_FI>>ET<,.EB*P5 35/"JJFKMM!8$TLKD89%$TZH/L
MSI)?RK&R25!0S)6O)%7[BO8#7>1'6=_S:;'$YM%JJ.UEMOY$NEQMAVLJIW?X
M55=9BNM3*F\@T532]-LH"XBF3LGE!0*'[B1?/[T8,7B.S^5M^32V-Q:5E-:V
MW6@LK**^GPE8=C:"GQ?27!$5UN?F+NY!HM234!!%/(&.=<#N)F0X>18X!@:M
M_F'V$?(GF6-K(Y_XVFM(L/!Q YO^4@Q1V=1)N8-1'9E9[+:42U1U<=4NKYK2
M58X)H()T,?-"$ZL1HM#H^:T^OM^BAV>ALK]U?4V\M6^LO;X>6]T*2T>@CO*G
M,VME96 KI<W.58U]6]KG)+$BA,;(H1OSA=TWR=\DZ*D--KS]9S'Q]D_-T16O
M_F0J]EMNB;..N:XB4]:2H&F* "G9-\YZ6=5;,^5(TF"64%2LUJ[//A3'TT51
M0SP3UVK2YLZJ&8,JM;:971U5I46AH$ -,55G@#%DVC'R3.65$;&GH.G1A$YP
MTD..VL3EK:FV)E#H2XIY*7 "VQP,<U2=]FFL:X.O.G+A?,3'.>L0WV6S2(L<
MY0.=X-UF?MOV!=HD,U-PAXGB=BC&&QXJ:>IDM0^B?.@,C%-T9Q%N?9.S<;V_
M<(2P;-#+%&4+[,^R&[_Y!T<?\6#.KY!K^C4FCTU98%I'3 06(OX9 Y@=O:1%
MO,C(E>LSIX(RRFNFGC&_&F>&DNO\P?/C2=#PW,LG?6M6/L]5F(^L&7_+J;F^
M0\=+*@#Z'86F$R6\KLIMJ?6T,U35A?<O8QR8BV/ B0J*:R2,0,G?>0?EAS$Z
MDI:^\R>LK.@:[R#.&NLYEZ34VU#F^;6%)68#;$8_,5U#J!;FPRR37%936EK<
ME::6%J0%AP)/ T',\7/)GR*T?DZ#RJ\V5Y;<U;2T+<#L>E<>CXV?L3W!:J>O
MV6AQZ8#H@6/B;:9ZG<X3_,,][_:A50OG,@3PW#7Q3:TO,60Q=3.25)'9LH<R
MTV"$V,>R>+).27!*/8N?/(V"0-T4X\5I"LDK7CP1K\@\6'D[I+&I\P/)L B[
M%TA%EJ]0\RFFCM!R#!I^R[Q]N;_#Q6$]:2R@^TL8I2D!%F!/^7V%B-0R(($=
M!W6^YY?29_+7FQLJ]UG%IL175N2"+@NI\MK[@S0R:;17MF'<TD^8IQ&'(,-*
M+%^8<0Y)$'F1L@=-NOZ^NAK]7=77P_QG'UE_?9:(W+ET\^H=1L. (HH:$'.U
M=J1J3:X.:P&2=EJV4OXQR%$R_;A"DG9NAUFFK"%T)62JLY<BWNUJZC-VE7E
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MX"C'UXAU0UT03"H!VR>P@\XRE.8&$.N^Z+U3?\NPD?,0R8:$;03R:B;0@ED
M;4NSV8HL4-1;VM7_ #U=.4XPIPT3WE/'1BHK4_'0&ZQ:^6MG?5D:;7GM:#(!
M9UCK?05Y%YGQAH V$#:\EI]=9-KI(XPI)ZQ2$#1UE%+&T;\ETC7 O.77G:4G
M&P&Z(!LJO8+(;EM3S:E:@T&H) BK+^PLKVJ##@HQZ<6%)#%%">-]NO5K7?A2
MJ]P*0#KO2LIU\KE5JN?,SM3C0IRK>K&L-,7<S@5HFOS((\;-%9 5=U$6:A+U
MBEF*BG&D=[N<Q7N#KV>D[39VNF.RF,QTT,%+D:R?=;<VUS\]84N6K#E82H4T
M.9*EJ*V42:Q%L1&V)DA*LG'F7[;&AP3Z;NL%2,D//><V)%M<U%M_'4,G1"JN
M6"?[)!IFHNV%1R#Q:F:0@U\,THA40D?V_MO@>(D894^P\LA:<:,T+B\".?46
M%/9MDV)E55E.-U#6UI<]"=<@7)>0I(H'22W;"4CJ?MNF;*QT\B!B>-::XFY_
M:VD-6V@SY,/0#M<)-H;*:2:QBN;6ZU-JW\.EGO))*@ 6&:L= V(IE4BHD\DL
M#Y9 4,75Z%F6(BMTZW7%Z;+025]=+-4!69M<E]6:*NBRN>AUT\D$B'QP$SF5
MMD7:6PBN$2+[S)8O08BH[@ -6P4\H-G:2Z,:DL.6J ZLZ$65:#NH9#*:U(HT
M%&LCH:.1(T_!@!_'+;(U[EGC1(PVN?JM["1IOV:>'_*5AT%%+F^YYD^;-V)-
M#:VQT]7;54ML_30TM95&9UE4ZXA-8PJ-Z23SJCII9F_V!]#[PN3_ .T7+)]Y
M9U([EY8%OD4%M>Y9#?*OM)<K7C,<]GW(Y)E:Z1KG-G<BR(JH_P!_02FD0E91
MUAD@;"U[U+9)%))+)&L3TC:/(V:-D#VSJU7*YLB*Q%1$151R!S^@/0'H#T!Z
M ]!8OW%5Z)\6M^#?@]%^3_FJO^?NQ6?%&M1&^R^Z^_NONB>WU"_T!Z ] >@/
M0'H#T!Z ] >@/0'H#T'3L?\ ZGG>Z>Z?AE>Z>_M[_P#0?]/?_3W]!YWOU$=2
MZ#O:'RZHMI:U1=IR;R%YMR:G*BS0,$\N"POAOXN/RPM^RLE;72RPMNG03F0+
M%'(CHYD2&5OL\*>4'[8*WQBTW6B+#CPFCJ<CLKGE5 ##U2GI^CZCJ%9P^;KU
MTZUY$%46VXH^:E9^&:$.^:XXJ$M(7_BL!DBG<&)VW[6-AS*_U.3W_%#P(J>Q
MX)FM00MAT2J3.D]YUP>=RP%3'N>&9N**XH\_9QVDM98RUUP]R/BC$<D;IT!0
M"?LOUH>\Y7S8KF/'&WG1[26:^ QW7V]7HN?Y<G+<XO<X<<=R[EFPLZ#5G1==
M]IV6L%#4LDKO^D5-$5"Y VIC75K'?HEA<(?7VPDS$MHU,(KAD:*8%&>,>D#8
M[8B0N-A,+Q$1(/=[5^G_ $W!JMPYQU5^W#S0M'WZD1 ^$?B&PB(6& PL=]=L
M_(2&O(^T^$)L-H4P=I\8BM4I%F9\'M1OQ]!T2OV86>@,Y[F*#D-597O5(<?H
ML'!1[^^W1MERW0V^RJG1ZB@Y_A=KH,?N:>SI8II:AX10S8WO]K"&0(J.()8^
M%'E3O/)NDW&HT?,:;E%0)T>[Q5"&%8W]\);&Y32WN OK@*RL,5BJF]'-ES$T
MT$M%+8U\4A'QD7[XJN:&H;Q3ZO!P#QN\^NGVZ&7M1D/*/M6UAJSZVML-@;6Y
MKB'&-7&ATUY=#PFEN$ =#$4CAAHIR?OODBAB=\ [I'[-+FYTVGYS<\+QD@6+
MP^PZ1L];CNHW72.<R9/(8RIN; D+8XWF)N:BK;__ "L44T:V=35(A03A272J
ML+) X/,KJV@Z_P#J9\BNGZFA YD=:<H8'_%V(FPKE@STFVYV1769PFEYWSNY
M!L1ZRO+G"G;3S#CRRPK$LD,R_8"2W<?(:LX)1<Q1M)GI+GJ=[L@!]7T#6+Q?
MG58!@N23:C4066PMX= V/3V]+0EUM:UH,;"RQY959' R>7T$5 _V;Z[04^7N
M*7Q^ 0+3=UK.-9,G9F]'I3Y[TRITFM)DO+7*<+OJDVSDI,*0*(@$MXL,K8G3
MQ-&$;*P)/=NY!T;<>2'CV5R7><HYWT/#\MT>L@.Z)SK5:W*N#T<M]A[=E55X
MK6\GTQ8]='L"/D:-.R29T*2/%<]51H9KEF/U&WU/1<OWNB\>M5T#$W',"9MC
M0<98P'?$ZG+6MR99W&?Z3MNFEVG0HG &0#6+;" 0QQLGQC2 >>60'EI./\)L
MPKP>JYSQN&NRPUN*F=N>6\^,NLX:(*$?-)"Z+/2/GF%L2G&-#F;\D_!_%9$Q
MBI$T.B#R+CE8RTI++DO 3*% _P"8MIP.>8L,TZBCC&&)T[R*S/5*5<H(UP1.
MDTL<HSG&?8D%E1DB.!04'-,'G;$4N7 <V%L4G=3 ZFCP]3265R9,\%K:^A+@
M%IM*$"ZN(?%'&V=AW\@QR+_Y>*.- TI?LQLQYO,SQ"LBSQ+@2FXWUG\>*Q!L
M;69EN-98\I/EG=)7.GNK2CHYGGPI]F64)TDSFO=+[^P,R447/7E2'$_&C:5"
M757<5:;HK,?1(6DI>?Q]\:7>TA9D%;6O/E;+7#C(^7\)ONDD4C [MI4U8!CZ
MVSMA+<.&VN[%N><ZYHS:]ID6HA:-BHJ P"TI#;A3)2VO<^=]5\97.5OP61H1
M0[11:;K1CL+R^JY\'%B.A<IZ!%+>%:Z[T6TL\F='HPZ+04N>H#282#XX(8EO
MUE(5[V-F/@2.!TS >L:?#=YR.6J-'38*-][J:9\M9J\^3T*HG,QAI])_(5=Q
MN,MGGZ.NL*.AL089#JU9JQ7-?&C4D;-Z"FKYOXXT]3;J;Q'B @0D$<%C> <'
MY]%;!GU.IK\^)#:4K<VXVAL[>HG84JSHCR!"))D^X1*.OH,<)X]>.@"BE:CA
M'/,U_%5+*EA;.68*Z9--(>.<VK*1F&G-=%\QGBRG*R45:V4C[KQ7P1R/!R\;
ME\YF*6W!RW.^*U\16BIYR*SG^(S=!<W]!77,YI3*]]#14E"1#15<I0\DQLI;
MAAWQEP_*6;_H!%+GT=?;]9\M<X('$?G=CTNBSAK-36UUD#89;.\-YJ<N5T%0
M,%/4Q664DEG#K(@XWCFH6-$3&Y8/BT'0,P'CS=5)U0SD7#,IGZREA;<5A?*^
M:W%RW=W%8RVNB9:5V7?_ "N? @F^!#0GU9$#ON#M+5(FKZ!M/*GE5>5X]]AR
MF#P^4P0_^-6U,?>4.=3(TH]A=@OLM!H&5X-'!-"\ :1Z,/E'_D&#^\;?@*R6
M-P9"TM.VYS-%6>KP'-]9!D,-!6E35&\M:FLBJ0*@^TNNB4]T=RJ:>^6<RE$>
M77E21P_DN^Y!)^,C8(P[^PP67TXM'I+GG..Z7DSX+6"L_FN>5^@TNKF/)*U%
M4<&%<L)DR=_!#$PN6 )X@-Q5L,'BC1[8"G GDX7P'17D$IO-/'N"J-HH9776
M:Y9G#;^<S360\0'X[!@ZBJK\UH;JKDA!*6J/AB)C-'5\<#VM4,U#X[^/;*&J
M^?&^9/+1+[.:&JLL!QT<C^=O8X8*;^#O)\%6)I[IYD!R,BB$A+_$A;&,Z(A%
M?Z!RZ:HSF(Q^I%RAF2IYK*R#G_BLAF"\72J=;! H7=T=;5)9AY<^_H8!QW(X
M=8#IPU:QD;8T<T(I8<%\'FQY 5TUE56L17+.&WE'#9-O)\H6%9";4N6]FSIX
M]@P#0#VE=-6I/(]@"'1#3+"HLGVFA*EH=B.4':'0&QU)^G^P$VY:)8&D.GS<
MX1V/T)\0 S;4-TMP6I _YC9PSH0RO@SX(Q@([1:RP_@Y)JD0$F@I*[,:02%:
M*/6R5-:>>5#>6-7%7S 3U.(N*JK20HN><B*GG"<8QOSG=+&"V\++#K^#W6P\
MI)?^VUFW4^-GC]4Q\D;;ZH-E[5;2WS&I+L:KHL-+9CZK1#W1Q+BP28(VQ3I\
M$D_\Z]?0>@RV./%BJ<O'9'CH9 #I9+^&"VKCQTI+9D+J>0$\*[K;F1;$64$E
M99?A\9%5D?W$C1P1UR_&_'N&UEJ0?'[Q?A7275B):21>/O. ]/3@#&E@.I\W
M$#SR!M]7V-S-^&4^ ;\9/=LDD;45\GH._3^*/C84,#8D>)W'*];XJLJQ6:_B
MO-;$2Z-*)69CPQ$QO\>D=P34R_=;!)$4M8,Y73(Z21L@*P7AW">8Z^770\UX
M-FYL[:3R5_4*?DW+\;N<*'DPHK2TCHC:GGCC_P ?/A1(+7HV4])'E*CD2!J?
M$) Z;7*9#!19"0VJ%/"L;VO4:<.SD3)4-U71CW\]9ICCPOY6BJKATTT*1MA;
M*YS%C8V2&:8/%1Y20_RGE[Y66V>I'VE/:WMU/3S'NN:_7FUP';M[#9LM81A!
M+,I(K6=[:T"5K?Y!PRQNF=(D,GH(Q=K#P8CP7VF6%(S<6*D1JZ,9VDAS5P)8
MREU =>] ZG05S9&1DFH.4GQ9">D,T,<KHXXP:6S"I<W9"UF@K.429>VFKFUD
MV.S\PEB+=9C)0WZDU(TMO?D" 16]%-5SNF8UTI%M#)$L;51K@>G09SEP>5V0
M.-R^8IA%=99706H%133S9BZI3CTV-"(=/2SL.L"3'.KPBG^XUA7R-G1K481"
MT%!F@0(M H59+65R6%'E8X3LH3_&69!=35I:G60X,\0<B:&D"M5BF!D#8.CW
MI/#,CXOQT!@[4[)E=J[K:IJ#2!+&? 5S2H,S"J6K JI778$>BD?(+:&068#A
MG"$D$'%%P_?6;[\;Y80<.H%Q\I)$]EK*O1R4^VJ"#=):U5P/5%L*M#+&R6!=
M"):9JI.N:J]G<:RY&G@*0(Q[IW/G2*0$B7R'*O"M-L5;X?4W=+46<7P-Q9M1
M3TV>GM0B*Z[_ (^X':+LY ;T7[TT@=DE:]CG0"M^PD37 XM-F1XH:NZ@&G==
MB'V2)#99N^N*RQLCK0/2YN BG@+:(^6DKH&PCR%2E0D@3?&<*,YHZR @=1KV
M9L.*&KJ\K'=Z/8YJOM\Z 9MJBP'SU777;)M41%4DSA6M!5YRLE@BIH 9Y*=K
MXH_9QA#?M@U-TY*OJ,^]U-?DZ (S"39W+Y'/6VJBQDTU8S.:0"I#6ZI)3J<:
MD_FQ;%]<++&UZNF1Y[$>QZ Y(FKJ0ZH6YO>B4Y+@+S/TUE?@&ZN<:@H;86SM
M/Q*=*?,:,.SL;&P0(E\8LY]R$RR'?),YSW1P!U-/O>;V+"+T[LM%5WI#K*QI
MYR8>C#FTNE(KJ3+QL.TM86-?XP^D!,*&?]Q(1B0X6PO%F1TJ^@9W*W(D?3.A
M:S0=&M[ZOO>747\)?W64N0?LI4[-B$3D8\6E6[M(Z>IAF,&<U'?"M+_.+:K4
M=&@/_6=4P5E5C2KTN[L?Y"H-H9K*CS.Z-MYK8H B:OH\'#7?>@)GS8=[^..C
M(SXB1K*=[WQ/:D@P=2:]PZ#9/:WF@J\K:4NP!,S<5=#NJ.OQ]-4I_$M.ECG-
M/!SUI92RO088A'06H05B@Z?E0M0T&'J>:-.[#T#H%;K=<58Z;",O)[&I_@#8
MP1=7J;O*:$$2PUE)':68%/44,C03X@6EK(%(YSE8Q\R \V-EYWCX:&FTVJ&&
MGJ@*4"\R]OG]0??:ZPMQ";1'W,,60:VWU=@/I'3MK7''63TM$9(QS8F3M#H7
M6I2*$0-EO:Q4\X=7)J*EP.WJJRIEB"JKZ@Q]Z ;F0<,/!-7@)^$A,]I&HI/L
MD4"M^\@.?)M,IH[A:O&["Z'L;8(H]D.&P6M&U)3M=F[IQUE8YY^:CM:S/CU&
MI69+N0M1/R[<="7$QMD->##<O"V=AR^3.2;) \]>;7:-GKG5=;K*-HEWH[ <
M:,?_ .9E#),5;6-;-6B5ACT'.E0E\7XCFS0SAFLMP6VQT^2V#2*>[_A=9,[\
MF^H"?G]R]M?\3KO88O05@U'=@9R2/X1.,E? H<+W3/>]_N&2AYJ;55E&(7?@
M9(MA.D%Q>KR^.4*3/L>,,.GOHP;4<2D(GIZD**2WDM?PHU^8S89QTC80$@O$
M3.]*\>O*+B.KY5U>@Q]N'WWQKRXFJH\0*72T<_6NHX[-3F4]-JF6.:#L!*6R
M6=A]M1F#3S#1P+&LJM=$'U!/"&G+SWCO3T!]]8:FPH^G^1E/8Z>VK,[2VFDL
M*SR.ZP$=?V5-D:ZHRU2?<EPO)F&KA1@H))%9#&R-K6H$M/0'H#T!Z ]!:[Y*
MG]JM1WNGU<U7)[>Z>_T1S%]U3_G]%]!=Z ] >@/0'H#T!Z ] >@L:Q&*]4^7
M][_F[Y.<[ZJUK?[455^+?9J?1/9/07^@/0'H#T!Z#IV'L@!WO[HGX9/NK?;W
M]OLO]_;Y(K??_P!OT]!YV_UL<C;Q 'RE.TNGI]1:]6ZERCN9\$+'4L\8V\\,
M?'):RD&K_P [_P":)=-*%"QQ \GVBB")IFC0Q0-B]!(#JO@US+HG4;WL;M7T
M5=AT[))1V=S3DYF-TN46"&6KS%?86>0L-2F+%."2&.J-G)AA%)@:OO']ID09
M<SPKS]Z9'-LNX^2=Q6%'UFF+M3^FN-E9KZ>Q_EL1H;YQN9GLV:'($UD[ IW3
M/09T+(8_B]4>T&MJ/U4^,LHX.?*K-^%54VYN^D#*.S*%T85_:V<9;M!69^3!
MA0UFWN:FGKFFEUL<A+/LM524A:CW!LA$!7\@46OM[LEQ$4<%5!,YD558"E"%
MRQ!27<S+ H@UX-DKD<.K"G*YZ.^;F1O]!JJR%D;_ //4?+%L9IE1"O@5XDD5
M-M.Z$ D>_GZ!Y%-$A0FS .0&WC%1\B'$1$#P2CN<[[B+[2@[^4\$N;8VYTVI
MY]UCKF1M=SI9M!J[#.7@6;T%]J)("*R36'VE-1UY.A->)=SN6U=,:9*R=7>S
M561[P=WCW%G\:<-946X[)JJ:\:8)+D=5OQ[[+YJS/LOY=]M64P&>JHHB;:[,
M#5"AQQ326O5TCGN65\P:@?U]88&QQ/EB4RI-$,VWE_VG&ZS<5%S4YS964M[R
MOB:DMR5H(T>FM(K!8(Q1"21&#E0L59(2XWEQ2@]-5X,\VP5924^?Z7V_+4HL
MA[1X</U7.8//ETEPXBSNL9<UX8XD0]5%L(U&L0U@$J2)&-5TGW/9\0,_^P/D
M%KS_ /7+Y6@E7?2;XZWJ9[S3"]&V\&^L\X]2L,?E:B@ET$,T+\^7)4M!#K1Y
M3&BE*^1WY"0O9&$Q.S\.H/(>GSF+V598%Y=KLJ632Y[=I6UKK&5:XVI_RX<H
M&WHMV?3'U9!%2;%50&CFD?8;*R-TKW!T#?%;-V!EN$_K_?[&RAM9;"EJM!UX
MRS@6\-I]$$RUJ)'UMG-F=$/1(6061\7&M$:K127N*G:@+A!B^<;7?Z1F>H^G
MZ7G?BOB[;G=UT;:WEQ4ZNVM.POQ[=!L[ZD@(NCIGMG^;IUA=^2Q'-A:D*,G>
M'=\NOU<^1'DR*:;S[LN;\1.B7%WE+/2]7\<>A]GH=3IP<11W=)G*:TI="R]Q
MD8T#+='23LK_ ,Q\,;AVS-;-*]P0VY_^B?SRR'3,5O=G^SWMG;:;-:+.V6DY
M[T'JNMJ\ST'.5-D067DKRQR.'K-0!!,R97M)',^2S.=\F*U7>X;+(_U][- 8
M(8\K@*LMA)$[OP_*_P PYJV)7?D)!/&%"14O(+^),BJ^21/MO>CF^ZL;Z"!'
M>?TA^9'5.KW/0^8?L/[/XVY,EE!%FN0\O[1N+/*Y%*^KJ!+XP.^W.%TVIL[3
M57%?-:E3$3__ %V0C4;\(F>@MXW^B_L>8/T^L\H^J4WGOT"0:L_[9:WR \@.
M_9B[Y>L(UF[2485ER[+YZOT=#K[6Q9.^0RL_-KT&5(7R?DR(P'EZ9^G,_5Y7
M8@87G7(>;[O8YBSJ(>ATWECYAOL,E>V8UR/!I:NIEKI*^\EI);928Q3?B(9.
MKVSL^VY44-61W^V7\ZX"!IZ3]D&V?,)($2(3:=2NV-".'E)^1H5</P2<0:6*
M,V9[/MN8Z221R/=]5=Z#9?R?]0^_Y73N@G\>O#?I&LNJ7-B=$W?0O*/S0O3^
MCW])1 UANDMZ"SR5K1UG\G80$%L"':HXCC)F1K\9'_((>^0_^WO\CNFF9^?Q
MXV7)/"L06ZUU_KZ[C?E!Y5ZH76V.K5DLC00NH8#44&%K8#)39YQJFOA_.FL9
MW2R(USF/!&<9_P!N[YNX#<Q776O*</R/YY/37(-QRK:>5_DAS^K*MRP@A*30
M Z?DO(\AI:^>GAC)@E&;*X4Z CVF:OM\?02]E_2MNY98&R<>Y-(.-$R2+W_:
M#^RZ)OY,;_G'%*)'EEA(9"O_ -+FD<]T?LB-8B(B(&ORP_VX7[)7:F_MLIYV
M_P#;C/6N_P!)M*+*9#R8[(36XT:QN;2QS=.$=JO'B_U6D=F:HR*N_+MK0LHM
ML;YYGN=*^/T$C>"_H'[_ ,MRFC@ZJ[E?D-T[8;DS2ZKK%MY[>=G([[254=='
M39</24?*\%48FTM\A2)(# :+4UTA(CVME171->H++M?Z,O(/?X[0UW*IL!PG
MI]E'0!T/:<_^PGSPV6CS%=3V]$66.)E=]S[0XXU3Z6KE!C_)&E_#<]A,:_<;
M[>@A03_MFOV#7-E1S[+SGKNB9VIOJ^RL\!NNV]-L,3L*D*]9?'Y^^K*3@.>G
M'#TDWW6%RC2L*C6=9(Y5>QJ^@W%V/ZU.K70ET%:>'G@%.->1%*:R;RQ\T)R)
M5*:7#+7,-3D\$X04H9\L#GQ+](/C&V+X(U&!J^[I_MWO-G=Z>NL>#]UR'C%C
M:X&N^_S+(>8OE7T>O.U ]C9V<VTEVG:^,;RYA+>XMD<0 ,(@<"-<]4=(][G@
MJN$?H0\[.;VVOL.X]?QOE:'IZ$&FKJW6^=?EGQK_ !>2.PL["X)&,X;P7'RW
M\-ZZT<V2"R:0T=6JZ!S%DE1P2!B_2CU0&L_"I."<+I9@6ES9\F#]J/[*R%HK
M4H(L*.UKV3<U11YQ&EJ_XL<Q)?9$54^CD#7+'_MJ_P!J[QPAK']A0UC%&.CK
MAG_J!Z**/:6<L@Y)I]4%-XOVL>9_+.C?/[(\V9'*BNF>_P"3W!.#DGZ$>J<\
MSL)FJYMQ#H/:;_/T-5V7M0_['_V)<YNNX76<'C'"U&OR^)P0F3KYU2)JPABC
M?C _5L7]J^WH$SWK]"WEST;-YRIXAL\!XM684Y\.LTF:\^?-7L=AJ,D72F"I
M@Y0.W<BU><KZ)ET@9KYHPE(=^(V)GVF_W>@9WE_^W&\\LUOL;J.L^6%)W;%9
MU]U_-<LUGE!W;+U&C!LPYA8JH?7<XX'D-KF18"HQ3$4(QL/WH%:H[DD>Y0VT
MY;]<76,5RI.)97P\_7E2<W?3YFAEK0_)'R];<H#C!*H;-$QZEW*':=MR$VG&
M:\UIC"IOQ8G2R2*UK6!''R=_4#YM=Z&R4'-^GX7Q7FI#]*5J;;B_F#Y/6>BZ
M -?5 5<-5VMQU'B^]%I*ZNF"25[0@FS%*Y%=*WX(C@:7BGZ2OV1<JZAA^@:C
MS)N.T9K)FW<]KR+IOF7VIV$U@]ABK_*5B%E<^\6^=:>HLZ<VY@.@+&,1S?P&
MP/;+%,Y(PE3V?]7_ )7=-Y3KN>8RBX#Q?3:0%C*3J>)\U/-:PU6%NXD$&'TM
M/6Z7G%GG;VT"J 6AP-L1Y88H9%]F*D;6N#7Z1_M\OV32&QVK?V']!*N*MPD-
M"9?^56YN8(  '_=#"M(@_$JBN"@8E((B?"+8A3.'F>R(B#[KG-#:=6?KR\@J
MD"KK@.-^+XD%1$ RN2#S<\\T=7J"(2%%^#))DY)H$C@*>WW1_P WH_\ N7W1
M/<-:_E]_MV^^^3FWK-QS[0<'\4[">L.AZ/\ ]I>[^0NML>PW<]F785FAZ'>]
M4Y7JRK$J@CMK"$9D44*2,.>LSI$C'9"#;\&_VR7;><]$*U7?>E8#RUQAN:3-
MKS[I?DOY)9&NK'.,IECLJZRY9R[)6OX,-72Q@2U,LJU9(C_:1C4B;[ALXV?Z
M4.0;BJIJ>R\(/"(46M%<*TRC[IY69ZTB&BRTV2"#6QHZ($VZK6TAD@DHQLLD
M,@D<4:M5&M^ :A0/]J'Y(3?FOO?.W01O^W6V-?!G]W;C5<.D$>^5\XU<?Q@M
M*0$-R,05T$DI2M;[RR/=]?0;)N-?H.R/-N7\WYSN^,^//<;W%4D2WO6=UY >
M506QV6QB*+=_DY]+3!1YNNL/XRV)%0@1D#F-:US(VI+(QH,MY.?[9+F_:JF7
M_LG5\Y\0MU8W=:1INC\K[#Y!ZX_69JMJIZP>@M,KT-MQEQB5C*^$Y\42EE0#
MQ1.>QCGM]!'7 _[4KJ&1Z/D]OJ/,Z]ZE2T=]7%WN)O\ 6[3'A:;-5T23-SD6
MEYYG<]L<C^3:3SR2$U!PDKF.C1WS5B_()QL_VYGCI'5GTB<2YXE;=DQGW(\_
MF'YW&L.LX'#SQ%?;)VWT=\VS?)/E[JKD>JJJN;Z"&75O]J/H-AN=-H^3^55Y
MX]X^V,KBJ'F64WO3.@4>;4("M%))DTG5!=5M+VWM# %)F)D.@C1SF,9"U(O=
MX/KXO?[9[.<(_G2NMVW-_,&ZLKVET%+<=QV?9JC_ !4RHK[<%(:VHYG)D:6Q
M#GEN92VM/@*DA,<Z5KU<[Z!I]_?1X:4'![+QZH>#>/O$.8=*%O>^9K3.Y#>V
MX55J!K#*^.QF1L0J7I-/JC[8@(+=DUA@T2,C'_(D-3W:V5[ \Z[>4EX\G/XN
MSQ6$LZO2FT&F,@O-O>FU5W-6TI$4,<6E(Q@1@[+.)@YL\A3ODI#(AV"PK&DD
M(<.EYYL:'_,@)8<F)56BZ#5Z7/4FEMX9KP=X5'?T#X%HJ4O:1G5)E^$.'8I[
M"MG?&*<DC&/20&W"YETMO9=Q7UA&5REKG:7/.)G *H\;!#4*-9 GPE66?S9^
M=L 9!;&6"22*N.?-.T'[2_%(DD!Q<ORN*JI9:AG),GO)KZ^STK#8^H-N;NHD
M=17<>"#OQ8,)4LN8; UT3TDLHPXWECQK\!X$?]P$UI>)]46XT.6BJ\B(==W=
MVX_F\VP''LX,6:%<7V?$5VAR2V(!U7*1(]"'$,0J&4:O:,Q$=&T'(XZ7=Y+J
M-X,W%YS3"WF-6SJ3\_JLOF1;G)'[JVLW7#(\S)BBC7@RHVMA2$@2 0:.0Q@\
MGW8V>@QQ7++S7;N^0;%!%XRQQT1^;Q\VY;<5U=$E!*--K3#URQL%9?NC(D^Z
M&>8DE>VQ>Y!I8(6Q(&.T7+MD_4DALY/RK-1G7055-/7]&U>K $&C_P +I!,A
M6:"B%M[^ZIY+&D&@@@>PP:OA/5T*P_94N .L+QK83'YJRM+7)F09DV-632[<
M PPJNUM)30RUM8RQQK(#%I8!)'E!C C73Y(IFRN;/+'*P'IX?KJZM!NJJVHZ
MRFJ:7K?5+$B06\M\S1U #-K&X@V92DL?\6H*:RK)AW$6A2"B"%D,GG:XI7(#
MQ!V2W*;Q=!S[Y8S8CZ*XJK6YN3P;:,.BN:X_*1WP\3(S!I!AA?O225:@/BKF
MP#LAD>DOS#%&?SILWXA>>_FR831+Q]QI[+.69P^+D-L,'CGP'3W-'G99J2W'
MF'#J"JG^0@FGD((251H(_02O\5O&<;O?ECX?<[REW>XBHC[WS/9YK06Y;=?5
M57\5TW$74][G\*.71Z66NM=-C)JXC_(C1@R!H_S*V4B;[KO0?1X\,4D_[$PO
MG/AM"Y^O^31=C8C"RA#GVYGDSU\JX,&$F(+D$%)LYI711+++]MBHW[CT3Y*$
MJ?0<?Q5K_=B-^+W*Z955WR]T8C6*Q/JW_P"2B+_3Z>@Y/0'H#T!Z ]!16HJH
MJ_U;[^WU7_7Z+]/Z+Z"OH#T!Z ] >@/0'H#T!Z ] >@/0'H.E9?_ %./_P!?
M_)%?3_C_ -"3_C]/0:-.J<6J[?Q@\8^O8_D=5TSH5!3>$&DEDPM?G2^F@4&'
MAYS+;2"#MMZTB^CRM"(:6T>(M'3PR_CQLD1%;(#?:;]I7%**ZU.)*X[YM2V>
M(O+#&DDT7A]UC35H-IE[.4 S/3Z3.U9;#F55E+^;[BG2_;6-8$?%)&QOH'MY
M-YV<U[_A]):\XY)Y@3!Y'6D8[55+_'*WRFFH-P'59_4DA3 Z1M59"QGTNRJK
MF)A$<D<E?:+\6O\ >6)0[G4/,3.\GPUMT'><:\M@,VEW1RVLD/%KV\.G,M;H
M.J$% I<[:V=Y 9)=&QH!'!!#-&QSTA9(UR^@85O[<_'"D?(0=R'S7S.:4D1;
M4VX\*>X4E$(-,9%7L9/;S5+(:%\QQ\<Y!ZL;\61+[_*9R?,+9^&]-[!Y%>6W
MDEA(_(GA-[:<#Y3R[GAVA3GN9EWSL'7]3T@])4X;J65WR.CI]#J8H [%\]:C
MWE.BD1(V-<X.;6>?^,Y:_(97L_&/+B+HTG(LQHM?E<5XNZ[H$$%SK8WB6M@3
M)BJS1T=6*7=T%N )!-(++\0Y%B7[+6ND!R>._L4Y#U_<7>:RW%?,>PU=%GQ-
M?-3V?C/O^>LM\D2:ZBCG+=O!<H%,=5: UK%+"^;XD5?9KOH] @_X\87N_,LY
MW&#:^*7<,[<=%\B]EU/ F97!<OWUQ3!;7FV K #CAJ7425]<V9]38BDI]3P#
MB%;*QK6M8H8VB_9]P4KZTOC7YN6%+>#U9CK2O\,>EV/WS09CQ:Z]E+B$MJ?0
MGVXRC/\ O H."2E=#.J?=D56!P>0]MTSSL\&.P.\?N#];Z1;=VP9>2SUKL<7
MF>:C7UQENAY6@V-J6+N.B5UGAMI7V6+LQE99@C2CD!-9&_[;7/0'][=Y'G<
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M?0"JJ?'V:KO=WLJHK?[4]E7Y+\G)[I[I[?3W7Z_T]!=Z ] >@/0'H#T!Z ]
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MZ\21LJ*U6_;E23H,GNSZ^_T^*^Z?U]!5?$K]L*N5O_SW?.-1$8Y)$_7KQ/\
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ME=[?'Z.7Y.^/T3W]OHJ^[O\ @WZ?U] .8QZ(CVM<B.8]$<B*B/C<CV.1%_\
ME,>U%1?]%3T%WH#T!Z ]!141R*U??V5%1?95:OLJ>R^RHJ*B_P#-/KZ :U&M
M:U/?V:B-3W57+[(GLGNYRJYR^W^JK[KZ 1/957W5??V^B_T3V_X?3W3W_P!?
M05] >@/06HU45RN=\D5WR8BHB?;3X-:K45/JONY%7W7Z_P!WM_3T%WH#T!Z
M] >@T4R]E"YQUSSI9UCEW+^J>/!/D=UY^Y*V[&'6F?KZWQO\!JC_ !LD#64Q
MG-ZGFMQI== =H;.YLZ^MK@Z^0R>-[8U>P$GS/SN\,-KWSE>3YYX5\^S/<]ST
M'G'RM[+!\Z"V6)PVDN\[#E]GJ'YR@+W.+U?^,'U9801XPPXY,; WFL=&.Z4%
MAD_,CQITEY+:]8\6^':"TJJ2UO:':<=K,ATN#(4V?P.;KM9R/9W%WF,Q9U'D
M)RZNB J-#D*Q#R:JF"89.@H@;XX .M^5_P"LR.^G?T+Q2P.UT^HYQ2:'8.-Y
M/R31VI>)T,5/I0*B'\YTUET0S20$?GYZKJ([ C5-&^]51DI)"]X+KA_G5XT3
M[+".X+XE38P_MVRY]AK+=U-#RS#YT@2YT;\6\J?1Y4L]^DER]92 O:(V-OY"
M2!AMD80Q(HP3F7_;SH .[Z#D/7/'ZISU+/?;>#$[#']<I;5PM-F;>4.HK^EU
M^MI\<!DMCH::N),C#:=([\MXM8UCCBH6/!U[O]O?"<SJA,AI.;]ASUN?49C2
M00W]'2T$H&?UE/9ZNHEU =[>5A^3T%AD0(I@Z@Z*,\^V,@IAV26LB"^@FAXI
M^4.&\O.40]?YY3ZBDS9%_:T(XNL&JA[&=U<P,F(Z-*:VN@E&,!L87JQ9DG'F
M62":-DL3V^@DIZ ] >@3^JR>8W.>M<GL\]3:O+W@RAW&?T-:);T]F*YS7J.=
M7'13BDQ?-B.1'M7V<B*GU1/0(FPX5Q>V!KJFSY7@#J:H=525M"5E*:;/AST+
M\])GRH:%XBTZ&YY<G7)7SK LH+1&-@=&WW10UW^6?<1\OY.<K\:@N>\[KP-8
M_CFS!WSKY .ALO;[R$@U6CJJ[(1XTX6;"G#\>C?:6C[49\]Z;7Q?:<Z/[GH-
MLWH#T!Z ] >@/0'H#T!Z ] >@/0'H#T!Z ] >@M:[Y(J_%S?9SF^SD]E7XJJ
M?)/95_M=[>Z?\O07>@/0'H#T!Z ] >@/0'H#T!Z ] >@/0'H#T!Z ] >@/0'
MH#T%K'H]C7M^7Q>U')\FN8[V5/=/DQZ->U?^2HBIZ"[T!Z"B_+W;[*B-^OR1
M6JJK_P#0_%WR1&^W^OT7W_Y>@KZ ]!:Y'K\?@YK?[D5WR:KO=G_RFM]GL^+E
M_P!%^J)_P7T%WH+7M1[7,=[JUR*B^RJU?9?Z^RM5%3_W>@N] >@/06M5R_+Y
M,5GL]4;_ '([Y-3^C_I_3Y?\%^OH+O0'H+7L9(U62-:]B^WNU[4<U?9?=/=J
MHJ+[*GH+O0"*B_5%]_\ V?\ +Z+_ /A] >@/0'H#T!Z ] >@/0'H#T%'?+XK
M\51'>R_%7(KFH[V^BJU'-5R(O^GNGO\ \?05] >@/0'H#T!Z"B_+W;[(BI[_
M -WNJHJ-]E^K41J_)?E[?3Z?3_7_ $]!H#M\-MRNX^<?3<O@+'J8&?\ *#>C
M7N)!K-;/62'U_C5X(UV0/M?\( LNEV<=+7Z>\NR:O-#EGW<58T46!TWW&3 U
M=,?U#J_9<9R#9?K)VN5Q]QL>06?1=](+Y,AU.4H]3J*(Z2N74V$5!BM'883)
MV\K;L^INBX@+4215'6+[GV0P.IT.DQUCJ\Z)^LGL75,-G^1YQ?Y>NQ7F/D[F
MZ[!193-U'5\M1U0F:NFVV/J[H]SAKL2=\V@'80VA@O4@DE<#10$=(AT.7T;_
M --W3=2#?;NP6TE1WDOF-)@JK>5AI%/32F7E9-8QV@OLT FYJ(%H(V64+;DB
ME8&4R -\O_SM;PH^(C$XI&U@-?)5B-9T'JK$A!D>5(Z%J,W+?=S9#9'->OO(
MQSO=KD5&J@<L/ZW/"N",V&/BD'V[$\:T-23>=0F4BQ$^*P&2/FVSW_?:K&^Z
MHJ?+X-^7O\6^P=;5_K.\&=V?66>U\?,YK#*8VKLJN31:'=7$8-A2K[U1T Q^
MIG&:6#[JD<BL5Z(JI[^RJB@[0WB+X\B1K"+S[[$2R/E6./6;AK/N2K\I9/BF
ME]OE([^YR_\ RG*JK]55?05E\1O'N9?>7 R.7X_#_P#G#=M_M^[%/[?VZ=/_
M -K U?\ W>W]%7T'"WP_\=F3N(;S^1)G#AB.?_F6^7W' EDF$9\5U*L3[4LK
ME]_;Y.]_9RJGMZ#D=XB^/3I))EP,BR2MC:]W^8[Q/=(HYXH_HFH^+?BPEZ?1
M$]_?Z_T3V!D?)3QXXK@>(;[<T/.->==8ZCFN:D'"T'7.R[,LJ-$":'F.:935
M)=ZNY*B+='#%'&0V%7?>?#*R-S%"!O*\7T+KG(=5E+SG,V/\DR=5APZ.Q,Y)
MY%9#E+:-UEA!.DV-=G>J?XEL3,MG*S41G2R$EJ:R8V,;\B*<<X<$'/U_)]7G
MM1AS[OD>5HZ.HVE?)-K:\+H\9PFOROFWPK-\ZEK['6:VYH8\WJ>0:<LI@LT4
MII]D*02.Z.&!K/0;H_0'H+7N5C5<C'2*GM_8SX_)?=43Z?)S6_3_ -OH+O0'
MH#T!Z ] >@/0'H#T!Z ] >@/0'H#T!Z ] >@/0'H*.<C45R^ZHG_ -"USU_]
MS6(YR_\ N3T%?0'H#T%JM:Y6JJ>ZL=\F_5?H[XN;[_3^O]KE]!=Z ] >@/0'
MH+4<BN<SV=[M1JJJL>C51WO[?%ZM1CU3X_5$553_ %_JGH+O0'H#T!Z ] >@
M/0'H#T%K?E]?E\47Y.]OBJK_ &^Z_'W]T3^Y4_K_ ,_07>@/0'H#T!Z ]!1S
MD:USE^2HUJN5&M<]WLB>Z_%C$<]SO^"(BJO^GH**]$5B>S_^HOLWV8]43V:K
M_P"]4:J1I[)_5WM]?I_543T%WH#T!Z"U7(CFL]G>[D<J*C'JWV;\??Y/1JL:
MJ_+Z(JHJ_7V]_9?07>@L;\$1R,:K4:YWNB1N9_=[JYRM3XI\ODJ^_NGNBKZ"
MJ.^;$<WW3YM1S?FQS7)\D]T^4;T8]JI[_5%]E3^B^@L8C4D=[^ZR_;B21_PD
M;&Y$^Y\?@KO>/Z*KO=$553W3W_JGH.3Y)\OC]??V^7O\7?'V]_;_ ,?M\/?_
M )>_OZ"CV-D:K'I[M7V]T]U3^BHY/JBHO]4]!=Z ] >@/06N<C/951R_)S6I
M\6/?]7+[(JHQKE:U%7ZJOLB)]55/07>@/0'H+41?DY?DJHJ-1&JC?BU4]_=4
M5&HY5=[_ %]U7^GT]!=Z ] >@/0'H/+[VGS_ .#^+/DQYX9:[\U>+>-'9ZWR
M&T]Y!@>D=#U%/+> [/QA\&Q,?L$QI6<T.(NKF2AR6N'J3[,(P"NL)!$E'*C;
M[,"/V,_<T]W5>9 ]$_:WX#'<>&V_.=CT2YS_ %6"OT=@$)J,]H>BX^AIQN45
M)H62EI_Y*N!'L#Y9YQT8R562.;*T''._;KS*AU>)R7-_V^^$>=Y99P]9)Z3N
M-UT"RZWTVHLKCLFQM>>28\/< S5DS:+C\M'71CRSQ@P%PF*1 3*Z"909"7]S
M?4=,/,+I/VN?K8R0+[;?RELY[TFA&M[//64^7GPT%%:W_-C9\K9YZ$"QCB^_
M_(M)<8YQDKFI%' &\J+]Z7Z@G_;9_P#/#?&9\COMM=\-[ ]J.D5K45TB"-8R
M-SW?^)R-;_[/0#?WJ?I^>YK6?L/\97.<J(B-WPZK[K]$^B#_ $]!R)^]#]0#
MG/:G[$/&#W9&^5WOT,)&_!C/F[XN6)&O?[?T:U5<J_1$]_IZ#C3]ZOZ?554_
M^>(>,:*B*JH_?C,5/;^J*CX&K\O^7]?05?\ O4_3]&]['?L1\8ODQSF.^/01
M'M^355J_%[(7,>WW3Z*BJB_Z>@HW]ZGZ?G+[-_8AXQJOU]D3?C>Z^R*OLB?8
M]W.7V^B)]57Z)]?0<C?WH?J =%),G[$/&#[<2L1_OT0)K_>151J-C=$DDG]%
M]_BB^R?5?IZ!DO(O]W_ZO[?C6]J.7>?OCY;]"-HV,RM72]\CY;/96)$XRP"2
M](%JK _)A/B<KBB0&I9L'1R#.CF<QZ!J^K/VV8JNX!I><2_M2\6[/KUOI\1I
M*3KUWY+-#M[>IS V>K]=37L]54W&8YX7>V1T1<$6?HHJPD>JLFS@/>1&TP'>
MXUY^<,[3J^4<^TG[!N+]HZQ==@Q4>+YYSKR/T>K@Z;;7?DER\ZDI&<]*@KJ&
MQ QN=J[ZW$)D%:>OW@H8E&@$<"P/5;Z ] >@/0'H#T!Z ] >@/0'H#T!Z ]!
M1K4:UK45RHUJ-17.5SE1$]O=SG*KG.7_ %5?JOH*^@/04]_=53Z^Z(B^_LJ)
M]??^CO;V5?I]?;^GH*^@/0'H#T!Z ]!:CD=\D1')\7?%?=KF^Z^R+[M5R)\F
M_7^J>Z>_H+O0'H#T!Z ] >@H[Y?%WP^/S^*_'Y>_Q^7M_;\O;Z_'W_KZ"OH+
M7/:U6(YR(LCO@Q%_^4[XN?\ %/\ G\&*O_N]!=Z ] >@M<QKU8KFHJL=\V>_
M_P EWLYOR3_G\7*G_O\ 07>@HB>RJOU^OM]%553Z>_\ 1%7V3^O^G]?05] >
M@/0'H*+\O=OM[>WO_=[^_O\ 'XK_ .'V_P!?E[?^[T%?0'H#T!Z ] >@/0'H
M#T!Z ] >@HGR^OR^/_B7X^WO_P"'_3W]_P#Y7H*^@/0'H#T!Z ] >@/041?D
MB*GNGNB+[*BM7Z_\45$5%]!7T!Z ] >@/0'H#T%&_+XM^?Q^?Q3Y?'W^/R]O
M[OC[_7X^_P#3T%?0?-'_ '$_IV\T/V(_M_\ -/?>,M=Q6V$ONH8+G-;E]GWC
M!8/H%Y?\[\9>#7.KMJ3"ZJXK=#=4]!G+\0B<H0<B&.![T9\GM]!KWO/]JO\
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MUM^R"&B"&L+2G\:!P2M)792 IWF+2+$ZSLSA*P<QS_\ M(C6YV*Q.BA(M?\
MZG"RN5LLS%:Y&@[N \I.Q]49=.YQQOB>VES5A)4Z83-^6E/;'YJTC+/"6OT
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M)14_B%P2PQV/*K!,^4W.SF'55M!%+ <,:5(4Q&_-B*B!%K46OZC ?*!>@9+
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M2M] >@/0'H#T!Z ] >@/0'H#T!Z#CF=*V)[H8VRRHGNR-S_M->O_  63XO\
MC]/]?9?0<GH#T!Z ] >@HCFN3W:J.3W<WW145/DURM<GNG^K7(J+_P %3T%?
M04]D]T=]?=$5$^J^WLJHJ_3W]E7^W^O]?05] >@/0'H+?=?DB?'W:K7*KO=/
MHJ*U&M]OZK\D55]_]/;T UGQ<]WR<OS5'>SG>[6^S6M]F)_\E%^/NJ?\55?0
M7>@/0'H#T!Z ] >@/0'H#T!Z ]!XB_.;R_Z%XY?L!\]LQDN2E=)M[KJ5=-5M
MJZS(Q0U=%MO&?Q7R&AL-?K]5GM$F>SS8B!AW_CB6$D,!Q!;X'0P/8@-_1_LU
MLM%SVS-R/C/<U1O-A+G5X"TZ'BN*()>=5SXS*NF*H'4];::JIK:R8"0(:V#4
MJ4$9XJJQ(985:$<@?V07&3/.[ZG#]YK?*JRPDN%T=US:H<'+-R0;KV JKZN"
MHJRGLPK&IL<_;20#J.XT*V&K6P2&_(>9R@MN4?MHT,MYL4+YK:9^@SNJ@R%/
MT+(V_(!<1AJ_1V^=RF8+BN;J'!:+3N;;[%[+0RKF$!#K7DRD1D#R.8\%+N/V
MX7=1#B-L=AY9\'K,3EX*[0YS)<WN;D,BV32W-#DWY4?#KSJVRN2!S0EPDF>G
M.SXDUDQUC+6R"1?=!X9/W?=BS^%H]#4KY-#W.AK9ER^"TV;SKA \K3V;.<VN
MGM]0%-<9C(6#=K3)/7,M#8Z_^+LHSED05GW'A*WCO[:NG=-T/6N71Z[K=!H.
M63YNYFV^UIJJ6BV%?JV343"<36Y$O02V]/7F"I8_'\]8#138GBJR!\,K@DN-
MYH]_9#=4)_8[4$US-'+-:'TM)%+)/26E4VH$J38;Z2ODM-+3ASRQ!5[I$@]Y
M622I.UPZ@J<=Y=]ELISK2?L6P'!'98M?2VX4,Y@1><IV3132_P =EVBK#;V-
MBQDP<I7Y$P_V'LG6:9J1AUB?*+NL,=62[OFO8"TJQ$)(&R4D?XLE06XN&6!A
M15HR\.TM49 QSB9VU\+2XFC-4F!_S C\N/(>:R:.-T*R)*CB$FEJ\_"XED9+
M52YL FSQ5[Q_Y$88,U263-B?+",K6P(Q%*>'*-Y?]<TDK:^F[7KAIKHB!M1)
M8T@[$G#)HHKXP\1^:+_+55JBU@&E0)1WV$#GM1S'?>B#%:[O6[WU9!G]YO2=
M/6.@I9(LQHZ+)#Y\8RI*-=4Z59" "@33ZVV!=]U!A()QYH8O@0QTL#I AW6^
M1-P%Y<^,O'&Y^F/H]5U/G3W[.DJ*;/VQPMGT\W1FC639LY3!R9NBO\K\S1IK
M&>YB-N18X XV-;]P/2%Y[1LE\'_+^.61D,;_ !G[>CYI'(QD+?\ MOH_E,YZ
M_P#@2)/[OE_I[>_H/.A^K[:]"UOG=XW?YYV7R0W\PO*>WP#Y_M.XUNI#B:/F
M:F,7130V6= S+;18/N#!N")1\0OW?FR9D\,ZAO0\\1-?$=R?0X;QBKO(6^J:
M/MU8^T.YZSH$^'IM=BJ[,W%+7!.Z3SU$?TX6Q_C2@Y'O%L:^ ADQ B1M=*#J
M^% FYK^0V8&^X)D_'2V$Z!IVB87% BUM$<!/%5ERZ4406ZOD6(RY),%AG?+"
M\P4.(G\4-LS1(0E[Z#@F<UPY'Q;][XQS-6-ONJO<UKD=%[-^OR<OT]OZ^@T-
MU^?[!@H*0[E/ZS<41H38->;IA+'$5F/?6T8_4*^VQ]33WAW;=)!7W5K2UU?9
MS5PBD@ V[2#F$-G1X,H3?\0<#>U%CA]'-XW8'A54+QJQH;$67 "4O3:*[)VL
M!M3B KMG2]J34XAN5'',)J8U/"BM?DD)J_9<UP;#/0:??),?L]?UOI-_S7P(
MQ'>[4CH_!B:ZZNA"\E9[2BQLT9UY8G;6WT4F3>N)N":B7/S3,'A&)6TFDKYV
MP2D3 VW&:/R(AVO);+9?K)XSC[AOD-EANAZC+04H]?S7*B<V.;5='QIECL92
M]A;4EPV"*2VA!%8'%/(,@LQKYIHPWD_V/7ZHURQN_P!4158_X?U3W_\ "[X/
M_P#@OH-<OF:!?VO1^;E4'B[6=\*HN9];.H-,?2ZK[F;UEJ)55V<R5?K\^6M?
M2LW=W"()9--@B@92*;,\R&%LL!00C=4]TL\YHWZC]26!J[I/'LVGQ^?K-C6Z
M*.XA#,Y32,YOI[L&UHXQ'$YVGF-'K?C-.Z*H&A<9%,R?V#>]FVS,SM PBKCI
M)V4M4V>EB>V2*HF:# DE7'(Q7-?& ]%B14545&>@3O4FWS^:[UF7SM)K]#)D
M-#'4932SFC4&E-?5%,BH;>>N!LCF 6RK]B3[4$KU;)[(U??T&I^ORUT#T#K]
MG@?UV8JTJ[+& -?LMM6;*EVAQL7**ZLML5"FVH"W&T]O3P)FQILR8L?R$; <
M,R%D$TH.!X!!V0WE5^R@FYPM9SBWM>O\U/L,O3J>\&22*DV=5!KXR+*OJRS'
M])"K(M(Z98&1O6V]XW2,^,CPVN>@LD8R5CXI&H^.1CF/:O\ 1S'HK7-7_DJ+
MZ#1_38*"@W?A#JBO&'(>/MO8[TJGT&PKIM+'> 65/T+5DY'E#!=U1@V! '4*
M3=VNDE)=-_*0F!$C+') _P#(0-X?H#T!Z#CE65&*L+6/D]V_%KWJQJI\D1WN
MY&O5/9ONJ?3ZKZ"*/<-[?\_ZSSVXJA);,-.9[D<BKD9.ZNE.N^W>+V.'/G=#
M\5:=65&KL'P?WHOQ=+]%;\O0=;J^\U%YXCW.ZB85GM+;45$1,RE MB2:]3-9
M4UYK0Z^&(JVF<H$CT^"-<Y4<OO[-]U0,;L?)/:YK(E:$+##6Y0]*'9M!:-<0
MH1,2#W N0:-C73D-5C^8 ,^K?_R]RI\E=$B!G>O]NU'.-E-29_&UMI$N<)LG
M64H5H^>10.4=]W@H#W@M8U8VW?+Z\5K5=[I'82-1$D?$OH,GR/=WG1=M8&Z"
MM_!A@Q=(4+7L#F2JB.9>V_QL1Y3OG.EFL4_VU]E]FQL:J+[JOH(@]E[[T;4%
M^.OX=!99&6Z\G,&V8^GS^D*L9L#57O&4L*+1.$>L]?7Z*+IYD%@CT4-(@_E(
MJ,CE1P8[BWG3T3IF0YP9LN7X\1FBYIXZZ:[J@JFWAK8;KKF#\/\ 37 X+;*V
M/CIJ_.V?D+;0#0%M?(V*M@625?A*Z4%AXF=^W]G;\OY<3GJ83-VDNX2PL[B:
MS(V;X*[/)J*OVDC*4%)1SC?Q')-$UB PQ)"KD1'*$@^D]+U?/NGS056;*M*R
MZL<72P%6+"S*:O\ R>=^0&QMK"A$#DB_"LW6>(KACY7N:R>(N-JK\T8J \@^
MPL2^>[38$4PSK7.%==KP@6ADS(<+A=7K**J1T#E4N=+H//02R,C5&RNE7[?]
MJM]!&?KODIL\@RGK!<W6H'I>SXKD$Y"C7<!H='M%H RKNNG@*BCCN14NI?QD
M5/LME@3Y>_L[V!Y?$.X(T7B?XPZ(PBW+-T'CSQ6[-,T!1I^@,*M.:YDV<J^/
MLWRV9US/),KB9B7.GDF5SI%5RJOH)$>@M57?)J(WW:OO\G>_M\?;V]D]O;Z_
M+_\ !Z"[T!Z ] >@M:OR]_=KF^SG)[.]OK[*J(Y/95_M=_5/]?;T%WH#T!Z
M] >@/0'H#T!Z ] >@/0'H#T%%5&HKG*C6HBJJJJ(B(G]555^B(GH!?=$543W
M5$7V3W]O=?\ 1/?_ $]_0">ZHBJGLJHGNGO[^R_ZI[_Z^WH*^@/0'H#T!Z ]
M >@/0'H#T!Z ] >@/0'H/E5_[A_I6PSW[B/-;/AZX=,F!I^(:@W*)>UP MH<
M/XS<N@B<7!H2X!'SA"O*1KA))D9-$U)1_N?:<@:2K;NFE2PJ7BVDN9_+'P #
M3W[<*[%J,C:Y"G'FJVTC-$V0<>!@<MI^/8DEHPB9()V,GCCD] AXNMV,M+9X
MZ/7W[*<$-EO-H ]+")!?R"6H4OXCLR^4:KA&M"!16Q0'*04,L+B$;*DBP,"T
MCJ6TO S!*71O2]MQZR0JR?<D'?FQ1UEU^;664UOI+NK^%J^1#"'SP#/83%''
M\(/^DD89#$==T=##4&5FM,SPV9G<RB#72Z*9^7(;  ^>">NK+"@8'&*VOF*%
M,KI@BFRR20I\V^\304%9VO=' &:"#H9]LH]^$5:U]AI;&NL8B]=%>!17$S"-
M"8'H+3.NG280Z6<J<"58VK$P<9D;@S4'8;>X+EKK'HMS76G\"8W^1/UV@LZZ
M7-FX]LU575'WM98F5K;*EG1'_E(Y!4]X"&QS?;8T%Q1Z+/7H(]H9V;48^*Y-
M*S8*'[76VHUY8RO/*.TVT*)OKXJ4>P&L&R$I7OAC_,G>U(T<WY.#&6G:KB@Q
M5QHJKH=K-$RY ,@J:;6:LU@.E]W US;@0C5UXCY84KK0L8B0<\@!"Q$?%#'(
MZ%H)2/K&IS-)=YP?KDH>=/)MDJTJ]/JK&^HZQ:6F6O2F>1NBW5X)-F=/,V*R
M%@@E,9]U"T>^&0<,B1TFX'ARC;7JVA,=,5.DG\'TAK*TO60V(&ANF/O'7+,O
M5AD VP8D<\,<D370S->U',59PYJ+O/5@I-(*=U;;3%7=>!G##!M9I9R2ZF*N
MNBZ[\JQM]&"0&\40 V.09K(@FCSP(YKF?!7!P?\ =O<5*""471M'$E=+4/I;
M5W4-"00Y#]02*5:0U(NKF9KV065E+]B2MAA>4_YDDQ)(CTE#:;^LKN.PU?[.
M_ >FO]Q;6 &O\A.5%V.7"U;3LN9KJOI5F65;I!'</#JR(V(&B"/"_)-^^]5]
ME:^5X?4!\W'%L\./*=P#IV')X^=>_">+^'^2TQ<)>(*Z'^05 /N).K?;[W_3
M]_\ Q?3W]!!KG?/^^Y/RO\39NHS<P?FTJNY?PTN6&U[M(;:/Y5G0&D6YFJ=\
M4<^EKQ6/:&R&)4%1%8B,;'"'+^VV\\:LSE.;WWD]V/J7&L0%DO(YBW_'!"W[
MO^.FY--)JBZ<S,V\.^')"H!I(HFU]7<5\DI34L8X&_CE1!*CP$RN!R/!YP.:
M;G:]"R9'0MI.'H=Z&X*]=.$4+0EC?;>44X@=LU,LBE)]IAL\LI$<4<4K&($V
M?0<4[4?#,Q5:B.BD:JN:KVHCF*BJYB.:KFI[_5$5%7_CZ#S+_P KXJE9G(UU
MYV?IRNKA^M2CV=-SSGL-@3_/^2Y=19_?,J^O:"DT)-CN1;(VA$HW% ?ARCQ0
M"Q$3LJ[ -AOACT?Q3NNI<ES/.=%MK#I\GB;9G987:NHEL)>=!=1%;LW:*6JT
MVAB*Z:S<E1DV40SEAK@#!1WI#)_8\-L'H- _F+C>(;WKGDED--W_ +=@KVVZ
MOX=T%_\ ]I,]4P6N7T.FAT _.JZOT4^\=G3<_+%;V!%Z.93C7D<AX3E4P1]>
M.\%!P67Q@Z;:<W3FOD_Y'''8;R?\?K75T M-:4(MUURQX&5L\ESOH(-X#9PU
MG+W<_9.A=6!)&'77$4(WY3RQE10WL>@UD^<=1FC^K<E30]2VF(F.Y-Y&@4]#
MC\B1=274$//YYM=93W5'O,AH:VT!RI$X]1'-'/426I4"2/C.=7KZ#7WR^A\6
MZ_EF\X2/YP>3]CM;;Q*\@];H[M])=P=F#Y$5F^)ZS5[G+&PLNZ,K79&'I%4+
M7&UZ'2D5L[PHI', F*<'H:R<4$&6S4 QQ5F-#GZ:(>R-;"PVQ@CKAF1'%L'9
M% THN-$DD1C6L1[E]D1/9/0)3L\='+R'J,6FGOQLY+S[81WQ.5%MCM(/3R4!
M[+&>B"H52Y,M8A%>Z"(;VFDD1&M^J^@TN7 'CU%WGL%)J_,GL-=TW0\(^W%S
M/&Y>YH*6PY_7\=K7@;"PH:VUT=KL]QBJQBVZDCF4MI!*>YA$;P9 6Q@^'ZWU
MS*^4?[//\2U>HV%1_P!^L*LMAL0;>OO:NZDI-;+HLK)%?/=;2UV2O9"*\*65
M&I(&/$L;4C^'H-OWH**J(BJJHB(BJJJOLB(GU555?HB(GH-"_*_\ J=/X,9&
MGV75^EW@VCW=K47=SDK&AP$><.[N63HBR<[;=*V)>:MLSM@?XZB*F_.D)J37
MPBFR#BR0CAOG5[&N8Q7(CG_+X-_U=\4]W>W_ +$]!=Z ] >@/045$<BHY$<B
M_P!45$5%_P#:B_3T J(ONBHBHOT7W_U_]OH*^@;KK.-M][S+:X?.:*QQUOI<
M\=2UNEI; JGLZ.8N-(D.K;(!DA !<+%7[<C8Y$:[V^3'M]V.#77=>%/E^?@Y
M\90^9TN6TDA^*M1NO/I.D:74"!84S)6E1@9L:1U>FR-CGB#\W/\ GVB.&L[*
M*PGBF;^-*2,2"TXSXL>4N)Z_S?==*\A0>AY/'4'0:*YR\<EZ*-=$:SIF[W]'
MHU!N@;V=+3+4VK!SHL,5B*/%65$+E^[_ -&(8-D+8T1SG*C%_N]X_:-&K&U6
M-1S?E[K\E<Y%7W^GT7V_T]_0<GH#T%KF,?\ 'YM:_P"+D>WY-1WQ>WZM<WW1
M?9S5_HO]4] ,8V-K6,:UC&-1C&,1&M8UJ(C6M:B(C6M1/9$3Z(GH+O0'H#T!
MZ ]!1RJUKG(USU1%5&M^/R<J)_X6_)S6^Z_\U1/05]!1?=45&K[+[+[*J>Z(
MOM]%5/=/?V7T GO[)[K[K[?543V]U_U7V]U]O05] >@/0'H#T!Z ] >@/0'H
M#T%/;ZH[Z^Z(J>WNOM]51?JWW]E7Z?1?ZIZ <UKVJUS4<UR*US7(BM<BI[*B
MHONBHJ>@KZ ]!:]RM:JHQTBI[?V,5B.7W5$5461S&_1%]U^O]$_X^@$:B*YW
MN[W<J*J*YRHGLGM_:U55&I[)]?;V]U]!=Z ]!X0/]Q%^^G]B_P"NC]A<WCQX
MP=$YQG>9,XCS+;-IM'R;+:ZUCO\ 3D:EML7)=W<)14L<Z5D2-B18V1-1J-9[
MJY[@T6._W;W[G%27X]7X\U72,=$J\&Y\[[4:?<^<:I_')]Q7JYO]WT]OC_3Z
M_0.+_P#ZV_W1?_=<XY__ $!Y[_\ N/H'L\=?]WY^R[*=EP>C\DKC"];XK4VT
M\^^YMC>9X#GN@UE.ZILHH0:W:PT5H30E0V\@LWW&0/\ FR-S%5J.]_0>Q/\
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M&;#:0PVWNJ2TCYOBI/Y$[10A2)),W\9$<V1(T<$"JG9?LPT6'V4XN0_7ZWJ
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M^/1($<=5&P9@_P 8FM%8"*L?P?"QZ!PW_P"C3]3UTF:EN_/?=(N*A%9FB/\
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MA#8,D@BIY@ZUOTW]\\N)IM)0\7\0AM372UR:/"6>8NR3M6VZT@K2A\\;%Y3
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MR>LT[[3'W6HU6:A(I*GFIU3GY;@#FJ6$UG:D[FRC^T+7E&R+F#6#"$2RPL]
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667931888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Jan. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--05-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AXIL Brands, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001718500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-4125218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9150 Wilshire Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Beverly Hills<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">638-8883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AXIL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667704976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 5,213,897<span></span>
</td>
<td class="nump">$ 3,253,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">1,444,218<span></span>
</td>
<td class="nump">509,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">2,664,489<span></span>
</td>
<td class="nump">3,394,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">724,778<span></span>
</td>
<td class="nump">809,126<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">10,047,382<span></span>
</td>
<td class="nump">7,966,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>OTHER ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">305,433<span></span>
</td>
<td class="nump">260,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">324,907<span></span>
</td>
<td class="nump">309,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">737,251<span></span>
</td>
<td class="nump">36,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_DeferredTaxAsset', window );">Deferred tax asset</a></td>
<td class="nump">121,791<span></span>
</td>
<td class="nump">231,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">20,720<span></span>
</td>
<td class="nump">16,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,152,215<span></span>
</td>
<td class="nump">2,152,215<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Other Assets</a></td>
<td class="nump">3,662,317<span></span>
</td>
<td class="nump">3,007,501<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">13,709,699<span></span>
</td>
<td class="nump">10,974,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,619,252<span></span>
</td>
<td class="nump">967,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_CustomerDepositCurrent', window );">Customer deposits</a></td>
<td class="nump">496,404<span></span>
</td>
<td class="nump">154,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, current</a></td>
<td class="nump">956,022<span></span>
</td>
<td class="nump">905,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="nump">143,342<span></span>
</td>
<td class="nump">146,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_DueToRelatedParty', window );">Due to related party</a></td>
<td class="nump">178,520<span></span>
</td>
<td class="nump">11,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current</a></td>
<td class="nump">207,077<span></span>
</td>
<td class="nump">36,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_IncomeTaxLiability', window );">Income tax liability</a></td>
<td class="nump">67,250<span></span>
</td>
<td class="nump">242,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">331,395<span></span>
</td>
<td class="nump">332,936<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">3,999,262<span></span>
</td>
<td class="nump">2,798,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG TERM LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability</a></td>
<td class="nump">531,081<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract liabilities</a></td>
<td class="nump">357,205<span></span>
</td>
<td class="nump">480,530<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long Term Liabilities</a></td>
<td class="nump">888,286<span></span>
</td>
<td class="nump">480,530<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">4,887,548<span></span>
</td>
<td class="nump">3,278,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (see Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 31,133,500 and 42,251,750 shares issued and outstanding as of November 30, 2024 and May 31, 2024, respectively</a></td>
<td class="nump">3,113<span></span>
</td>
<td class="nump">4,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: 450,000,000 shares authorized; 6,466,852 and 5,908,939 shares issued, issuable and outstanding as of November 30, 2024 and May 31, 2024, respectively</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">8,428,760<span></span>
</td>
<td class="nump">7,825,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings/(Accumulated deficit)</a></td>
<td class="nump">389,631<span></span>
</td>
<td class="num">(134,270)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">8,822,151<span></span>
</td>
<td class="nump">7,695,786<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 13,709,699<span></span>
</td>
<td class="nump">$ 10,974,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_CustomerDepositCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_CustomerDepositCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_DeferredTaxAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_DeferredTaxAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_DueToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_DueToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_IncomeTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_IncomeTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831774697744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">31,133,500<span></span>
</td>
<td class="nump">42,251,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">31,133,500<span></span>
</td>
<td class="nump">42,251,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">450,000,000<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">6,466,852<span></span>
</td>
<td class="nump">5,908,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,466,852<span></span>
</td>
<td class="nump">5,908,939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663848928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales, net</a></td>
<td class="nump">$ 7,732,574<span></span>
</td>
<td class="nump">$ 8,421,677<span></span>
</td>
<td class="nump">$ 13,583,846<span></span>
</td>
<td class="nump">$ 14,527,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,234,527<span></span>
</td>
<td class="nump">2,163,738<span></span>
</td>
<td class="nump">3,932,151<span></span>
</td>
<td class="nump">3,622,441<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">5,498,047<span></span>
</td>
<td class="nump">6,257,939<span></span>
</td>
<td class="nump">9,651,695<span></span>
</td>
<td class="nump">10,905,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">3,377,760<span></span>
</td>
<td class="nump">3,672,780<span></span>
</td>
<td class="nump">6,047,231<span></span>
</td>
<td class="nump">6,879,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation and related taxes</a></td>
<td class="nump">276,674<span></span>
</td>
<td class="nump">204,646<span></span>
</td>
<td class="nump">467,322<span></span>
</td>
<td class="nump">484,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional and consulting</a></td>
<td class="nump">736,169<span></span>
</td>
<td class="nump">694,258<span></span>
</td>
<td class="nump">1,684,018<span></span>
</td>
<td class="nump">1,303,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">434,573<span></span>
</td>
<td class="nump">422,343<span></span>
</td>
<td class="nump">920,955<span></span>
</td>
<td class="nump">800,292<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">4,825,176<span></span>
</td>
<td class="nump">4,994,027<span></span>
</td>
<td class="nump">9,119,526<span></span>
</td>
<td class="nump">9,467,836<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">672,871<span></span>
</td>
<td class="nump">1,263,912<span></span>
</td>
<td class="nump">532,169<span></span>
</td>
<td class="nump">1,437,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_GainOnDebtSettlement', window );">Gain on settlement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">79,182<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">79,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other income</a></td>
<td class="nump">2,041<span></span>
</td>
<td class="nump">3,189<span></span>
</td>
<td class="nump">4,307<span></span>
</td>
<td class="nump">13,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">27,340<span></span>
</td>
<td class="nump">37,825<span></span>
</td>
<td class="nump">55,971<span></span>
</td>
<td class="nump">76,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense and other finance charges</a></td>
<td class="num">(1,296)<span></span>
</td>
<td class="num">(1,640)<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
<td class="num">(3,284)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">28,085<span></span>
</td>
<td class="nump">118,556<span></span>
</td>
<td class="nump">58,982<span></span>
</td>
<td class="nump">165,240<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME BEFORE PROVISION FOR INCOME TAXES</a></td>
<td class="nump">700,956<span></span>
</td>
<td class="nump">1,382,468<span></span>
</td>
<td class="nump">591,151<span></span>
</td>
<td class="nump">1,602,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">67,250<span></span>
</td>
<td class="nump">364,393<span></span>
</td>
<td class="nump">67,250<span></span>
</td>
<td class="nump">430,382<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME</a></td>
<td class="nump">$ 633,706<span></span>
</td>
<td class="nump">$ 1,018,075<span></span>
</td>
<td class="nump">$ 523,901<span></span>
</td>
<td class="nump">$ 1,172,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract', window );"><strong>NET INCOME PER COMMON SHARE:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">6,450,226<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
<td class="nump">6,303,002<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">8,168,657<span></span>
</td>
<td class="nump">18,632,689<span></span>
</td>
<td class="nump">8,194,882<span></span>
</td>
<td class="nump">18,632,689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_GainOnDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_GainOnDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667801440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at May. 31, 2023</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 10,113,365<span></span>
</td>
<td class="num">$ (3,466,992)<span></span>
</td>
<td class="nump">$ 6,671,959<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at May. 31, 2023</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">102,215<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">102,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,172,527<span></span>
</td>
<td class="nump">1,172,527<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Nov. 30, 2023</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">10,215,580<span></span>
</td>
<td class="num">(2,294,465)<span></span>
</td>
<td class="nump">7,946,701<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Nov. 30, 2023</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Aug. 31, 2023</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">10,164,472<span></span>
</td>
<td class="num">(3,312,540)<span></span>
</td>
<td class="nump">6,877,518<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Aug. 31, 2023</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51,108<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,018,075<span></span>
</td>
<td class="nump">1,018,075<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Nov. 30, 2023</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">10,215,580<span></span>
</td>
<td class="num">(2,294,465)<span></span>
</td>
<td class="nump">7,946,701<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Nov. 30, 2023</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at May. 31, 2024</a></td>
<td class="nump">$ 4,225<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
<td class="nump">7,825,240<span></span>
</td>
<td class="num">(134,270)<span></span>
</td>
<td class="nump">7,695,786<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at May. 31, 2024</a></td>
<td class="nump">42,251,750<span></span>
</td>
<td class="nump">5,908,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">211,055<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">211,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">391,409<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">391,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Stock-based compensation, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_PreferredStockConvertedToCommonStock', window );">Preferred shares converted to common</a></td>
<td class="num">$ (1,112)<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_PreferredStockConvertedToCommonStockShares', window );">Preferred shares converted to common, shares</a></td>
<td class="num">(11,118,250)<span></span>
</td>
<td class="nump">555,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">523,901<span></span>
</td>
<td class="nump">523,901<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Nov. 30, 2024</a></td>
<td class="nump">$ 3,113<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">8,428,760<span></span>
</td>
<td class="nump">389,631<span></span>
</td>
<td class="nump">8,822,151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Nov. 30, 2024</a></td>
<td class="nump">31,133,500<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Aug. 31, 2024</a></td>
<td class="nump">$ 3,113<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">8,124,160<span></span>
</td>
<td class="num">(244,075)<span></span>
</td>
<td class="nump">7,883,845<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Aug. 31, 2024</a></td>
<td class="nump">31,133,500<span></span>
</td>
<td class="nump">6,464,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">138,423<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">138,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">166,177<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">166,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Stock-based compensation, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">633,706<span></span>
</td>
<td class="nump">633,706<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Nov. 30, 2024</a></td>
<td class="nump">$ 3,113<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">$ 8,428,760<span></span>
</td>
<td class="nump">$ 389,631<span></span>
</td>
<td class="nump">$ 8,822,151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Nov. 30, 2024</a></td>
<td class="nump">31,133,500<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_PreferredStockConvertedToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_PreferredStockConvertedToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_PreferredStockConvertedToCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_PreferredStockConvertedToCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663840048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 523,901<span></span>
</td>
<td class="nump">$ 1,172,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">47,335<span></span>
</td>
<td class="nump">56,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debts</a></td>
<td class="nump">27,954<span></span>
</td>
<td class="nump">64,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">602,464<span></span>
</td>
<td class="nump">102,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_GainOnDebtSettlement', window );">Gain on settlement</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(79,182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_GainOnForgivenessOfAccountPayable', window );">Gain on forgiveness of account payable</a></td>
<td class="num">(218,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">109,796<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(962,337)<span></span>
</td>
<td class="num">(600,626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">729,534<span></span>
</td>
<td class="num">(1,040,351)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">80,524<span></span>
</td>
<td class="num">(267,407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">870,357<span></span>
</td>
<td class="nump">1,092,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">165,959<span></span>
</td>
<td class="nump">576,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="num">(72,614)<span></span>
</td>
<td class="nump">175,135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">1,904,174<span></span>
</td>
<td class="nump">1,252,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangibles</a></td>
<td class="num">(41,840)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(65,783)<span></span>
</td>
<td class="num">(70,845)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(107,623)<span></span>
</td>
<td class="num">(70,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_RepaymentOfEquipmentFinancing', window );">Repayment of equipment financing</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="num">(3,252)<span></span>
</td>
<td class="num">(24,657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Advances (payments) from a related party</a></td>
<td class="nump">166,722<span></span>
</td>
<td class="num">(25,212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES</a></td>
<td class="nump">163,470<span></span>
</td>
<td class="num">(51,519)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET INCREASE IN CASH</a></td>
<td class="nump">1,960,021<span></span>
</td>
<td class="nump">1,129,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH - Beginning of period</a></td>
<td class="nump">3,253,876<span></span>
</td>
<td class="nump">4,832,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH - End of period</a></td>
<td class="nump">5,213,897<span></span>
</td>
<td class="nump">5,962,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">2,908<span></span>
</td>
<td class="nump">3,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">132,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability', window );">Initial recognition of right of use assets recognized as lease liability</a></td>
<td class="nump">$ 767,269<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_GainOnDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_GainOnDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_GainOnForgivenessOfAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_GainOnForgivenessOfAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_RepaymentOfEquipmentFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_RepaymentOfEquipmentFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662656208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 633,706<span></span>
</td>
<td class="nump">$ 1,018,075<span></span>
</td>
<td class="nump">$ 523,901<span></span>
</td>
<td class="nump">$ 1,172,527<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663849792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662642416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z3iC3pT4Djd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 1 &#8211; <span id="xdx_828_ziUXIm3aPqad">Organization</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of AXIL Brands, Inc.&#8217;s (together with
its subsidiary, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) ongoing rebranding efforts, the Company
changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of
Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company&#8217;s corporate
headquarters are located at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. Its phone number is (888) 638-8883. In
March 2022, the Company incorporated a subsidiary &#8220;Reviv3 Acquisition Corporation&#8221; (now known as &#8220;AXIL Distribution
Company&#8221;) and in June 2022, completed the acquisition of certain assets of Axil &amp; Associated Brands Corp. (&#8220;A&amp;A&#8221;).
The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection
products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality
hair and skin care products. These products lines are both sold throughout the United States, Canada, Europe and Asia. On February 14,
2024, the Company successfully completed efforts to uplist from the over-the-counter, (OTC), markets to the NYSE American stock exchange
(&#8220;NYSE American&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663377744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zvpE3JCN6Ai3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 &#8211; <span id="xdx_82F_zlTCelBBy6zh">Basis of Presentation and Summary of Significant Accounting
Policies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1KiO5NbTmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_868_zre0insn4Rnk">Basis of Presentation and Principles of Consolidation</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial
statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).
In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash
flows as of November 30, 2024 and 2023, and for the periods then ended, have been made. Those adjustments consist of normal and recurring
adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance
with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction
with the consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended
May 31, 2024. The results of operations for the six months ended November 30, 2024 are not necessarily indicative of the results to be
expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned
subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84D_ecustom--ReverseStockSplitPolicyTextBlock_zZ955FgpuPp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_zHsRGnbhVt3c">Reverse Stock Split</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#8220;Reverse Stock Split&#8221;) of the Company&#8217;s issued shares of common stock at a ratio of <span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130" title="Stockholders' Equity, Reverse Stock Split">1-for-20</span>
as approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). The Reverse Stock Split did not affect the total number
of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were
rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial
statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84C_eus-gaap--UseOfEstimates_zvidfFHySl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_867_zwgvJGhyzFW">Use of estimates</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the unaudited consolidated financial
statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures
at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.
Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and
classifications,&#160;the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation,
contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash
Common Stock issuances.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_eus-gaap--Reclassifications_zkT14GvCz1na" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zeSUlziXWNw4">Reclassifications</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to
prior periods to conform with the current year reporting.&#160;For the three and six months ended November 30, 2023, $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20230901__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zD2WgXf4u6J9" title="Professional and consulting">202,930</span>
and $<span id="xdx_907_eus-gaap--ProfessionalFees_pp0p0_c20230601__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zh6QZyGTvdzg" title="Professional and consulting">385,185</span>,
respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited
Consolidated Statements of Operations. There was no change to total operating expenses for the three and six months ended November
30, 2023 as a result of this reclassification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zTw4gLbOoMo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zEBkDwESyMa8">Cash and cash equivalents</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid debt instruments
and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents.&#160;The Company maintains
cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note
12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zv3GKsDdrzn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zVMaV74m9D62">Accounts receivable and allowance for doubtful
accounts</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2023, the Company adopted ASC 326, "<i>Financial
Instruments - Credit Losses</i>". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting
from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined
principally on the basis of past collection experience and known financial factors regarding specific customers.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivables comprise of receivables from
customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on
its best estimate of the amount of probable credit losses in its existing accounts receivable.&#160;The Company periodically reviews its
accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may
indicate that the realization of an account may be in doubt.&#160;Account balances deemed to be uncollectible are charged to bad debt
expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_849_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIjBX1hxhYf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_864_zlAoCORSDUE6">Prepaid expenses and other current assets</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets consist
primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within
a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns
for products sold. Prepayments to vendors for inventory was $<span id="xdx_905_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20241130_zUGxXAqETkN8" title="Prepaid expenses">498,832</span> and $<span id="xdx_900_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20240531_zH7SPyxxTLP8" title="Prepaid expenses">472,904</span> as of November 30, 2024 and May 31, 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zkpbuOtLVgLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zTHtq9eun4S8">Inventory</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company values inventory, consisting of finished
goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces
inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the
difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering
historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component
of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions,
customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory
held above the expected level of sales in the next 12 months is classified as non-current inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zKXkFLAkaayk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_zIQ8TP5SN98e">Property and Equipment</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost less accumulated
depreciation.&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized.&#160;When assets are retired or
disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84C_eus-gaap--ExtendedProductWarrantyPolicy_zEOXcIiOWQel" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zqbachsHvpt1">Product warranty</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides a one-year, two-year or three-year
limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements,
as they are incurred, to the cost of sales.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_z6vByfkhiAR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_865_zzxf2Lkpk1cb">Revenue recognition</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 606, &#8220;<i>Revenue from Contracts with Customers.</i>&#8221; This revenue recognition standard (new guidance)
has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction
price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company sells a variety of electronic hearing
and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase
order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation.
Consideration paid to the customer to promote and sell the Company&#8217;s products is typically recorded as a reduction in revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The five steps for the revenue recognition are
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Identify the contract with a customer.&#160;</i>The
Company generally considers completion of a sales order (which requires customer acceptance of the Company&#8217;s click-through terms
and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone)
or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that
are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other
circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts
prior to shipping the product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Identify the performance obligations in the contract</i>.
Product performance obligations include shipment of products and related accessories, and service performance obligations include extended
warranty coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">However, as the historical redemption rate under our
warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether
promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Determine the transaction price and allocation
to performance obligations</i>. The transaction price in the Company&#8217;s customer contracts consists of both fixed and variable consideration.
Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and
60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate
product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this
information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction
price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Allocate the transaction price to the performance
obligations in the contract</i>. For contracts that contain multiple performance obligations, the Company allocates the transaction price
to the performance obligations on a relative standalone selling price basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Recognize revenue when or as the Company satisfies
a performance obligation</i>. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services
(extended warranty) is recognized over time on a ratable basis over the warranty period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, and May 31, 2024, contract
liabilities amounted to $<span id="xdx_90D_eus-gaap--ContractWithCustomerLiability_c20241130_pp0p0" title="Contract liabilities">1,313,227</span> and $<span id="xdx_909_eus-gaap--ContractWithCustomerLiability_c20240531_pp0p0" title="Contract liabilities">1,385,841</span>, respectively. As of November 30, 2024, and May 31, 2024, <span id="xdx_90B_ecustom--ContractLiabilitiesDescription_c20240601__20241130" title="Contract Liabilities Description">contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#8217; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.</span></p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_z57l9uMigz14" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zqvxiBZJ3ZZk">Cost of Sales</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The primary components of cost of sales include the
cost of the product and shipping fees related to product procurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_840_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z8ymXoEuSYog" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_862_zXaYynZ5eZMf">Shipping and Handling Costs</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for shipping and handling fees
in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping
products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses
were $<span id="xdx_901_eus-gaap--SellingAndMarketingExpense_c20240901__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">265,138</span>&#160;and $<span id="xdx_90E_eus-gaap--SellingAndMarketingExpense_c20230901__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">308,081</span>&#160;for the three months ended November 30, 2024 and 2023, respectively. Shipping costs included in marketing
and selling expense were $<span id="xdx_90D_eus-gaap--SellingAndMarketingExpense_c20240601__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">515,052</span>&#160;and $<span id="xdx_90B_eus-gaap--SellingAndMarketingExpense_c20230601__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">561,533</span>&#160;for the six months ended November 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zzLHVS0EGpJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zjmE6fshcDsl">Sales, Marketing and Advertising</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales, marketing and advertising costs are expensed
as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_848_ecustom--CustomerDepositPolicytextBlock_zWEJWL9qWZP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_869_z92X6qG6e9Ni">Customer Deposits</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer deposits consisted of prepayments from customers
to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition
policy.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDkszICzqQik" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_zqmYKLPadtkd">Fair value measurements and fair value of financial instruments</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASC 820, &#8220;<i>Fair Value
Measurements and Disclosures</i>,&#8221; for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a
common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value
measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption
of ASC&#160;820 did not have an impact on the Company&#8217;s financial position or operating results, but did expand certain disclosures.
ASC&#160;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, ASC&#160;820 requires the use of valuation
techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%">Level 1:</td>
    <td style="width: 95%; text-align: justify">Observable inputs such as quoted market prices in active markets for identical assets or liabilities.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">Level 2:</td>
    <td style="text-align: justify">Observable market-based inputs or unobservable inputs that are corroborated by market data.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">Level 3:</td>
    <td style="text-align: justify">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity&#8217;s own assumptions.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with
features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of certain financial instruments,
including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their
fair values because of the short-term nature of these instruments.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_840_eus-gaap--BusinessCombinationsPolicy_zqCnndI63M7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zAntM9YjzNYh">Business Combinations</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For all business combinations (whether partial, full
or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair
values.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the excess purchase price over
the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized
separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration,
the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration
resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is
classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or
(2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings.
The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes
in assumed discount periods and rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zmPsBrPQdk6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_860_zCsbnrLRtgr4">Goodwill</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill is comprised of the purchase price of business
combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill
is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances
indicate the fair value of a reporting unit is below its carrying value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs its annual goodwill impairment
assessment on May 31st&#160;of each year or as impairment indicators dictate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When evaluating the potential impairment of goodwill,
management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions,
the competitive environment, changes in the market for the Company&#8217;s products and services, regulatory and political developments,
entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company&#8217;s
reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting
unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach
(discounted cash flow method).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the quantitative method&#160;we compare the
carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If
the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the
carrying amount exceeds the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When required, we arrive at our estimates of fair
value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified
assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows
requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital
requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or
estimates for future cash flows could produce different results.&#160;</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zABWBX4W2Vn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_zfLedypeYAJj">Income Taxes</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes pursuant to
the provision of ASC 740-10, &#8220;<i>Accounting for Income Taxes</i>,&#8221; which requires, among other things, an asset and liability
approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.
A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that
the net deferred asset will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows the provision of ASC 740-10 related
to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken
or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax
position is recognized in the financial statements in the period during which, based on all available evidence, management believes it
is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,
if any. Tax positions taken are not offset or aggregated with other positions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax positions that meet the more likely than not recognition
threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with
the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described
above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated
interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all
more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has adopted ASC 740-10-25, &#8220;<i>Definition
of Settlement</i>&#8221;, which provides guidance on how an entity should determine whether a tax position is effectively settled for
the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion
and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity
would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based
solely on the basis of its technical merits and the statute of limitations remains open.&#160;The federal and state income tax returns
of the Company are subject to examination by the Internal Revenue Service (&#8220;IRS&#8221;) and state taxing authorities, generally
for three years after they are filed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zANewW9YtlE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zNFy0f3NlU12">Impairment of long-lived assets</span></span></i>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least
annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying
amount of the asset. The amount of impairment is measured as the difference between the asset&#8217;s estimated fair value and its book
value. The Company did <span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240901__20241130_zxh0P51ZO9bg" title="Impairment loss"><span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230901__20231130_zKyUaTSGtFMd" title="Impairment loss"><span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240601__20241130_zRwo5Ux687G9" title="Impairment loss"><span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230601__20231130_zNLPD1gh5YXl" title="Impairment loss">no</span></span></span></span>t record any impairment loss during the three and six months ended November 30, 2024 and 2023.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHiOPClhqeG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zPgmegPTfds8">Stock-based compensation</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation is accounted for based on
the requirements of the Share-Based Payment Topic of ASC 718, &#8220;<i>Compensation &#8212; Stock Compensation</i>,&#8221; which requires
recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments
over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period).
ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date
fair value of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For non-employee stock option based awards, the Company
follows Accounting Standards Update (&#8220;ASU&#8221;) 2018-7, which substantially aligns share based compensation for employees and
non-employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zh4HBO8Z7JEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_866_zjck7fpzF5Yk">Net income per share of Common Stock</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net income per share is computed by dividing
the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted
average number of common shares and potentially dilutive securities outstanding during the period. For the three and six months ended
November 30, 2024 and 2023, certain stock options, preferred shares and restricted stock awards were excluded from the computation of
diluted common shares outstanding as they would have an anti-dilutive impact on the Company&#8217;s net income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The dilutive common stock equivalent shares consist
of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market
price during the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the computations of basic and diluted net
income per common share:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;<span id="xdx_8B0_zQdgvg0HpIRa" style="display: none">Schedule of net loss per share</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Three Months Ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Six Months Ended</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">633,706</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">1,018,075</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">523,901</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">1,172,527</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average basic shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,450,226</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,863,939</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,303,002</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,863,939</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,556,675</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,702,912</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156,033</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,750</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176,394</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,750</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted stock awards</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,723</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,574</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Weighted average dilutive shares</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">8,168,657</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">18,632,689</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">8,194,882</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">18,632,689</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Basic</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.10</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.17</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.08</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.20</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Diluted</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.08</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.05</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.06</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.06</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84D_eus-gaap--LoansAndLeasesReceivableLeaseFinancingPolicy_zXziGyZdOB9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_ziKHWCY2NGyf">Lease Accounting</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,&#160;&#8220;<i>Leases</i>,&#8221;
which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements
classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must
be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must
be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that
leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally
flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new
standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted
ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company renewed its lease for its previous corporate
headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expires on December 1, 2024.
The Company also signed a lease agreement in September 2024 for a warehouse and new corporate headquarters commencing October 1, 2024
and November 1, 2024, respectively. Please see Note 10 &#8211; &#8220;Commitments and Contingencies&#8221; under &#8220;Leases&#8221;
below for more information about the Company&#8217;s leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zV08KEVJvGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_860_z6ScJV7UD9Jf">Segment Reporting</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 280,&#160;&#8220;<i>Segment
Reporting</i>.&#8221; The Company&#8217;s management reviews the Company&#8217;s consolidated financial results when making decisions
about allocating resources and assessing the performance of the Company as a whole and has determined that the Company&#8217;s reportable
segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products.
See Note 13 &#8211; &#8220;Business Segment and Geographic Area Information&#8221; for more information about the Company&#8217;s reportable
segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zksyCEYMxJQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_862_z28abXgGfUld">Recently Issued Accounting Pronouncements</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, the FASB issued ASU No. 2020-06,&#160;<i>Debt
&#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity</i>&#160;(ASU
2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion
features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted
for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use
of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted
the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the
accompanying consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, the FASB issued ASU No. 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures
for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments
are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15,
2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form
10-K for the year ended May 31, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other accounting standards that have been issued or
proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements
upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its
financial condition, results of operations, cash flows or disclosures.</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764775280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndNontradeReceivableTextBlock', window );">Accounts Receivable, net</a></td>
<td class="text"><p id="xdx_807_eus-gaap--AccountsAndNontradeReceivableTextBlock_zkiuoBzzx8X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 3 &#8211; <span id="xdx_821_zrgaOMtjwVr8">Accounts Receivable, net</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts receivable, net consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zfEglMtFdYA8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_zCvvhfMaCLn7" style="display: none">Schedule of accounts receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20241130_zcGXqv9QmlHd" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20240531_zyvXupzbXfHf" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_40A_ecustom--CustomersReceivable_iI_pp0p0_maARNzFhC_zsZjx66yhui9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customers receivable</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">794,275</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">524,730</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--MerchantProcessorReceivable_iI_pp0p0_maARNzFhC_znk95gqsVRB8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Merchant processor receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746,123</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,417</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0p0_di_msARNzFhC_zcNpiXOHUmd2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Allowance for credit losses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(96,180</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,312</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNet_iTI_pp0p0_mtARNzFhC_zMBgqu5MXpae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Accounts receivables, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">1,444,218</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">509,835</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded bad debt expense of $<span id="xdx_908_eus-gaap--ProvisionForDoubtfulAccounts_c20240901__20241130_pp0p0" title="Bad debt expense">9,169</span>&#160;and
$<span id="xdx_906_eus-gaap--ProvisionForDoubtfulAccounts_c20230901__20231130_pp0p0" title="Bad debt expense">11,461</span>&#160;during the three months ended November 30, 2024 and 2023, respectively. The Company recorded bad debt expense of $<span id="xdx_907_eus-gaap--ProvisionForDoubtfulAccounts_c20240601__20241130_pp0p0" title="Bad debt expense">27,954</span>&#160;and
$<span id="xdx_905_eus-gaap--ProvisionForDoubtfulAccounts_c20230601__20231130_pp0p0" title="Bad debt expense">64,327</span>&#160;during the six months ended November 30, 2024 and 2023, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndNontradeReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/326/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndNontradeReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764930576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory, net</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_zQaOJ1D34cO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 4 &#8211; <span id="xdx_827_zwuKjPLzs3b">Inventory, net</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQPmoAn3C74g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_8B8_zt6fxJlr2iU6" style="display: none">Schedule of inventory</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20241130_zVQ9PDDXWHsg" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240531_zFCk6573cjn7" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzXX2_zCFXMLNXsqt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Finished Goods</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,543,218</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,190,344</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzXX2_zQYeEbXnk2M7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Raw Materials</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">121,271</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">203,679</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pp0p0_mtINzXX2_zHSkA94FCv8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,664,489</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,394,023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At November 30, 2024 and May 31, 2024, inventory held
at third party locations amounted to $<span id="xdx_90C_ecustom--InventoryHeldAtThirdPartyLocation_c20241130_pp0p0" title="Inventory held at third party location">88,869</span> and $<span id="xdx_900_ecustom--InventoryHeldAtThirdPartyLocation_c20240531_pp0p0" title="Inventory held at third party location">58,242</span>, respectively. At November 30, 2024 and May 31, 2024, inventory in-transit amounted
to $<span id="xdx_906_eus-gaap--OtherInventoryInTransit_c20241130_pp0p0" title="Inventory in-transit">13,500</span> and $<span id="xdx_902_eus-gaap--OtherInventoryInTransit_c20240531_pp0p0" title="Inventory in-transit">15,738</span>, respectively. At November 30, 2024 and May 31, 2024, the Company had provided $<span id="xdx_909_eus-gaap--InventoryValuationReserves_c20241130_pp0p0" title="Inventory valuation reserves"><span id="xdx_90E_eus-gaap--InventoryValuationReserves_iI_pp0p0_c20240531_zuTHFYTWiI83" title="Inventory valuation reserves">46,895</span></span> as obsolescence reserve
on some slow-moving inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764893392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zH8HGPS6khpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 5 &#8211; <span id="xdx_825_zFDZ8BsSTeM1">Property and Equipment</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Property and equipment, stated at cost, consisted of the following:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2GWsdOhehEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zZM4bkJ0CW5e" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Estimated Life</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">Promotional display racks</td><td style="width: 5%">&#160;</td>
    <td style="width: 14%; text-align: center"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_zmVtSEqBtMz6" title="Property, Plant and Equipment, Useful Life">2</span> years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment">30,709</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment">30,709</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and Fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zI7ZmzqIurm8" title="Property, Plant and Equipment, Useful Life">5</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment">37,475</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment">5,759</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer Equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGfbB5qho1zj" title="Property, Plant and Equipment, Useful Life">3</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">10,496</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">22,130</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plant Equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFCguvgvnSK3" title="Property, Plant and Equipment, Useful Life">5</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zQ7XKIpAh0Fe" title="Property, Plant and Equipment, Useful Life">10</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">309,868</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">264,168</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zd1mvCVj4Lvk" title="Property, Plant and Equipment, Useful Life">5</span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zIXFa8EAw6gh" title="Property, Plant and Equipment, Useful Life">10</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">8,838</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">8,838</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Automobile</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zHxqfhoHalJg" title="Property, Plant and Equipment, Useful Life">5</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment">24,347</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment">24,347</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241130_zwUMtgha9WF6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation">(116,300</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20240531_z000zixLNiMc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation">(95,003</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Property, plant and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net">305,433</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20240531_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net">260,948</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense amounted to $<span id="xdx_905_eus-gaap--Depreciation_c20240901__20241130_pp0p0" title="Depreciation">11,405</span>&#160;and
$<span id="xdx_907_eus-gaap--Depreciation_c20230901__20231130_pp0p0" title="Depreciation">8,410</span>&#160;for the three months ended November 30, 2024 and 2023, respectively.&#160; Depreciation expense amounted to $<span id="xdx_906_eus-gaap--Depreciation_c20240601__20241130_pp0p0" title="Depreciation">21,298</span>&#160;and
$<span id="xdx_908_eus-gaap--Depreciation_c20230601__20231130_pp0p0" title="Depreciation">17,272</span>&#160;for the six months ended November 30, 2024 and 2023, respectively.&#160;</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831774707232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zguFpp5uxYUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 6 &#8211; <span id="xdx_823_z6Uhh7kgwgN3">Intangible Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The intangible assets consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zyaYPM7537Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_z8At2VUSQIMi" style="display: none">Schedule of intangible assets</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Estimated Life</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">Licensing Rights</td><td style="width: 5%">&#160;</td>
    <td style="width: 14%; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_zi7HW1fuLJpe" title="Estimated Life">3</span> years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross">22,080</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross">34,024</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer Relationships</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSLHkNU7bBH9" title="Estimated Life">3</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">70,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">70,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade Names</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zZRpwtenzfMd" title="Estimated Life">10</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">275,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">275,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Website</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_zXcB2ZTexEoc" title="Estimated Life">5</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">100,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">100,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Product Certification Testing</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_zM5fUUFl9c5b" title="Estimated Life">3</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">41,840</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"><span style="-sec-ix-hidden: xdx2ixbrl0921">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20241130_zSBR5ODyoqX9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization">(184,013</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20240531_zpUHuV4qQNRg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization">(169,920</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="padding-bottom: 4.5pt">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net">324,907</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20240531_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net">309,104</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Goodwill arising through the business combination in June 2022 was $<span id="xdx_903_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c20241130_pp0p0" title="Goodwill">2,152,215</span>
at November 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization expense amounted to $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20240901__20241130_pp0p0" title="Amortization expense">23,035</span>&#160;and
$<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230901__20231130_pp0p0" title="Amortization expense">19,375</span>&#160;for the three months ended November 30, 2024 and 2023, respectively. Amortization expense amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20240601__20241130_pp0p0" title="Amortization expense">26,037</span>&#160;and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230601__20231130_pp0p0" title="Amortization expense">35,522</span>&#160;for
the six months ended November 30, 2024 and 2023, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764860272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><p id="xdx_805_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zoJ3xIbBI4wi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 7 &#8211; <span id="xdx_82A_zi7twkN03lb3">Other Current Liabilities</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Other current liabilities comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zCoQczWtSoEk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other Current Liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_z4FtypkJUlch" style="display: none">Schedule of other current liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20241130_zAEYbhTpI7E1" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240531_zD9zWNpuHOP8" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_400_ecustom--CreditCards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Credit Cards</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,631</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,734</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--RoyaltyPaymentAccrual_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Royalty Payment Accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,376</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales Tax Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,377</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">231,283</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,387</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">92,543</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pp0p0_z91toXAqLkcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other current liabilities</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">331,395</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">332,936</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667436176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zbx6fxUSAZWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8 &#8211; <span id="xdx_828_zta7KHKnUwZh">Notes Payable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended May 31, 2020, a commercial bank
granted to the Company a loan (the &#8220;Loan&#8221;) in the amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20200531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Face Amount">150,000</span>, which is administered under the authority and regulations
of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the &#8220;EIDL&#8221;) of the Coronavirus
Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;). The Loan, which is evidenced by a note dated May 18, 2020,&#160;bears
interest at an annual rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20200501__20200518__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pdd" title="Interest rate">3.75%</span> and&#160;is payable in installments of principal and interest of $731 per month, beginning May 18,
2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all
items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to
be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively,
&#8220;qualifying expenses&#8221;). The Company used the loan proceeds for qualifying expenses. During the year ended May 31, 2022, the
Company received additional $<span id="xdx_902_ecustom--LoanForgiveness_c20210601__20220531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Loan forgiveness">10,000</span> of borrowings under the program. The Company received a loan forgiveness for $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfDebt_c20210601__20220531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Additional borrowings">10,000</span> during the year
ended May 31, 2022. The Company recorded, on the accompanying unaudited consolidated financial statements, and paid interest of $<span id="xdx_90D_eus-gaap--InterestPayableCurrent_c20241130__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Accrued interest">1,296</span>,
and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_c20240531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Accrued interest">562</span>, during the three months ended November 30, 2024 and 2023, respectively.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024 and May 31, 2024, the outstanding
balance of the loan amounted to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20241130__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Face Amount">143,342</span> and $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20240531__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Face Amount">146,594</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The amounts of loan payments due in the next 12 months ended November 30,
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zREqc0YqAEMh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_z5kRlsW8vI45" style="display: none">Schedule of notes payments due in the next twelve months</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" id="xdx_49B_20241130_z90Ho0QES69i" style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDziXa_zntJ4gzaSQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: left; padding-bottom: 1.5pt">2025</td><td style="width: 5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">143,342</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDziXa_zdkhvG0hOYh7" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">143,342</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764857216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text"><p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlTCg739clH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 &#8211; <span id="xdx_823_zV2iCKBitmnd">Stockholders&#8217; Equity</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Shares Authorized</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, the authorized capital of
the Company consists of <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20241130_zhm3Oq1APjji" title="Common stock, shares authorized">450,000,000</span> shares of common stock, par value $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241130_zxuzCyArBJ6h" title="Common stock, par or stated value per share">0.0001</span> per share and <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20241130_zHNxxCP5jpS5" title="Preferred stock, shares authorized">300,000,000</span> shares of preferred stock, par
value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241130_ziRoz8uRXUyc" title="Preferred stock, par or stated value per share">0.0001</span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#8220;Reverse Stock Split&#8221;) of the Company&#8217;s issued shares of common stock at a ratio of <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130_zeAM3IL2B7Ik" title="Reverse stock split">1-for-20</span>,
as approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). The Reverse Stock Split did not change the par value
of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the
Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to
the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the financial statements give retroactive
effect to the Reverse Stock Split for all periods presented, unless otherwise specified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Preferred Stock</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preferred stock may be issued from time to time
in one or more series. The Board is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock
in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited,
or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications,
limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board providing the issuance of
such shares. The Board is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue
of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status
that they had prior to the adoption of the resolution originally fixing the number of shares of such series.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal year ended May 31, 2023, the Company
issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220601__20230531_pdd" title="Shares issued during the period">250,000,000</span> shares of non-voting Series A Preferred Stock, which, following the Reverse Stock Split of the Company&#8217;s common
stock, are convertible into shares of the Company&#8217;s common stock on a twenty-to-one ratio. These 250,000,000 shares of non-voting
Series A Preferred Stock were valued at the fair market value of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220601__20230531_pp0p0" title="Shares issued value during the period">3,100,000</span> at issuance.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The holders of shares of Series A Preferred Stock
have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the common stock
unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon
the number of shares of common stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation,
or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out
of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of common stock.
The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Company or any holder or holders
of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time
after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock into one fully paid and nonassessable
share of common stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of
shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company&#8217;s
common stock as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The conversion provisions of the Company&#8217;s Series
A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split, and the number of shares of Series A Preferred
Stock issued and outstanding was not affected by the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2024, the Company entered into repurchase
agreements with certain stockholders of the Company to purchase in the aggregate&#160;<span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20240301__20240305__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Number of share purchased">207,748,250</span>&#160;shares of Series A Preferred Stock
of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company&#8217;s common stock on an as converted basis) for the aggregate
cash consideration of $<span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodValue_c20240301__20240305__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pp0p0" title="Cash consideration">1,246,490</span>. Such repurchase was approved by the Company&#8217;s Board of Directors. Following the repurchase,&#160;<span id="xdx_90F_ecustom--RemainingOutstanding_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Remaining outstanding">42,251,750</span>&#160;shares
of Series A Preferred Stock remained outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the fiscal
year 2024, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024, certain
stockholders of <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Number of shares converted">11,118,250</span> preferred shares converted their preferred stock into <span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Number of shares converted">555,913</span> shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024 and May 31, 2024,&#160;<span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_c20241130_zU0cwAGJs4o6" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20241130_zvp8hnNuFDnc" title="Preferred stock, shares outstanding">31,133,500</span></span>
and <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20240531_zC9U5G14uGf1" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20240531_zp5HJZn6QMkc" title="Preferred stock, shares outstanding">42,251,750</span></span> shares of Series A Preferred Stock, respectively, were issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Common Stock</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20241130_zQ5NE3DnsbDl" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20241130_zHhfv5SnU4al" title="Common stock, shares outstanding">6,466,852</span></span> shares of common
stock were issued and outstanding.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Reverse Stock Split as more fully discussed in
Note 2, did not change the par value of the common stock, modify any voting rights or other terms of the common stock, or change the number
of authorized shares of the Company. Any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole
share.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">Stock Options</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective February 14, 2024, the Board amended the
Company&#8217;s original 2022 Equity Incentive Plan (as amended the &#8220;Plan&#8221;), which was originally approved on March 21, 2022.
The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors,
non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i)&#160;Incentive Stock
Options (to eligible employees only); (ii)&#160;Nonqualified Stock Options; (iii)&#160;Restricted Stock; (iv)&#160;Stock Awards; (v)&#160;Performance
Shares; or (vi)&#160;any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March
21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend
or terminate the Plan without stockholder approval, subject to certain exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 8, 2024, the Board of Directors approved
the amendment and restatement of the Plan in order to increase the number of shares authorized for issuance under the Plan by 800,000
shares, any or all of which may be issued pursuant to grants of &#8220;incentive stock options&#8221; (within the meaning of Section 422
of the Internal Revenue Code). The amendment and restatement of the Plan became effective December 18, 2024, following shareholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of shares initially authorized for
issuance under the Plan was 500,000 shares. The Plan has since been amended to increase the number of shares authorized for issuance under
the Plan to 2,050,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in
2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of
the total number of shares of the Company&#8217;s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii)
such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change
unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable
year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be
added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance
or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including
a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option,
or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares
available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease
in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision
or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure
of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued
shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Two types of options may be granted under the Plan:
(1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of
the option not less than the fair market value of the common stock on the grant date, or,&#160;in the case of an Incentive Stock Option
granted to a Ten Percent Stockholder, 110%&#160;of the fair market value of the common stock on the grant date; and (2) Non-qualified
Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value
of the common stock on the grant date, but not less than par value of the stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board may grant or sell restricted stock to participants
(i.e., shares that are subject to a subject to restrictions or limitations as to the participant&#8217;s ability to sell, transfer, pledge
or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted
stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction
period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant
awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout
is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each equity-based award granted under the Plan will
be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the
Board may determine, consistent with the provisions of the Plan.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subject to the Plan&#8217;s terms, the Board has full
power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled,
forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will
be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of share-based
compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term,
expected volatility of the Company&#8217;s stock price over the expected term, expected risk-free interest rate over the expected option
term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for
estimating the fair value of stock options granted to employees and directors which are subject to ASC 718 requirements. These amounts
are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants.
The Company recognizes compensation on a straight-line basis over the requisite service period for each award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the simplified method to estimate
the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical
data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based
on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield
is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase
if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 13, 2024, the Company issued stock options
to one consultant to purchase, in aggregate, up to&#160;<span id="xdx_905_ecustom--NumberOfOptionIssued_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Number of option issued">5,000</span>&#160;shares of its common stock, at an exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Exercise price">4.00</span> per share
valued at $<span id="xdx_900_ecustom--ValueOfOptionIssued_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pp0p0" title="Value of option issued">20,000</span> and expiring on October 31, 2034. The options vest quarterly over a year beginning on February 28, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 14, 2024, the Company issued to two Company
officers stock options to purchase, in the aggregate, up to&#160;<span id="xdx_904_ecustom--NumberOfOptionIssued_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pdd" title="Number of option issued">600,000</span>&#160;shares of its common stock, at an exercise price of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pdd" title="Exercise price">4.01</span>
per share valued at $<span id="xdx_908_ecustom--ValueOfOptionIssued_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pp0p0" title="Value of option issued">2,406,000</span> and expiring in ten years from the date of grant. The options vest over forty-eight equal monthly installments
starting on the grant date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended August 31, 2024, the
Company issued stock options, to two consultants, to purchase, in the aggregate, up to 24,000 shares of its common stock, at an exercise
price equal to the Company&#8217;s closing price on the NYSE American on the date of grant. The options are valued at approximately $195,960
and expire in ten years from the date of grant.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the weighted-average
assumptions used to estimate the fair value of the stock options granted during the six months ended November 30, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4m0elWfo1i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)">
  <tr style="vertical-align: bottom; background-color: white">
    <td><span id="xdx_8B0_zu3zfXyKET7i" style="display: none">Schedule of stock option assumptions</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Risk free interest rate</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20240601__20241130_pdd" title="Risk free interest rate">3.95%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Expected life</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240601__20241130_zeXIQ76XcgFg" title="Expected life">7</span> years</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%">Expected volatility</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: center"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20240601__20241130_pdd" title="Expected volatility">464%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Expected dividend</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20240601__20241130_pdd" title="Expected dividend"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></span></td></tr>
  </table>
<p id="xdx_8AB_z9Zi8GQwDbO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the activities for
the Company&#8217;s stock options for the&#160;six months ended November 30, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcf8H5MW7gj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B3_zO4GfUn4yHef" style="display: none">Schedule of stock options activities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Term</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 49%">Outstanding as of May 31, 2024</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240531_zmDANmVyPacd" style="width: 10%; text-align: right" title="Number of Options Outstanding, Beginning">268,750</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240531_zk70Sqto5p5l" style="width: 10%; text-align: right" title="Weighted Average  Exercise Price, Beginning">1.84</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220601__20230531_zHQzQR79BUvi" title="Weighted Average  Remaining Term">7.9</span></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240601__20241130_pdd" style="text-align: right" title="Number of Options Outstanding, Granted">629,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240601__20241130_pdd" style="text-align: right" title="Weighted Average  Exercise Price, Granted">4.17</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240601__20241130_zFC9aO68cFB4" style="text-align: right" title="Number of Options Outstanding, Exercised/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1091">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240601__20241130_z6mNOLm5jdrc" style="text-align: right" title="Weighted Average  Exercise Price, Exercised/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1093">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Less: Unvested at November 30, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNI_di_c20241130_zrASSeGiVmr5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending">(650,500</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending">4.11</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240601__20241130_z9TzsyXY4sU2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term">6.7</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Vested at November 30, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Vested">247,250</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Exercise Price, Vested">2.13</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240601__20241130_z2H6GyxahMn7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term, Vested">7.6</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zEyF8TTRe7ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024,
the Company expensed $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20240601__20241130_pp0p0" title="Stock options expense">211,055</span>
with respect to options, of which $130,208 was included in General and administrative, and $80,847 in Sales and marketing,
respectively, in the accompanying Consolidated Statements of Operations. During the six months ended November 30, 2023, the Company
expensed $<span id="xdx_905_eus-gaap--StockOptionPlanExpense_c20230601__20231130_pp0p0" title="Stock options expense">102,215</span>
with respect to stock options, which was included in General and administrative in the accompanying Consolidated Statements of
Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Restricted Stock Awards and Restricted Shares Issued </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s non-employee directors participate
in the Company&#8217;s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan,
on February 14, 2024, the Company granted each of its three non-employee directors Board members <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20240201__20240214__srt--TitleOfIndividualAxis__custom--ThreeBoardMembersMember_pdd" title="Number of restricted stock awards issued">5,000</span> restricted stock awards for an
aggregate of 15,000 shares of the Company&#8217;s common stock that will vest on the one-year anniversary of the grant, subject to the
respective director&#8217;s continued service as a member of the Board, with a total grant date fair value of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20240201__20240214__srt--TitleOfIndividualAxis__custom--ThreeBoardMembersMember_pp0p0" title="Fair value of restricted stock">195,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Effective May
28, 2024, a former officer entered into a Separation Agreement and Release (the &#8220;Release&#8221;), which includes a standard release
of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting
Agreement, dated May 28, 2024, with the former officer (the &#8220;Consulting Agreement&#8221;), pursuant to which the former officer
agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier.
Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted
common stock valued at $298,800, which vested upon grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Effective November
13, 2024, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241101__20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Stock issued for services">2,000</span> shares of restricted common stock to a consultant for services relating to expansion of the Company
into new markets<span style="background-color: white">. The shares were valued at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20241101__20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_zHbzROlYoNGk" title="Stock issued for valued">8,000</span>
based on the </span>Company&#8217;s closing price on the NYSE American on the date of grant<span style="background-color: white">. The
shares</span> vested upon grant and will be expensed over the six month service period of the consultant beginning
from the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the stock grants is being recorded
over the term of the service related to each grant. During the six months ended November 30, 2024, the Company expensed $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20240601__20241130__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p0" title="Stock-based compensation expense">97,500</span> related
to restricted stock awards included in General and administrative in the accompanying Consolidated Statements of Operations, and $293,909
related to restricted stock expenses of which $293,054 was included in General and administrative and $855 in Sales and marketing, respectively,
in the accompanying Consolidated Statements of Operations. During the six months ended November 30, 2023, the Company expensed $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20230601__20231130__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p0" title="Stock-based compensation expense">0</span> related
to restricted stock awards and restricted stock expense.</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764860272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znaBUnwxGuB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 10 &#8211; <span id="xdx_824_zW8EEHrSqLm9">Commitments and Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Leases</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in Note 2 above, the Company adopted
ASU 2016-02, &#8220;Leases<i>&#8221; </i>on June 1, 2019, which require lessees to report on their balance sheets a right-of-use asset
and a lease liability in connection with most lease agreements classified as operating leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company treats a contract as a lease when the
contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or if the Company directs
the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (&#8220;ROU&#8221;)
assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company&#8217;s right to
use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company&#8217;s obligation to make payments
over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of
the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease.
In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services,
which are considered non-lease components for accounting purposes. For our real estate leases, the Company applies a practical expedient
to include these non-lease components in calculating the ROU asset and lease liability. For variable costs that may change during the
lifetime of the lease, the Company expenses as incurred.&#160;Since the interest rate implicit in a lease is generally not readily determinable
for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental
borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease
term to obtain an asset of similar value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews the impairment of ROU assets consistent
with the approach applied for the Company&#8217;s other long-lived assets. The Company reviews the recoverability of long-lived assets
when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment
of possible impairment is based on the Company&#8217;s ability to recover the carrying value of the asset from the expected undiscounted
future pre-tax cash flows of the related operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lease expense is recognized on a straight-line basis
over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring
after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024, the
Company entered into two new lease agreements. The Company&#8217;s lease agreements do not contain any residual value guarantees or restrictive
covenants. The Company&#8217;s lease agreements do not have an explicit renewal option, and the termination options are available in the
event of material breaches. The expiration dates of the leases are on various dates between December 1, 2024 and January 31, 2029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computed an initial lease liability of
$<span id="xdx_90A_ecustom--InitialLeaseLiability_c20241130_pp0p0" title="Initial lease liability">767,269</span>&#160;for the two new lease agreements and an initial ROU asset in the same amount which was recorded on the books at the commencement
of the leases. During the three months ended November 30, 2024 and 2023, the Company recorded operating lease costs in the amount of $<span id="xdx_901_eus-gaap--OperatingLeaseCost_c20240901__20241130_pp0p0" title="Operating lease cost">49,080</span>&#160;and
$<span id="xdx_908_eus-gaap--OperatingLeaseCost_c20230901__20231130_pp0p0" title="Operating lease cost">18,659</span>, respectively. During the six months ended November 30, 2024 and 2023, the Company recorded operating lease costs in the amount
of $<span id="xdx_90B_eus-gaap--OperatingLeaseCost_c20240601__20241130_pp0p0" title="Operating lease cost">67,739</span>&#160;and $<span id="xdx_90D_eus-gaap--OperatingLeaseCost_c20230601__20231130_pp0p0" title="Operating lease cost">37,317</span>, respectively. Operating lease and short-term lease expenses are included in General and administrative expenses
on the accompanying Consolidated Statements of Operations.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average remaining term and discount
rate for the Company&#8217;s operating leases as of November 30, 2024&#160;was&#160;<span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241130_zv7Wkco6HRAe">3.8</span>&#160;years
and&#160;<span id="xdx_902_eus-gaap--LesseeOperatingLeaseDiscountRate_c20241130_pdd">13.0%</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Supplemental balance sheet information related to leases was as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_zAcrHm0htup8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span id="xdx_8B2_z15bIRVPzzG" style="display: none">Schedule of supplemental balance sheet information</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20241130_zdjHzwYHe515" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20240531_z5EzBjvpJgff" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_402_ecustom--RightOfUseAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-left: 9pt">Right of use assets</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">899,239</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">131,970</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Accumulated reduction</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(161,988</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95,218</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Operating lease assets, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">737,251</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">36,752</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">899,239</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">131,970</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AccumulatedReduction_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Accumulated reduction</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(161,081</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95,218</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease liability, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,158</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,752</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--OperatingLeaseLiabilityCurrentPortion_iNI_pp0p0_di_zt6NgcuV3QU8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(207,077</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,752</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Non-current portion</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">531,081</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_z4tmRNVK2rdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Maturities of operating lease liabilities were as follows as of November
30, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4BZ0rSSOCh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_z4FOsnbl7Pd2" style="display: none">Schedule of maturities of operating lease liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20241130_zbzsam2y0Xal" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Operating Lease (fiscal year-end)</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz3IL_z87XRggIyeae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 81%">2025 (six months remaining)</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">94,651</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz3IL_zEiMUpr53XD6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">258,005</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz3IL_zwm8rKEk30a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269,437</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz3IL_zWnpCyRufoUb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,420</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz3IL_zg63Cy6ZHG2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2029</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">128,040</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz3IL_zCE6kpDMo5Wi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">968,553</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zOI7bPagT1s4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(230,395</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zN4FhJcJ6L6a" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">738,158</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zmCeY9ct0J87" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Accounts Payable</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended November 30, 2024, the
Company renewed its relationship with an entity, and as a result of the agreement, $<span id="xdx_90E_eus-gaap--AccruedRoyaltiesCurrent_c20241130_pp0p0" title="Due in royalties">218,699</span> previously due in relation to royalties, was
forgiven and included in Sales and marketing in the accompanying Consolidated Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, we become involved in various lawsuits
and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of
the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure
purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and
circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate
and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments
on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent
with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with
certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of
operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings
are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution
of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As
a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular
period, depending upon the size of the loss or our income for that particular period.</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831767610016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zY7tVSnUtwI5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 11 &#8211; <span id="xdx_820_zDsw2jZNwHch">Related Party Transactions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s Chairman and Chief Executive
Officer (&#8220;CEO&#8221;), Jeff Toghraie, is the managing director of Intrepid Global Advisors (&#8220;Intrepid&#8221;). Intrepid
has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the
year. Intrepid was paid approximately $<span id="xdx_900_ecustom--ConsultingFee_c20240601__20241130__srt--CounterpartyNameAxis__custom--IntrepidMember_pp0p0" title="Consulting fee">127,000</span>
in consulting fees for the six months ended November 30, 2024. As of November 30, 2024 and May 31, 2024, the Company had amounts
payable to Intrepid of $<span id="xdx_90E_ecustom--PayableToRelatedParty_c20241130__srt--CounterpartyNameAxis__custom--IntrepidMember_pp0p0" title="Payable to related party">178,520</span>
and $<span id="xdx_909_ecustom--PayableToRelatedParty_iI_pp0p0_c20240531__srt--CounterpartyNameAxis__custom--IntrepidMember_z6sDuFaoVwxi" title="Payable to related party">11,798</span>,
respectively. These advances were short-term in nature and non-interest bearing. The Company's Board Member, Chief Financial Officer
("CFO"), and Chief Operating Officer ("COO") has a controlling interest in BZ Capital Strategies. BZ Capital
Strategies was&#160;paid $<span id="xdx_904_ecustom--ConsultingFee_c20240601__20241130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BZCapitalStrategiesMember_pp0p0" title="Consulting fee">75,000</span>
in consulting fees&#160;for the six months ended November 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764783424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations</a></td>
<td class="text"><p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_zCKNLGKmQ1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 12 &#8211; <span id="xdx_82C_zMt8WgS5RPJ8">Concentrations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Concentration of Credit Risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the
Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents
instruments. The Company maintains its cash in bank deposits accounts. The Company&#8217;s account at this institution is insured by the
Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20241130_pp0p0" title="Cash, FDIC insured amount">250,000</span>. At November 30, 2024 and May 31, 2024, the Company held cash
of approximately $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20241130_pp0p0" title="Cash, uninsured amount">4,463,897</span> and $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_c20240531_pp0p0" title="Cash, uninsured amount">3,003,876</span>, respectively, in excess of federally insured limits. The Company has not experienced any losses
in such accounts through November 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Concentration of Revenue, Accounts Receivable,
Product Line, and Supplier</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company predominantly sells the products direct-to-consumer.
There was no single customer that accounted for greater than 10% of consolidated net sales for the three and six months ended November
30, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended November 30, 2024, approximately&#160;<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage">90.2%</span>&#160;of
our consolidated net sales were to customers located in the U.S. (based on the customer&#8217;s shipping address). During the three months
ended November 30, 2023, approximately&#160;<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20230901__20231130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage">94.6%</span>&#160;of our consolidated net sales were to customers located in the U.S. (based on the
customer&#8217;s shipping address). All Company assets are located in the U.S.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2024, approximately&#160;<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage">91.2%</span>&#160;of
our consolidated net sales were to customers located in the U.S. (based on the customer&#8217;s shipping address). During the six months
ended November 30, 2023, approximately&#160;<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_c20230601__20231130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage">93.9%</span>&#160;of our consolidated net sales were to customers located in the U.S. (based on the
customer&#8217;s shipping address).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, accounts receivable from
customers that accounted for more than&#160;10%&#160;of sales transactions were from one customer amounting to <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_pdd" title="Concentration risk, percentage">14.5%</span>. As of May 31, 2024,
no single customer accounted for more than&#160;10%&#160;of accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Manufacturing is outsourced primarily overseas via
a number of third-party vendors. The two largest vendors accounted for&#160;<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage">73.2%</span>&#160;and&#160;<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorOneMember_pdd" title="Concentration risk, percentage">15.9%</span>, respectively,&#160;of all purchases
for the three months ended November 30, 2024. For the three months ended November 30, 2023, the largest vendor accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20230901__20231130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage">82.7%</span> of
all purchases. For the six months ended November 30, 2024, the two largest vendors accounted for&#160;<span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage">61.8%</span>&#160;and&#160;<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorOneMember_pdd" title="Concentration risk, percentage">26.0%</span>, respectively,&#160;of
all purchases. For the six months ended November 30, 2023, the largest vendor accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20230601__20231130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage">86.7%</span> of all purchases.</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764765856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Area Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographic Area Information</a></td>
<td class="text"><p id="xdx_805_eus-gaap--SegmentReportingDisclosureTextBlock_zmPxQC5GHzWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 13 &#8211; <span id="xdx_82A_zLtLMcALAsfg">Business Segment and Geographic Area Information</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Business Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company, directly or through its subsidiaries,
markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing
enhancement and hearing protection business. The Company&#8217;s determination of its reportable segments is based on how its chief operating
decision makers manage the business.&#160;</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company&#8217;s segment information is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_za2t9Oc9lZTg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Segment and Geographic Area Information (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;<span id="xdx_8B2_zdNxLoyJPpM9" style="display: none">Schedule of segment information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended November 30,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months ended November 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">284,545</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">230,741</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">836,054</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">545,594</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">7,448,029</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">8,190,936</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">12,747,792</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">13,982,352</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Total net sales</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">7,732,574</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">8,421,677</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">13,583,846</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">14,527,946</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Segment gross profit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">173,507</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">172,583</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">429,996</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">394,107</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">5,324,540</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">6,085,356</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">9,221,699</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">10,511,398</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total segment gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130_pp0p0" style="text-align: right" title="Total segment gross profit">5,498,047</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GrossProfit_c20230901__20231130_pp0p0" style="text-align: right" title="Total segment gross profit">6,257,939</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GrossProfit_c20240601__20241130_pp0p0" style="text-align: right" title="Total segment gross profit">9,651,695</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GrossProfit_c20230601__20231130_pp0p0" style="text-align: right" title="Total segment gross profit">10,905,505</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and Marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SellingAndMarketingExpense_c20240901__20241130_pp0p0" style="text-align: right" title="Selling and Marketing">3,377,760</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SellingAndMarketingExpense_c20230901__20231130_pp0p0" style="text-align: right" title="Selling and Marketing">3,672,780</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SellingAndMarketingExpense_c20240601__20241130_pp0p0" style="text-align: right" title="Selling and Marketing">6,047,231</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SellingAndMarketingExpense_c20230601__20231130_pp0p0" style="text-align: right" title="Selling and Marketing">6,879,621</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240901__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">1,447,416</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230901__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">1,321,247</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240601__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">3,072,295</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230601__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">2,588,215</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated operating income</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ConsolidatedOperatingIncomeLoss_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">672,871</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ConsolidatedOperatingIncomeLoss_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">1,263,912</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--ConsolidatedOperatingIncomeLoss_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">532,169</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ConsolidatedOperatingIncomeLoss_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">1,437,669</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets">4,039,069</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets">5,439,289</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zSd1tXeKzgJb" style="text-align: right" title="Consolidated total assets">4,039,069</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zgJkAQWpELv2" style="text-align: right" title="Consolidated total assets">5,439,289</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">9,670,630</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">7,686,720</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z1wRJEG4eV49" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">9,670,630</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z50CV28EbXtj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">7,686,720</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total assets</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,709,699</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,126,009</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130_zWjVhJ4qa31b" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,709,699</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20231130_ztQM5MICcI22" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,126,009</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments for property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1358">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1360">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1364">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">65,783</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">19,885</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">107,623</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">70,845</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total payments for property and equipment</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">65,783</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">19,885</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">107,623</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">70,845</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">839</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">1,417</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">1,678</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">2,835</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">33,601</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">26,368</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">45,657</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">53,187</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total depreciation and amortization</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">34,440</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">27,785</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">47,335</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">56,022</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zrmtTLXO59qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Geographic Area Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For geographic area information of sales for the three
and six months ended November 30, 2024, see Note 12 &#8211; Concentrations.</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764897344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zuG215MeHdzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 14 &#8211; <span id="xdx_823_zZPYnc6cMxJ6">Income Taxes</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We calculated our interim tax provision in accordance
with ASC 270, &#8220;<i>Interim Reporting</i>,&#8221; and ASC 740, &#8220;<i>Accounting for Income Taxes</i>.&#8221; As the end of each
interim quarterly period, we estimate our annual effective tax rate and apply that rate to our ordinary quarterly earnings to calculate
the tax related to ordinary income. The tax effects of other items that are excluded from ordinary income are discretely calculated and
recognized in the period in which they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recorded an income tax expense of $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20240901__20241130_zHVgCTFNkh4" title="Income tax expense">67,250</span> for the
three months ended November 30, 2024 and an income tax expense of $<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230901__20231130_zbV5EC57EQea" title="Income tax expense">364,393</span> for the three months ended November 30, 2023. We recorded an
income tax expense of $<span id="xdx_903_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20240601__20241130_zE13RdFSUPu3" title="Income tax expense">67,250</span> for the six months ended November 30, 2024 and an income tax expense of $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230601__20231130_zVLhqALjhiW2" title="Income tax expense">430,382</span> for the six months ended
November 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any uncertain tax positions
or events leading to uncertainty in a tax position. The Company&#8217;s 2020, 2021, 2022 and 2023 Corporate Income Tax Returns are subject
to IRS examination.&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663429056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1KiO5NbTmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_868_zre0insn4Rnk">Basis of Presentation and Principles of Consolidation</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial
statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).
In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash
flows as of November 30, 2024 and 2023, and for the periods then ended, have been made. Those adjustments consist of normal and recurring
adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance
with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction
with the consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended
May 31, 2024. The results of operations for the six months ended November 30, 2024 are not necessarily indicative of the results to be
expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned
subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ReverseStockSplitPolicyTextBlock', window );">Reverse Stock Split</a></td>
<td class="text"><p id="xdx_84D_ecustom--ReverseStockSplitPolicyTextBlock_zZ955FgpuPp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_zHsRGnbhVt3c">Reverse Stock Split</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#8220;Reverse Stock Split&#8221;) of the Company&#8217;s issued shares of common stock at a ratio of <span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130" title="Stockholders' Equity, Reverse Stock Split">1-for-20</span>
as approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). The Reverse Stock Split did not affect the total number
of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were
rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial
statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--UseOfEstimates_zvidfFHySl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_867_zwgvJGhyzFW">Use of estimates</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the unaudited consolidated financial
statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures
at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.
Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and
classifications,&#160;the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation,
contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash
Common Stock issuances.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Reclassifications', window );">Reclassifications</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--Reclassifications_zkT14GvCz1na" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zeSUlziXWNw4">Reclassifications</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to
prior periods to conform with the current year reporting.&#160;For the three and six months ended November 30, 2023, $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20230901__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zD2WgXf4u6J9" title="Professional and consulting">202,930</span>
and $<span id="xdx_907_eus-gaap--ProfessionalFees_pp0p0_c20230601__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zh6QZyGTvdzg" title="Professional and consulting">385,185</span>,
respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited
Consolidated Statements of Operations. There was no change to total operating expenses for the three and six months ended November
30, 2023 as a result of this reclassification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zTw4gLbOoMo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zEBkDwESyMa8">Cash and cash equivalents</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid debt instruments
and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents.&#160;The Company maintains
cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note
12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts receivable and allowance for doubtful accounts</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zv3GKsDdrzn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zVMaV74m9D62">Accounts receivable and allowance for doubtful
accounts</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2023, the Company adopted ASC 326, "<i>Financial
Instruments - Credit Losses</i>". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting
from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined
principally on the basis of past collection experience and known financial factors regarding specific customers.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivables comprise of receivables from
customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on
its best estimate of the amount of probable credit losses in its existing accounts receivable.&#160;The Company periodically reviews its
accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may
indicate that the realization of an account may be in doubt.&#160;Account balances deemed to be uncollectible are charged to bad debt
expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock', window );">Prepaid expenses and other current assets</a></td>
<td class="text"><p id="xdx_849_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIjBX1hxhYf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_864_zlAoCORSDUE6">Prepaid expenses and other current assets</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets consist
primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within
a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns
for products sold. Prepayments to vendors for inventory was $<span id="xdx_905_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20241130_zUGxXAqETkN8" title="Prepaid expenses">498,832</span> and $<span id="xdx_900_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20240531_zH7SPyxxTLP8" title="Prepaid expenses">472,904</span> as of November 30, 2024 and May 31, 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zkpbuOtLVgLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zTHtq9eun4S8">Inventory</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company values inventory, consisting of finished
goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces
inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the
difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering
historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component
of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions,
customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory
held above the expected level of sales in the next 12 months is classified as non-current inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zKXkFLAkaayk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_zIQ8TP5SN98e">Property and Equipment</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost less accumulated
depreciation.&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized.&#160;When assets are retired or
disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Product warranty</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--ExtendedProductWarrantyPolicy_zEOXcIiOWQel" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zqbachsHvpt1">Product warranty</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides a one-year, two-year or three-year
limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements,
as they are incurred, to the cost of sales.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_z6vByfkhiAR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_865_zzxf2Lkpk1cb">Revenue recognition</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 606, &#8220;<i>Revenue from Contracts with Customers.</i>&#8221; This revenue recognition standard (new guidance)
has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction
price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company sells a variety of electronic hearing
and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase
order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation.
Consideration paid to the customer to promote and sell the Company&#8217;s products is typically recorded as a reduction in revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The five steps for the revenue recognition are
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Identify the contract with a customer.&#160;</i>The
Company generally considers completion of a sales order (which requires customer acceptance of the Company&#8217;s click-through terms
and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone)
or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that
are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other
circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts
prior to shipping the product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Identify the performance obligations in the contract</i>.
Product performance obligations include shipment of products and related accessories, and service performance obligations include extended
warranty coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">However, as the historical redemption rate under our
warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether
promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Determine the transaction price and allocation
to performance obligations</i>. The transaction price in the Company&#8217;s customer contracts consists of both fixed and variable consideration.
Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and
60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate
product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this
information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction
price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Allocate the transaction price to the performance
obligations in the contract</i>. For contracts that contain multiple performance obligations, the Company allocates the transaction price
to the performance obligations on a relative standalone selling price basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Recognize revenue when or as the Company satisfies
a performance obligation</i>. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services
(extended warranty) is recognized over time on a ratable basis over the warranty period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2024, and May 31, 2024, contract
liabilities amounted to $<span id="xdx_90D_eus-gaap--ContractWithCustomerLiability_c20241130_pp0p0" title="Contract liabilities">1,313,227</span> and $<span id="xdx_909_eus-gaap--ContractWithCustomerLiability_c20240531_pp0p0" title="Contract liabilities">1,385,841</span>, respectively. As of November 30, 2024, and May 31, 2024, <span id="xdx_90B_ecustom--ContractLiabilitiesDescription_c20240601__20241130" title="Contract Liabilities Description">contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#8217; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.</span></p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_z57l9uMigz14" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zqvxiBZJ3ZZk">Cost of Sales</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The primary components of cost of sales include the
cost of the product and shipping fees related to product procurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ShippingAndHandlingCostsPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><p id="xdx_840_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z8ymXoEuSYog" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_862_zXaYynZ5eZMf">Shipping and Handling Costs</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for shipping and handling fees
in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping
products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses
were $<span id="xdx_901_eus-gaap--SellingAndMarketingExpense_c20240901__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">265,138</span>&#160;and $<span id="xdx_90E_eus-gaap--SellingAndMarketingExpense_c20230901__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">308,081</span>&#160;for the three months ended November 30, 2024 and 2023, respectively. Shipping costs included in marketing
and selling expense were $<span id="xdx_90D_eus-gaap--SellingAndMarketingExpense_c20240601__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">515,052</span>&#160;and $<span id="xdx_90B_eus-gaap--SellingAndMarketingExpense_c20230601__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense">561,533</span>&#160;for the six months ended November 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Sales, Marketing and Advertising</a></td>
<td class="text"><p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zzLHVS0EGpJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zjmE6fshcDsl">Sales, Marketing and Advertising</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales, marketing and advertising costs are expensed
as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_CustomerDepositPolicytextBlock', window );">Customer Deposits</a></td>
<td class="text"><p id="xdx_848_ecustom--CustomerDepositPolicytextBlock_zWEJWL9qWZP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_869_z92X6qG6e9Ni">Customer Deposits</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer deposits consisted of prepayments from customers
to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition
policy.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value measurements and fair value of financial instruments</a></td>
<td class="text"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDkszICzqQik" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_zqmYKLPadtkd">Fair value measurements and fair value of financial instruments</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASC 820, &#8220;<i>Fair Value
Measurements and Disclosures</i>,&#8221; for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a
common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value
measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption
of ASC&#160;820 did not have an impact on the Company&#8217;s financial position or operating results, but did expand certain disclosures.
ASC&#160;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, ASC&#160;820 requires the use of valuation
techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%">Level 1:</td>
    <td style="width: 95%; text-align: justify">Observable inputs such as quoted market prices in active markets for identical assets or liabilities.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">Level 2:</td>
    <td style="text-align: justify">Observable market-based inputs or unobservable inputs that are corroborated by market data.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">Level 3:</td>
    <td style="text-align: justify">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity&#8217;s own assumptions.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with
features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of certain financial instruments,
including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their
fair values because of the short-term nature of these instruments.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><p id="xdx_840_eus-gaap--BusinessCombinationsPolicy_zqCnndI63M7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zAntM9YjzNYh">Business Combinations</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For all business combinations (whether partial, full
or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair
values.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the excess purchase price over
the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized
separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration,
the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration
resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is
classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or
(2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings.
The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes
in assumed discount periods and rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zmPsBrPQdk6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_860_zCsbnrLRtgr4">Goodwill</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill is comprised of the purchase price of business
combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill
is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances
indicate the fair value of a reporting unit is below its carrying value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs its annual goodwill impairment
assessment on May 31st&#160;of each year or as impairment indicators dictate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When evaluating the potential impairment of goodwill,
management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions,
the competitive environment, changes in the market for the Company&#8217;s products and services, regulatory and political developments,
entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company&#8217;s
reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting
unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach
(discounted cash flow method).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the quantitative method&#160;we compare the
carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If
the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the
carrying amount exceeds the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When required, we arrive at our estimates of fair
value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified
assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows
requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital
requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or
estimates for future cash flows could produce different results.&#160;</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zABWBX4W2Vn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_zfLedypeYAJj">Income Taxes</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes pursuant to
the provision of ASC 740-10, &#8220;<i>Accounting for Income Taxes</i>,&#8221; which requires, among other things, an asset and liability
approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.
A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that
the net deferred asset will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows the provision of ASC 740-10 related
to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken
or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax
position is recognized in the financial statements in the period during which, based on all available evidence, management believes it
is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,
if any. Tax positions taken are not offset or aggregated with other positions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax positions that meet the more likely than not recognition
threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with
the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described
above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated
interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all
more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has adopted ASC 740-10-25, &#8220;<i>Definition
of Settlement</i>&#8221;, which provides guidance on how an entity should determine whether a tax position is effectively settled for
the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion
and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity
would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based
solely on the basis of its technical merits and the statute of limitations remains open.&#160;The federal and state income tax returns
of the Company are subject to examination by the Internal Revenue Service (&#8220;IRS&#8221;) and state taxing authorities, generally
for three years after they are filed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zANewW9YtlE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zNFy0f3NlU12">Impairment of long-lived assets</span></span></i>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least
annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying
amount of the asset. The amount of impairment is measured as the difference between the asset&#8217;s estimated fair value and its book
value. The Company did <span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240901__20241130_zxh0P51ZO9bg" title="Impairment loss"><span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230901__20231130_zKyUaTSGtFMd" title="Impairment loss"><span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240601__20241130_zRwo5Ux687G9" title="Impairment loss"><span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230601__20231130_zNLPD1gh5YXl" title="Impairment loss">no</span></span></span></span>t record any impairment loss during the three and six months ended November 30, 2024 and 2023.</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHiOPClhqeG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zPgmegPTfds8">Stock-based compensation</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation is accounted for based on
the requirements of the Share-Based Payment Topic of ASC 718, &#8220;<i>Compensation &#8212; Stock Compensation</i>,&#8221; which requires
recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments
over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period).
ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date
fair value of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For non-employee stock option based awards, the Company
follows Accounting Standards Update (&#8220;ASU&#8221;) 2018-7, which substantially aligns share based compensation for employees and
non-employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income per share of Common Stock</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zh4HBO8Z7JEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_866_zjck7fpzF5Yk">Net income per share of Common Stock</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net income per share is computed by dividing
the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted
average number of common shares and potentially dilutive securities outstanding during the period. For the three and six months ended
November 30, 2024 and 2023, certain stock options, preferred shares and restricted stock awards were excluded from the computation of
diluted common shares outstanding as they would have an anti-dilutive impact on the Company&#8217;s net income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The dilutive common stock equivalent shares consist
of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market
price during the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the computations of basic and diluted net
income per common share:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;<span id="xdx_8B0_zQdgvg0HpIRa" style="display: none">Schedule of net loss per share</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Three Months Ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Six Months Ended</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">633,706</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">1,018,075</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">523,901</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">1,172,527</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average basic shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,450,226</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,863,939</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,303,002</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,863,939</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,556,675</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,702,912</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156,033</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,750</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176,394</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,750</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted stock awards</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,723</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,574</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Weighted average dilutive shares</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">8,168,657</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">18,632,689</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">8,194,882</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">18,632,689</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Basic</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.10</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.17</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.08</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.20</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Diluted</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.08</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.05</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.06</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.06</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy', window );">Lease Accounting</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--LoansAndLeasesReceivableLeaseFinancingPolicy_zXziGyZdOB9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86A_ziKHWCY2NGyf">Lease Accounting</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,&#160;&#8220;<i>Leases</i>,&#8221;
which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements
classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must
be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must
be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that
leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally
flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new
standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted
ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company renewed its lease for its previous corporate
headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expires on December 1, 2024.
The Company also signed a lease agreement in September 2024 for a warehouse and new corporate headquarters commencing October 1, 2024
and November 1, 2024, respectively. Please see Note 10 &#8211; &#8220;Commitments and Contingencies&#8221; under &#8220;Leases&#8221;
below for more information about the Company&#8217;s leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zV08KEVJvGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_860_z6ScJV7UD9Jf">Segment Reporting</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 280,&#160;&#8220;<i>Segment
Reporting</i>.&#8221; The Company&#8217;s management reviews the Company&#8217;s consolidated financial results when making decisions
about allocating resources and assessing the performance of the Company as a whole and has determined that the Company&#8217;s reportable
segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products.
See Note 13 &#8211; &#8220;Business Segment and Geographic Area Information&#8221; for more information about the Company&#8217;s reportable
segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zksyCEYMxJQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_862_z28abXgGfUld">Recently Issued Accounting Pronouncements</span></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, the FASB issued ASU No. 2020-06,&#160;<i>Debt
&#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity</i>&#160;(ASU
2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion
features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted
for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use
of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted
the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the
accompanying consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, the FASB issued ASU No. 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures
for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments
are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15,
2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form
10-K for the year ended May 31, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other accounting standards that have been issued or
proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements
upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its
financial condition, results of operations, cash flows or disclosures.</p>














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_CustomerDepositPolicytextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_CustomerDepositPolicytextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ReverseStockSplitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ReverseStockSplitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ShippingAndHandlingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ShippingAndHandlingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org/705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recording, valuing, and reporting amounts due from lessees pursuant to contractual arrangements, which are secured, at a minimum, by the asset being rented, and in measuring certain revenues, expenses and gains and losses arising from creating, acquiring, collecting, terminating, modifying and holding lease agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481440/840-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 840<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481161/840-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Reclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Reclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764892656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of net loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;<span id="xdx_8B0_zQdgvg0HpIRa" style="display: none">Schedule of net loss per share</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Three Months Ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Six Months Ended</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td><td><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>November 30,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">633,706</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">1,018,075</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">523,901</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right">1,172,527</td><td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average basic shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,450,226</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,863,939</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,303,002</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,863,939</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,556,675</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,702,912</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156,033</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,750</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176,394</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,750</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted stock awards</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,723</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,574</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Weighted average dilutive shares</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">8,168,657</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">18,632,689</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">8,194,882</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4.5pt double; text-align: right">18,632,689</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Basic</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.10</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.17</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.08</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.20</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle">Diluted</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.08</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.05</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.06</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">0.06</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831766985568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zfEglMtFdYA8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_zCvvhfMaCLn7" style="display: none">Schedule of accounts receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20241130_zcGXqv9QmlHd" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20240531_zyvXupzbXfHf" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_40A_ecustom--CustomersReceivable_iI_pp0p0_maARNzFhC_zsZjx66yhui9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customers receivable</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">794,275</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">524,730</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--MerchantProcessorReceivable_iI_pp0p0_maARNzFhC_znk95gqsVRB8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Merchant processor receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746,123</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,417</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0p0_di_msARNzFhC_zcNpiXOHUmd2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Allowance for credit losses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(96,180</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,312</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNet_iTI_pp0p0_mtARNzFhC_zMBgqu5MXpae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Accounts receivables, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">1,444,218</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">509,835</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663337280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQPmoAn3C74g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_8B8_zt6fxJlr2iU6" style="display: none">Schedule of inventory</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20241130_zVQ9PDDXWHsg" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240531_zFCk6573cjn7" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzXX2_zCFXMLNXsqt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Finished Goods</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,543,218</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,190,344</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzXX2_zQYeEbXnk2M7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Raw Materials</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">121,271</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">203,679</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pp0p0_mtINzXX2_zHSkA94FCv8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,664,489</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,394,023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662620720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2GWsdOhehEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zZM4bkJ0CW5e" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Estimated Life</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">Promotional display racks</td><td style="width: 5%">&#160;</td>
    <td style="width: 14%; text-align: center"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_zmVtSEqBtMz6" title="Property, Plant and Equipment, Useful Life">2</span> years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment">30,709</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment">30,709</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and Fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zI7ZmzqIurm8" title="Property, Plant and Equipment, Useful Life">5</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment">37,475</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment">5,759</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer Equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGfbB5qho1zj" title="Property, Plant and Equipment, Useful Life">3</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">10,496</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">22,130</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plant Equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFCguvgvnSK3" title="Property, Plant and Equipment, Useful Life">5</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zQ7XKIpAh0Fe" title="Property, Plant and Equipment, Useful Life">10</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">309,868</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">264,168</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office equipment</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zd1mvCVj4Lvk" title="Property, Plant and Equipment, Useful Life">5</span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zIXFa8EAw6gh" title="Property, Plant and Equipment, Useful Life">10</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">8,838</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment">8,838</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Automobile</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zHxqfhoHalJg" title="Property, Plant and Equipment, Useful Life">5</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment">24,347</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment">24,347</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241130_zwUMtgha9WF6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation">(116,300</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20240531_z000zixLNiMc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation">(95,003</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Property, plant and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net">305,433</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20240531_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net">260,948</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667444320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zyaYPM7537Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_z8At2VUSQIMi" style="display: none">Schedule of intangible assets</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Estimated Life</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">Licensing Rights</td><td style="width: 5%">&#160;</td>
    <td style="width: 14%; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_zi7HW1fuLJpe" title="Estimated Life">3</span> years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross">22,080</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross">34,024</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer Relationships</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSLHkNU7bBH9" title="Estimated Life">3</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">70,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">70,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade Names</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zZRpwtenzfMd" title="Estimated Life">10</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">275,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">275,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Website</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_zXcB2ZTexEoc" title="Estimated Life">5</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">100,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">100,000</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Product Certification Testing</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_zM5fUUFl9c5b" title="Estimated Life">3</span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross">41,840</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"><span style="-sec-ix-hidden: xdx2ixbrl0921">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20241130_zSBR5ODyoqX9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization">(184,013</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20240531_zpUHuV4qQNRg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization">(169,920</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="padding-bottom: 4.5pt">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net">324,907</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20240531_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net">309,104</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764897344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zCoQczWtSoEk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other Current Liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_z4FtypkJUlch" style="display: none">Schedule of other current liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20241130_zAEYbhTpI7E1" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240531_zD9zWNpuHOP8" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_400_ecustom--CreditCards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Credit Cards</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,631</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,734</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--RoyaltyPaymentAccrual_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Royalty Payment Accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,376</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales Tax Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,377</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">231,283</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,387</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">92,543</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pp0p0_z91toXAqLkcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other current liabilities</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">331,395</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">332,936</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764878464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of notes payments due in the next twelve months</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zREqc0YqAEMh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_z5kRlsW8vI45" style="display: none">Schedule of notes payments due in the next twelve months</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" id="xdx_49B_20241130_z90Ho0QES69i" style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDziXa_zntJ4gzaSQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: left; padding-bottom: 1.5pt">2025</td><td style="width: 5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">143,342</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDziXa_zdkhvG0hOYh7" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">143,342</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662581024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of stock option assumptions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4m0elWfo1i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)">
  <tr style="vertical-align: bottom; background-color: white">
    <td><span id="xdx_8B0_zu3zfXyKET7i" style="display: none">Schedule of stock option assumptions</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Risk free interest rate</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20240601__20241130_pdd" title="Risk free interest rate">3.95%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Expected life</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240601__20241130_zeXIQ76XcgFg" title="Expected life">7</span> years</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%">Expected volatility</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: center"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20240601__20241130_pdd" title="Expected volatility">464%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Expected dividend</td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20240601__20241130_pdd" title="Expected dividend"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock options activities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcf8H5MW7gj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B3_zO4GfUn4yHef" style="display: none">Schedule of stock options activities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Term</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 49%">Outstanding as of May 31, 2024</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240531_zmDANmVyPacd" style="width: 10%; text-align: right" title="Number of Options Outstanding, Beginning">268,750</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240531_zk70Sqto5p5l" style="width: 10%; text-align: right" title="Weighted Average  Exercise Price, Beginning">1.84</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220601__20230531_zHQzQR79BUvi" title="Weighted Average  Remaining Term">7.9</span></td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240601__20241130_pdd" style="text-align: right" title="Number of Options Outstanding, Granted">629,000</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240601__20241130_pdd" style="text-align: right" title="Weighted Average  Exercise Price, Granted">4.17</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240601__20241130_zFC9aO68cFB4" style="text-align: right" title="Number of Options Outstanding, Exercised/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1091">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240601__20241130_z6mNOLm5jdrc" style="text-align: right" title="Weighted Average  Exercise Price, Exercised/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1093">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Less: Unvested at November 30, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNI_di_c20241130_zrASSeGiVmr5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending">(650,500</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending">4.11</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240601__20241130_z9TzsyXY4sU2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term">6.7</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Vested at November 30, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Vested">247,250</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Exercise Price, Vested">2.13</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240601__20241130_z2H6GyxahMn7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term, Vested">7.6</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662652304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock', window );">Schedule of supplemental balance sheet information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_zAcrHm0htup8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span id="xdx_8B2_z15bIRVPzzG" style="display: none">Schedule of supplemental balance sheet information</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20241130_zdjHzwYHe515" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20240531_z5EzBjvpJgff" style="text-align: right">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>November 30, 2024</b></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>May 31, 2024</b></td></tr>
  <tr id="xdx_402_ecustom--RightOfUseAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-left: 9pt">Right of use assets</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">899,239</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">131,970</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Accumulated reduction</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(161,988</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95,218</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Operating lease assets, net</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">737,251</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">36,752</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">899,239</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">131,970</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AccumulatedReduction_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Accumulated reduction</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(161,081</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95,218</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease liability, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,158</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,752</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--OperatingLeaseLiabilityCurrentPortion_iNI_pp0p0_di_zt6NgcuV3QU8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(207,077</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,752</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Non-current portion</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">531,081</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">&#8212;</span></td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturities of operating lease liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4BZ0rSSOCh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_z4FOsnbl7Pd2" style="display: none">Schedule of maturities of operating lease liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20241130_zbzsam2y0Xal" style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Operating Lease (fiscal year-end)</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz3IL_z87XRggIyeae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 81%">2025 (six months remaining)</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">94,651</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz3IL_zEiMUpr53XD6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">258,005</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz3IL_zwm8rKEk30a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269,437</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz3IL_zWnpCyRufoUb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,420</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz3IL_zg63Cy6ZHG2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2029</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">128,040</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz3IL_zCE6kpDMo5Wi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">968,553</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zOI7bPagT1s4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(230,395</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zN4FhJcJ6L6a" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td style="border-bottom: Black 4.5pt double; text-align: right">738,158</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764759696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Area Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of segment information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_za2t9Oc9lZTg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Segment and Geographic Area Information (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;<span id="xdx_8B2_zdNxLoyJPpM9" style="display: none">Schedule of segment information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended November 30,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months ended November 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">284,545</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">230,741</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">836,054</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales">545,594</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">7,448,029</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">8,190,936</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">12,747,792</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales">13,982,352</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Total net sales</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">7,732,574</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">8,421,677</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">13,583,846</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales">14,527,946</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Segment gross profit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">173,507</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">172,583</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">429,996</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit">394,107</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">5,324,540</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">6,085,356</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">9,221,699</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit">10,511,398</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total segment gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130_pp0p0" style="text-align: right" title="Total segment gross profit">5,498,047</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GrossProfit_c20230901__20231130_pp0p0" style="text-align: right" title="Total segment gross profit">6,257,939</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GrossProfit_c20240601__20241130_pp0p0" style="text-align: right" title="Total segment gross profit">9,651,695</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GrossProfit_c20230601__20231130_pp0p0" style="text-align: right" title="Total segment gross profit">10,905,505</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and Marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SellingAndMarketingExpense_c20240901__20241130_pp0p0" style="text-align: right" title="Selling and Marketing">3,377,760</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SellingAndMarketingExpense_c20230901__20231130_pp0p0" style="text-align: right" title="Selling and Marketing">3,672,780</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SellingAndMarketingExpense_c20240601__20241130_pp0p0" style="text-align: right" title="Selling and Marketing">6,047,231</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SellingAndMarketingExpense_c20230601__20231130_pp0p0" style="text-align: right" title="Selling and Marketing">6,879,621</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240901__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">1,447,416</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230901__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">1,321,247</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240601__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">3,072,295</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230601__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative">2,588,215</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated operating income</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ConsolidatedOperatingIncomeLoss_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">672,871</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ConsolidatedOperatingIncomeLoss_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">1,263,912</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--ConsolidatedOperatingIncomeLoss_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">532,169</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ConsolidatedOperatingIncomeLoss_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)">1,437,669</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets">4,039,069</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets">5,439,289</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zSd1tXeKzgJb" style="text-align: right" title="Consolidated total assets">4,039,069</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zgJkAQWpELv2" style="text-align: right" title="Consolidated total assets">5,439,289</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">9,670,630</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">7,686,720</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z1wRJEG4eV49" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">9,670,630</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z50CV28EbXtj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets">7,686,720</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total assets</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,709,699</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,126,009</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130_zWjVhJ4qa31b" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,709,699</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20231130_ztQM5MICcI22" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets">13,126,009</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments for property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1358">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1360">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl1364">&#8212;</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">65,783</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">19,885</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">107,623</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment">70,845</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total payments for property and equipment</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">65,783</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">19,885</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">107,623</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment">70,845</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 6.75pt">Hair care and skin care</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">839</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">1,417</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">1,678</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization">2,835</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt">Hearing enhancement and protection</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">33,601</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">26,368</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">45,657</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization">53,187</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt">Consolidated total depreciation and amortization</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">34,440</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">27,785</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">47,335</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4.5pt">&#160;</td>
    <td style="border-bottom: Black 4.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization">56,022</td><td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663889504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 633,706<span></span>
</td>
<td class="nump">$ 1,018,075<span></span>
</td>
<td class="nump">$ 523,901<span></span>
</td>
<td class="nump">$ 1,172,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares</a></td>
<td class="nump">6,450,226<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
<td class="nump">6,303,002<span></span>
</td>
<td class="nump">5,863,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>&#160;Dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Convertible preferred stock</a></td>
<td class="nump">1,556,675<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="nump">1,702,912<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Stock options</a></td>
<td class="nump">156,033<span></span>
</td>
<td class="nump">268,750<span></span>
</td>
<td class="nump">176,394<span></span>
</td>
<td class="nump">268,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_RestrictedStockAwards', window );">Restricted stock awards</a></td>
<td class="nump">5,723<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,574<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average dilutive shares</a></td>
<td class="nump">8,168,657<span></span>
</td>
<td class="nump">18,632,689<span></span>
</td>
<td class="nump">8,194,882<span></span>
</td>
<td class="nump">18,632,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_RestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_RestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663969056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional and consulting</a></td>
<td class="nump">$ 736,169<span></span>
</td>
<td class="nump">$ 694,258<span></span>
</td>
<td class="nump">$ 1,684,018<span></span>
</td>
<td class="nump">$ 1,303,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Prepaid expenses</a></td>
<td class="nump">498,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 472,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">1,313,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,313,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,385,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ContractLiabilitiesDescription', window );">Contract Liabilities Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#8217; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expense</a></td>
<td class="nump">3,377,760<span></span>
</td>
<td class="nump">3,672,780<span></span>
</td>
<td class="nump">$ 6,047,231<span></span>
</td>
<td class="nump">6,879,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=axil_CustomerMember', window );">Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expense</a></td>
<td class="nump">$ 265,138<span></span>
</td>
<td class="nump">308,081<span></span>
</td>
<td class="nump">$ 515,052<span></span>
</td>
<td class="nump">561,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional and consulting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ContractLiabilitiesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ContractLiabilitiesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=axil_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=axil_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831768616112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable, net (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_CustomersReceivable', window );">Customers receivable</a></td>
<td class="nump">$ 794,275<span></span>
</td>
<td class="nump">$ 524,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_MerchantProcessorReceivable', window );">Merchant processor receivable</a></td>
<td class="nump">746,123<span></span>
</td>
<td class="nump">78,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less: Allowance for credit losses</a></td>
<td class="num">(96,180)<span></span>
</td>
<td class="num">(93,312)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivables, net</a></td>
<td class="nump">$ 1,444,218<span></span>
</td>
<td class="nump">$ 509,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_CustomersReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_CustomersReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_MerchantProcessorReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_MerchantProcessorReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667421616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, net (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">$ 9,169<span></span>
</td>
<td class="nump">$ 11,461<span></span>
</td>
<td class="nump">$ 27,954<span></span>
</td>
<td class="nump">$ 64,327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831830497584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory, net (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Goods</a></td>
<td class="nump">$ 2,543,218<span></span>
</td>
<td class="nump">$ 3,190,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw Materials</a></td>
<td class="nump">121,271<span></span>
</td>
<td class="nump">203,679<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 2,664,489<span></span>
</td>
<td class="nump">$ 3,394,023<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831665247888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory, net (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_InventoryHeldAtThirdPartyLocation', window );">Inventory held at third party location</a></td>
<td class="nump">$ 88,869<span></span>
</td>
<td class="nump">$ 58,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryInTransit', window );">Inventory in-transit</a></td>
<td class="nump">13,500<span></span>
</td>
<td class="nump">15,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">$ 46,895<span></span>
</td>
<td class="nump">$ 46,895<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_InventoryHeldAtThirdPartyLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_InventoryHeldAtThirdPartyLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryInTransit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryInTransit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667451440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less:Accumulated Depreciation</a></td>
<td class="num">$ (116,300)<span></span>
</td>
<td class="num">$ (95,003)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 305,433<span></span>
</td>
<td class="nump">260,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=axil_PromotionalRisplayRacksMember', window );">Promotional Risplay Racks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Plant Equipment</a></td>
<td class="nump">$ 30,709<span></span>
</td>
<td class="nump">30,709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Plant Equipment</a></td>
<td class="nump">$ 37,475<span></span>
</td>
<td class="nump">5,759<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Plant Equipment</a></td>
<td class="nump">$ 10,496<span></span>
</td>
<td class="nump">22,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Plant Equipment</a></td>
<td class="nump">$ 309,868<span></span>
</td>
<td class="nump">264,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Plant Equipment</a></td>
<td class="nump">$ 8,838<span></span>
</td>
<td class="nump">8,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Plant Equipment</a></td>
<td class="nump">$ 24,347<span></span>
</td>
<td class="nump">$ 24,347<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=axil_PromotionalRisplayRacksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=axil_PromotionalRisplayRacksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663964848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 11,405<span></span>
</td>
<td class="nump">$ 8,410<span></span>
</td>
<td class="nump">$ 21,298<span></span>
</td>
<td class="nump">$ 17,272<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831664114992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated Amortization</a></td>
<td class="num">$ (184,013)<span></span>
</td>
<td class="num">$ (169,920)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived Intangible Assets, Net</a></td>
<td class="nump">$ 324,907<span></span>
</td>
<td class="nump">309,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_LicensingRightsMember', window );">Licensing Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived Intangible Assets, Gross</a></td>
<td class="nump">$ 22,080<span></span>
</td>
<td class="nump">34,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived Intangible Assets, Gross</a></td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived Intangible Assets, Gross</a></td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_WebsiteMember', window );">Website [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived Intangible Assets, Gross</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_ProductCertificationTestingMember', window );">Product Certification Testing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived Intangible Assets, Gross</a></td>
<td class="nump">$ 41,840<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_LicensingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_LicensingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_WebsiteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_WebsiteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_ProductCertificationTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=axil_ProductCertificationTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663398944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Goodwill</a></td>
<td class="nump">$ 2,152,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,152,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 23,035<span></span>
</td>
<td class="nump">$ 19,375<span></span>
</td>
<td class="nump">$ 26,037<span></span>
</td>
<td class="nump">$ 35,522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662688096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_CreditCards', window );">Credit Cards</a></td>
<td class="nump">$ 3,631<span></span>
</td>
<td class="nump">$ 5,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_RoyaltyPaymentAccrual', window );">Royalty Payment Accrual</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales Tax Payable</a></td>
<td class="nump">315,377<span></span>
</td>
<td class="nump">231,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">12,387<span></span>
</td>
<td class="nump">92,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Total other current liabilities</a></td>
<td class="nump">$ 331,395<span></span>
</td>
<td class="nump">$ 332,936<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_CreditCards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_CreditCards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_RoyaltyPaymentAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_RoyaltyPaymentAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831662849632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable (Details)<br></strong></div></th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 143,342<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 143,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667197440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 18, 2020</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>May 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=axil_EconomicInjuryDisasterLoanProgramMember', window );">Economic Injury Disaster Loan Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_LoanForgiveness', window );">Loan forgiveness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Additional borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,296<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=axil_EIDLMember', window );">EIDL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,342<span></span>
</td>
<td class="nump">$ 146,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_LoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_LoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=axil_EconomicInjuryDisasterLoanProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=axil_EconomicInjuryDisasterLoanProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=axil_EIDLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=axil_EIDLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663873392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.95%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">464.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663907376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Beginning</a></td>
<td class="nump">268,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning</a></td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Term</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Outstanding, Granted</a></td>
<td class="nump">629,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">$ 4.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options Outstanding, Exercised/Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised/Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Ending</a></td>
<td class="num">(650,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Number of Options Outstanding, Ending</a></td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options Outstanding, Vested</a></td>
<td class="nump">247,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested</a></td>
<td class="nump">$ 2.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Term, Vested</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831660497248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 13, 2024</div></th>
<th class="th"><div>Mar. 05, 2024</div></th>
<th class="th"><div>Feb. 14, 2024</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Oct. 14, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued value during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,133,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,133,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,251,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,133,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,133,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,251,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,908,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,466,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,908,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,423<span></span>
</td>
<td class="nump">$ 51,108<span></span>
</td>
<td class="nump">$ 211,055<span></span>
</td>
<td class="nump">$ 102,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602,464<span></span>
</td>
<td class="nump">102,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=axil_RestrictedStockAwardsMember', window );">Restricted Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=axil_ThreeBoardMembersMember', window );">Three Board Members [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Number of restricted stock awards issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Fair value of restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=axil_OneConsultantMember', window );">One Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_NumberOfOptionIssued', window );">Number of option issued</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ValueOfOptionIssued', window );">Value of option issued</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for services</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for valued</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=axil_OfficersMember', window );">Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_NumberOfOptionIssued', window );">Number of option issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ValueOfOptionIssued', window );">Value of option issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,406,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of share purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,748,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,246,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_RemainingOutstanding', window );">Remaining outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,251,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,118,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">555,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_NumberOfOptionIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_NumberOfOptionIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_RemainingOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_RemainingOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ValueOfOptionIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ValueOfOptionIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=axil_RestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=axil_RestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=axil_ThreeBoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=axil_ThreeBoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=axil_OneConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=axil_OneConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=axil_OfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=axil_OfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831664266448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_RightOfUseAssets', window );">Right of use assets</a></td>
<td class="nump">$ 899,239<span></span>
</td>
<td class="nump">$ 131,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated reduction</a></td>
<td class="num">(161,988)<span></span>
</td>
<td class="num">(95,218)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets, net</a></td>
<td class="nump">737,251<span></span>
</td>
<td class="nump">36,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_LeaseLiability', window );">Lease liability</a></td>
<td class="nump">899,239<span></span>
</td>
<td class="nump">131,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_AccumulatedReduction', window );">Accumulated reduction</a></td>
<td class="num">(161,081)<span></span>
</td>
<td class="num">(95,218)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability, net</a></td>
<td class="nump">738,158<span></span>
</td>
<td class="nump">36,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_OperatingLeaseLiabilityCurrentPortion', window );">Current portion</a></td>
<td class="num">(207,077)<span></span>
</td>
<td class="num">(36,752)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current portion</a></td>
<td class="nump">$ 531,081<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_AccumulatedReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_AccumulatedReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_OperatingLeaseLiabilityCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_OperatingLeaseLiabilityCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_RightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_RightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831660512848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025 (six months remaining)</a></td>
<td class="nump">$ 94,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">258,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">269,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">218,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">128,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">968,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(230,395)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 738,158<span></span>
</td>
<td class="nump">$ 36,752<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831664050912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_InitialLeaseLiability', window );">Initial lease liability</a></td>
<td class="nump">$ 767,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 767,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 49,080<span></span>
</td>
<td class="nump">$ 18,659<span></span>
</td>
<td class="nump">$ 67,739<span></span>
</td>
<td class="nump">$ 37,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Lessee, Operating Lease, Discount Rate</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Due in royalties</a></td>
<td class="nump">$ 218,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_InitialLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_InitialLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764658208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=axil_BZCapitalStrategiesMember', window );">BZ Capital Strategies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ConsultingFee', window );">Consulting fee</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=axil_IntrepidMember', window );">Intrepid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ConsultingFee', window );">Consulting fee</a></td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_PayableToRelatedParty', window );">Payable to related party</a></td>
<td class="nump">$ 178,520<span></span>
</td>
<td class="nump">$ 11,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ConsultingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ConsultingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_PayableToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_PayableToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=axil_BZCapitalStrategiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=axil_BZCapitalStrategiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=axil_IntrepidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=axil_IntrepidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831667909040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash, uninsured amount</a></td>
<td class="nump">$ 4,463,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,463,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,003,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">90.20%<span></span>
</td>
<td class="nump">94.60%<span></span>
</td>
<td class="nump">91.20%<span></span>
</td>
<td class="nump">93.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=axil_PurchasesMember', window );">Purchases [Member] | Product Concentration Risk [Member] | Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">73.20%<span></span>
</td>
<td class="nump">82.70%<span></span>
</td>
<td class="nump">61.80%<span></span>
</td>
<td class="nump">86.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=axil_PurchasesMember', window );">Purchases [Member] | Product Concentration Risk [Member] | Vendors One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">15.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=axil_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=axil_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=axil_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=axil_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=axil_PurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=axil_PurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=axil_VendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=axil_VendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=axil_VendorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=axil_VendorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831663925040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Area Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net sales</a></td>
<td class="nump">$ 7,732,574<span></span>
</td>
<td class="nump">$ 8,421,677<span></span>
</td>
<td class="nump">$ 13,583,846<span></span>
</td>
<td class="nump">$ 14,527,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total segment gross profit</a></td>
<td class="nump">5,498,047<span></span>
</td>
<td class="nump">6,257,939<span></span>
</td>
<td class="nump">9,651,695<span></span>
</td>
<td class="nump">10,905,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and Marketing</a></td>
<td class="nump">3,377,760<span></span>
</td>
<td class="nump">3,672,780<span></span>
</td>
<td class="nump">6,047,231<span></span>
</td>
<td class="nump">6,879,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and Administrative</a></td>
<td class="nump">1,447,416<span></span>
</td>
<td class="nump">1,321,247<span></span>
</td>
<td class="nump">3,072,295<span></span>
</td>
<td class="nump">2,588,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axil_ConsolidatedOperatingIncomeLoss', window );">Consolidated operating income (loss)</a></td>
<td class="nump">672,871<span></span>
</td>
<td class="nump">1,263,912<span></span>
</td>
<td class="nump">532,169<span></span>
</td>
<td class="nump">1,437,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Consolidated total assets</a></td>
<td class="nump">13,709,699<span></span>
</td>
<td class="nump">13,126,009<span></span>
</td>
<td class="nump">13,709,699<span></span>
</td>
<td class="nump">13,126,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Consolidated total payments for property and equipment</a></td>
<td class="nump">65,783<span></span>
</td>
<td class="nump">19,885<span></span>
</td>
<td class="nump">107,623<span></span>
</td>
<td class="nump">70,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Consolidated total depreciation and amortization</a></td>
<td class="nump">34,440<span></span>
</td>
<td class="nump">27,785<span></span>
</td>
<td class="nump">47,335<span></span>
</td>
<td class="nump">56,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=axil_HairCareAndSkinCareMember', window );">Hair care and skin care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net sales</a></td>
<td class="nump">284,545<span></span>
</td>
<td class="nump">230,741<span></span>
</td>
<td class="nump">836,054<span></span>
</td>
<td class="nump">545,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total segment gross profit</a></td>
<td class="nump">173,507<span></span>
</td>
<td class="nump">172,583<span></span>
</td>
<td class="nump">429,996<span></span>
</td>
<td class="nump">394,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Consolidated total assets</a></td>
<td class="nump">4,039,069<span></span>
</td>
<td class="nump">5,439,289<span></span>
</td>
<td class="nump">4,039,069<span></span>
</td>
<td class="nump">5,439,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Consolidated total payments for property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Consolidated total depreciation and amortization</a></td>
<td class="nump">839<span></span>
</td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">2,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=axil_HearingEnhancementAndProtectionMember', window );">Hearing enhancement and protection [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net sales</a></td>
<td class="nump">7,448,029<span></span>
</td>
<td class="nump">8,190,936<span></span>
</td>
<td class="nump">12,747,792<span></span>
</td>
<td class="nump">13,982,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total segment gross profit</a></td>
<td class="nump">5,324,540<span></span>
</td>
<td class="nump">6,085,356<span></span>
</td>
<td class="nump">9,221,699<span></span>
</td>
<td class="nump">10,511,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Consolidated total assets</a></td>
<td class="nump">9,670,630<span></span>
</td>
<td class="nump">7,686,720<span></span>
</td>
<td class="nump">9,670,630<span></span>
</td>
<td class="nump">7,686,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Consolidated total payments for property and equipment</a></td>
<td class="nump">65,783<span></span>
</td>
<td class="nump">19,885<span></span>
</td>
<td class="nump">107,623<span></span>
</td>
<td class="nump">70,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Consolidated total depreciation and amortization</a></td>
<td class="nump">$ 33,601<span></span>
</td>
<td class="nump">$ 26,368<span></span>
</td>
<td class="nump">$ 45,657<span></span>
</td>
<td class="nump">$ 53,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axil_ConsolidatedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axil_ConsolidatedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=axil_HairCareAndSkinCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=axil_HairCareAndSkinCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=axil_HearingEnhancementAndProtectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=axil_HearingEnhancementAndProtectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45831764869728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 67,250<span></span>
</td>
<td class="nump">$ 364,393<span></span>
</td>
<td class="nump">$ 67,250<span></span>
</td>
<td class="nump">$ 430,382<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>72
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;:?7=JD5%%4V!645*$-;=I7H4#\#9R3(;19/A;+BX2:.0]M=>MX;6 %1;5/
M*LM0-#UL 1_$/#1Q!OKTEL?V/L2-1G_<?"!C< C2$W*3^*=6V&-$&5IE&8JG
MD0VL!Z6KH&QO()\^D5_%LQ47MW*@4\_HH.<X5LYCY!M:!1R*)Y0-YR-_(C<!
MP(:ST.?YF(G4,&[9/8,29CU&[45\C.A#J^Q#\<2RX86JDPHR08YZ0B8:WD9$
M*N+)##H<^ET&]LK>$ZVNK,C'B$.TRD,4#S$;Y%$0@#L\<9L-\@&N(Y\2.R=N
M>4Y[#OD<1NDB5(*,91:)%5>!%?X848E668GB$0>%?UQ+*SQN.<E"*!;6M8^V
MQTA,M(I,%$\YKW$]LP=U_2C7B145MQN+5?Y]\#Z,(ELF\7!]0UQ6!2B&9Y[7
MN.5S?*?D*DQ\:VWO\?1&UGF#8Z0H5J4HAL>>UZ!W,M4P+/T9+FM?57L<SQU&
MK9$8US4EK6(4PQ-07K$C)7@]&&XP&%C''5S5%*L*3PS//!]D_@FSD F6#O>8
M]-U!&_!<*]\Q\A*K\A+#0\YCJ"'WRAFA[,?I3V0B_$Q!3UHA<2=/QC'$CXF6
M_M<3\KUS:O(36<)GPXI'F2!+H8KY1NM=.$::8E6:8GCT>50\"),YF3S'4QE9
MX?=,.$$TMG(=(S6Q*C4Q/-=LNY-</?D+GLQ%;?3?8W3[96*-2+BL*5\5D=A!
M$6G[K5I,%^4="0.*_6M\C^,7ZW2XAZN:<E9IB!V4AFX2+52Q!&*^P_D6W,J)
M.]9Q'B,&L2H&L8-BD/D6ATP/F6 NE?U=A/O<RJ3-?5^ #9@$A:&5]Q@YR*UR
MD'M0#IK$/(K(.$OA=&JMVCT^=?.YN*PI7I5^W(/2SU4LU-P\E>_ 02\@(,1+
MGEC[=8]A[;PNKFL*6H4?]Z YI,E"0#]B>+A-/=XQ0I"[LQIVT S2RQ%^DJ\=
MDD^9ADB;F.'32OQME\D*MU[N9M:J5\-^M]\?]" 1KW81.SMKHZ;Z\B7CE/AF
MFJ!8)BV/ELO2HWPQME-=7JQI?^2F>%,2B1E(G=,S^'55+!,7.UHN\Y76J=1:
MQOGF0O! *',!G)])J;<[Y@?*Q?KAOU!+ P04    " #)02A:]2]S X<'  "U
M'P  &    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;+69;7/B.!+'OXJ*V[J;
MK6(&/?A)F80JAK [U#%)+I"[NI<.5H)KC,78@DSNTU_;.!BL!W;K<B\2;&C)
M_Y:E_G5+ER^R^%ZNA%#HYSK+RZO>2JG-Q6!0+E=B'9>?Y$;D\,N3+-:Q@MOB
M>5!N"A$G=:-U-J 8!X-UG.:]X67]W5TQO)1;E:6YN"M0N5VOX^+UB\CDRU6/
M]-Z^N$^?5ZKZ8C"\W,3/8B[4P^:N@+O!H9<D78N\3&6."O%TU1N1BS'C58/:
MXI^I>"F/KE'ERJ.4WZN;:7+5PY4BD8FEJKJ(X6,GQB++JIY QX^FT][AF57#
MX^NWWG^KG0=G'N-2C&7VKS11JZM>U$.)>(JWF;J7+U]%XY!?];>465G_1R^-
M+>ZAY;94<MTT!@7K--]_QC^;@3AJ0#Q+ ]HTH-T&S-* -0U8[>A>6>W6=:SB
MX64A7U!164-OU44]-G5K\";-J]<X5P7\FD([-1S?WLQO9]/KT6)RC;Z,9J.;
M\03-OTXFBSGZ\)#'VR15(OD5?40/\VOTX9=?+P<*'ELU'BR;1WS9/X):'G$C
M=Y\0PWU$,?4,S<?NYM_B5\2(J?4 ?#TX3 \.T[H[9G/XX?Y^<K- H_D<?+PP
MN;/OP#-W4*VKBW(3+\55#Q9.*8J=Z W_^A<2X,\FY]ZILQ-?V<%7YNI].([+
ME<G!?:N@;E6M\]W0IX1%/+P<[(ZUZW:,^BP*@X/=B2SO(,MSRAHMEW*;JQ+"
MP%*DN_@Q$WV4"V62NN_)/Y) /,^C).I(U>U\S"/FFY7Z!Z6^4^DTWXE<R>+5
MJL_7GDN#P/,BWM&GVS'&/4R966!P$!@X!=X58A.G"1(_(:Z7HD1QGB"I5J*
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M)V(CR]0RSW4X>3SPCB)^HU*W([X7!I:82UN(43?$QC)7!52R*$OCQS1+52J
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MOER)&,:^,H#?GR3@M;FI3FX/)_7#_P)02P,$%     @ R4$H6EJUSR4# P
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MTA_<WXWN;Z[/^X\7Y^BL?]._&UR@T=7%Q>,('3VE) NIA/ 8'0T)AU1&(&E
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MEK+@Q<6CZ$@VR\_N,9/J)I W(W59 ZX#U/L)8_*MHZ\#U?7/_PM02P,$%
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M::L?LI=/JA;$2[YEMBVJO^CE@!5X@)9/A<YV=;"Y@UV2'G[C[W5'G 08'CB
MU@'4#O!: E@=P-[:@E<'>&]M@=<!E?3A07O5<5&LX]%EGKV@O$0;MO*@ZOTJ
MVO17DI839:YS\]_$Q.G19#:=S_YS&XT7,D+SA?FYD]/%',T^HMF]?!@O;@T
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MBG13_0S]+BV*-*Z>/M)P1;,2P-Z_3]/B]:+\9?ONGRMF_P-02P,$%     @
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M1VH8V^)&%2K:4I *&&R0#Z*Q(W6MFQ9,C3(5&R3'"17R76%L7M:V@[/)4H
MX)"R U#@!R$CJZH.]ACF 17Q@*>\J8B1F@+&Z&1GVK5:Z0IPALO#&[W%-;(@
M4]O EN'X]<:T,&Y$C/DC7HSAL.NZ*PM81*'516A@SI]=16:-P4'D_W@AAR<B
M4*.!5V+<X!K7+"TDO1<OK,,5(*)N@$"50DNH)N/3__(TO]=9P[1.?LONU6S"
M',+''&0R/]6:.[5A.T +#/%9HQ%DS^&&"%J KD!C[F3#;0,G6NA$WVW!Y.O
MEDM@"SB%@Q0I%($Z__L4$;3%*"/D&GBW6]?(%O6N HS8;F%-84 R1^H*A-9&
MFLY4K6Y$/8%C42)S,8W R%0VRQE9@8%T:< !(*BZ;5U%<,+ D?JL;W4#HG73
MUODW=;,M3:O>+9>:W!X1Y']E0$]0$Y-SQF_:.X*FT0!V!ACEQ2PM9FFQ6&$-
M;.84F"/*/B^!VNL =+O.&E;7<':@OFR1M0IVQ:/@J\DIT.YT.E9?+1%9V]:
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M&#"X[!S(7S<7< Z!&T4D*>A;2?[ [8==^$(W,9-EQ<6+A4A%/4#C(J4)L3"
MSS1$=7TOYS!P@]X  F+I!<!B=]"-H!>Y(8OA4/UX>\U-E[.J1YB&6E[3Y^UN
M.R6GS7!X"V]&[)RK52XT%+@DJ'\5TU!2S=AJ#".K>E0LI*&7J)<937I4-H#\
M2TGELS/L >U_Q^0W4$L#!!0    ( ,E!*%JR#H<!PP(  /X%   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;(U4P5+;,!"]YRMV3(>3!]NR$QQ(,I-
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MXH(:-NW &-GVVVTC#;6T)W?T.*&R!J0O)<WX@;$!QN=N^2]02P,$%     @
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M6\C-='!+C:-LR9:.?D,.WALKJ)@(>2G6"'37V*Q0[^\;KO@/2.-N,;@4A6L
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MH+(.=+^0E/+N8 ,TOYSQ/U!+ P04    " #)02A:^<D$:7<4   >/   &0
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M_WAKOCUT5&#[Q\[RG.\DP24(2G.JI[8 0^MNJR@3$ CCF%"K#[=9NIB&*"T
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M^2R^X<(>43+3]-&?S(5NM#@SZUS6VT/4'B-M.2:%=B;<S="]7MJ"L'5KU7/
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M2KQ/ I(-NJ)]6MW0_;<-F@_GWNYHG$)-7WWL%LZ5+  -U^1G]9',G7B2GCW
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M)'VJ>B&54*M:8%T(HDTK+1H\I=B,!$!6\RB:4=RA"GXK+P8K21UIA&]4974
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M>U/SSZV2J!ET ,_7!@@;+XA!]XGTYK]02P,$%     @ R4$H6MS%X!7K @
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M -I/)7U'N\ >T/Q7)O\ 4$L#!!0    ( ,E!*%H@OD_>0P0  '<)   9
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MBLN$1F'^$MTIC9ES84C@M *]-",E94Y#69(HI&D4T;@L1MEF#T]@)"5\E^3
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MQ7/<-W'EUT*[!9A?*@@8.\[ ]$5U]1=02P,$%     @ R4$H6CU8/;/A @
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MM*]1\S>L()&X>_9A<*@#AP,AY-$UFMLFN7?$LJ,(% GC*<9*R*\[I!>]'4?
MF.0V.^(^Q,&V4(X3Y$RP>6V-Z^Q,7&B &+*%^!],_1K#+QS6HMM"RW(<@BZ6
M7UY9E:?D.EVS[F#U@YJ%5/NHAKYP^N+B$0W=P_F0PA@%<4P_]^ Z1ZL^>-+U
MZ% Z0?B!<YSW5UE%H;QS KX<,B398"<-$_0GZ'FSK;4FO#[J%(#/^03_QB\6
M4[6X7,:SR^48:B\=:B]'47L-I'/N+W$J4!:%>0C%HZ"&47P4/BEG:^;(&<[
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ML0S@13G3X%MDHB$@"H5P!]UX8E/P,("X]4:>)ZRS(O&M.$;JA9Q^X\FZ05R
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MQT(]6,EB>:X.1USP@.42163@^>7$^0FCU-WD:\EA1:[2TA..4"3/XNF%3+W
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M^ML?>!-#K_H:"F4PJ'JZP3QX&F:!XVB(@C:'-O0&$B1 H^27 K:@[!*$Z'0
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M ;K& ?!\78'MEB\X@?L/.%[_'U!+ P04    " #)02A:95X-6UX#  !G!P
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M/[3V41U_A5,\F<.K5&O\EQR'NP5>K@[&JNYDC PZ(8>5OYSR<&%0TC<,V,F
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M%0UT-#Z SA=:NT?'%^C_(J9_ %!+ P04    " #)02A:.CMCQ: "  #'!0
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M8SHZ@Y?V@:<=7OJ_ G_#32F4:360OQ<K8S5VSS^GLN"=C$X[<1-U;1I6PBS
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MIX#/UTK9@^ <])\7\_\ 4$L#!!0    ( ,E!*%I9\!P7DP0  +X*   9
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MIE2)#%1>2 Z6*@%,\,%GVT+=ZN1],8<;L,(3B5<YX: >*,A!,\B'4P%<)&4
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MY*]H^F/-U(.%OM([>*;(O$6W1<I4V[+IA-8Y^%06)*;G@T(O9G%'!^-?WN'
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M\MM'^:!X8>[JYUQ!N30_5Y1  Z\%X/V"<_7XH W47Z#&_P-02P,$%     @
MR4$H6B]!$>J@ @  ^@8  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL
MK55=;YLP%/TK%INF3FH+F(^D&4%*4TV;U$Y5JVX/TQX<YR98-9C93M+^^]F&
ML#0AV<M>P!_W',XQ]UYG&R&?50&@T4O)*S7V"JWKD>\K6D!)U*6HH3(["R%+
MHLU4+GU52R!S!RJYCX,@]4O"*B_/W-J]S#.QTIQ5<"^16I4ED:_7P,5F[(7>
M=N&!+0MM%_P\J\D2'D$_U??2S/R.9<Y*J!03%9*P&'N3<#1-;;P+^,Y@HW;&
MR#J9"?%L)U_G8R^P@H #U9:!F-<:IL"Y)3(R?K><7O=)"]P=;]D_.^_&RXPH
MF K^@\UU,?:&'IK#@JRX?A";+]#Z22P?%5RY)]HTL7'B(;I26I0MV"@H6=6\
MR4M[#CN ,#X"P"T [P.B(X"H!43.:*/,V;HAFN29%!LD;;1ALP-W-@YMW+#*
M_L5'+<TN,SB=3R@5JTHK]  4V)K,.)RCRF3/V0UHPKCZB"[0T^,-.GO_,?.U
M^:+%^;1EOV[8\1'V;V)]B:+@'.$ QSWPZ6GX'7E%4=B']HW-SBONO&)'%QVA
MFTJ8,XUNA5+HYV2FM#1)]*O/5<,3]_/8PAJIFE 8>Z9R%,@U>/F'=V$:?.KS
M^)_(WEB..LO1*?9\ZC((I#(5M_V_?88;EM2QV,)?YX.K& ^2S%_O6CD,2W \
MB((N[(W(N!,9GQ1Y!Y(6I-*HEH*"4D+^0VU#E^RJC=,01WMJ>\*&<3CH%YMT
M8I.38F^-P!&:<-/^2$4!F4:*:)-8W"06J#[!R8&2BZLT' 9[@OO"HBC$_8K3
M3G%Z4G%7XG\/5;D:[U.:'OSA,(YC' [WI![&)<'5,$KVI/H[G<G>"G=$+EFE
M$(>% 0:7 V-6-IVVF6A1NV8U$]HDKAL6YG(":0/,_D((O9W8_M===_D?4$L#
M!!0    ( ,E!*%I-47IXE@(  +8'   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;*U5;6_3,!#^*U9 :)/&G+=FK*21VJ8()#9-FP8?$!_<Y-I8<^)@
MN^WX]]A.&MHMK2;8E\9W?I[G?&?W+MYP\2 + (4>2U;)D5,H50\QEED!)9'G
MO(9*[RRX*(G2IEAB60L@N265#/NN&^&2T,I)8NN[$4G,5XK1"FX$DJNR).+W
M!!C?C!S/V3INZ;)0QH&3N"9+N -U7]\(;>%.):<E5)+R"@E8C)RQ-YR%!F\!
MWRALY,X:F4SFG#\8XTL^<EQS(&"0*:- ]&<-4V#,".EC_&HUG2ZD(>ZNM^J?
M;.XZESF1,.7L.\U5,7(^."B'!5DQ=<LWGZ'-9V#T,LZD_46;!CL8."A;2<7+
MEJQ/4-*J^9+'M@X[!.\0P6\)_E-">( 0M(3@I1'"EA"^-,*@)=C4<9.[+5Q*
M%$EBP3=(&+16,PM;?<O6]:*5>2=W2NA=JGDJ&6<97U5*HEO(@*[)G,$9JO3[
M/$E!$<HDNB9"$'.;I^@]NK]+T<G;TQ@K'=LHX*R-,VGB^ ?B!.B*5ZJ0:%;E
MD/?PT^/\Z @?ZYR[Q/UMXA/_J. U7Y^CP#U#ONN'/>>9OIP>]*7S?]%G_QQ]
MKQA!]PH"JQ<<T)L*R*E"7[F4Z,=X+I70?^"??;?<Z(3].J:I#65-,A@YNFM)
M$&MPDG=OO,C]V%?BUQ1+7U-L]DIB>Y<1=I<1'E-/)B37K6ZN$#SJ:2"A[QH:
MA<@JF%&P3BZ]Z#+&Z]WR/@=Y7AAY^ZCT.<J_N!R$^ZC9<U04!OY%AVHRQ3N-
MJ 2QM!- (MMBFM?8>;LA,[:]]8E_X@VG7H\_U4.IF2%_Y9N)=D7$DE82,5CH
M4.[YA>Z3HID2C:%X;=O@G"O=5.VRT(,5A 'H_07G:FN8 -VH3OX 4$L#!!0
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MI=XDB_/J7[!<K?7%XDF1\RRI@T4&292N_I+7NA%K =#;$8#J +09@'<$X#H
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M^86>L:C+;MU1?&'KRI0K7:5LL]0W%1 F0+^?<:XV'2/0WGW2WU!+ P04
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M5[I.V^9"OZ0@3(">GW&N7CJF6'=O<_X74$L#!!0    ( ,E!*%KI_HT'_P$
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MOQ8+J0H8Z[.E)5SZPQJ^O>,Z-UPMRV25L4E88@C6D35J98VTLFZR+)<O.[A
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MN4?@N!4X[J/'&Z8/)%, A D$PT>B*$*7S!ITYT"V^ZHX& 2CNTGD5QT")JV
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M(5M[N1O#@9[,;@E?T$JHHY\K9N\\5JG@[;#3+B2KS;SPS*2:/LSE4@V(P'6
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M>7S/.9=+?\7%HYP!*/2[H$P.G)E2\PO7E=D,"BS/^!R8WIEP46"EIV+JRKD
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MZB_:-7TM \4E%S1O@N45Y&E1O^.OS40<!4B./L!I IQ^@/="@-L$N*=F\)H
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M:%7=F E#.A/4=-NWZ90:O(QS31$2%D#"0DA8! 3K+(QQNS#&T/>],:3$D+
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MGW075F][UR>";JIMV@<J!,VKPS7!"6&J@_S\D5*Q/U$)VG\^6/X'4$L#!!0
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MY!-02P$"% ,4    " #)02A:!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,E!*%KVTMX#[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( ,E!*%J97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ R4$H6@Q3WP[B!0  N!\  !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( ,E!*%KU+W,#AP<  +4?   8              " @28.  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #)02A:6K7/)0,#   *"@
M&               @('C%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ R4$H6F<[2(4V!P  LB$  !@              ("!'!D  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( ,E!*%I=X-HR'P<
M &@Q   8              " @8@@  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    " #)02A:.?Y]Q3@'  #-'@  &               @('=
M)P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ R4$H6E"+
M$*Z' @  O@<  !@              ("!2R\  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( ,E!*%J15' X0P(  ) &   8
M  " @0@R  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #)
M02A:YE3$/O\$  "4"@  &               @(&!-   >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ R4$H6EL^UWUC'0  950  !D
M         ("!MCD  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    " #)02A:3P \DM\"  !'!@  &0              @(%05P  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( ,E!*%JR#H<!PP(  /X%
M   9              " @69:  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ R4$H6N2XTP(Z P  ^@8  !D              ("!8%T
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #)02A:&V^N
MM4L#  #Z!@  &0              @('18   >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( ,E!*%KT*=K$MP(  !$&   9
M  " @5-D  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
MR4$H6D+(F4/Q @  ?@8  !D              ("!06<  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    " #)02A:^<D$:7<4   >/   &0
M            @(%I:@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( ,E!*%K)KNH,U L  "X=   9              " @1=_  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ R4$H6MS%X!7K @
M8P8  !D              ("!(HL  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    " #)02A:(+Y/WD,$  !W"0  &0              @(%$
MC@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( ,E!*%JQ
M?2*\B04  %T-   9              " @;Z2  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ R4$H6CU8/;/A @  3 8  !D
M     ("!?I@  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M" #)02A:9 3?+4X?  ",8P  &0              @(&6FP  >&PO=V]R:W-H
M965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( ,E!*%IE7@U;7@,  &<'   9
M              " @1N[  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L!
M A0#%     @ R4$H6N[(@TR6 @  M 4  !D              ("!L+X  'AL
M+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #)02A:I#6B>FH"
M  !*!0  &0              @(%]P0  >&PO=V]R:W-H965T<R]S:&5E=#(V
M+GAM;%!+ 0(4 Q0    ( ,E!*%I$F-;_^ (  &<&   9              "
M@1[$  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ R4$H
M6D9Q*NKB @  +@8  !D              ("!3<<  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    " #)02A:.CMCQ: "  #'!0  &0
M        @(%FR@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( ,E!*%KH?\_V1 (  "D%   9              " @3W-  !X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ R4$H6JWSPCT" P  $ <
M !D              ("!N,\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    " #)02A:0J9BU8@#  !J"   &0              @('QT@
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( ,E!*%I9\!P7
MDP0  +X*   9              " @;#6  !X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ R4$H6MND*/A!!   "!(  !D
M ("!>ML  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #)
M02A:#ACYTD &  "-&@  &0              @('RWP  >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( ,E!*%HO01'JH (  /H&   9
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M970T,"YX;6Q02P$"% ,4    " #)02A:G,B#SY$"  #"!P  &0
M    @(&J]@  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M ,E!*%H23DU++@0  -07   9              " @7+Y  !X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ R4$H6KU_NJ>[ @  !PD  !D
M             ("!U_T  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    " #)02A:AJE-2+D"  "G!P  &0              @(')  $ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( ,E!*%KI_HT'_P$
M &,$   9              " @;D# 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ R4$H6L6SF,3< P  PQ8  !D              ("!
M[P4! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #)02A:
M1U')M6@"   J!@  &0              @($""@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( ,E!*%KAAX>MI@,  "$0   9
M      " @:$, 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ R4$H6G@QNFE-"P  <Y,  !D              ("!?A ! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #)02A:&(4WL0X#  !^"@
M&0              @($"' $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( ,E!*%ICZ3O!  ,  &T*   9              " @4<? 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ R4$H6D7(IB-M
M P  4 T  !D              ("!?B(! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    " #)02A:4! >)]T"   0"@  &0
M@($B)@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( ,E!
M*%IP(@TOBP0  (@@   9              " @38I 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ R4$H6OG]Q4].!@  8"   !D
M         ("!^"T! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
M    " #)02A:41R &HD"  "Y!P  &0              @(%]- $ >&PO=V]R
M:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( ,E!*%H[=M]G)@,  $P2
M   -              "  3TW 0!X;"]S='EL97,N>&UL4$L! A0#%     @
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H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !  $  =Q$  %-$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>127</ContextCount>
  <ElementCount>269</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995612 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995613 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995614 - Disclosure - Accounts Receivable, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/AccountsReceivableNet</Role>
      <ShortName>Accounts Receivable, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Inventory, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/InventoryNet</Role>
      <ShortName>Inventory, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995616 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995617 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995618 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995619 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://reviv.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995620 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995621 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995622 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995623 - Disclosure - Concentrations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/Concentrations</Role>
      <ShortName>Concentrations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995624 - Disclosure - Business Segment and Geographic Area Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation</Role>
      <ShortName>Business Segment and Geographic Area Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995626 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995627 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995628 - Disclosure - Accounts Receivable, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/AccountsReceivableNetTables</Role>
      <ShortName>Accounts Receivable, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/AccountsReceivableNet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995629 - Disclosure - Inventory, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/InventoryNetTables</Role>
      <ShortName>Inventory, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/InventoryNet</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995630 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/PropertyAndEquipment</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995631 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/IntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995632 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995633 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://reviv.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/NotesPayable</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995634 - Disclosure - Stockholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/StockholdersEquity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995636 - Disclosure - Business Segment and Geographic Area Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables</Role>
      <ShortName>Business Segment and Geographic Area Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995637 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995638 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995639 - Disclosure - Accounts Receivable, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/AccountsReceivableNetDetails</Role>
      <ShortName>Accounts Receivable, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/AccountsReceivableNetTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995640 - Disclosure - Accounts Receivable, net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/AccountsReceivableNetDetailsNarrative</Role>
      <ShortName>Accounts Receivable, net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/AccountsReceivableNetTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995641 - Disclosure - Inventory, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/InventoryNetDetails</Role>
      <ShortName>Inventory, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/InventoryNetTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995642 - Disclosure - Inventory, net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/InventoryNetDetailsNarrative</Role>
      <ShortName>Inventory, net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/InventoryNetTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995643 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995644 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/IntangibleAssetsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995646 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/IntangibleAssetsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995647 - Disclosure - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995648 - Disclosure - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://reviv.com/role/NotesPayableDetails</Role>
      <ShortName>Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/NotesPayableTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995649 - Disclosure - Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://reviv.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/NotesPayableTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995650 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995651 - Disclosure - Stockholders' Equity (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/StockholdersEquityDetails1</Role>
      <ShortName>Stockholders' Equity (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995652 - Disclosure - Stockholders??? Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>Stockholders??? Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/StockholdersEquityTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995653 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995654 - Disclosure - Commitments and Contingencies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/CommitmentsAndContingenciesDetails1</Role>
      <ShortName>Commitments and Contingencies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995656 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/RelatedPartyTransactions</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995657 - Disclosure - Concentrations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/ConcentrationsDetailsNarrative</Role>
      <ShortName>Concentrations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/Concentrations</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995658 - Disclosure - Business Segment and Geographic Area Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails</Role>
      <ShortName>Business Segment and Geographic Area Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="axil-20241130_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995659 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://reviv.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://reviv.com/role/IncomeTaxes</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>axil-20241130.xsd</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="axil-20241130_10q.htm">axil-20241130_10q.htm</File>
    <File>axil-20241130_cal.xml</File>
    <File>axil-20241130_def.xml</File>
    <File>axil-20241130_lab.xml</File>
    <File>axil-20241130_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="633">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "axil-20241130_10q.htm": {
   "nsprefix": "axil",
   "nsuri": "http://reviv.com/20241130",
   "dts": {
    "schema": {
     "local": [
      "axil-20241130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "inline": {
     "local": [
      "axil-20241130_10q.htm"
     ]
    },
    "calculationLink": {
     "local": [
      "axil-20241130_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "axil-20241130_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "axil-20241130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "axil-20241130_pre.xml"
     ]
    }
   },
   "keyStandard": 234,
   "keyCustom": 35,
   "axisStandard": 15,
   "axisCustom": 0,
   "memberStandard": 17,
   "memberCustom": 19,
   "hidden": {
    "total": 61,
    "http://fasb.org/us-gaap/2024": 45,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://reviv.com/20241130": 11
   },
   "contextCount": 127,
   "entityCount": 1,
   "segmentCount": 38,
   "elementCount": 499,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 633,
    "http://xbrl.sec.gov/dei/2024": 30,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://reviv.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://reviv.com/role/ConsolidatedBalanceSheets",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://reviv.com/role/ConsolidatedStatementsOfOperations",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-05-31_us-gaap_PreferredStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-05-31_us-gaap_PreferredStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://reviv.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://reviv.com/role/Organization",
     "longName": "995612 - Disclosure - Organization",
     "shortName": "Organization",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies",
     "longName": "995613 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://reviv.com/role/AccountsReceivableNet",
     "longName": "995614 - Disclosure - Accounts Receivable, net",
     "shortName": "Accounts Receivable, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://reviv.com/role/InventoryNet",
     "longName": "995615 - Disclosure - Inventory, net",
     "shortName": "Inventory, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://reviv.com/role/PropertyAndEquipment",
     "longName": "995616 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://reviv.com/role/IntangibleAssets",
     "longName": "995617 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://reviv.com/role/OtherCurrentLiabilities",
     "longName": "995618 - Disclosure - Other Current Liabilities",
     "shortName": "Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://reviv.com/role/NotesPayable",
     "longName": "995619 - Disclosure - Notes Payable",
     "shortName": "Notes Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://reviv.com/role/StockholdersEquity",
     "longName": "995620 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://reviv.com/role/CommitmentsAndContingencies",
     "longName": "995621 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://reviv.com/role/RelatedPartyTransactions",
     "longName": "995622 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://reviv.com/role/Concentrations",
     "longName": "995623 - Disclosure - Concentrations",
     "shortName": "Concentrations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation",
     "longName": "995624 - Disclosure - Business Segment and Geographic Area Information",
     "shortName": "Business Segment and Geographic Area Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://reviv.com/role/IncomeTaxes",
     "longName": "995625 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995626 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995627 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://reviv.com/role/AccountsReceivableNetTables",
     "longName": "995628 - Disclosure - Accounts Receivable, net (Tables)",
     "shortName": "Accounts Receivable, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://reviv.com/role/InventoryNetTables",
     "longName": "995629 - Disclosure - Inventory, net (Tables)",
     "shortName": "Inventory, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://reviv.com/role/PropertyAndEquipmentTables",
     "longName": "995630 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://reviv.com/role/IntangibleAssetsTables",
     "longName": "995631 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://reviv.com/role/OtherCurrentLiabilitiesTables",
     "longName": "995632 - Disclosure - Other Current Liabilities (Tables)",
     "shortName": "Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://reviv.com/role/NotesPayableTables",
     "longName": "995633 - Disclosure - Notes Payable (Tables)",
     "shortName": "Notes Payable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://reviv.com/role/StockholdersEquityTables",
     "longName": "995634 - Disclosure - Stockholders\u2019 Equity (Tables)",
     "shortName": "Stockholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://reviv.com/role/CommitmentsAndContingenciesTables",
     "longName": "995635 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables",
     "longName": "995636 - Disclosure - Business Segment and Geographic Area Information (Tables)",
     "shortName": "Business Segment and Geographic Area Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails",
     "longName": "995637 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "995638 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "axil:ReverseStockSplitPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-05-31",
      "name": "us-gaap:PrepaidExpenseCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "axil:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://reviv.com/role/AccountsReceivableNetDetails",
     "longName": "995639 - Disclosure - Accounts Receivable, net (Details)",
     "shortName": "Accounts Receivable, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:CustomersReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:CustomersReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://reviv.com/role/AccountsReceivableNetDetailsNarrative",
     "longName": "995640 - Disclosure - Accounts Receivable, net (Details Narrative)",
     "shortName": "Accounts Receivable, net (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://reviv.com/role/InventoryNetDetails",
     "longName": "995641 - Disclosure - Inventory, net (Details)",
     "shortName": "Inventory, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://reviv.com/role/InventoryNetDetailsNarrative",
     "longName": "995642 - Disclosure - Inventory, net (Details Narrative)",
     "shortName": "Inventory, net (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:InventoryHeldAtThirdPartyLocation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:InventoryHeldAtThirdPartyLocation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://reviv.com/role/PropertyAndEquipmentDetails",
     "longName": "995643 - Disclosure - Property and Equipment (Details)",
     "shortName": "Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://reviv.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "995644 - Disclosure - Property and Equipment (Details Narrative)",
     "shortName": "Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://reviv.com/role/IntangibleAssetsDetails",
     "longName": "995645 - Disclosure - Intangible Assets (Details)",
     "shortName": "Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://reviv.com/role/IntangibleAssetsDetailsNarrative",
     "longName": "995646 - Disclosure - Intangible Assets (Details Narrative)",
     "shortName": "Intangible Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://reviv.com/role/OtherCurrentLiabilitiesDetails",
     "longName": "995647 - Disclosure - Other Current Liabilities (Details)",
     "shortName": "Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:CreditCards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:CreditCards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://reviv.com/role/NotesPayableDetails",
     "longName": "995648 - Disclosure - Notes Payable (Details)",
     "shortName": "Notes Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://reviv.com/role/NotesPayableDetailsNarrative",
     "longName": "995649 - Disclosure - Notes Payable (Details Narrative)",
     "shortName": "Notes Payable (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2020-05-31_custom_EconomicInjuryDisasterLoanProgramMember",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-05-31_custom_EconomicInjuryDisasterLoanProgramMember",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://reviv.com/role/StockholdersEquityDetails",
     "longName": "995650 - Disclosure - Stockholders' Equity (Details)",
     "shortName": "Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-01to2024-11-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://reviv.com/role/StockholdersEquityDetails1",
     "longName": "995651 - Disclosure - Stockholders' Equity (Details 1)",
     "shortName": "Stockholders' Equity (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-05-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-05-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://reviv.com/role/StockholdersEquityDetailsNarrative",
     "longName": "995652 - Disclosure - Stockholders\u2019 Equity (Details Narrative)",
     "shortName": "Stockholders\u2019 Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-06-012023-05-31",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://reviv.com/role/CommitmentsAndContingenciesDetails",
     "longName": "995653 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:RightOfUseAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:RightOfUseAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://reviv.com/role/CommitmentsAndContingenciesDetails1",
     "longName": "995654 - Disclosure - Commitments and Contingencies (Details 1)",
     "shortName": "Commitments and Contingencies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "995655 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "axil:InitialLeaseLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "995656 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2024-06-012024-11-30_custom_BZCapitalStrategiesMember",
      "name": "axil:ConsultingFee",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-012024-11-30_custom_BZCapitalStrategiesMember",
      "name": "axil:ConsultingFee",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://reviv.com/role/ConcentrationsDetailsNarrative",
     "longName": "995657 - Disclosure - Concentrations (Details Narrative)",
     "shortName": "Concentrations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-30",
      "name": "us-gaap:CashFDICInsuredAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-05-31",
      "name": "us-gaap:CashUninsuredAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails",
     "longName": "995658 - Disclosure - Business Segment and Geographic Area Information (Details)",
     "shortName": "Business Segment and Geographic Area Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:OtherGeneralAndAdministrativeExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://reviv.com/role/IncomeTaxesDetailsNarrative",
     "longName": "995659 - Disclosure - Income Taxes (Details Narrative)",
     "shortName": "Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2024-09-012024-11-30",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "axil-20241130_10q.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndNontradeReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndNontradeReceivableTextBlock",
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, net",
        "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r267"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Current Liabilities",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r702"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://reviv.com/role/AccountsReceivableNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNetDetails",
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "totalLabel": "Accounts receivables, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r649",
      "r710",
      "r888",
      "r889"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedRoyaltiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due in royalties",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r659"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less:Accumulated Depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r148",
      "r519"
     ]
    },
    "axil_AccumulatedReduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "AccumulatedReduction",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated reduction",
        "label": "AccumulatedReduction"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r702",
      "r922"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r563",
      "r824",
      "r825",
      "r826",
      "r827",
      "r869",
      "r925"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales, Marketing and Advertising",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r736",
      "r747",
      "r757",
      "r782"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r785"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r778"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r778",
      "r786",
      "r790",
      "r798"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation and related taxes",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r418"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/AccountsReceivableNetDetails": {
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r264",
      "r270",
      "r271",
      "r273",
      "r889"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization expense",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r290",
      "r296",
      "r681"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r125",
      "r152",
      "r180",
      "r214",
      "r222",
      "r247",
      "r251",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r449",
      "r453",
      "r469",
      "r509",
      "r599",
      "r673",
      "r674",
      "r702",
      "r717",
      "r860",
      "r861",
      "r877"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails",
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS",
        "verboseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r160",
      "r180",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r449",
      "r453",
      "r469",
      "r702",
      "r860",
      "r861",
      "r877"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated total assets",
        "documentation": "Amount of net assets (liabilities)."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r449",
      "r453",
      "r469",
      "r860",
      "r861",
      "r877"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "us-gaap_AutomobilesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AutomobilesMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Automobiles [Member]",
        "documentation": "Vehicles that are used primarily for transporting people."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "axil_BZCapitalStrategiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "BZCapitalStrategiesMember",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BZ Capital Strategies [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Principles of Consolidation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r146",
      "r657"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH - Beginning of period",
        "periodEndLabel": "CASH - End of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r81",
      "r176"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCREASE IN CASH",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r81"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, FDIC insured amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "axil_CashPaidDuringPeriodForAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "CashPaidDuringPeriodForAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid during the period for:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashUninsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashUninsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, uninsured amount",
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r153",
      "r154",
      "r155",
      "r180",
      "r201",
      "r205",
      "r209",
      "r211",
      "r216",
      "r217",
      "r266",
      "r323",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r361",
      "r362",
      "r365",
      "r368",
      "r375",
      "r469",
      "r553",
      "r554",
      "r555",
      "r556",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r585",
      "r608",
      "r630",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r806",
      "r820",
      "r828"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r216",
      "r361",
      "r362",
      "r363",
      "r365",
      "r368",
      "r373",
      "r375",
      "r553",
      "r554",
      "r555",
      "r556",
      "r687",
      "r806",
      "r820"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (see Note 10)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r118",
      "r512",
      "r584"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r315",
      "r316",
      "r651",
      "r853",
      "r858"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r707",
      "r708",
      "r709",
      "r711",
      "r712",
      "r713",
      "r714",
      "r824",
      "r825",
      "r827",
      "r869",
      "r920",
      "r925"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Common stock, par or stated value per share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r585"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r585",
      "r605",
      "r925",
      "r926"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.0001 par value: 450,000,000 shares authorized; 6,466,852 and 5,908,939 shares issued, issuable and outstanding as of November 30, 2024 and May 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r514",
      "r702"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r44",
      "r45",
      "r258",
      "r650"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r44",
      "r45",
      "r258",
      "r548",
      "r650"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r44",
      "r45",
      "r258",
      "r650",
      "r808"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/Concentrations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration risk, percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r44",
      "r45",
      "r258"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r24",
      "r44",
      "r110",
      "r650"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r44",
      "r45",
      "r258",
      "r650"
     ]
    },
    "axil_ConsolidatedOperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ConsolidatedOperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated operating income (loss)"
       }
      }
     },
     "auth_ref": []
    },
    "axil_ConsultingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ConsultingFee",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fee"
       }
      }
     },
     "auth_ref": []
    },
    "axil_ContractLiabilitiesDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ContractLiabilitiesDescription",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Liabilities Description"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities, current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r18"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r500"
     ]
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Sales",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r336",
      "r363",
      "r492",
      "r496",
      "r507",
      "r660",
      "r662"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "axil_CreditCards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "CreditCards",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Cards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r258"
     ]
    },
    "axil_CustomerDepositCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "CustomerDepositCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "auth_ref": []
    },
    "axil_CustomerDepositPolicytextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "CustomerDepositPolicytextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "axil_CustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "CustomerMember",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r842",
      "r843",
      "r844",
      "r845",
      "r847",
      "r849",
      "r851",
      "r852"
     ]
    },
    "axil_CustomersReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "CustomersReceivable",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/AccountsReceivableNetDetails": {
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/NotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r178",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r321",
      "r322",
      "r332",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r348",
      "r355",
      "r356",
      "r358",
      "r476"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r476",
      "r477",
      "r683",
      "r684",
      "r699"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r351",
      "r872"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r357",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r699",
      "r821",
      "r872",
      "r873"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r36",
      "r39",
      "r48",
      "r98",
      "r99",
      "r184",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r357",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r699",
      "r821",
      "r872",
      "r873"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income taxes",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r137",
      "r823"
     ]
    },
    "axil_DeferredTaxAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "DeferredTaxAsset",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r31"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r31"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated total depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r214",
      "r227",
      "r251",
      "r673",
      "r674"
     ]
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DilutiveSecuritiesAbstract",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive securities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r731",
      "r743"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "axil_DueToRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "DueToRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party"
       }
      }
     },
     "auth_ref": []
    },
    "axil_EIDLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "EIDLMember",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EIDL [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r199",
      "r201",
      "r209",
      "r210",
      "r211",
      "r213",
      "r444",
      "r447",
      "r463",
      "r464",
      "r504",
      "r525",
      "r665"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r201",
      "r209",
      "r210",
      "r211",
      "r213",
      "r444",
      "r447",
      "r463",
      "r464",
      "r504",
      "r525",
      "r665"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income per share of Common Stock",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r212"
     ]
    },
    "axil_EconomicInjuryDisasterLoanProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "EconomicInjuryDisasterLoanProgramMember",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Economic Injury Disaster Loan Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r140",
      "r164",
      "r165",
      "r166",
      "r185",
      "r186",
      "r187",
      "r189",
      "r194",
      "r196",
      "r198",
      "r215",
      "r268",
      "r269",
      "r303",
      "r376",
      "r434",
      "r435",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r462",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r478",
      "r479",
      "r486",
      "r524",
      "r542",
      "r543",
      "r544",
      "r563",
      "r630"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r736",
      "r747",
      "r757",
      "r782"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r733",
      "r744",
      "r754",
      "r779"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ExtendedProductWarrantyPolicy",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product warranty",
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value measurements and fair value of financial instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r277",
      "r295",
      "r681"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r501",
      "r502",
      "r655"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r295",
      "r502",
      "r681"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r295",
      "r297",
      "r298",
      "r301",
      "r501",
      "r655",
      "r681"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r655"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets",
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "verboseLabel": "Finite-lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r849"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "axil_GainOnDebtSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "GainOnDebtSettlement",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on settlement",
        "negatedLabel": "Gain on settlement"
       }
      }
     },
     "auth_ref": []
    },
    "axil_GainOnForgivenessOfAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "GainOnForgivenessOfAccountPayable",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on forgiveness of account payable",
        "label": "GainOnForgivenessOfAccountPayable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r610"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r278",
      "r503",
      "r674",
      "r680",
      "r693",
      "r702",
      "r839",
      "r840"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r838",
      "r841"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Total segment gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r75",
      "r124",
      "r180",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r469",
      "r667",
      "r673",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r860"
     ]
    },
    "axil_HairCareAndSkinCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "HairCareAndSkinCareMember",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hair care and skin care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_HearingEnhancementAndProtectionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "HearingEnhancementAndProtectionMember",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hearing enhancement and protection [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r290",
      "r300"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of long-lived assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r93"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "INCOME BEFORE PROVISION FOR INCOME TAXES",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r120",
      "r124",
      "r505",
      "r521",
      "r667",
      "r673",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r311",
      "r312",
      "r466",
      "r467",
      "r468",
      "r539",
      "r541",
      "r615",
      "r655",
      "r694",
      "r891"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r466",
      "r467",
      "r468",
      "r539",
      "r541",
      "r615",
      "r655",
      "r694",
      "r891"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r421",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r432",
      "r436",
      "r438",
      "r439",
      "r440",
      "r558",
      "r690"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations",
      "http://reviv.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for income taxes",
        "verboseLabel": "Income tax expense",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r138",
      "r197",
      "r198",
      "r214",
      "r230",
      "r251",
      "r424",
      "r425",
      "r437",
      "r526",
      "r690"
     ]
    },
    "axil_IncomeTaxLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "IncomeTaxLiability",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r422",
      "r423",
      "r429",
      "r430",
      "r431",
      "r433",
      "r552"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r83",
      "r819",
      "r864",
      "r865"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r818"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r211"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible preferred stock",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r207",
      "r211"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r778",
      "r786",
      "r790",
      "r798"
     ]
    },
    "axil_InitialLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "InitialLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "axil_InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial recognition of right of use assets recognized as lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r801"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r801"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r801"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r299",
      "r302",
      "r654",
      "r655"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense and other finance charges",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r816"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r174",
      "r175"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "axil_IntrepidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "IntrepidMember",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrepid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/InventoryNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory, net",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/InventoryNetDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/InventoryNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished Goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "axil_InventoryHeldAtThirdPartyLocation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "InventoryHeldAtThirdPartyLocation",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/InventoryNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory held at third party location"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://reviv.com/role/InventoryNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets",
      "http://reviv.com/role/InventoryNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, net",
        "totalLabel": "Inventory",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r658",
      "r702"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r145",
      "r157",
      "r274",
      "r275",
      "r276",
      "r499",
      "r663"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/InventoryNetDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/InventoryNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw Materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "us-gaap_InventoryValuationReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryValuationReserves",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/InventoryNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory valuation reserves",
        "documentation": "Amount of valuation reserve for inventory."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r813"
     ]
    },
    "axil_LeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "LeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liability",
        "label": "LeaseLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDiscountRate",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Discount Rate",
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of maturities of operating lease liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 (six months remaining)",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities [Default Label]",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r51",
      "r52",
      "r53",
      "r55",
      "r56",
      "r57",
      "r58",
      "r180",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r450",
      "r453",
      "r454",
      "r469",
      "r583",
      "r666",
      "r717",
      "r860",
      "r877",
      "r878"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r119",
      "r516",
      "r702",
      "r822",
      "r837",
      "r871"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r144",
      "r180",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r450",
      "r453",
      "r454",
      "r469",
      "r702",
      "r860",
      "r877",
      "r878"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r55",
      "r56",
      "r57",
      "r58",
      "r180",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r450",
      "r453",
      "r454",
      "r469",
      "r860",
      "r877",
      "r878"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG TERM LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "axil_LicensingRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "LicensingRightsMember",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_LoanForgiveness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "LoanForgiveness",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan forgiveness"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansAndLeasesReceivableLeaseFinancingPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansAndLeasesReceivableLeaseFinancingPolicy",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Accounting",
        "documentation": "Disclosure of accounting policy for recording, valuing, and reporting amounts due from lessees pursuant to contractual arrangements, which are secured, at a minimum, by the asset being rented, and in measuring certain revenues, expenses and gains and losses arising from creating, acquiring, collecting, terminating, modifying and holding lease agreements."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r113"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/NotesPayableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/NotesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r117",
      "r345",
      "r359",
      "r683",
      "r684",
      "r699",
      "r886"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/NotesPayableDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/NotesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r184",
      "r350"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r854",
      "r855",
      "r856"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r33",
      "r854",
      "r855",
      "r856"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r258",
      "r688",
      "r703",
      "r706",
      "r863",
      "r890",
      "r892",
      "r893",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r382",
      "r419",
      "r465",
      "r497",
      "r538",
      "r540",
      "r547",
      "r575",
      "r576",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r652",
      "r653",
      "r679",
      "r687",
      "r689",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r862",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "axil_MerchantProcessorReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "MerchantProcessorReceivable",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/AccountsReceivableNetDetails": {
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merchant processor receivable"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r382",
      "r419",
      "r465",
      "r497",
      "r538",
      "r540",
      "r547",
      "r575",
      "r576",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r652",
      "r653",
      "r679",
      "r687",
      "r689",
      "r695",
      "r696",
      "r697",
      "r704",
      "r862",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "auth_ref": [
      "r258",
      "r688",
      "r703",
      "r706",
      "r863",
      "r890",
      "r892",
      "r893",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r84"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows",
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCOME",
        "label": "Net income",
        "verboseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r84",
      "r121",
      "r142",
      "r161",
      "r162",
      "r166",
      "r180",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r197",
      "r198",
      "r208",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r444",
      "r447",
      "r464",
      "r469",
      "r523",
      "r607",
      "r628",
      "r629",
      "r715",
      "r860"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET INCOME PER COMMON SHARE:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently Issued Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other income (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INCOME (EXPENSE):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52"
     ]
    },
    "axil_NumberOfOptionIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "NumberOfOptionIssued",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of option issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "axil_OfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "OfficersMember",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_OneConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "OneConsultantMember",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Consultant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_OneCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "OneCustomerMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING EXPENSES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "INCOME FROM OPERATIONS",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r667",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r701"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails",
      "http://reviv.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease liability, net",
        "verboseLabel": "Present value of lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liability, current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "axil_OperatingLeaseLiabilityCurrentPortion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "OperatingLeaseLiabilityCurrentPortion",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current portion",
        "label": "OperatingLeaseLiabilityCurrentPortion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails",
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liability",
        "verboseLabel": "Non-current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails",
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use asset",
        "verboseLabel": "Operating lease assets, net",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "axil_OperatingLeaseRightOfUseAssetAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated reduction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r701"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/Organization"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r109",
      "r549",
      "r550"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r151",
      "r508",
      "r674",
      "r717"
     ]
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other current liabilities",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r924"
     ]
    },
    "us-gaap_OtherInventoryInTransit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInventoryInTransit",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/InventoryNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory in-transit",
        "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported."
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total other current liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r510",
      "r579",
      "r580",
      "r717",
      "r887",
      "r921"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r702"
     ]
    },
    "us-gaap_OtherNonoperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "documentation": "Amount of income related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r738",
      "r749",
      "r759",
      "r784"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r762",
      "r787"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r762",
      "r787"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r766"
     ]
    },
    "axil_PayableToRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "PayableToRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable to related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of intangibles",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated total payments for property and equipment",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r866",
      "r867",
      "r868"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "axil_PreferredStockConvertedToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "PreferredStockConvertedToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred shares converted to common"
       }
      }
     },
     "auth_ref": []
    },
    "axil_PreferredStockConvertedToCommonStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "PreferredStockConvertedToCommonStockShares",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred shares converted to common, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r707",
      "r708",
      "r711",
      "r712",
      "r713",
      "r714",
      "r920",
      "r925"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "verboseLabel": "Preferred stock, par or stated value per share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r361"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r585"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r361"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r585",
      "r605",
      "r925",
      "r926"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 31,133,500 and 42,251,750 shares issued and outstanding as of November 30, 2024 and May 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r513",
      "r702"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_PrepaidExpenseCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrentAndNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r159",
      "r598",
      "r885"
     ]
    },
    "axil_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional borrowings",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances (payments) from a related party",
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts."
       }
      }
     },
     "auth_ref": []
    },
    "axil_ProductCertificationTestingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ProductCertificationTestingMember",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Certification Testing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductConcentrationRiskMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional and consulting",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r715",
      "r923",
      "r924"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r161",
      "r162",
      "r172",
      "r180",
      "r188",
      "r194",
      "r197",
      "r198",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r444",
      "r447",
      "r448",
      "r451",
      "r452",
      "r464",
      "r469",
      "r505",
      "r522",
      "r562",
      "r607",
      "r628",
      "r629",
      "r691",
      "r692",
      "r716",
      "r815",
      "r860"
     ]
    },
    "axil_PromotionalRisplayRacksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "PromotionalRisplayRacksMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promotional Risplay Racks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r485"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r132",
      "r135",
      "r136"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plant Equipment",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r147",
      "r520"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets",
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r485",
      "r506",
      "r520",
      "r702"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r132",
      "r135",
      "r518"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property and equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r485"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNetDetailsNarrative",
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bad debts",
        "verboseLabel": "Bad debt expense",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r272"
     ]
    },
    "axil_PurchasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "PurchasesMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r380",
      "r382",
      "r409",
      "r410",
      "r411",
      "r419",
      "r465",
      "r494",
      "r495",
      "r497",
      "r538",
      "r540",
      "r547",
      "r575",
      "r576",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r652",
      "r653",
      "r679",
      "r687",
      "r689",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r709",
      "r857",
      "r862",
      "r870",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r380",
      "r382",
      "r409",
      "r410",
      "r411",
      "r419",
      "r465",
      "r494",
      "r495",
      "r497",
      "r538",
      "r540",
      "r547",
      "r575",
      "r576",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r652",
      "r653",
      "r679",
      "r687",
      "r689",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r709",
      "r857",
      "r862",
      "r870",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable and allowance for doubtful accounts",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r265",
      "r836"
     ]
    },
    "us-gaap_Reclassifications": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Reclassifications",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassifications",
        "documentation": "The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r733",
      "r744",
      "r754",
      "r779"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r381",
      "r490",
      "r491",
      "r511",
      "r517",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r604",
      "r606",
      "r637"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r611",
      "r612",
      "r615"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r381",
      "r490",
      "r491",
      "r511",
      "r517",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r604",
      "r606",
      "r637",
      "r876"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r488",
      "r489",
      "r491",
      "r493",
      "r559",
      "r560",
      "r561",
      "r613",
      "r614",
      "r615",
      "r634",
      "r636"
     ]
    },
    "axil_RemainingOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "RemainingOutstanding",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "axil_RepaymentOfEquipmentFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "RepaymentOfEquipmentFinancing",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of equipment financing"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of note payable",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "auth_ref": [
      "r182",
      "r183",
      "r336",
      "r363",
      "r492",
      "r496",
      "r507",
      "r661",
      "r662"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r734",
      "r745",
      "r755",
      "r780"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r746",
      "r756",
      "r781"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r742",
      "r753",
      "r763",
      "r788"
     ]
    },
    "axil_RestrictedStockAwards": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "RestrictedStockAwards",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards"
       }
      }
     },
     "auth_ref": []
    },
    "axil_RestrictedStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "RestrictedStockAwardsMember",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings/(Accumulated deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r100",
      "r515",
      "r545",
      "r546",
      "r557",
      "r586",
      "r702"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r185",
      "r186",
      "r187",
      "r189",
      "r194",
      "r196",
      "r198",
      "r268",
      "r269",
      "r303",
      "r434",
      "r435",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r455",
      "r457",
      "r458",
      "r460",
      "r462",
      "r478",
      "r479",
      "r542",
      "r544",
      "r563",
      "r925"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r656",
      "r664"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales, net",
        "verboseLabel": "Total net sales",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r167",
      "r180",
      "r214",
      "r223",
      "r224",
      "r245",
      "r251",
      "r255",
      "r257",
      "r258",
      "r266",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r469",
      "r505",
      "r673",
      "r860"
     ]
    },
    "axil_ReverseStockSplitPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ReverseStockSplitPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split"
       }
      }
     },
     "auth_ref": []
    },
    "axil_RightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "RightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_RoyaltyPaymentAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "RoyaltyPaymentAccrual",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Payment Accrual"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Tax Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r807"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://reviv.com/role/AccountsReceivableNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts receivable",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r67"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net loss per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r295",
      "r297",
      "r298",
      "r301",
      "r501",
      "r655",
      "r681"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r848"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://reviv.com/role/InventoryNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventory",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r68",
      "r69",
      "r70"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://reviv.com/role/NotesPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of notes payments due in the next twelve months",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://reviv.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r485"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://reviv.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r611",
      "r612",
      "r615"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of segment information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock options activities",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option assumptions",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r96",
      "r98",
      "r99",
      "r100",
      "r153",
      "r154",
      "r155",
      "r216",
      "r361",
      "r362",
      "r363",
      "r365",
      "r368",
      "r373",
      "r375",
      "r553",
      "r554",
      "r555",
      "r556",
      "r687",
      "r806",
      "r820"
     ]
    },
    "axil_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ScheduleOfSupplementalBalanceSheetInformationTableTextBlock",
     "presentation": [
      "http://reviv.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of supplemental balance sheet information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r125",
      "r214",
      "r219",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r258",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r301",
      "r313",
      "r314",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r670",
      "r673",
      "r674",
      "r680",
      "r705",
      "r890",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Segment and Geographic Area Information",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r214",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r234",
      "r236",
      "r237",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r258",
      "r668",
      "r671",
      "r672",
      "r673",
      "r675",
      "r677",
      "r678"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r254",
      "r257",
      "r669",
      "r670",
      "r676"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "verboseLabel": "Selling and marketing expense",
        "terseLabel": "Selling and Marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Stock-based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options Outstanding, Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Options Outstanding, Beginning",
        "negatedLabel": "Number of Options Outstanding, Ending",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Beginning",
        "label": "Number of Options Outstanding, Ending",
        "verboseLabel": "Exercise price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options Outstanding, Vested",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Vested",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised/Forfeited",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r387",
      "r406",
      "r407",
      "r408",
      "r409",
      "r412",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Term, Vested",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation, shares",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "axil_ShippingAndHandlingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ShippingAndHandlingCostsPolicyTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping and Handling Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r177"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://reviv.com/role/BusinessSegmentAndGeographicAreaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r125",
      "r141",
      "r214",
      "r219",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r258",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r301",
      "r305",
      "r313",
      "r314",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r670",
      "r673",
      "r674",
      "r680",
      "r705",
      "r890",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r153",
      "r154",
      "r155",
      "r180",
      "r201",
      "r205",
      "r209",
      "r211",
      "r216",
      "r217",
      "r266",
      "r323",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r361",
      "r362",
      "r365",
      "r368",
      "r375",
      "r469",
      "r553",
      "r554",
      "r555",
      "r556",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r585",
      "r608",
      "r630",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r806",
      "r820",
      "r828"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r64",
      "r65",
      "r140",
      "r164",
      "r165",
      "r166",
      "r185",
      "r186",
      "r187",
      "r189",
      "r194",
      "r196",
      "r198",
      "r215",
      "r268",
      "r269",
      "r303",
      "r376",
      "r434",
      "r435",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r462",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r478",
      "r479",
      "r486",
      "r524",
      "r542",
      "r543",
      "r544",
      "r563",
      "r630"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r215",
      "r479",
      "r500",
      "r551",
      "r574",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r585",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606",
      "r609",
      "r610",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r630",
      "r710"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r215",
      "r260",
      "r479",
      "r500",
      "r551",
      "r574",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r585",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606",
      "r609",
      "r610",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r630",
      "r710"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r748",
      "r758",
      "r783"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued during the period",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r59",
      "r60",
      "r100",
      "r553",
      "r630",
      "r644"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of restricted stock awards issued",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r59",
      "r60",
      "r100"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options Outstanding, Exercised/Forfeited",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r59",
      "r60",
      "r100",
      "r393"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for valued",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued value during the period",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r59",
      "r60",
      "r100",
      "r563",
      "r630",
      "r644",
      "r716"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of restricted stock",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r100"
     ]
    },
    "us-gaap_StockOptionPlanExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionPlanExpense",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options expense",
        "documentation": "Amount of noncash expense for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share purchased",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r59",
      "r60",
      "r100",
      "r556",
      "r630",
      "r646"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash consideration",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r59",
      "r60",
      "r100",
      "r563",
      "r630",
      "r646",
      "r716"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://reviv.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets",
      "http://reviv.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r64",
      "r65",
      "r89",
      "r587",
      "r605",
      "r631",
      "r632",
      "r702",
      "r717",
      "r822",
      "r837",
      "r871",
      "r925"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://reviv.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r179",
      "r360",
      "r362",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r376",
      "r461",
      "r633",
      "r635",
      "r648"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Reverse Stock Split",
        "verboseLabel": "Reverse stock split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "axil_ThreeBoardMembersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ThreeBoardMembersMember",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Board Members [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r835",
      "r875"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r849",
      "r850",
      "r851",
      "r852"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r130",
      "r131",
      "r133",
      "r134"
     ]
    },
    "axil_ValueOfOptionIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "ValueOfOptionIssued",
     "crdr": "credit",
     "presentation": [
      "http://reviv.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of option issued"
       }
      }
     },
     "auth_ref": []
    },
    "axil_VendorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "VendorOneMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendors One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_VendorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "VendorsMember",
     "presentation": [
      "http://reviv.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "axil_WebsiteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://reviv.com/20241130",
     "localname": "WebsiteMember",
     "presentation": [
      "http://reviv.com/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Website [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted",
        "label": "Weighted average dilutive shares",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r211"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://reviv.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails",
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic",
        "label": "Weighted average basic shares",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r211"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://reviv.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://reviv.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479910/205-30-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481440/840-10-50-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-4"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "840",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481161/840-30-50-4"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310/tableOfContent"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/326/tableOfContent"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/705/tableOfContent"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0001520138-25-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001520138-25-000029-xbrl.zip
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MZ<:C/EE4U;7XA.Z0+79C?[H/RQCF(CL:N'*(535&;J;&EF71]KU27.%YK$Q
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MV88D1$\2,PR7X23?0S(6:$\]"/[]I6N\+'U.+L.SWG/FB#.]4O1S2[;&&%?
M#+J]=\(?X!V<X%TXM#)=61Z,+^[(5@L_UOUA]F+3T( 5>#7^9>IRQ38S]F@
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MUZFW;.J]@O^](=)X?(;$,28 1#\ 8;)[?);),"(T0C$!(85CP2?>QV<_N9@
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MJ4X5*A=4Z7?QNE"Y*AT5J[>WY7J]7*TD LR'0OVZ7+EJ5"LT=5&D.$84\ML
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M=E<I98@*AO&E Q.T =;;+$?AH@:+^@2?!^E,64.H(JV>@?8"CMQ]3;LGVS/
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MG4?M,<\;+J0=S7BU4%<-%#)U@(OY!Z8!E7W?"?_18P=P,4[CJ;L4_\/'))F
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MZA9J]3A9:9\F #B*;O'1!&.?-*C_]R2FPM.5 (NU!);@8 >7-GDTLG.Z2U;
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MZ)*7LK28)VPO(]N ]@H[BOA?8%X ?/)CL, ]7]QRM;ZAOM>V7M[AP8=.@4(
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M#@@TU+=D(=_LP$NNPLE Y.81%V%QD$Q8]Z9U=%LGZC(7DOCH$HYF)1[Z[^E
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M4/SQ18T\^7EADD2S6<)=SJ2SG92R762VFV$HXG*8&!DJ#2U3"%,(4PCW&\+
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MZ;P@T5G2X?D)&/ 3W&GMO6_M\3LAHP@ H.1V&[IXLCY";IINV/!QMH&VPBT
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MFY1X%1 NM5@VN@ =H]V9'HS-T]/;7]_;WZOY9Q#/:)ADG.S(>_K L' X.V5
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MG,+^@)%D]"?O/K5<*E)&RX#=?$>U-'C]V.KMTO[K'UWYO6</=)J!]&!X0\D
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M>DFZS'K=YV_ SX)FWH-6+M_"_UF(8/XJ'2WP!L\QNCX^+47P1$2%C5<-Q"B
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MYLV18/V4$R5O@1?W8:B^-[0=<E2AD$.*8#X(^'.?1ZJ1H[,5'7T$&@7Y*?K
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M#4\E2XSO[B=F4(@49,J_\BAL:3L@A=RQ35R]KX3RAWA/B#$YBC&^P@CK>)6
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M-*MK5"*4+@B<%9%+K#O%/)6^K!@J0S$3WP0H.1!%A)0G74:HEW4Z)E[$M*F
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MR!$A11!A?-H5U^PJX:H 0.J ,1-DA_J#NXJTP.FB)MSLAZ$.DDZ]I3ER>L_
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M%)L%I5Q9<Z;J9@D I:2K?JD^G/)JG,2;_OV7?MB]L6Y+I_6G]-B+T=CJ@QR
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M,N5IY*7C)!_T2Y).<<TFY?1CAYR#.[FA-!(+!UZ.-K.JGV\C;>;E4TE<A\E
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M()4*DGL$1%V?F6#L3/?M[[WI3Z]M'][^35T!2IUIY<B;C&^_7IN]L-_!@JX
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M1^_I5)J FBA2*E#<G  NA2$:O$-'-J@/]SHR;F(MQ2#7KO0$ IA8?C\$86'
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M@E\.-NN*.C^][=K1(<)>Z_K:>F]_'7G5W'*,S]M=:?N<EMYLAXLJ145H+A7
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M<:J')$7>_#@< 2#IC3_)B P>I6.7<U\8K3D"?&UF3!--9NK0-R*SU?H!2$I
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MQ S55O?.]M'F% N+!\3J^_(596"B"C[K$Y :(NCRS*[D@ZN%!P_5JWO7^XG
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M%D'XF]2"1QO',SX\MW@NV&9K]6(ZS83D@$G?7SV\*>&/JR0M_Z*W:NEFN5R
M*ZNBE<I-K;2JIK+YXLWC3"+8<,'FDQ/!2C6:Y7(!WILJJ*M-S6AL+1&44XG
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M=;;IY/.GZJ?3P\ZIL8QW<5LD23&CUYY>DKR,%'F!\%>&\*F;,UV:CV1?HC1
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MY7>G4^M\>OA8>_6.0:8":)8O.Q+MB!;S#2Y)<]@)AFP8=N"!#@-$8H_4B?F
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M6,U%58B9MO"94W@<1"F9J0#"9VEA,]^!"C">@/H >-_[3$LBQ J9\FM $H4
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M7:: C(E-PZ$6%S)6*L,J<QAV?].'^(026MH$+MPVH"Q)G0"^BOZU/LGPB:N
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MB= N[ 8U_^0QRX7(*L(K=X@Y&-VHP$)M)V I)B&9PB9.V(]R"G;7&B&!$J/
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MXMP9,B-F.I',T:)>I##X'OF[+ 9QO;!&@7NXF&X2815Y:6E2E$6*UNGQ,*.
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MKL-_E)SI)1&7&00S_PX HBBZ]77MUG 7 .5IYGBA^X ^-!0/&"J! D $5,!
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M*JXLN3P!PF4*?#(YRU[=RXAKE1%/G_QPS>SP0.:DMQ 2KRH(GEQ"$%R*[[_
M?;4>V&N WL7\83W3N *?7+N*:\7;!SB%H **_60.A\YGG1&1>1M<]1Y)*Q2N
M%*V"8Y6*T4RF]ZCYAE S3L#$$_UB/@'L /\C!&7,!E5PCZEO#5,?9%2H>T1]
M^X@Z+E)_)C-@>\C\[O'S[>"G]"W=ZPG?%F:,,C=" ZN(;@4WUV,9URTP&.Y_
M'CT2AZ&*@E?B6)ZJU_#.GP6JK#"T>/3(K.N@]\',RZ,] FR\$B\7N1G>[I.^
MJ^U]K[EWQ_ISK;VZ-5B%9=.,JYE[3?RMI:>J[1JI*;U1MW^>/:O9/\TGT.G6
MYBI?_]:S'UK#3G4*,-A_\QC0T(*12:KDIT<3-4U BQ4+0N,EL 1;/:XB%4C$
M=4<=5V=T2.4QT@J3QQ>3Y'W8ZS[L=;EYVH-=HO/KL-M]W[W;8:_Q+,ST[$U
M;&_5(%&N<Z<2*;)*1CU<Y(E HL]06O=B51\1V4+YX32$1Q*.:+4%U8P7DWV.
M808[#928G).;<J+R,W1^-D)AGI#B0$7R#$P'X.OI(DDE>CI%,]*UG\P7,CYO
MKM[X0=FSJK:W8CF'M8:KUUIQC[;$U,J8@U>;3H#*X<_(-XOP*C(8;*92!9-Q
M6'""L4" '08B$UB#'Q4 !EBWR K?5UF6I.C@=:9 &)V%\"K\ G_B:@ >A(M
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MZ5UWV#T<#+L(?0]A# #*0K Z2!A9\IX7>2$C0+:: X?EX!QFGJ2Y_(19'^W
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MM',M,L;4G,/=)EK,5YJ9Q?FF^U0]!-(05N8R0U/RMP1]&:<C,<5"ZH\B#;.
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M]O?>N ]L&N\8&'8'A[@0K\P8<'H-4Z3>VD(DDEW5%3M,ZW)8QYUAC6L*;',
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M@!E,W?!@#C>=O[5#WZ4;,WI\BP8:3,I8,F9:JZ*?IGA+A^[#2#U?(AJ>^@"
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M2P5!B@GPHY=*,R!Q$LN0,BAMT'4L390J4V <)1.M4H_9H5:1B'';L"U -!;
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M;+E:;;Q[RF4QIJ(CQ67]\AT_A>L7\W\!4$L#!!0    ( ,E!*%K8!Q3MN04
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MAS.?OPI6]1-T\B:MGZ[_!E!+ P04    " #)02A:$1U [!N[  "1300 &P
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M-=V\,<O;6HY21267? <&42J.*_&Y'AF8TT(XD5R])9:+;%KBE6,#=Z$M\-:
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M-. -=S]^2R&V5U!D*:J(O@F'N+@OTA4%FQ:Q7?H2)T">(ZK(0L^=:MURN=B
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MWBP'H0&'GEZ!SS1XR++IM"TR#"YV$+ 899W;S138+<&!A<.'9A46%V!Y#^5
MT$&A)'W.S,0;25Y202EL-_)$;3&&MQ%PL,)4C['>I-'LA#"XR[/4A?*A0@[/
MY,K<^RQXF-18(#FP+0\L7\WDWM(_+#2;UM?ZF%(_>#H E^$S;\OUM>VD336P
M#>5VF8@OEX+W(^1R-R^+(#@X*AQXC120EVT\'<"*8"R=!(GT B*[C!:/)IAC
M#+W6)]G$UOMTPN%4(>JU%QPZ3"R'D!2-"X(\P3+GJ28A(/*T9J+.FMSFTS:A
M8^4(?(6YS\-CU'4[Y191!<E[A?:2#)4N@\+9H@DAAOH)OTJ,.,7,2"W;-?OJ
MJM"![!,"__KUKW8Q>/HM3P4+8L$:P;M 59,XKCW0=XT'<Q#ID&98K$Z]$MFV
M3AJGDB:4R"HB/U')24JK2ZQ[$7>(9UQ/T^Z>5C6F](Y"V(A2;C8C0HH\YXZZ
M1*MCO]O)_#OB%[YA!/_1*H)_/Q'\1ZL(_BJ"?QL1_.>W'<%_(X;.)U2^=6UI
MM47^BY&^&)/)IIX:<MHF8LB%:31OGN>: .X78_M0 5M7S:6VK$W%@E*"3Q:M
MW+'=2=T-#M#:F$G/.H@\N1SI?/:F:I),LWP.QQPLI >R,[PY?(YG!Z166;V(
MCDQ*\3LF[Z/GB58$BR,#$\5:/PP<<#:'L]S\ A=K%YLO9MPVBXR#H>)>AOZ2
MBAPS'L!KQ@T.Z^9+-CND@T;C66K6+[*F#$R2R]G;0<&;.F2Q?E1>(:*,FK=$
M<,XRX)JKQ<^/V53@3Q<;(1$PD3,O%MQJ^=C]3;@A/5>E_2JU8HUQT_(,@L\,
M-VRJA1)VPE6<.X.Y7XJG!3.6S(BU)S!.<"A>ZD?,;@& !WWA";*C8T5?^>K!
M1G]BK+%K[4!]AOID>@&?&$TP>^U^X3GQ[SHTQDOKR06)."X"1(P0WH/OGUA$
MJF>?"B@I-6/VY92-L/LEL$6(=D] 5IVDCZ5/\QX[8(%W3_I0?Q8QS6',Y.;
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M2,0B#109*763WE0R&I=E8L<FS)@>!VR#8WM-J8HA4\I".G/^984R7Z@=-<9
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M.32V>!&7JA V':3CX$!'EK@]$,>GD%B8<*!3!DZ7.5?](T-HWU+^7XT@C2"
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M7>^1Z4X'O>%;-R/\##R>A[,?_GX(G2M/A<U;?OYHXE7+2F@%_?:;MT-><WW
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MSLV+;].Y6=?'NSU_OK[SY\5#/']^VIX_V_-G>_Y\\?GS\ML\?^@1^_1X@T
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M,WM@M:N/,)%T&4/B'2XPK S2/79<(KTE)B<%XST8Y[/]%48[L+V!CQZ6@<\
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M78)SS+]8//AM].K%X4L4=3J >G_%Z9BR+U>#=;VW>7Z7O=W??WAX>)'2>_1
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M4Q;V/44 4V10=0<SL#F^IN7=9=T43"[G>R8 &[>T"H;4VJO3<?A@99/S/74
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M]Y56#G(<;7:0(_JA4O>/NSB68KG7M*+62Y-:HVO^XW/_@JLT/(N&E_VKWO6
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MS;?$I\(L@1.YO )Z->0HKX)NPC"L/N#<_>!;XKZ))0-O%+7KV#89N!O&5MV
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M0C%]P!JT235Y?0ZFHBG5I#MV,16Q"43T %*F5T56BQ^L:#FIH$YPH];H1GW
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M_9B?KHHY$8K-Z@9IR_B1*P#.0,:XNN5G^2'VSA$-_7 1R4BJ+S^K&X(M8T>
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M4IFZ.[6*L_WV7Y'^?T7Z^]7M](%&^F>+LV<M\T>>Q''^0B&[H_P5]+4H5 E
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M:/E]0JFEA!LE^L;<^DX]I8@_BU(TQ'/GSL'P_]PSL[#?_#]02P,$%     @
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M!E5&B%O!\5\W6SI]++8$TZ_A)GYA_])/^74&+KV5F7C;2:G1WM5E3;&OKL:
M#X5K$SC28GLTVP*3QLF:5KCE:,?KW#K*O=5N&12,G/3\)"O?'(T:N-])U#TE
M)QL\]9ZYFC()=.J94O/ >[O+V,A6=NAL.0YI?_01!SGU%V53GW$MQS1;IO/W
M]78M=0V2Y\[FR#):S?2X_1!$P\L8]1N_PL#I'Y2#<</FN<$*Q)1)MZ6N-?$N
MIV$\)2->;G6!N!T?F0#I4C[28;S6TW2?NUN-D]#:+\2]0/,T$D:"IRDQ<#S-
M;+F,0VSG7Q18EUY%2[?M2Z1 [S*Q8=>73(EUYBJ&1%]L"SJ)?XP3P[Q8@G,:
M9:&BV8FLZ(/ :$7%3(B@V./@2.2&CJP*S!<'IVE1K0[RQ<'\:E=N6B1!KHLU
M'52"TU66X57K++O8FX.1XG#.PL(,+Z%:+=Z74:X7Y^AQAW@QB)=SWO7C6^I5
MTSQ.5_?QZJG0K!LK@,[6B[5$FW5B*<J[<HS4A,V$&HM*,!Q75F^PW>.$QWOD
M3_%&W^]I+9RNW9FI=];OU'#O@K+GJ-P@[9C T=>"!!%FYQ7UHA)A+I6D(MF6
M3Q\#1C,*8GVA<!@_.7HZ=2CZH%_Q8T[[0W7?TP,XZW.DQ)J^IO/4>_,J*?4;
MML*<NU'G)(NV83'&I(CIU(W[F@7."]JI:3>G348N-ZCM*M#>I-9;P!")+4W)
MTAVS0QU#5%G"Z4%8($:!R?H:/Q:&"!LYU&5/HB/;[DUD..]JLB GC9)94"QB
MX O$X.>=X$QH*V3K.)RF_[DEN^LX#W+*]38+4JKG%0GDZ[W#3)WYI(&5:3R3
MI9UW11U 5CC_65FCTAS5]H@5@*H2SMWY3:;7MQI=M9ZZDXY ::^.YA$0 ?3Y
M"&U, 7 ZG.8X!%^NF2WYZ4";<^,BWLN9<15MZ7GQ/MB[8FP9"A-AOK:6+>O#
MG/XB',;9-J4.:A.08L?F6XJH%CG,U2ZDCF2]&2G#>->'@9@8Y[2'\MGO>4<G
MLQ2/LS3?)D6@V'94PYQU'1J231\BP7AO>@,Q88LQQ6@//?<0H=S0))H5]S["
M77M+J>V;NO,82"O+.,GWD,FY5SL-[GX1%PF>+:=I%#_'T39(%/Y>@7/E\+4T
M:X\O!7E7A(F9L-3)L#P2:9[E_/S]>9W^@C[%5UE HE*'&A^@A#IS!@:RC5=0
MX+R+P8*<H >&1AR.*CR<V<;H*Z5E6-?J89R&F<CH=4),V@#OZM"Q$D)+&,;!
MBM4]S@L2AT65MXC_K,9%:.'.W(0%Z<95:+#>!6%)4,RV45M4\\G2YMR#R&E:
M$+R)([4Z^@AG@I!3:S30?0RCV:6<^BU=@^#T"'PG'T=S-F5=D"#-@Y!O[%_M
MVD\TW<60 MPF[AE:L6XR'UMK[^H[F++HACB,CV7OLI14_\G,8GSF2+*K_ZA2
M53VP;!MX%2M".$Q@9Q[*2+AQ5DJD=^58T>NKY.H_FJQB>PLX_FS,VBWE*5NR
M]#[.OUSMKG :/JT#HEM6-YNY/2AJ5XGNB5&]C7>U#20JKJVVS-AY]R^H,8.2
M+NHA2'!^CY]QNL5W6'\21(%UNHFCH]O9P)$!P0A*QT[LXSBL+1W GLLP4]=:
M>/97NEF\!@Y&5&:.%@[JA-/]D\5>"Q6SBK]66OF(P39401:'K3"!(S<KGLIX
M;(GVSKT#E6)SAC()R.F^HSY/F8#PK@8M+>F.(\2,93P^=)"7,1DY/G1O48'>
MF7N-A7=1#:*I#-MU[F#FM.Y/0:Y;!Q @[L*[Y>3VP=S=Y]XUH"$EM'B-.G<#
MEU>4:9JW!W#6N%)B3=-VGL)H6!FE?K-6&#>-2KLF4[.V((X;5B#7:]KF.:3&
M[9-2-2\;%( 9"S11E5?;/$YQGC_@U=KV7B2YC9<85QU]:9RKS,"[FH:P%%)[
M59#S;@+\$L1D'/ 4A0]?XI3]4^U&-&!G#L5(N'$M2J1W65C1Z^N!X5$85,DA
M<VI2_M>9>Y=?<$#B=#5)G]@E 4R1E# =HA:8;W5IQ&)GZ$XX0RJR%Y&-%1!!
M#: JB*NT17AOS&6V:<S/T\7E./Q^E3W_$.&X[-WH/_:=&OV/W\?9,R:C1W8C
M0%CTJBUY[D).2EI,-<)#[^)0,1(74Y]Y@OT*Y;JAK[-PRW3'%G E->@^=M7,
M,E)U*[>?@6AD":%^&]<0ODSNN(%'](<C]N,W2;"2T.\]=]7$4EIU&W<>@FAD
M&2,A\+'&( ;RU<S7. ])O&&=AZX>'9CS1I>0%-J^A8$E 9&86@DMK"?'?H]7
MU<4^[.;&:D*D<6,*O&O7KZ7=[PND8!"BL6&H["W:1JBQ\J2C49IN@^0>;S*B
MDT\7YEHU,I)]L;0QH#0B(::41HE%)=B3(O[7-B %)LG.* H!Z5H7"JI]:?1@
MH-0AYZ842 /WJQ$>GLO/BAE%(D*=3S<49(6I1P\'2B<*<NHI28/WJY2')YPD
M[/J,(#4[%!G8M5K4A/MZ$9&@%*.DI]0,MT"5"1S93)[9Z)P.DRPKV\+[%(]
M6Z>?!@Q60GV&EBKB9HC9>5+2'),XB^@PFY@T)"!=JT=!M:^;'@R48N3<E%HI
MX8CC_8MDDD96$FEP?@32HRF71P4"*(XN,Y,T*-JG,&[B/ R2DLL-_5M_U]^
M=2T0)=V^2 0@**&HV"G%4AK4FN$F7@7S-QP0.[FTD'[$(E"52Z6! 11*GYM)
M)@SO123C+2$=UNH>1PUUMBEK(-OLSRIP((1B(">>1^#PCE \]4"3M(B+W4V<
MX+NM)"I$#G&E#16Y6A/]YR"TH" EI-?D,,1PJ 1Z:?EZER M6!X^977Z,+<*
MD)/LJJ"+ :0$*3&%&O98GA;1BR+&_/Q",DTC_/)O>*>LEX!SJPD%S:XH>B!
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MM2D+==U'$-76Z+?:WK\N1WF.B]R@P#[(I=;D!-NJZB+ Z$=*2X@V>WB8+!Z
MJ* :*5J)0<"ZUX2"KBB-'A"80N3LA%PMG^[O)W<+5 KF9^^*&0?YTRB-V/],
M_KZ-GX.$]<:C8AP0LJ.CP,]!LNV?JQAHZU)1@ZK35IB5(1C%#6$K*) :>9==
MM;)/)\DAIO0?$WR'E8Y*CG7JJ'1T.XY*!@0C&QT[H4>KL(@TX N4XM.N/QPB
MG6G*[G+-R$ZMF"[$I5!DY-KZ:#\'(PL)J;X:&@@,#<P)W@1Q-'G9X#3'U!/R
M[9U./ZRHJY6E2\4,J$I;2!9F8/1ESU62>()9(ER:YBA((Y3QK;RPBI<->#'>
M%6FC/8\J,^K)GW**K B26]OAM>I *BNDB:$>0=+$'6V= 1,R&=R]4M2D1=&(
M6#">QT!0"!)8_#*Y!S,UFY-L@TFQFU..!?6:;*2_8:M1ZH&/WL1MMV8FW^W/
MU'@P<K(@*?9@I0GON7"-AS&*NHG3N,"W\3..IFE!6<=TD%]],DJ)F8Q<BLRN
M FV9Z2W ",V*ICA&KY'5H B&RF94_P';P;[%08[OX]53,5M^RLOJ*.IOL'&I
M,2OZ;8EI#< HS(9E7V <Q;9"MGDEL6/%%;S$"5?,V[?OWW#5L+_\?LWV_@B.
M%L&+3"4*C M5:.DQ%4@!WEM=QTK8DJU@J A>3M/*Q[N0_7Q1)><VPJE[$*EU
MG,'^L7<1J#G)@V6!S*P_9%GT-4Y4M=D_=MGL?5+M-J^?@6GP'J%^:]>/O;=T
M?[9F.:GS.S^VF1=#7$\1V,F75$I7 &I!15LM'V)02P!BPZN:>[88W2(@<0RW
M<? 8)W$1XYQ.LWF(XE.61)CD;,I=[ PK:?;F+L4RM%)M.=G:@NES!A(6+C>9
MCJZFM]/%=/* 1G?7Z&$Q&__;+[/;Z\G]PW]'D__U:;KX&R25VH7<Z P\*=$B
M^$:-AJBV86$X+9WY7_"MM]SGP8YMMQLVDQ1@'V$1<L*RN(@N$HQ^M/24D1&;
M$GVF19#Q-B^R-2;7>,/B3>5JT"*=+8CHJ3;+(G*8=Q&8N0G>HP*CJ$3['QF/
MLY2[NU_CXJEF5SO%G=Z1V)DZ#>(;4)E.#)^%G7>U'4!6O-&Q-$7)OMN[J ,B
MO$OQ+BNP71<F1;H4FH9J6U<2&!@9J;F)5S50Y)G[K.LM7F3W.&&'>.8!*?HG
MVE4@=TOW*H+[M?L^PGM3:VD)J_=;C(H,D1))FYN<."W[\5N EOV2R<C?)J!-
M7Z2W\*ZI032%R3G#-IW/[F1=C\*IL).!:[P(7AIZL@]$AG+F5M04&[\B0KR+
M0,]+#"]@0+XKV#2]?\_"EJ?%V;]NYTN&=KYCJ*8L[!Z*4._"L>,GWU6LXW9;
M8U?O*K(6D&_MV,G&LV*,^Q#6BNE&]=["5(QU?*_!QI..[")]M09@_)$-2V$P
M,[O[@!:3^X^PUH(5 S/CYKB%'8"!LW[[W&@$1G"V3 TC:.]JTRY&&35G;0UF
M$5&O/TM3,"H<QM=F-=&[(*6>?(C7!]"?6O>C8$=GEC%"MUFZ0@M,UE"':.::
M>I.+021@I:$7!" 9L#1G<<%S3+&,"1E/)XS34"T+K87;+LQ(O=MM*>& NBH3
M1[%[:BSX&:JP;8.^S3%F*<<Q>OOF.^]:&QRH!B4T;5@PVBL(/QL<<"8+,/,_
M"YR3ZC &KX\N%X\4Z3B/@8IJ+V]!'P9&-&INDKP$U2&9O$R?^?^_^?[-FS=O
MV7X;>F:&?T'OW[RY>%/^'\K+[)K!MGC*2/P/'-'';R_>OG]_\2-]RMS:G]Y=
MO/OQ[<4__]B 8W:S8%1F/-AGY41!SDY@W67/F*4LI[]R@9AL..YCL&/E\C]<
M(%K(!O/;H!((,\PF3ZDVI90 <]WARDCV>]DV!HQZ%<1D_6F6*G7[,_K3CUK=
M_OGB3W_^\\6__/B.*^['BY_>_,O%3^]_ZJKV@O]OP(^B_C'T.XHBGO,Q2.9!
M'$W3<;")Z5!7T19*M-/H3#WE3GBF' I&VWI^0H!F@T8L>\QEG**P-/ NHWM<
M!'&*HTE 4I;@>Q2&V_66QVI<XV4<QJJ1HHVA2W'95Z2M,[,5&,E94Q5.25>&
M"%>6/WS;LD51:0QQLF(]EO8].;&;E,!:.U'RDR^AM.%T/L(-O$O&=*C'O&RD
M,(-T#,NP(B>U@24U2[;R$X"OXN15=Z8V#\B,\%S=$1_YSC'AUQE83?/4QOYF
MSZ8*J2?4*DLPW>H@NL9I=S-M :;(\C:-43-MLGH9HI$_!:HJH%9>WP*HXA0T
MC4H39L(@%3?EL^\!+Z(V\*VT+G&3RDHT:(5U*-JJJUP\ :DL]85/UE:^-::X
M\LG2!+3:S)<^J227G>G"IR/7B <.Z:PL/:TD#QG,69B!T:$]5_T2-)PQG'"7
MFG$ I[7PI#>;H9L&#E%?EH.VKJ[@C=B$&FF':TJT5UVI!VH**%P]:8=H4BT!
M&9\-N(W3SL2KH@S#,M#W< X@:24P2*.Q\KQ?<P6>(9))B79[^XJ6<O<B%BD4
MC*+T_!1G,_?W%0*ZF? >/^-TJXRVW#]VNWW9)=7=I"R?@=%"CY 0NA8D&$BN
M[W&6%[,E2RC*=QXP>8Y#G#]DB7J0HS9PVRN9B'?[)!4:C&:,%,7^*.>YO7.F
M)N]"^D"R/)^3;*D,B.@@G*;^%:EULO_N'\/:%12)"8F &0)M.,2[ IJC==6U
M4::[;35X+P<>5;2E!QW[8#!NQ,10..,_G]R/%M.[#VCR[_/)W0.$H[0/.*'%
MK:@;_!B0+[A5&U6HAL; :>"+D7@G $:)!J,F(T7IT(:'AJYK ^]R&B6\7!SQ
MF=Y5D..(SN58+0(6=*B7EJVQTSC1017JA(U:68*1WR"ZDOEZ@^2*K%-L%<$+
M@ $3Z]AQGO.HUQNLG&V),,>7@DE)]BX"ZV# J$=!3'+A5P.K#ZSEVP2$Z_J
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MO']8U_BQL![KJL NA:XGW!:L' E&>%IZ?0$Q,-!19[<>)A^K1/O3D-;K*:!
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M$B"(TM)E#C '+U5[9ZE6K7^IQOD7U@U\HBU/BB!."_,Q%8.-4SG:T.\(4&<
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MI_G^[$1U\J$\K68Q\#ZH&&=C\2,JV0S/#R@#2LJ,(_F+9\-Y20A717'U9OS
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M7=W&SS@:XND.*\JI^(ZH;$>8!Y0#IF,^@KR@Y*8H-B),:!&7"2L#RH[]PU-
M\%60XXB.*5AX07D!Y::ZE7+*CZ]2PFPW3S],/*@DIV?\#J]JY\S?\&*@>>/#
MJR#-1';YR(I"8:LL[[J>!"2-TU4^QX37ULX_&ZV<[MG:5:&S:ZLW >-@[7@*
MN3EQ06?2?&2PP03ES+(\'+->9VEYU,&[\&XS^LW0C^@6TX\BWP<K\O^N%AOJ
M,T**MS.L")>2/*1R;7T.L0<CU@-(]Y7+H:V+2+VKM'\8?,AI0TM;G\?WK<\:
M6AF"4>(0ML9,$MXU>(>_M@Y-DBRE_PQQ:P'63H[#BW&IS$,KV1;IT#+ Z/5
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MFNI (3)SQ.T!J_%3CI?;Y#9>JOREE24(/8I5L1+DW@R^(@6N@R1Y@4I[Q J
M*\D/1'M276L$0HB="EAID%O EU^;IJ \KK<)F#S$HS#<KK<)VP&[QAN"PYB/
M8^F_$UQ==C=:LYP/_^!_5]99O2USHN*=[F^>^*7T=M-.4C:X/=+3UDNZB]KZ
M#=3^$>]?49N,XOUT(4[3"4C(=1((M)Z#<:X24GU)@%* ?89OXVS/7 #,[.WZ
M2;?)&HSR!E,6EX6:M.P<?('*@BYY26!FWIK:F>;>=J8N53JD,FU]VMB!4>8
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MA3R=27704@@B,%H ^!X'$A6B4$R6_GPVX=EJ</F_T[2BE=_C$,?/JN!O&SL
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MQ$U 'H(P2 !MWB+6@6*W+*%B^MK(-FG31E6V Q7<)X6>Q_S5*DBR<5JT2S&
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MPXZ,\!VGDFDJEMU9')>\9L"GBX5NY#65AR*.LM>S&XJ+_'4<IY2[XJ^0@K*
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MQHUL<,9^$&>Y6VWN./43OHK\JY"HWI O*5XIBAS5X(BZTDZLUBYZWR2*?0X
MO5H6.7JAP3A3MQ0)]I_8\UX?X%BCDT$.8'"DP6SYL6]Q;>>>8$6ECT>N'CZ3
M4-\5C +(H0M (@ V8W0*Y6(?TC-L@L@A#:W](=A]1*F9\9C%+($<C-"&C],]
M2\G,^13Y/-PL9]1+>?:*G3Y>5U\<-R3!B3Z3O1B=Z/*%>W<\\$S=IE0&-U#
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M9&*\LT?;E1'>M21EW41XYQ_\/;Z[S=CL/5(_#66X9F6A("GR!/<709C*=Q&
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M8QDDC/VT)-C1"EU7UI$9+HL?N"W+NU%NL-Z1QN0= (+.V]CSTE4:RECQ"RK
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M5:$'[+8EK V"Z,L-H_+ZH=$BAA[)V\%0"4+FI$,\;P+R()\Z%*C8)T-E8?3
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MO%#$PL"7=T!VR5JN(X^MZ(T8-W2GES8I[%M<34@!&3:0 31_:?#6].);J<A
M5GQ-NDC-4'3HMUE>YVSL_3L-."T";$27U;Y\N0W%L8MBYSMM0148&'0*+ZB
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M,'HS+FAT;5!+ 0(4 Q0    ( ,E!*%H\Z(JCF0<  .8N   ;
M  "  4U\ 0!A>&EL+3(P,C0Q,3,P7S$P<65X,S%Z,2YH=&U02P$"% ,4
M" #)02A:1D9M3YH'  "T+@  &P              @ $?A $ 87AI;"TR,#(T
M,3$S,%\Q,'%E>#,Q>C(N:'1M4$L! A0#%     @ R4$H6@\JB5##!0  .!<
M !L              ( !\HL! &%X:6PM,C R-#$Q,S!?,3!Q97@S,GHQ+FAT
M;5!+ 0(4 Q0    ( ,E!*%K8!Q3MN04  ,$6   ;              "  >Z1
M 0!A>&EL+3(P,C0Q,3,P7S$P<65X,S)Z,BYH=&U02P$"% ,4    " #)02A:
M$1U [!N[  "1300 &P              @ '@EP$ 87AI;"TR,#(T,3$S,%\Q
M,'%E>#DY>C$N:'1M4$L! A0#%     @ R4$H6KI,A2O<$   2ML  !4
M         ( !-%," &%X:6PM,C R-#$Q,S!?8V%L+GAM;%!+ 0(4 Q0    (
M ,E!*%J:60_VI!H  +%\ 0 5              "  4-D @!A>&EL+3(P,C0Q
M,3,P7V1E9BYX;6Q02P$"% ,4    " #)02A:VO6@++Y9  "%# 4 %0
M        @ $:?P( 87AI;"TR,#(T,3$S,%]L86(N>&UL4$L! A0#%     @
MR4$H6DE:P61M0   OPX$ !4              ( !"]D" &%X:6PM,C R-#$Q
M,S!?<')E+GAM;%!+ 0(4 Q0    ( ,E!*%HQ9+<-$AD   (;   ,
M      "  :L9 P!I;6%G95\P,2YJ<&=02P4&      T #0!^ P  YS(#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>axil-20241130_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:axil="http://reviv.com/20241130"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="axil-20241130.xsd" xlink:type="simple"/>
    <context id="From2024-06-01to2024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="From2024-09-012024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_PromotionalRisplayRacksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">axil:PromotionalRisplayRacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_PromotionalRisplayRacksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">axil:PromotionalRisplayRacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_srt_MinimumMember_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_srt_MaximumMember_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_AutomobilesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_AutomobilesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_LicensingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:LicensingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_LicensingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:LicensingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_WebsiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:WebsiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_WebsiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:WebsiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_ProductCertificationTestingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:ProductCertificationTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_ProductCertificationTestingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">axil:ProductCertificationTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2020-05-31_custom_EconomicInjuryDisasterLoanProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="From2020-05-012020-05-18_custom_EconomicInjuryDisasterLoanProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="From2021-06-012022-05-31_custom_EconomicInjuryDisasterLoanProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_EconomicInjuryDisasterLoanProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_EconomicInjuryDisasterLoanProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EconomicInjuryDisasterLoanProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_EIDLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EIDLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_EIDLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">axil:EIDLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="From2022-06-012023-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-03-05_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-05</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_PreferredStockMember105062531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_CommonStockMember105062546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-13_custom_OneConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:OneConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="AsOf2024-10-14_custom_OfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:OfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-14</instant>
        </period>
    </context>
    <context id="From2024-02-012024-02-14_custom_ThreeBoardMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">axil:ThreeBoardMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-14</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-13_custom_OneConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:OneConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_custom_RestrictedStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">axil:RestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_custom_RestrictedStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">axil:RestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_custom_IntrepidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:IntrepidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_IntrepidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:IntrepidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_IntrepidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">axil:IntrepidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_custom_BZCapitalStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">axil:BZCapitalStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">axil:VendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">axil:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_HairCareAndSkinCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_custom_HairCareAndSkinCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HairCareAndSkinCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_HearingEnhancementAndProtectionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_custom_HearingEnhancementAndProtectionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718500</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">axil:HearingEnhancementAndProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-06-01to2024-11-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2024-06-01to2024-11-30" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-06-01to2024-11-30" id="Fact000005">--05-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-06-01to2024-11-30" id="Fact000006">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-06-01to2024-11-30" id="Fact000007">0001718500</dei:EntityCentralIndexKey>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-05-31"
      id="xdx2ixbrl0125"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-11-30"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-05-31"
      id="xdx2ixbrl0137"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:GainOnDebtSettlement
      contextRef="From2024-09-012024-11-30"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:GainOnDebtSettlement
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl0249"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-09-012024-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-09-012024-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-09-012024-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0342"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-09-012023-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-09-012023-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-09-012023-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-09-012023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:PreferredStockConvertedToCommonStock
      contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:PreferredStockConvertedToCommonStock
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-06-012023-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-06-012023-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-06-012023-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:GainOnDebtSettlement
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:GainOnForgivenessOfAccountPayable
      contextRef="From2023-06-012023-11-30"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-06-012023-11-30"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-06-012023-11-30"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:RepaymentOfEquipmentFinancing
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-06-012023-11-30"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability
      contextRef="From2023-06-012023-11-30"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:RestrictedStockAwards
      contextRef="From2023-09-012023-11-30"
      id="xdx2ixbrl0733"
      unitRef="Shares"
      xsi:nil="true"/>
    <axil:RestrictedStockAwards
      contextRef="From2023-06-012023-11-30"
      id="xdx2ixbrl0735"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-05-31_custom_ProductCertificationTestingMember"
      id="xdx2ixbrl0921"
      unitRef="USD"
      xsi:nil="true"/>
    <axil:RoyaltyPaymentAccrual
      contextRef="AsOf2024-11-30"
      id="xdx2ixbrl0948"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl1077"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl1091"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-06-01to2024-11-30"
      id="xdx2ixbrl1093"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-05-31"
      id="xdx2ixbrl1179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember"
      id="xdx2ixbrl1358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember"
      id="xdx2ixbrl1360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember"
      id="xdx2ixbrl1362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember"
      id="xdx2ixbrl1364"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-06-01to2024-11-30" id="Fact000013">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2024-06-01to2024-11-30" id="Fact000014">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-06-01to2024-11-30" id="Fact000015">2024-11-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-06-01to2024-11-30" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-06-01to2024-11-30" id="Fact000017">001-41958</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-06-01to2024-11-30" id="Fact000018">AXIL Brands, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-06-01to2024-11-30" id="Fact000019">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-06-01to2024-11-30" id="Fact000020">47-4125218</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-06-01to2024-11-30" id="Fact000021">9150 Wilshire Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-06-01to2024-11-30" id="Fact000022">Suite 245</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-06-01to2024-11-30" id="Fact000023">Beverly Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-06-01to2024-11-30" id="Fact000024">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-06-01to2024-11-30" id="Fact000025">90212</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-06-01to2024-11-30" id="Fact000026">888</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-06-01to2024-11-30" id="Fact000027">638-8883</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-06-01to2024-11-30" id="Fact000028">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-06-01to2024-11-30" id="Fact000029">AXIL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-06-01to2024-11-30" id="Fact000030">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2024-06-01to2024-11-30" id="Fact000031">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-06-01to2024-11-30" id="Fact000032">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-06-01to2024-11-30" id="Fact000033">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-06-01to2024-11-30" id="Fact000034">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-06-01to2024-11-30" id="Fact000035">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2024-06-01to2024-11-30" id="Fact000036">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-01-03"
      decimals="INF"
      id="Fact000038"
      unitRef="Shares">6466852</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000046"
      unitRef="USD">5213897</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">3253876</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000049"
      unitRef="USD">1444218</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">509835</us-gaap:AccountsReceivableNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000052"
      unitRef="USD">2664489</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">3394023</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000055"
      unitRef="USD">724778</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">809126</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000058"
      unitRef="USD">10047382</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">7966860</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000064"
      unitRef="USD">305433</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">260948</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000067"
      unitRef="USD">324907</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">309104</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000070"
      unitRef="USD">737251</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">36752</us-gaap:OperatingLeaseRightOfUseAsset>
    <axil:DeferredTaxAsset
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000073"
      unitRef="USD">121791</axil:DeferredTaxAsset>
    <axil:DeferredTaxAsset
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000074"
      unitRef="USD">231587</axil:DeferredTaxAsset>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000076"
      unitRef="USD">20720</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">16895</us-gaap:OtherAssets>
    <us-gaap:Goodwill
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">2152215</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000080"
      unitRef="USD">2152215</us-gaap:Goodwill>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000082"
      unitRef="USD">3662317</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">3007501</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000085"
      unitRef="USD">13709699</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">10974361</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000094"
      unitRef="USD">1619252</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">967596</us-gaap:AccountsPayableCurrent>
    <axil:CustomerDepositCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000097"
      unitRef="USD">496404</axil:CustomerDepositCurrent>
    <axil:CustomerDepositCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000098"
      unitRef="USD">154762</axil:CustomerDepositCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000100"
      unitRef="USD">956022</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000101"
      unitRef="USD">905311</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000103"
      unitRef="USD">143342</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">146594</us-gaap:NotesPayableCurrent>
    <axil:DueToRelatedParty
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000106"
      unitRef="USD">178520</axil:DueToRelatedParty>
    <axil:DueToRelatedParty
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000107"
      unitRef="USD">11798</axil:DueToRelatedParty>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000109"
      unitRef="USD">207077</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000110"
      unitRef="USD">36752</us-gaap:OperatingLeaseLiabilityCurrent>
    <axil:IncomeTaxLiability
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000112"
      unitRef="USD">67250</axil:IncomeTaxLiability>
    <axil:IncomeTaxLiability
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000113"
      unitRef="USD">242296</axil:IncomeTaxLiability>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000115"
      unitRef="USD">331395</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000116"
      unitRef="USD">332936</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000118"
      unitRef="USD">3999262</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000119"
      unitRef="USD">2798045</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000124"
      unitRef="USD">531081</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000127"
      unitRef="USD">357205</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000128"
      unitRef="USD">480530</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000130"
      unitRef="USD">888286</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000131"
      unitRef="USD">480530</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000133"
      unitRef="USD">4887548</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">3278575</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000145"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000147"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000149"
      unitRef="Shares">300000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000151"
      unitRef="Shares">300000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000153"
      unitRef="Shares">31133500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000155"
      unitRef="Shares">31133500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000157"
      unitRef="Shares">42251750</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000159"
      unitRef="Shares">42251750</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000142"
      unitRef="USD">3113</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000143"
      unitRef="USD">4225</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000164"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000166"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000168"
      unitRef="Shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000170"
      unitRef="Shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000172"
      unitRef="Shares">6466852</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000174"
      unitRef="Shares">6466852</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000176"
      unitRef="Shares">5908939</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact000178"
      unitRef="Shares">5908939</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000161"
      unitRef="USD">647</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000162"
      unitRef="USD">591</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000180"
      unitRef="USD">8428760</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000181"
      unitRef="USD">7825240</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000183"
      unitRef="USD">389631</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000184"
      unitRef="USD">-134270</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000186"
      unitRef="USD">8822151</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000187"
      unitRef="USD">7695786</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000189"
      unitRef="USD">13709699</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000190"
      unitRef="USD">10974361</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000192"
      unitRef="USD">7732574</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000193"
      unitRef="USD">8421677</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000194"
      unitRef="USD">13583846</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000195"
      unitRef="USD">14527946</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000197"
      unitRef="USD">2234527</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000198"
      unitRef="USD">2163738</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000199"
      unitRef="USD">3932151</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000200"
      unitRef="USD">3622441</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000202"
      unitRef="USD">5498047</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000203"
      unitRef="USD">6257939</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000204"
      unitRef="USD">9651695</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000205"
      unitRef="USD">10905505</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000212"
      unitRef="USD">3377760</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000213"
      unitRef="USD">3672780</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000214"
      unitRef="USD">6047231</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000215"
      unitRef="USD">6879621</us-gaap:SellingAndMarketingExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000217"
      unitRef="USD">276674</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000218"
      unitRef="USD">204646</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000219"
      unitRef="USD">467322</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000220"
      unitRef="USD">484635</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000222"
      unitRef="USD">736169</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000223"
      unitRef="USD">694258</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000224"
      unitRef="USD">1684018</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000225"
      unitRef="USD">1303288</us-gaap:ProfessionalFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000227"
      unitRef="USD">434573</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000228"
      unitRef="USD">422343</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000229"
      unitRef="USD">920955</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000230"
      unitRef="USD">800292</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000232"
      unitRef="USD">4825176</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000233"
      unitRef="USD">4994027</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000234"
      unitRef="USD">9119526</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000235"
      unitRef="USD">9467836</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000237"
      unitRef="USD">672871</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000238"
      unitRef="USD">1263912</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000239"
      unitRef="USD">532169</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000240"
      unitRef="USD">1437669</us-gaap:OperatingIncomeLoss>
    <axil:GainOnDebtSettlement
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000248"
      unitRef="USD">79182</axil:GainOnDebtSettlement>
    <axil:GainOnDebtSettlement
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000250"
      unitRef="USD">79182</axil:GainOnDebtSettlement>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000252"
      unitRef="USD">2041</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000253"
      unitRef="USD">3189</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000254"
      unitRef="USD">4307</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000255"
      unitRef="USD">13024</us-gaap:OtherNonoperatingIncome>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000257"
      unitRef="USD">27340</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000258"
      unitRef="USD">37825</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000259"
      unitRef="USD">55971</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000260"
      unitRef="USD">76318</us-gaap:InterestIncomeOther>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000262"
      unitRef="USD">1296</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000263"
      unitRef="USD">1640</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000264"
      unitRef="USD">1296</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000265"
      unitRef="USD">3284</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000267"
      unitRef="USD">28085</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000268"
      unitRef="USD">118556</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000269"
      unitRef="USD">58982</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000270"
      unitRef="USD">165240</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000272"
      unitRef="USD">700956</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000273"
      unitRef="USD">1382468</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000274"
      unitRef="USD">591151</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000275"
      unitRef="USD">1602909</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000277"
      unitRef="USD">67250</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000278"
      unitRef="USD">364393</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000279"
      unitRef="USD">67250</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000280"
      unitRef="USD">430382</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000282"
      unitRef="USD">633706</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000283"
      unitRef="USD">1018075</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000284"
      unitRef="USD">523901</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000285"
      unitRef="USD">1172527</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000292"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000293"
      unitRef="USDPShares">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000294"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000295"
      unitRef="USDPShares">0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000297"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000298"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000299"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000300"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000307"
      unitRef="Shares">6450226</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000308"
      unitRef="Shares">5863939</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000309"
      unitRef="Shares">6303002</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000310"
      unitRef="Shares">5863939</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000312"
      unitRef="Shares">8168657</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000313"
      unitRef="Shares">18632689</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000314"
      unitRef="Shares">8194882</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000315"
      unitRef="Shares">18632689</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000323"
      unitRef="Shares">31133500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000317"
      unitRef="USD">3113</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000325"
      unitRef="Shares">6464852</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000318"
      unitRef="USD">647</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000319"
      unitRef="USD">8124160</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000320"
      unitRef="USD">-244075</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact000321"
      unitRef="USD">7883845</us-gaap:StockholdersEquity>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000329"
      unitRef="USD">138423</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000331"
      unitRef="USD">138423</us-gaap:StockOptionPlanExpense>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000339"
      unitRef="Shares">2000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-09-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000335"
      unitRef="USD">166177</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000337"
      unitRef="USD">166177</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-09-012024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000344"
      unitRef="USD">633706</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000345"
      unitRef="USD">633706</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000353"
      unitRef="Shares">31133500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000347"
      unitRef="USD">3113</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000355"
      unitRef="Shares">6466852</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000348"
      unitRef="USD">647</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000349"
      unitRef="USD">8428760</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000350"
      unitRef="USD">389631</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000351"
      unitRef="USD">8822151</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000363"
      unitRef="Shares">250000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000357"
      unitRef="USD">25000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000365"
      unitRef="Shares">5863939</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000358"
      unitRef="USD">586</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000359"
      unitRef="USD">10164472</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000360"
      unitRef="USD">-3312540</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31"
      decimals="0"
      id="Fact000361"
      unitRef="USD">6877518</us-gaap:StockholdersEquity>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-09-012023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000369"
      unitRef="USD">51108</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000371"
      unitRef="USD">51108</us-gaap:StockOptionPlanExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-09-012023-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000376"
      unitRef="USD">1018075</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000377"
      unitRef="USD">1018075</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000385"
      unitRef="Shares">250000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000379"
      unitRef="USD">25000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000387"
      unitRef="Shares">5863939</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000380"
      unitRef="USD">586</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000381"
      unitRef="USD">10215580</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000382"
      unitRef="USD">-2294465</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact000383"
      unitRef="USD">7946701</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000395"
      unitRef="Shares">42251750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000389"
      unitRef="USD">4225</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000397"
      unitRef="Shares">5908939</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000390"
      unitRef="USD">591</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000391"
      unitRef="USD">7825240</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000392"
      unitRef="USD">-134270</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000393"
      unitRef="USD">7695786</us-gaap:StockholdersEquity>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000401"
      unitRef="USD">211055</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000403"
      unitRef="USD">211055</us-gaap:StockOptionPlanExpense>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000411"
      unitRef="Shares">2000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000407"
      unitRef="USD">391409</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000409"
      unitRef="USD">391409</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <axil:PreferredStockConvertedToCommonStockShares
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000419"
      unitRef="Shares">-11118250</axil:PreferredStockConvertedToCommonStockShares>
    <axil:PreferredStockConvertedToCommonStock
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000413"
      unitRef="USD">-1112</axil:PreferredStockConvertedToCommonStock>
    <axil:PreferredStockConvertedToCommonStockShares
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000421"
      unitRef="Shares">555913</axil:PreferredStockConvertedToCommonStockShares>
    <axil:PreferredStockConvertedToCommonStock
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000414"
      unitRef="USD">56</axil:PreferredStockConvertedToCommonStock>
    <axil:PreferredStockConvertedToCommonStock
      contextRef="From2024-06-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000415"
      unitRef="USD">1056</axil:PreferredStockConvertedToCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000426"
      unitRef="USD">523901</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000427"
      unitRef="USD">523901</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000435"
      unitRef="Shares">31133500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000429"
      unitRef="USD">3113</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000437"
      unitRef="Shares">6466852</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000430"
      unitRef="USD">647</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000431"
      unitRef="USD">8428760</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000432"
      unitRef="USD">389631</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000433"
      unitRef="USD">8822151</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000445"
      unitRef="Shares">250000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000439"
      unitRef="USD">25000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000447"
      unitRef="Shares">5863939</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000440"
      unitRef="USD">586</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000441"
      unitRef="USD">10113365</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000442"
      unitRef="USD">-3466992</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31"
      decimals="0"
      id="Fact000443"
      unitRef="USD">6671959</us-gaap:StockholdersEquity>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-06-012023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000451"
      unitRef="USD">102215</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000453"
      unitRef="USD">102215</us-gaap:StockOptionPlanExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000458"
      unitRef="USD">1172527</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000459"
      unitRef="USD">1172527</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000467"
      unitRef="Shares">250000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">25000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000469"
      unitRef="Shares">5863939</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000462"
      unitRef="USD">586</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000463"
      unitRef="USD">10215580</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000464"
      unitRef="USD">-2294465</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact000465"
      unitRef="USD">7946701</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000474"
      unitRef="USD">523901</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000475"
      unitRef="USD">1172527</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000480"
      unitRef="USD">47335</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000481"
      unitRef="USD">56022</us-gaap:DepreciationAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000483"
      unitRef="USD">27954</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000484"
      unitRef="USD">64327</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">602464</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000487"
      unitRef="USD">102215</us-gaap:ShareBasedCompensation>
    <axil:GainOnDebtSettlement
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000490"
      unitRef="USD">79182</axil:GainOnDebtSettlement>
    <axil:GainOnForgivenessOfAccountPayable
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000492"
      unitRef="USD">218699</axil:GainOnForgivenessOfAccountPayable>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000495"
      unitRef="USD">109796</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000501"
      unitRef="USD">962337</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000502"
      unitRef="USD">600626</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000504"
      unitRef="USD">-729534</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000505"
      unitRef="USD">1040351</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000507"
      unitRef="USD">-80524</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000508"
      unitRef="USD">267407</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000510"
      unitRef="USD">870357</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000511"
      unitRef="USD">1092735</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000513"
      unitRef="USD">165959</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000514"
      unitRef="USD">576718</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000516"
      unitRef="USD">-72614</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000517"
      unitRef="USD">175135</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000519"
      unitRef="USD">1904174</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000520"
      unitRef="USD">1252113</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000525"
      unitRef="USD">41840</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000528"
      unitRef="USD">65783</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000529"
      unitRef="USD">70845</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000531"
      unitRef="USD">-107623</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000532"
      unitRef="USD">-70845</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <axil:RepaymentOfEquipmentFinancing
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000538"
      unitRef="USD">-1650</axil:RepaymentOfEquipmentFinancing>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000540"
      unitRef="USD">3252</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000541"
      unitRef="USD">24657</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000543"
      unitRef="USD">166722</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000544"
      unitRef="USD">-25212</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000546"
      unitRef="USD">163470</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000547"
      unitRef="USD">-51519</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000549"
      unitRef="USD">1960021</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000550"
      unitRef="USD">1129749</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000552"
      unitRef="USD">3253876</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-05-31"
      decimals="0"
      id="Fact000553"
      unitRef="USD">4832682</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000555"
      unitRef="USD">5213897</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact000556"
      unitRef="USD">5962431</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000564"
      unitRef="USD">2908</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000565"
      unitRef="USD">3284</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000567"
      unitRef="USD">132500</us-gaap:IncomeTaxesPaid>
    <axil:InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000573"
      unitRef="USD">767269</axil:InitialRecognitionOfRightOfUseAssetsRecognizedAsLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000576">&lt;p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z3iC3pT4Djd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 1 &#x2013; &lt;span id="xdx_828_ziUXIm3aPqad"&gt;Organization&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As part of AXIL Brands, Inc.&#x2019;s (together with
its subsidiary, the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) ongoing rebranding efforts, the Company
changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of
Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company&#x2019;s corporate
headquarters are located at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. Its phone number is (888) 638-8883. In
March 2022, the Company incorporated a subsidiary &#x201c;Reviv3 Acquisition Corporation&#x201d; (now known as &#x201c;AXIL Distribution
Company&#x201d;) and in June 2022, completed the acquisition of certain assets of Axil &amp;amp; Associated Brands Corp. (&#x201c;A&amp;amp;A&#x201d;).
The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection
products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality
hair and skin care products. These products lines are both sold throughout the United States, Canada, Europe and Asia. On February 14,
2024, the Company successfully completed efforts to uplist from the over-the-counter, (OTC), markets to the NYSE American stock exchange
(&#x201c;NYSE American&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000578">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zvpE3JCN6Ai3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 2 &#x2013; &lt;span id="xdx_82F_zlTCelBBy6zh"&gt;Basis of Presentation and Summary of Significant Accounting
Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1KiO5NbTmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zre0insn4Rnk"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited consolidated financial
statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).
In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash
flows as of November 30, 2024 and 2023, and for the periods then ended, have been made. Those adjustments consist of normal and recurring
adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance
with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction
with the consolidated financial statements and notes thereto included in the Company&#x2019;s annual report on Form 10-K for the year ended
May 31, 2024. The results of operations for the six months ended November 30, 2024 are not necessarily indicative of the results to be
expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned
subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--ReverseStockSplitPolicyTextBlock_zZ955FgpuPp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zHsRGnbhVt3c"&gt;Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) of the Company&#x2019;s issued shares of common stock at a ratio of &lt;span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130" title="Stockholders' Equity, Reverse Stock Split"&gt;1-for-20&lt;/span&gt;
as approved by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). The Reverse Stock Split did not affect the total number
of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were
rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial
statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zvidfFHySl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zwgvJGhyzFW"&gt;Use of estimates&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the unaudited consolidated financial
statements in conformity with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures
at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.
Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and
classifications,&#160;the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation,
contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash
Common Stock issuances.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--Reclassifications_zkT14GvCz1na" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zeSUlziXWNw4"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain reclassifications have been made to
prior periods to conform with the current year reporting.&#160;For the three and six months ended November 30, 2023, $&lt;span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20230901__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zD2WgXf4u6J9" title="Professional and consulting"&gt;202,930&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--ProfessionalFees_pp0p0_c20230601__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zh6QZyGTvdzg" title="Professional and consulting"&gt;385,185&lt;/span&gt;,
respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited
Consolidated Statements of Operations. There was no change to total operating expenses for the three and six months ended November
30, 2023 as a result of this reclassification.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zTw4gLbOoMo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zEBkDwESyMa8"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all highly liquid debt instruments
and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents.&#160;The Company maintains
cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note
12).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zv3GKsDdrzn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zVMaV74m9D62"&gt;Accounts receivable and allowance for doubtful
accounts&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 1, 2023, the Company adopted ASC 326, "&lt;i&gt;Financial
Instruments - Credit Losses&lt;/i&gt;". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting
from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined
principally on the basis of past collection experience and known financial factors regarding specific customers.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivables comprise of receivables from
customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on
its best estimate of the amount of probable credit losses in its existing accounts receivable.&#160;The Company periodically reviews its
accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may
indicate that the realization of an account may be in doubt.&#160;Account balances deemed to be uncollectible are charged to bad debt
expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIjBX1hxhYf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zlAoCORSDUE6"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Prepaid expenses and other current assets consist
primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within
a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns
for products sold. Prepayments to vendors for inventory was $&lt;span id="xdx_905_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20241130_zUGxXAqETkN8" title="Prepaid expenses"&gt;498,832&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20240531_zH7SPyxxTLP8" title="Prepaid expenses"&gt;472,904&lt;/span&gt; as of November 30, 2024 and May 31, 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zkpbuOtLVgLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zTHtq9eun4S8"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company values inventory, consisting of finished
goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces
inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the
difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering
historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component
of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions,
customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory
held above the expected level of sales in the next 12 months is classified as non-current inventory.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zKXkFLAkaayk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zIQ8TP5SN98e"&gt;Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment are carried at cost less accumulated
depreciation.&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized.&#160;When assets are retired or
disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ExtendedProductWarrantyPolicy_zEOXcIiOWQel" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zqbachsHvpt1"&gt;Product warranty&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company provides a one-year, two-year or three-year
limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements,
as they are incurred, to the cost of sales.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_z6vByfkhiAR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zzxf2Lkpk1cb"&gt;Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows Accounting Standards Codification
(&#x201c;ASC&#x201d;) 606, &#x201c;&lt;i&gt;Revenue from Contracts with Customers.&lt;/i&gt;&#x201d; This revenue recognition standard (new guidance)
has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction
price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company sells a variety of electronic hearing
and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase
order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation.
Consideration paid to the customer to promote and sell the Company&#x2019;s products is typically recorded as a reduction in revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;The five steps for the revenue recognition are
as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Identify the contract with a customer.&#160;&lt;/i&gt;The
Company generally considers completion of a sales order (which requires customer acceptance of the Company&#x2019;s click-through terms
and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone)
or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that
are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other
circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts
prior to shipping the product.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Identify the performance obligations in the contract&lt;/i&gt;.
Product performance obligations include shipment of products and related accessories, and service performance obligations include extended
warranty coverage.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;However, as the historical redemption rate under our
warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether
promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Determine the transaction price and allocation
to performance obligations&lt;/i&gt;. The transaction price in the Company&#x2019;s customer contracts consists of both fixed and variable consideration.
Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and
60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate
product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this
information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction
price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Allocate the transaction price to the performance
obligations in the contract&lt;/i&gt;. For contracts that contain multiple performance obligations, the Company allocates the transaction price
to the performance obligations on a relative standalone selling price basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Recognize revenue when or as the Company satisfies
a performance obligation&lt;/i&gt;. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services
(extended warranty) is recognized over time on a ratable basis over the warranty period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024, and May 31, 2024, contract
liabilities amounted to $&lt;span id="xdx_90D_eus-gaap--ContractWithCustomerLiability_c20241130_pp0p0" title="Contract liabilities"&gt;1,313,227&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--ContractWithCustomerLiability_c20240531_pp0p0" title="Contract liabilities"&gt;1,385,841&lt;/span&gt;, respectively. As of November 30, 2024, and May 31, 2024, &lt;span id="xdx_90B_ecustom--ContractLiabilitiesDescription_c20240601__20241130" title="Contract Liabilities Description"&gt;contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#x2019; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_z57l9uMigz14" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zqvxiBZJ3ZZk"&gt;Cost of Sales&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The primary components of cost of sales include the
cost of the product and shipping fees related to product procurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z8ymXoEuSYog" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zXaYynZ5eZMf"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for shipping and handling fees
in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping
products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses
were $&lt;span id="xdx_901_eus-gaap--SellingAndMarketingExpense_c20240901__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;265,138&lt;/span&gt;&#160;and $&lt;span id="xdx_90E_eus-gaap--SellingAndMarketingExpense_c20230901__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;308,081&lt;/span&gt;&#160;for the three months ended November 30, 2024 and 2023, respectively. Shipping costs included in marketing
and selling expense were $&lt;span id="xdx_90D_eus-gaap--SellingAndMarketingExpense_c20240601__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;515,052&lt;/span&gt;&#160;and $&lt;span id="xdx_90B_eus-gaap--SellingAndMarketingExpense_c20230601__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;561,533&lt;/span&gt;&#160;for the six months ended November 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zzLHVS0EGpJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zjmE6fshcDsl"&gt;Sales, Marketing and Advertising&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Sales, marketing and advertising costs are expensed
as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--CustomerDepositPolicytextBlock_zWEJWL9qWZP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_z92X6qG6e9Ni"&gt;Customer Deposits&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Customer deposits consisted of prepayments from customers
to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition
policy.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDkszICzqQik" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zqmYKLPadtkd"&gt;Fair value measurements and fair value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company adopted ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurements and Disclosures&lt;/i&gt;,&#x201d; for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a
common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value
measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption
of ASC&#160;820 did not have an impact on the Company&#x2019;s financial position or operating results, but did expand certain disclosures.
ASC&#160;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Additionally, ASC&#160;820 requires the use of valuation
techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; width: 5%"&gt;Level 1:&lt;/td&gt;
    &lt;td style="width: 95%; text-align: justify"&gt;Observable inputs such as quoted market prices in active markets for identical assets or liabilities.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;Level 2:&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;Level 3:&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Unobservable inputs for which there is little or no market data, which require the use of the reporting entity&#x2019;s own assumptions.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company analyzes all financial instruments with
features of both liabilities and equity under the Financial Accounting Standard Board&#x2019;s (&#x201c;FASB&#x201d;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The estimated fair value of certain financial instruments,
including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their
fair values because of the short-term nature of these instruments.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--BusinessCombinationsPolicy_zqCnndI63M7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zAntM9YjzNYh"&gt;Business Combinations&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For all business combinations (whether partial, full
or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair
values.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill represents the excess purchase price over
the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized
separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration,
the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration
resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is
classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or
(2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings.
The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes
in assumed discount periods and rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zmPsBrPQdk6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zCsbnrLRtgr4"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill is comprised of the purchase price of business
combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill
is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances
indicate the fair value of a reporting unit is below its carrying value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company performs its annual goodwill impairment
assessment on May 31st&#160;of each year or as impairment indicators dictate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;When evaluating the potential impairment of goodwill,
management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions,
the competitive environment, changes in the market for the Company&#x2019;s products and services, regulatory and political developments,
entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company&#x2019;s
reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting
unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach
(discounted cash flow method).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the quantitative method&#160;we compare the
carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If
the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the
carrying amount exceeds the fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;When required, we arrive at our estimates of fair
value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified
assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows
requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital
requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or
estimates for future cash flows could produce different results.&#160;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zABWBX4W2Vn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zfLedypeYAJj"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes pursuant to
the provision of ASC 740-10, &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;,&#x201d; which requires, among other things, an asset and liability
approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.
A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that
the net deferred asset will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows the provision of ASC 740-10 related
to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken
or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax
position is recognized in the financial statements in the period during which, based on all available evidence, management believes it
is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,
if any. Tax positions taken are not offset or aggregated with other positions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Tax positions that meet the more likely than not recognition
threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with
the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described
above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated
interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all
more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has adopted ASC 740-10-25, &#x201c;&lt;i&gt;Definition
of Settlement&lt;/i&gt;&#x201d;, which provides guidance on how an entity should determine whether a tax position is effectively settled for
the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion
and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity
would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based
solely on the basis of its technical merits and the statute of limitations remains open.&#160;The federal and state income tax returns
of the Company are subject to examination by the Internal Revenue Service (&#x201c;IRS&#x201d;) and state taxing authorities, generally
for three years after they are filed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zANewW9YtlE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zNFy0f3NlU12"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company reviews long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least
annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying
amount of the asset. The amount of impairment is measured as the difference between the asset&#x2019;s estimated fair value and its book
value. The Company did &lt;span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240901__20241130_zxh0P51ZO9bg" title="Impairment loss"&gt;&lt;span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230901__20231130_zKyUaTSGtFMd" title="Impairment loss"&gt;&lt;span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240601__20241130_zRwo5Ux687G9" title="Impairment loss"&gt;&lt;span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230601__20231130_zNLPD1gh5YXl" title="Impairment loss"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;t record any impairment loss during the three and six months ended November 30, 2024 and 2023.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHiOPClhqeG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zPgmegPTfds8"&gt;Stock-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock-based compensation is accounted for based on
the requirements of the Share-Based Payment Topic of ASC 718, &#x201c;&lt;i&gt;Compensation &#x2014; Stock Compensation&lt;/i&gt;,&#x201d; which requires
recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments
over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period).
ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date
fair value of the award.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For non-employee stock option based awards, the Company
follows Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-7, which substantially aligns share based compensation for employees and
non-employees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zh4HBO8Z7JEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zjck7fpzF5Yk"&gt;Net income per share of Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic net income per share is computed by dividing
the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted
average number of common shares and potentially dilutive securities outstanding during the period. For the three and six months ended
November 30, 2024 and 2023, certain stock options, preferred shares and restricted stock awards were excluded from the computation of
diluted common shares outstanding as they would have an anti-dilutive impact on the Company&#x2019;s net income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The dilutive common stock equivalent shares consist
of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market
price during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The following table sets forth the computations of basic and diluted net
income per common share:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B0_zQdgvg0HpIRa" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For the Three Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;Net income&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;633,706&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;1,018,075&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;523,901&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;1,172,527&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average basic shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,450,226&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,863,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,303,002&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,863,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;Dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,556,675&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,500,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,702,912&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,500,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156,033&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176,394&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Restricted stock awards&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,723&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0733"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,574&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0735"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Weighted average dilutive shares&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;8,168,657&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;18,632,689&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;8,194,882&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;18,632,689&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.17&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Diluted&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--LoansAndLeasesReceivableLeaseFinancingPolicy_zXziGyZdOB9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_ziKHWCY2NGyf"&gt;Lease Accounting&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,&#160;&#x201c;&lt;i&gt;Leases&lt;/i&gt;,&#x201d;
which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements
classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must
be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must
be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that
leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally
flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new
standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted
ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company renewed its lease for its previous corporate
headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expires on December 1, 2024.
The Company also signed a lease agreement in September 2024 for a warehouse and new corporate headquarters commencing October 1, 2024
and November 1, 2024, respectively. Please see Note 10 &#x2013; &#x201c;Commitments and Contingencies&#x201d; under &#x201c;Leases&#x201d;
below for more information about the Company&#x2019;s leases.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zV08KEVJvGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z6ScJV7UD9Jf"&gt;Segment Reporting&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows ASC 280,&#160;&#x201c;&lt;i&gt;Segment
Reporting&lt;/i&gt;.&#x201d; The Company&#x2019;s management reviews the Company&#x2019;s consolidated financial results when making decisions
about allocating resources and assessing the performance of the Company as a whole and has determined that the Company&#x2019;s reportable
segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products.
See Note 13 &#x2013; &#x201c;Business Segment and Geographic Area Information&#x201d; for more information about the Company&#x2019;s reportable
segments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zksyCEYMxJQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z28abXgGfUld"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August 2020, the FASB issued ASU No. 2020-06,&#160;&lt;i&gt;Debt
&#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity&lt;/i&gt;&#160;(ASU
2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion
features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted
for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use
of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted
the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the
accompanying consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2023, the FASB issued ASU No. 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures
for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments
are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15,
2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form
10-K for the year ended May 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other accounting standards that have been issued or
proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements
upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its
financial condition, results of operations, cash flows or disclosures.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000580">&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1KiO5NbTmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zre0insn4Rnk"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited consolidated financial
statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).
In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash
flows as of November 30, 2024 and 2023, and for the periods then ended, have been made. Those adjustments consist of normal and recurring
adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance
with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction
with the consolidated financial statements and notes thereto included in the Company&#x2019;s annual report on Form 10-K for the year ended
May 31, 2024. The results of operations for the six months ended November 30, 2024 are not necessarily indicative of the results to be
expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned
subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <axil:ReverseStockSplitPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000582">&lt;p id="xdx_84D_ecustom--ReverseStockSplitPolicyTextBlock_zZ955FgpuPp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zHsRGnbhVt3c"&gt;Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) of the Company&#x2019;s issued shares of common stock at a ratio of &lt;span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130" title="Stockholders' Equity, Reverse Stock Split"&gt;1-for-20&lt;/span&gt;
as approved by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). The Reverse Stock Split did not affect the total number
of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were
rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial
statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</axil:ReverseStockSplitPolicyTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2024-06-01to2024-11-30" id="Fact000584">1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:UseOfEstimates contextRef="From2024-06-01to2024-11-30" id="Fact000593">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zvidfFHySl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zwgvJGhyzFW"&gt;Use of estimates&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the unaudited consolidated financial
statements in conformity with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures
at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.
Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and
classifications,&#160;the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation,
contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash
Common Stock issuances.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:Reclassifications contextRef="From2024-06-01to2024-11-30" id="Fact000595">&lt;p id="xdx_84B_eus-gaap--Reclassifications_zkT14GvCz1na" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zeSUlziXWNw4"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain reclassifications have been made to
prior periods to conform with the current year reporting.&#160;For the three and six months ended November 30, 2023, $&lt;span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20230901__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zD2WgXf4u6J9" title="Professional and consulting"&gt;202,930&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--ProfessionalFees_pp0p0_c20230601__20231130__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zh6QZyGTvdzg" title="Professional and consulting"&gt;385,185&lt;/span&gt;,
respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited
Consolidated Statements of Operations. There was no change to total operating expenses for the three and six months ended November
30, 2023 as a result of this reclassification.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:Reclassifications>
    <us-gaap:ProfessionalFees
      contextRef="From2023-09-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact000597"
      unitRef="USD">202930</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-06-012023-11-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact000599"
      unitRef="USD">385185</us-gaap:ProfessionalFees>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000601">&lt;p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zTw4gLbOoMo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zEBkDwESyMa8"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all highly liquid debt instruments
and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents.&#160;The Company maintains
cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note
12).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000603">&lt;p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zv3GKsDdrzn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zVMaV74m9D62"&gt;Accounts receivable and allowance for doubtful
accounts&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 1, 2023, the Company adopted ASC 326, "&lt;i&gt;Financial
Instruments - Credit Losses&lt;/i&gt;". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting
from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined
principally on the basis of past collection experience and known financial factors regarding specific customers.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivables comprise of receivables from
customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on
its best estimate of the amount of probable credit losses in its existing accounts receivable.&#160;The Company periodically reviews its
accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may
indicate that the realization of an account may be in doubt.&#160;Account balances deemed to be uncollectible are charged to bad debt
expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <axil:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000612">&lt;p id="xdx_849_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIjBX1hxhYf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zlAoCORSDUE6"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Prepaid expenses and other current assets consist
primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within
a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns
for products sold. Prepayments to vendors for inventory was $&lt;span id="xdx_905_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20241130_zUGxXAqETkN8" title="Prepaid expenses"&gt;498,832&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_c20240531_zH7SPyxxTLP8" title="Prepaid expenses"&gt;472,904&lt;/span&gt; as of November 30, 2024 and May 31, 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</axil:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000614"
      unitRef="USD">498832</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000616"
      unitRef="USD">472904</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000618">&lt;p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zkpbuOtLVgLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zTHtq9eun4S8"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company values inventory, consisting of finished
goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces
inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the
difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering
historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component
of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions,
customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory
held above the expected level of sales in the next 12 months is classified as non-current inventory.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000620">&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zKXkFLAkaayk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zIQ8TP5SN98e"&gt;Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment are carried at cost less accumulated
depreciation.&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized.&#160;When assets are retired or
disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ExtendedProductWarrantyPolicy contextRef="From2024-06-01to2024-11-30" id="Fact000622">&lt;p id="xdx_84C_eus-gaap--ExtendedProductWarrantyPolicy_zEOXcIiOWQel" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zqbachsHvpt1"&gt;Product warranty&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company provides a one-year, two-year or three-year
limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements,
as they are incurred, to the cost of sales.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ExtendedProductWarrantyPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000624">&lt;p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_z6vByfkhiAR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zzxf2Lkpk1cb"&gt;Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows Accounting Standards Codification
(&#x201c;ASC&#x201d;) 606, &#x201c;&lt;i&gt;Revenue from Contracts with Customers.&lt;/i&gt;&#x201d; This revenue recognition standard (new guidance)
has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction
price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company sells a variety of electronic hearing
and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase
order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation.
Consideration paid to the customer to promote and sell the Company&#x2019;s products is typically recorded as a reduction in revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;The five steps for the revenue recognition are
as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Identify the contract with a customer.&#160;&lt;/i&gt;The
Company generally considers completion of a sales order (which requires customer acceptance of the Company&#x2019;s click-through terms
and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone)
or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that
are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other
circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts
prior to shipping the product.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Identify the performance obligations in the contract&lt;/i&gt;.
Product performance obligations include shipment of products and related accessories, and service performance obligations include extended
warranty coverage.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;However, as the historical redemption rate under our
warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether
promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Determine the transaction price and allocation
to performance obligations&lt;/i&gt;. The transaction price in the Company&#x2019;s customer contracts consists of both fixed and variable consideration.
Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and
60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate
product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this
information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction
price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Allocate the transaction price to the performance
obligations in the contract&lt;/i&gt;. For contracts that contain multiple performance obligations, the Company allocates the transaction price
to the performance obligations on a relative standalone selling price basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Recognize revenue when or as the Company satisfies
a performance obligation&lt;/i&gt;. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services
(extended warranty) is recognized over time on a ratable basis over the warranty period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024, and May 31, 2024, contract
liabilities amounted to $&lt;span id="xdx_90D_eus-gaap--ContractWithCustomerLiability_c20241130_pp0p0" title="Contract liabilities"&gt;1,313,227&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--ContractWithCustomerLiability_c20240531_pp0p0" title="Contract liabilities"&gt;1,385,841&lt;/span&gt;, respectively. As of November 30, 2024, and May 31, 2024, &lt;span id="xdx_90B_ecustom--ContractLiabilitiesDescription_c20240601__20241130" title="Contract Liabilities Description"&gt;contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#x2019; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000633"
      unitRef="USD">1313227</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000635"
      unitRef="USD">1385841</us-gaap:ContractWithCustomerLiability>
    <axil:ContractLiabilitiesDescription contextRef="From2024-06-01to2024-11-30" id="Fact000637">contract liabilities associated
with product invoiced but not received by customers at the balance sheet date was&#160;$0 and $0, respectively; contract liabilities associated
with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $1,087,639 and $1,251,710,
respectively; and contract liabilities associated with unfulfilled performance obligations for customers&#x2019; right of return was $221,511
and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three
years. Approximately $404,820 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized
in fiscal year 2026, and $104,356 in fiscal year 2027 and $55,313 in fiscal year 2028. Contract liabilities associated with gift cards
purchased by customers amounted to $4,077 and $3,930, respectively as of November 30, 2024 and May 31, 2024.</axil:ContractLiabilitiesDescription>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000646">&lt;p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_z57l9uMigz14" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zqvxiBZJ3ZZk"&gt;Cost of Sales&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The primary components of cost of sales include the
cost of the product and shipping fees related to product procurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:CostOfSalesPolicyTextBlock>
    <axil:ShippingAndHandlingCostsPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000648">&lt;p id="xdx_840_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z8ymXoEuSYog" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zXaYynZ5eZMf"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for shipping and handling fees
in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping
products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses
were $&lt;span id="xdx_901_eus-gaap--SellingAndMarketingExpense_c20240901__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;265,138&lt;/span&gt;&#160;and $&lt;span id="xdx_90E_eus-gaap--SellingAndMarketingExpense_c20230901__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;308,081&lt;/span&gt;&#160;for the three months ended November 30, 2024 and 2023, respectively. Shipping costs included in marketing
and selling expense were $&lt;span id="xdx_90D_eus-gaap--SellingAndMarketingExpense_c20240601__20241130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;515,052&lt;/span&gt;&#160;and $&lt;span id="xdx_90B_eus-gaap--SellingAndMarketingExpense_c20230601__20231130__srt--MajorCustomersAxis__custom--CustomerMember_pp0p0" title="Selling and marketing expense"&gt;561,533&lt;/span&gt;&#160;for the six months ended November 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</axil:ShippingAndHandlingCostsPolicyTextBlock>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-09-012024-11-30_custom_CustomerMember"
      decimals="0"
      id="Fact000650"
      unitRef="USD">265138</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-09-012023-11-30_custom_CustomerMember"
      decimals="0"
      id="Fact000652"
      unitRef="USD">308081</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-06-012024-11-30_custom_CustomerMember"
      decimals="0"
      id="Fact000654"
      unitRef="USD">515052</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-06-012023-11-30_custom_CustomerMember"
      decimals="0"
      id="Fact000656"
      unitRef="USD">561533</us-gaap:SellingAndMarketingExpense>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000658">&lt;p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zzLHVS0EGpJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zjmE6fshcDsl"&gt;Sales, Marketing and Advertising&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Sales, marketing and advertising costs are expensed
as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <axil:CustomerDepositPolicytextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000660">&lt;p id="xdx_848_ecustom--CustomerDepositPolicytextBlock_zWEJWL9qWZP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_z92X6qG6e9Ni"&gt;Customer Deposits&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Customer deposits consisted of prepayments from customers
to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition
policy.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</axil:CustomerDepositPolicytextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-06-01to2024-11-30" id="Fact000662">&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDkszICzqQik" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zqmYKLPadtkd"&gt;Fair value measurements and fair value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company adopted ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurements and Disclosures&lt;/i&gt;,&#x201d; for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a
common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value
measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption
of ASC&#160;820 did not have an impact on the Company&#x2019;s financial position or operating results, but did expand certain disclosures.
ASC&#160;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Additionally, ASC&#160;820 requires the use of valuation
techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; width: 5%"&gt;Level 1:&lt;/td&gt;
    &lt;td style="width: 95%; text-align: justify"&gt;Observable inputs such as quoted market prices in active markets for identical assets or liabilities.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;Level 2:&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap"&gt;Level 3:&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Unobservable inputs for which there is little or no market data, which require the use of the reporting entity&#x2019;s own assumptions.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company analyzes all financial instruments with
features of both liabilities and equity under the Financial Accounting Standard Board&#x2019;s (&#x201c;FASB&#x201d;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The estimated fair value of certain financial instruments,
including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their
fair values because of the short-term nature of these instruments.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2024-06-01to2024-11-30" id="Fact000671">&lt;p id="xdx_840_eus-gaap--BusinessCombinationsPolicy_zqCnndI63M7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zAntM9YjzNYh"&gt;Business Combinations&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For all business combinations (whether partial, full
or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair
values.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill represents the excess purchase price over
the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized
separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration,
the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration
resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is
classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or
(2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings.
The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes
in assumed discount periods and rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000673">&lt;p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zmPsBrPQdk6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zCsbnrLRtgr4"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill is comprised of the purchase price of business
combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill
is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances
indicate the fair value of a reporting unit is below its carrying value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company performs its annual goodwill impairment
assessment on May 31st&#160;of each year or as impairment indicators dictate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;When evaluating the potential impairment of goodwill,
management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions,
the competitive environment, changes in the market for the Company&#x2019;s products and services, regulatory and political developments,
entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company&#x2019;s
reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting
unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach
(discounted cash flow method).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the quantitative method&#160;we compare the
carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If
the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the
carrying amount exceeds the fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;When required, we arrive at our estimates of fair
value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified
assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows
requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital
requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or
estimates for future cash flows could produce different results.&#160;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000682">&lt;p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zABWBX4W2Vn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zfLedypeYAJj"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes pursuant to
the provision of ASC 740-10, &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;,&#x201d; which requires, among other things, an asset and liability
approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.
A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that
the net deferred asset will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows the provision of ASC 740-10 related
to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken
or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax
position is recognized in the financial statements in the period during which, based on all available evidence, management believes it
is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,
if any. Tax positions taken are not offset or aggregated with other positions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Tax positions that meet the more likely than not recognition
threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with
the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described
above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated
interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all
more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has adopted ASC 740-10-25, &#x201c;&lt;i&gt;Definition
of Settlement&lt;/i&gt;&#x201d;, which provides guidance on how an entity should determine whether a tax position is effectively settled for
the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion
and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity
would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based
solely on the basis of its technical merits and the statute of limitations remains open.&#160;The federal and state income tax returns
of the Company are subject to examination by the Internal Revenue Service (&#x201c;IRS&#x201d;) and state taxing authorities, generally
for three years after they are filed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000684">&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zANewW9YtlE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zNFy0f3NlU12"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company reviews long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least
annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying
amount of the asset. The amount of impairment is measured as the difference between the asset&#x2019;s estimated fair value and its book
value. The Company did &lt;span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240901__20241130_zxh0P51ZO9bg" title="Impairment loss"&gt;&lt;span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230901__20231130_zKyUaTSGtFMd" title="Impairment loss"&gt;&lt;span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20240601__20241130_zRwo5Ux687G9" title="Impairment loss"&gt;&lt;span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_pp0p0_do_c20230601__20231130_zNLPD1gh5YXl" title="Impairment loss"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;t record any impairment loss during the three and six months ended November 30, 2024 and 2023.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000686"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000688"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000690"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000692"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2024-06-01to2024-11-30" id="Fact000701">&lt;p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHiOPClhqeG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zPgmegPTfds8"&gt;Stock-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock-based compensation is accounted for based on
the requirements of the Share-Based Payment Topic of ASC 718, &#x201c;&lt;i&gt;Compensation &#x2014; Stock Compensation&lt;/i&gt;,&#x201d; which requires
recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments
over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period).
ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date
fair value of the award.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For non-employee stock option based awards, the Company
follows Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-7, which substantially aligns share based compensation for employees and
non-employees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000703">&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zh4HBO8Z7JEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zjck7fpzF5Yk"&gt;Net income per share of Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic net income per share is computed by dividing
the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted
average number of common shares and potentially dilutive securities outstanding during the period. For the three and six months ended
November 30, 2024 and 2023, certain stock options, preferred shares and restricted stock awards were excluded from the computation of
diluted common shares outstanding as they would have an anti-dilutive impact on the Company&#x2019;s net income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The dilutive common stock equivalent shares consist
of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market
price during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The following table sets forth the computations of basic and diluted net
income per common share:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B0_zQdgvg0HpIRa" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For the Three Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;Net income&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;633,706&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;1,018,075&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;523,901&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;1,172,527&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average basic shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,450,226&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,863,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,303,002&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,863,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;Dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,556,675&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,500,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,702,912&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,500,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156,033&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176,394&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Restricted stock awards&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,723&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0733"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,574&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0735"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Weighted average dilutive shares&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;8,168,657&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;18,632,689&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;8,194,882&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;18,632,689&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.17&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Diluted&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000705">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zCbmstCr4sQj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B0_zQdgvg0HpIRa" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240901__20241130_z4EVS2NdCY4b" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230901__20231130_zITNEXNdxroi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20240601__20241130_zkgkVJazyRw1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230601__20231130_zNMh8ASsg3J8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For the Three Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;b&gt;November 30,&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;Net income&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;633,706&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;1,018,075&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;523,901&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; width: 10%; text-align: right"&gt;1,172,527&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zT4ylX9VNXU3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted average basic shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,450,226&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,863,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,303,002&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,863,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;Dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,556,675&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,500,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,702,912&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,500,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156,033&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176,394&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RestrictedStockAwards_i01_zGulRNBmkV4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Restricted stock awards&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,723&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0733"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,574&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0735"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zxa8ytroWKe4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Weighted average dilutive shares&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;8,168,657&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;18,632,689&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;8,194,882&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;18,632,689&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.17&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; vertical-align: middle"&gt;Diluted&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000707"
      unitRef="USD">633706</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000708"
      unitRef="USD">1018075</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000709"
      unitRef="USD">523901</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000710"
      unitRef="USD">1172527</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000712"
      unitRef="Shares">6450226</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000713"
      unitRef="Shares">5863939</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000714"
      unitRef="Shares">6303002</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000715"
      unitRef="Shares">5863939</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000722"
      unitRef="Shares">1556675</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000723"
      unitRef="Shares">12500000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000724"
      unitRef="Shares">1702912</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000725"
      unitRef="Shares">12500000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000727"
      unitRef="Shares">156033</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000728"
      unitRef="Shares">268750</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000729"
      unitRef="Shares">176394</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000730"
      unitRef="Shares">268750</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <axil:RestrictedStockAwards
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000732"
      unitRef="Shares">5723</axil:RestrictedStockAwards>
    <axil:RestrictedStockAwards
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000734"
      unitRef="Shares">12574</axil:RestrictedStockAwards>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000737"
      unitRef="Shares">8168657</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000738"
      unitRef="Shares">18632689</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000739"
      unitRef="Shares">8194882</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000740"
      unitRef="Shares">18632689</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000747"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000748"
      unitRef="USDPShares">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000749"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000750"
      unitRef="USDPShares">0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000752"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000753"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact000754"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-06-012023-11-30"
      decimals="INF"
      id="Fact000755"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:LoansAndLeasesReceivableLeaseFinancingPolicy contextRef="From2024-06-01to2024-11-30" id="Fact000764">&lt;p id="xdx_84D_eus-gaap--LoansAndLeasesReceivableLeaseFinancingPolicy_zXziGyZdOB9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_ziKHWCY2NGyf"&gt;Lease Accounting&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,&#160;&#x201c;&lt;i&gt;Leases&lt;/i&gt;,&#x201d;
which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements
classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must
be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must
be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that
leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally
flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new
standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted
ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company renewed its lease for its previous corporate
headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expires on December 1, 2024.
The Company also signed a lease agreement in September 2024 for a warehouse and new corporate headquarters commencing October 1, 2024
and November 1, 2024, respectively. Please see Note 10 &#x2013; &#x201c;Commitments and Contingencies&#x201d; under &#x201c;Leases&#x201d;
below for more information about the Company&#x2019;s leases.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:LoansAndLeasesReceivableLeaseFinancingPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000766">&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zV08KEVJvGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z6ScJV7UD9Jf"&gt;Segment Reporting&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows ASC 280,&#160;&#x201c;&lt;i&gt;Segment
Reporting&lt;/i&gt;.&#x201d; The Company&#x2019;s management reviews the Company&#x2019;s consolidated financial results when making decisions
about allocating resources and assessing the performance of the Company as a whole and has determined that the Company&#x2019;s reportable
segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products.
See Note 13 &#x2013; &#x201c;Business Segment and Geographic Area Information&#x201d; for more information about the Company&#x2019;s reportable
segments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000768">&lt;p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zksyCEYMxJQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z28abXgGfUld"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August 2020, the FASB issued ASU No. 2020-06,&#160;&lt;i&gt;Debt
&#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity&lt;/i&gt;&#160;(ASU
2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion
features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted
for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use
of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted
the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the
accompanying consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2023, the FASB issued ASU No. 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures
for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments
are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15,
2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form
10-K for the year ended May 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other accounting standards that have been issued or
proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements
upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its
financial condition, results of operations, cash flows or disclosures.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsAndNontradeReceivableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000775">&lt;p id="xdx_807_eus-gaap--AccountsAndNontradeReceivableTextBlock_zkiuoBzzx8X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 3 &#x2013; &lt;span id="xdx_821_zrgaOMtjwVr8"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Accounts receivable, net consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zfEglMtFdYA8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zCvvhfMaCLn7" style="display: none"&gt;Schedule of accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20241130_zcGXqv9QmlHd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20240531_zyvXupzbXfHf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CustomersReceivable_iI_pp0p0_maARNzFhC_zsZjx66yhui9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Customers receivable&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;794,275&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;524,730&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--MerchantProcessorReceivable_iI_pp0p0_maARNzFhC_znk95gqsVRB8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Merchant processor receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746,123&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;78,417&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0p0_di_msARNzFhC_zcNpiXOHUmd2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Allowance for credit losses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(96,180&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,312&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableNet_iTI_pp0p0_mtARNzFhC_zMBgqu5MXpae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Accounts receivables, net&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;1,444,218&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;509,835&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recorded bad debt expense of $&lt;span id="xdx_908_eus-gaap--ProvisionForDoubtfulAccounts_c20240901__20241130_pp0p0" title="Bad debt expense"&gt;9,169&lt;/span&gt;&#160;and
$&lt;span id="xdx_906_eus-gaap--ProvisionForDoubtfulAccounts_c20230901__20231130_pp0p0" title="Bad debt expense"&gt;11,461&lt;/span&gt;&#160;during the three months ended November 30, 2024 and 2023, respectively. The Company recorded bad debt expense of $&lt;span id="xdx_907_eus-gaap--ProvisionForDoubtfulAccounts_c20240601__20241130_pp0p0" title="Bad debt expense"&gt;27,954&lt;/span&gt;&#160;and
$&lt;span id="xdx_905_eus-gaap--ProvisionForDoubtfulAccounts_c20230601__20231130_pp0p0" title="Bad debt expense"&gt;64,327&lt;/span&gt;&#160;during the six months ended November 30, 2024 and 2023, respectively.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsAndNontradeReceivableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000777">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zfEglMtFdYA8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zCvvhfMaCLn7" style="display: none"&gt;Schedule of accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20241130_zcGXqv9QmlHd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20240531_zyvXupzbXfHf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CustomersReceivable_iI_pp0p0_maARNzFhC_zsZjx66yhui9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Customers receivable&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;794,275&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;524,730&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--MerchantProcessorReceivable_iI_pp0p0_maARNzFhC_znk95gqsVRB8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Merchant processor receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746,123&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;78,417&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pp0p0_di_msARNzFhC_zcNpiXOHUmd2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Allowance for credit losses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(96,180&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,312&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableNet_iTI_pp0p0_mtARNzFhC_zMBgqu5MXpae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Accounts receivables, net&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;1,444,218&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;509,835&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <axil:CustomersReceivable
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000779"
      unitRef="USD">794275</axil:CustomersReceivable>
    <axil:CustomersReceivable
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000780"
      unitRef="USD">524730</axil:CustomersReceivable>
    <axil:MerchantProcessorReceivable
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000782"
      unitRef="USD">746123</axil:MerchantProcessorReceivable>
    <axil:MerchantProcessorReceivable
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000783"
      unitRef="USD">78417</axil:MerchantProcessorReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000785"
      unitRef="USD">96180</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000786"
      unitRef="USD">93312</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000788"
      unitRef="USD">1444218</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000789"
      unitRef="USD">509835</us-gaap:AccountsReceivableNet>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000791"
      unitRef="USD">9169</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000793"
      unitRef="USD">11461</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000795"
      unitRef="USD">27954</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000797"
      unitRef="USD">64327</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000799">&lt;p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_zQaOJ1D34cO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 4 &#x2013; &lt;span id="xdx_827_zwuKjPLzs3b"&gt;Inventory, net&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Inventory consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQPmoAn3C74g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_8B8_zt6fxJlr2iU6" style="display: none"&gt;Schedule of inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20241130_zVQ9PDDXWHsg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240531_zFCk6573cjn7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzXX2_zCFXMLNXsqt5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,543,218&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,190,344&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzXX2_zQYeEbXnk2M7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Raw Materials&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;121,271&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;203,679&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pp0p0_mtINzXX2_zHSkA94FCv8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Inventory&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,664,489&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,394,023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At November 30, 2024 and May 31, 2024, inventory held
at third party locations amounted to $&lt;span id="xdx_90C_ecustom--InventoryHeldAtThirdPartyLocation_c20241130_pp0p0" title="Inventory held at third party location"&gt;88,869&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--InventoryHeldAtThirdPartyLocation_c20240531_pp0p0" title="Inventory held at third party location"&gt;58,242&lt;/span&gt;, respectively. At November 30, 2024 and May 31, 2024, inventory in-transit amounted
to $&lt;span id="xdx_906_eus-gaap--OtherInventoryInTransit_c20241130_pp0p0" title="Inventory in-transit"&gt;13,500&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--OtherInventoryInTransit_c20240531_pp0p0" title="Inventory in-transit"&gt;15,738&lt;/span&gt;, respectively. At November 30, 2024 and May 31, 2024, the Company had provided $&lt;span id="xdx_909_eus-gaap--InventoryValuationReserves_c20241130_pp0p0" title="Inventory valuation reserves"&gt;&lt;span id="xdx_90E_eus-gaap--InventoryValuationReserves_iI_pp0p0_c20240531_zuTHFYTWiI83" title="Inventory valuation reserves"&gt;46,895&lt;/span&gt;&lt;/span&gt; as obsolescence reserve
on some slow-moving inventory.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000801">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQPmoAn3C74g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_8B8_zt6fxJlr2iU6" style="display: none"&gt;Schedule of inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20241130_zVQ9PDDXWHsg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240531_zFCk6573cjn7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzXX2_zCFXMLNXsqt5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,543,218&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,190,344&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzXX2_zQYeEbXnk2M7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Raw Materials&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;121,271&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;203,679&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pp0p0_mtINzXX2_zHSkA94FCv8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Inventory&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,664,489&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,394,023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000803"
      unitRef="USD">2543218</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000804"
      unitRef="USD">3190344</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000806"
      unitRef="USD">121271</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000807"
      unitRef="USD">203679</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000809"
      unitRef="USD">2664489</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000810"
      unitRef="USD">3394023</us-gaap:InventoryNet>
    <axil:InventoryHeldAtThirdPartyLocation
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000812"
      unitRef="USD">88869</axil:InventoryHeldAtThirdPartyLocation>
    <axil:InventoryHeldAtThirdPartyLocation
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000814"
      unitRef="USD">58242</axil:InventoryHeldAtThirdPartyLocation>
    <us-gaap:OtherInventoryInTransit
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000816"
      unitRef="USD">13500</us-gaap:OtherInventoryInTransit>
    <us-gaap:OtherInventoryInTransit
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000818"
      unitRef="USD">15738</us-gaap:OtherInventoryInTransit>
    <us-gaap:InventoryValuationReserves
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000820"
      unitRef="USD">46895</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000822"
      unitRef="USD">46895</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000824">&lt;p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zH8HGPS6khpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 5 &#x2013; &lt;span id="xdx_825_zFDZ8BsSTeM1"&gt;Property and Equipment&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Property and equipment, stated at cost, consisted of the following:&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2GWsdOhehEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zZM4bkJ0CW5e" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Estimated Life&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;Promotional display racks&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_zmVtSEqBtMz6" title="Property, Plant and Equipment, Useful Life"&gt;2&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment"&gt;30,709&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment"&gt;30,709&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zI7ZmzqIurm8" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;37,475&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;5,759&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGfbB5qho1zj" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;10,496&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;22,130&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Plant Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFCguvgvnSK3" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zQ7XKIpAh0Fe" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;309,868&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;264,168&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zd1mvCVj4Lvk" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zIXFa8EAw6gh" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;8,838&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;8,838&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Automobile&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zHxqfhoHalJg" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;24,347&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;24,347&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241130_zwUMtgha9WF6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation"&gt;(116,300&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20240531_z000zixLNiMc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation"&gt;(95,003&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total Property, plant and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net"&gt;305,433&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20240531_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net"&gt;260,948&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense amounted to $&lt;span id="xdx_905_eus-gaap--Depreciation_c20240901__20241130_pp0p0" title="Depreciation"&gt;11,405&lt;/span&gt;&#160;and
$&lt;span id="xdx_907_eus-gaap--Depreciation_c20230901__20231130_pp0p0" title="Depreciation"&gt;8,410&lt;/span&gt;&#160;for the three months ended November 30, 2024 and 2023, respectively.&#160; Depreciation expense amounted to $&lt;span id="xdx_906_eus-gaap--Depreciation_c20240601__20241130_pp0p0" title="Depreciation"&gt;21,298&lt;/span&gt;&#160;and
$&lt;span id="xdx_908_eus-gaap--Depreciation_c20230601__20231130_pp0p0" title="Depreciation"&gt;17,272&lt;/span&gt;&#160;for the six months ended November 30, 2024 and 2023, respectively.&#160;&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000826">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2GWsdOhehEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zZM4bkJ0CW5e" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Estimated Life&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;Promotional display racks&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_zmVtSEqBtMz6" title="Property, Plant and Equipment, Useful Life"&gt;2&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment"&gt;30,709&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PromotionalRisplayRacksMember_pp0p0" style="width: 12%; text-align: right" title="Plant Equipment"&gt;30,709&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zI7ZmzqIurm8" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;37,475&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;5,759&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGfbB5qho1zj" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;10,496&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;22,130&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Plant Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFCguvgvnSK3" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zQ7XKIpAh0Fe" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;309,868&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;264,168&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zd1mvCVj4Lvk" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zIXFa8EAw6gh" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;8,838&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;8,838&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Automobile&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zHxqfhoHalJg" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20241130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;24,347&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20240531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_pp0p0" style="text-align: right" title="Plant Equipment"&gt;24,347&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241130_zwUMtgha9WF6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation"&gt;(116,300&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20240531_z000zixLNiMc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less:Accumulated Depreciation"&gt;(95,003&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total Property, plant and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net"&gt;305,433&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20240531_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, net"&gt;260,948&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_custom_PromotionalRisplayRacksMember"
      id="Fact000828">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-11-30_custom_PromotionalRisplayRacksMember"
      decimals="0"
      id="Fact000830"
      unitRef="USD">30709</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-05-31_custom_PromotionalRisplayRacksMember"
      decimals="0"
      id="Fact000832"
      unitRef="USD">30709</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_us-gaap_FurnitureAndFixturesMember"
      id="Fact000834">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-11-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000836"
      unitRef="USD">37475</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-05-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000838"
      unitRef="USD">5759</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_us-gaap_ComputerEquipmentMember"
      id="Fact000840">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-11-30_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact000842"
      unitRef="USD">10496</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-05-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact000844"
      unitRef="USD">22130</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentMember"
      id="Fact000846">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentMember"
      id="Fact000848">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-11-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      id="Fact000850"
      unitRef="USD">309868</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-05-31_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      id="Fact000852"
      unitRef="USD">264168</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_srt_MinimumMember_us-gaap_OfficeEquipmentMember"
      id="Fact000854">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_srt_MaximumMember_us-gaap_OfficeEquipmentMember"
      id="Fact000856">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-11-30_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact000858"
      unitRef="USD">8838</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-05-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact000860"
      unitRef="USD">8838</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-11-30_us-gaap_AutomobilesMember"
      id="Fact000862">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-11-30_us-gaap_AutomobilesMember"
      decimals="0"
      id="Fact000864"
      unitRef="USD">24347</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-05-31_us-gaap_AutomobilesMember"
      decimals="0"
      id="Fact000866"
      unitRef="USD">24347</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000868"
      unitRef="USD">116300</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000870"
      unitRef="USD">95003</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000872"
      unitRef="USD">305433</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000874"
      unitRef="USD">260948</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000876"
      unitRef="USD">11405</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000878"
      unitRef="USD">8410</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000880"
      unitRef="USD">21298</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000882"
      unitRef="USD">17272</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000889">&lt;p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zguFpp5uxYUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 6 &#x2013; &lt;span id="xdx_823_z6Uhh7kgwgN3"&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The intangible assets consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zyaYPM7537Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_z8At2VUSQIMi" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Estimated Life&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;Licensing Rights&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_zi7HW1fuLJpe" title="Estimated Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;22,080&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;34,024&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer Relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSLHkNU7bBH9" title="Estimated Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;70,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;70,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade Names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zZRpwtenzfMd" title="Estimated Life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;275,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;275,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Website&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_zXcB2ZTexEoc" title="Estimated Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Product Certification Testing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_zM5fUUFl9c5b" title="Estimated Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;41,840&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0921"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20241130_zSBR5ODyoqX9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization"&gt;(184,013&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20240531_zpUHuV4qQNRg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization"&gt;(169,920&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net"&gt;324,907&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20240531_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net"&gt;309,104&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Goodwill arising through the business combination in June 2022 was $&lt;span id="xdx_903_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c20241130_pp0p0" title="Goodwill"&gt;2,152,215&lt;/span&gt;
at November 30, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization expense amounted to $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20240901__20241130_pp0p0" title="Amortization expense"&gt;23,035&lt;/span&gt;&#160;and
$&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230901__20231130_pp0p0" title="Amortization expense"&gt;19,375&lt;/span&gt;&#160;for the three months ended November 30, 2024 and 2023, respectively. Amortization expense amounted to $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20240601__20241130_pp0p0" title="Amortization expense"&gt;26,037&lt;/span&gt;&#160;and $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230601__20231130_pp0p0" title="Amortization expense"&gt;35,522&lt;/span&gt;&#160;for
the six months ended November 30, 2024 and 2023, respectively.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000891">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zyaYPM7537Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_z8At2VUSQIMi" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Estimated Life&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;Licensing Rights&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_zi7HW1fuLJpe" title="Estimated Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;22,080&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensingRightsMember_pp0p0" style="width: 12%; text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;34,024&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer Relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSLHkNU7bBH9" title="Estimated Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;70,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;70,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade Names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zZRpwtenzfMd" title="Estimated Life"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;275,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;275,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Website&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_zXcB2ZTexEoc" title="Estimated Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Product Certification Testing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_zM5fUUFl9c5b" title="Estimated Life"&gt;3&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20241130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;41,840&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProductCertificationTestingMember_pp0p0" style="text-align: right" title="Finite-lived Intangible Assets, Gross"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0921"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20241130_zSBR5ODyoqX9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization"&gt;(184,013&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20240531_zpUHuV4qQNRg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated Amortization"&gt;(169,920&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net"&gt;324,907&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20240531_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Finite-lived Intangible Assets, Net"&gt;309,104&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-11-30_custom_LicensingRightsMember"
      id="Fact000893">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-11-30_custom_LicensingRightsMember"
      decimals="0"
      id="Fact000895"
      unitRef="USD">22080</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-05-31_custom_LicensingRightsMember"
      decimals="0"
      id="Fact000897"
      unitRef="USD">34024</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-11-30_us-gaap_CustomerRelationshipsMember"
      id="Fact000899">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-11-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact000901"
      unitRef="USD">70000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-05-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact000903"
      unitRef="USD">70000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-11-30_us-gaap_TradeNamesMember"
      id="Fact000905">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-11-30_us-gaap_TradeNamesMember"
      decimals="0"
      id="Fact000907"
      unitRef="USD">275000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-05-31_us-gaap_TradeNamesMember"
      decimals="0"
      id="Fact000909"
      unitRef="USD">275000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-11-30_custom_WebsiteMember"
      id="Fact000911">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-11-30_custom_WebsiteMember"
      decimals="0"
      id="Fact000913"
      unitRef="USD">100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-05-31_custom_WebsiteMember"
      decimals="0"
      id="Fact000915"
      unitRef="USD">100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-11-30_custom_ProductCertificationTestingMember"
      id="Fact000917">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-11-30_custom_ProductCertificationTestingMember"
      decimals="0"
      id="Fact000919"
      unitRef="USD">41840</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000923"
      unitRef="USD">184013</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000925"
      unitRef="USD">169920</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000927"
      unitRef="USD">324907</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000929"
      unitRef="USD">309104</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000931"
      unitRef="USD">2152215</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact000933"
      unitRef="USD">23035</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact000935"
      unitRef="USD">19375</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact000937"
      unitRef="USD">26037</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact000939"
      unitRef="USD">35522</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000941">&lt;p id="xdx_805_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zoJ3xIbBI4wi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 7 &#x2013; &lt;span id="xdx_82A_zi7twkN03lb3"&gt;Other Current Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Other current liabilities comprised of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zCoQczWtSoEk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other Current Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_z4FtypkJUlch" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20241130_zAEYbhTpI7E1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240531_zD9zWNpuHOP8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CreditCards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Credit Cards&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,631&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,734&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RoyaltyPaymentAccrual_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Royalty Payment Accrual&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0948"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,376&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sales Tax Payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315,377&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;231,283&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,387&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;92,543&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pp0p0_z91toXAqLkcl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;331,395&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;332,936&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000943">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zCoQczWtSoEk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other Current Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_z4FtypkJUlch" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20241130_zAEYbhTpI7E1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240531_zD9zWNpuHOP8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CreditCards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Credit Cards&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,631&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,734&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RoyaltyPaymentAccrual_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Royalty Payment Accrual&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0948"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,376&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sales Tax Payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315,377&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;231,283&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,387&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;92,543&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pp0p0_z91toXAqLkcl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;331,395&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;332,936&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <axil:CreditCards
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000945"
      unitRef="USD">3631</axil:CreditCards>
    <axil:CreditCards
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000946"
      unitRef="USD">5734</axil:CreditCards>
    <axil:RoyaltyPaymentAccrual
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000949"
      unitRef="USD">3376</axil:RoyaltyPaymentAccrual>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000951"
      unitRef="USD">315377</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000952"
      unitRef="USD">231283</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000954"
      unitRef="USD">12387</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000955"
      unitRef="USD">92543</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000957"
      unitRef="USD">331395</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact000958"
      unitRef="USD">332936</us-gaap:OtherLiabilities>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000960">&lt;p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zbx6fxUSAZWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 8 &#x2013; &lt;span id="xdx_828_zta7KHKnUwZh"&gt;Notes Payable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended May 31, 2020, a commercial bank
granted to the Company a loan (the &#x201c;Loan&#x201d;) in the amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20200531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Face Amount"&gt;150,000&lt;/span&gt;, which is administered under the authority and regulations
of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the &#x201c;EIDL&#x201d;) of the Coronavirus
Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;). The Loan, which is evidenced by a note dated May 18, 2020,&#160;bears
interest at an annual rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20200501__20200518__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pdd" title="Interest rate"&gt;3.75%&lt;/span&gt; and&#160;is payable in installments of principal and interest of $731 per month, beginning May 18,
2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all
items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to
be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively,
&#x201c;qualifying expenses&#x201d;). The Company used the loan proceeds for qualifying expenses. During the year ended May 31, 2022, the
Company received additional $&lt;span id="xdx_902_ecustom--LoanForgiveness_c20210601__20220531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Loan forgiveness"&gt;10,000&lt;/span&gt; of borrowings under the program. The Company received a loan forgiveness for $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfDebt_c20210601__20220531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Additional borrowings"&gt;10,000&lt;/span&gt; during the year
ended May 31, 2022. The Company recorded, on the accompanying unaudited consolidated financial statements, and paid interest of $&lt;span id="xdx_90D_eus-gaap--InterestPayableCurrent_c20241130__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Accrued interest"&gt;1,296&lt;/span&gt;,
and $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrent_c20240531__us-gaap--LongtermDebtTypeAxis__custom--EconomicInjuryDisasterLoanProgramMember_pp0p0" title="Accrued interest"&gt;562&lt;/span&gt;, during the three months ended November 30, 2024 and 2023, respectively.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024 and May 31, 2024, the outstanding
balance of the loan amounted to $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20241130__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Face Amount"&gt;143,342&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20240531__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Face Amount"&gt;146,594&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The amounts of loan payments due in the next 12 months ended November 30,
are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zREqc0YqAEMh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_z5kRlsW8vI45" style="display: none"&gt;Schedule of notes payments due in the next twelve months&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20241130_z90Ho0QES69i" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDziXa_zntJ4gzaSQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: left; padding-bottom: 1.5pt"&gt;2025&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"&gt;143,342&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDziXa_zdkhvG0hOYh7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;143,342&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-05-31_custom_EconomicInjuryDisasterLoanProgramMember"
      decimals="0"
      id="Fact000962"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-05-012020-05-18_custom_EconomicInjuryDisasterLoanProgramMember"
      decimals="INF"
      id="Fact000964"
      unitRef="Pure">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <axil:LoanForgiveness
      contextRef="From2021-06-012022-05-31_custom_EconomicInjuryDisasterLoanProgramMember"
      decimals="0"
      id="Fact000966"
      unitRef="USD">10000</axil:LoanForgiveness>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2021-06-012022-05-31_custom_EconomicInjuryDisasterLoanProgramMember"
      decimals="0"
      id="Fact000968"
      unitRef="USD">10000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2024-11-30_custom_EconomicInjuryDisasterLoanProgramMember"
      decimals="0"
      id="Fact000970"
      unitRef="USD">1296</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2024-05-31_custom_EconomicInjuryDisasterLoanProgramMember"
      decimals="0"
      id="Fact000972"
      unitRef="USD">562</us-gaap:InterestPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-11-30_custom_EIDLMember"
      decimals="0"
      id="Fact000981"
      unitRef="USD">143342</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-05-31_custom_EIDLMember"
      decimals="0"
      id="Fact000983"
      unitRef="USD">146594</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000985">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zREqc0YqAEMh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_z5kRlsW8vI45" style="display: none"&gt;Schedule of notes payments due in the next twelve months&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20241130_z90Ho0QES69i" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDziXa_zntJ4gzaSQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: left; padding-bottom: 1.5pt"&gt;2025&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"&gt;143,342&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDziXa_zdkhvG0hOYh7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;143,342&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000987"
      unitRef="USD">143342</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebt
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000989"
      unitRef="USD">143342</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact000991">&lt;p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlTCg739clH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 9 &#x2013; &lt;span id="xdx_823_zV2iCKBitmnd"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Shares Authorized&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024, the authorized capital of
the Company consists of &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20241130_zhm3Oq1APjji" title="Common stock, shares authorized"&gt;450,000,000&lt;/span&gt; shares of common stock, par value $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241130_zxuzCyArBJ6h" title="Common stock, par or stated value per share"&gt;0.0001&lt;/span&gt; per share and &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20241130_zHNxxCP5jpS5" title="Preferred stock, shares authorized"&gt;300,000,000&lt;/span&gt; shares of preferred stock, par
value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241130_ziRoz8uRXUyc" title="Preferred stock, par or stated value per share"&gt;0.0001&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective as of January 16, 2024, the Company effected
a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) of the Company&#x2019;s issued shares of common stock at a ratio of &lt;span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240601__20241130_zeAM3IL2B7Ik" title="Reverse stock split"&gt;1-for-20&lt;/span&gt;,
as approved by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). The Reverse Stock Split did not change the par value
of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the
Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to
the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the financial statements give retroactive
effect to the Reverse Stock Split for all periods presented, unless otherwise specified.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preferred stock may be issued from time to time
in one or more series. The Board is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock
in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited,
or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications,
limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board providing the issuance of
such shares. The Board is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue
of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status
that they had prior to the adoption of the resolution originally fixing the number of shares of such series.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the fiscal year ended May 31, 2023, the Company
issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220601__20230531_pdd" title="Shares issued during the period"&gt;250,000,000&lt;/span&gt; shares of non-voting Series A Preferred Stock, which, following the Reverse Stock Split of the Company&#x2019;s common
stock, are convertible into shares of the Company&#x2019;s common stock on a twenty-to-one ratio. These 250,000,000 shares of non-voting
Series A Preferred Stock were valued at the fair market value of $&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220601__20230531_pp0p0" title="Shares issued value during the period"&gt;3,100,000&lt;/span&gt; at issuance.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holders of shares of Series A Preferred Stock
have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the common stock
unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon
the number of shares of common stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation,
or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out
of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of common stock.
The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Company or any holder or holders
of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time
after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock into one fully paid and nonassessable
share of common stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of
shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company&#x2019;s
common stock as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The conversion provisions of the Company&#x2019;s Series
A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split, and the number of shares of Series A Preferred
Stock issued and outstanding was not affected by the Reverse Stock Split.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 5, 2024, the Company entered into repurchase
agreements with certain stockholders of the Company to purchase in the aggregate&#160;&lt;span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20240301__20240305__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Number of share purchased"&gt;207,748,250&lt;/span&gt;&#160;shares of Series A Preferred Stock
of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company&#x2019;s common stock on an as converted basis) for the aggregate
cash consideration of $&lt;span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodValue_c20240301__20240305__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pp0p0" title="Cash consideration"&gt;1,246,490&lt;/span&gt;. Such repurchase was approved by the Company&#x2019;s Board of Directors. Following the repurchase,&#160;&lt;span id="xdx_90F_ecustom--RemainingOutstanding_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Remaining outstanding"&gt;42,251,750&lt;/span&gt;&#160;shares
of Series A Preferred Stock remained outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the fiscal
year 2024, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the six months ended November 30, 2024, certain
stockholders of &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd" title="Number of shares converted"&gt;11,118,250&lt;/span&gt; preferred shares converted their preferred stock into &lt;span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20240601__20241130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Number of shares converted"&gt;555,913&lt;/span&gt; shares of common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024 and May 31, 2024,&#160;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_c20241130_zU0cwAGJs4o6" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20241130_zvp8hnNuFDnc" title="Preferred stock, shares outstanding"&gt;31,133,500&lt;/span&gt;&lt;/span&gt;
and &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20240531_zC9U5G14uGf1" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20240531_zp5HJZn6QMkc" title="Preferred stock, shares outstanding"&gt;42,251,750&lt;/span&gt;&lt;/span&gt; shares of Series A Preferred Stock, respectively, were issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Common Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024, &lt;span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20241130_zQ5NE3DnsbDl" title="Common stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20241130_zHhfv5SnU4al" title="Common stock, shares outstanding"&gt;6,466,852&lt;/span&gt;&lt;/span&gt; shares of common
stock were issued and outstanding.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Reverse Stock Split as more fully discussed in
Note 2, did not change the par value of the common stock, modify any voting rights or other terms of the common stock, or change the number
of authorized shares of the Company. Any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole
share.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Stock Options&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective February 14, 2024, the Board amended the
Company&#x2019;s original 2022 Equity Incentive Plan (as amended the &#x201c;Plan&#x201d;), which was originally approved on March 21, 2022.
The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors,
non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i)&#160;Incentive Stock
Options (to eligible employees only); (ii)&#160;Nonqualified Stock Options; (iii)&#160;Restricted Stock; (iv)&#160;Stock Awards; (v)&#160;Performance
Shares; or (vi)&#160;any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March
21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend
or terminate the Plan without stockholder approval, subject to certain exceptions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 8, 2024, the Board of Directors approved
the amendment and restatement of the Plan in order to increase the number of shares authorized for issuance under the Plan by 800,000
shares, any or all of which may be issued pursuant to grants of &#x201c;incentive stock options&#x201d; (within the meaning of Section 422
of the Internal Revenue Code). The amendment and restatement of the Plan became effective December 18, 2024, following shareholder approval.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The total number of shares initially authorized for
issuance under the Plan was 500,000 shares. The Plan has since been amended to increase the number of shares authorized for issuance under
the Plan to 2,050,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in
2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of
the total number of shares of the Company&#x2019;s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii)
such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change
unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable
year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be
added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance
or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including
a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option,
or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares
available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease
in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision
or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure
of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued
shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Two types of options may be granted under the Plan:
(1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of
the option not less than the fair market value of the common stock on the grant date, or,&#160;in the case of an Incentive Stock Option
granted to a Ten Percent Stockholder, 110%&#160;of the fair market value of the common stock on the grant date; and (2) Non-qualified
Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value
of the common stock on the grant date, but not less than par value of the stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Board may grant or sell restricted stock to participants
(i.e., shares that are subject to a subject to restrictions or limitations as to the participant&#x2019;s ability to sell, transfer, pledge
or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted
stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction
period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant
awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout
is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Each equity-based award granted under the Plan will
be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the
Board may determine, consistent with the provisions of the Plan.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Subject to the Plan&#x2019;s terms, the Board has full
power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled,
forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will
be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company estimates the fair value of share-based
compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term,
expected volatility of the Company&#x2019;s stock price over the expected term, expected risk-free interest rate over the expected option
term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for
estimating the fair value of stock options granted to employees and directors which are subject to ASC 718 requirements. These amounts
are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants.
The Company recognizes compensation on a straight-line basis over the requisite service period for each award.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company utilizes the simplified method to estimate
the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical
data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based
on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield
is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase
if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 13, 2024, the Company issued stock options
to one consultant to purchase, in aggregate, up to&#160;&lt;span id="xdx_905_ecustom--NumberOfOptionIssued_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Number of option issued"&gt;5,000&lt;/span&gt;&#160;shares of its common stock, at an exercise price of $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Exercise price"&gt;4.00&lt;/span&gt; per share
valued at $&lt;span id="xdx_900_ecustom--ValueOfOptionIssued_c20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pp0p0" title="Value of option issued"&gt;20,000&lt;/span&gt; and expiring on October 31, 2034. The options vest quarterly over a year beginning on February 28, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 14, 2024, the Company issued to two Company
officers stock options to purchase, in the aggregate, up to&#160;&lt;span id="xdx_904_ecustom--NumberOfOptionIssued_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pdd" title="Number of option issued"&gt;600,000&lt;/span&gt;&#160;shares of its common stock, at an exercise price of $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pdd" title="Exercise price"&gt;4.01&lt;/span&gt;
per share valued at $&lt;span id="xdx_908_ecustom--ValueOfOptionIssued_c20241014__srt--CounterpartyNameAxis__custom--OfficersMember_pp0p0" title="Value of option issued"&gt;2,406,000&lt;/span&gt; and expiring in ten years from the date of grant. The options vest over forty-eight equal monthly installments
starting on the grant date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the three months ended August 31, 2024, the
Company issued stock options, to two consultants, to purchase, in the aggregate, up to 24,000 shares of its common stock, at an exercise
price equal to the Company&#x2019;s closing price on the NYSE American on the date of grant. The options are valued at approximately $195,960
and expire in ten years from the date of grant.&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents the weighted-average
assumptions used to estimate the fair value of the stock options granted during the six months ended November 30, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4m0elWfo1i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span id="xdx_8B0_zu3zfXyKET7i" style="display: none"&gt;Schedule of stock option assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;Risk free interest rate&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20240601__20241130_pdd" title="Risk free interest rate"&gt;3.95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;Expected life&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240601__20241130_zeXIQ76XcgFg" title="Expected life"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 82%"&gt;Expected volatility&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: center"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20240601__20241130_pdd" title="Expected volatility"&gt;464%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;Expected dividend&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20240601__20241130_pdd" title="Expected dividend"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1077"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_z9Zi8GQwDbO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the activities for
the Company&#x2019;s stock options for the&#160;six months ended November 30, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcf8H5MW7gj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zO4GfUn4yHef" style="display: none"&gt;Schedule of stock options activities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of Options&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt; Exercise Price&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt; Remaining Term&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 49%"&gt;Outstanding as of May 31, 2024&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240531_zmDANmVyPacd" style="width: 10%; text-align: right" title="Number of Options Outstanding, Beginning"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240531_zk70Sqto5p5l" style="width: 10%; text-align: right" title="Weighted Average  Exercise Price, Beginning"&gt;1.84&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220601__20230531_zHQzQR79BUvi" title="Weighted Average  Remaining Term"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240601__20241130_pdd" style="text-align: right" title="Number of Options Outstanding, Granted"&gt;629,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240601__20241130_pdd" style="text-align: right" title="Weighted Average  Exercise Price, Granted"&gt;4.17&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240601__20241130_zFC9aO68cFB4" style="text-align: right" title="Number of Options Outstanding, Exercised/Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240601__20241130_z6mNOLm5jdrc" style="text-align: right" title="Weighted Average  Exercise Price, Exercised/Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Less: Unvested at November 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNI_di_c20241130_zrASSeGiVmr5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending"&gt;(650,500&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending"&gt;4.11&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240601__20241130_z9TzsyXY4sU2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term"&gt;6.7&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested at November 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Vested"&gt;247,250&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Exercise Price, Vested"&gt;2.13&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240601__20241130_z2H6GyxahMn7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term, Vested"&gt;7.6&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zEyF8TTRe7ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the six months ended November 30, 2024,
the Company expensed $&lt;span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20240601__20241130_pp0p0" title="Stock options expense"&gt;211,055&lt;/span&gt;
with respect to options, of which $130,208 was included in General and administrative, and $80,847 in Sales and marketing,
respectively, in the accompanying Consolidated Statements of Operations. During the six months ended November 30, 2023, the Company
expensed $&lt;span id="xdx_905_eus-gaap--StockOptionPlanExpense_c20230601__20231130_pp0p0" title="Stock options expense"&gt;102,215&lt;/span&gt;
with respect to stock options, which was included in General and administrative in the accompanying Consolidated Statements of
Operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Restricted Stock Awards and Restricted Shares Issued &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s non-employee directors participate
in the Company&#x2019;s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan,
on February 14, 2024, the Company granted each of its three non-employee directors Board members &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20240201__20240214__srt--TitleOfIndividualAxis__custom--ThreeBoardMembersMember_pdd" title="Number of restricted stock awards issued"&gt;5,000&lt;/span&gt; restricted stock awards for an
aggregate of 15,000 shares of the Company&#x2019;s common stock that will vest on the one-year anniversary of the grant, subject to the
respective director&#x2019;s continued service as a member of the Board, with a total grant date fair value of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20240201__20240214__srt--TitleOfIndividualAxis__custom--ThreeBoardMembersMember_pp0p0" title="Fair value of restricted stock"&gt;195,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;Effective May
28, 2024, a former officer entered into a Separation Agreement and Release (the &#x201c;Release&#x201d;), which includes a standard release
of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting
Agreement, dated May 28, 2024, with the former officer (the &#x201c;Consulting Agreement&#x201d;), pursuant to which the former officer
agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier.
Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted
common stock valued at $298,800, which vested upon grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;Effective November
13, 2024, the Company issued &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241101__20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_pdd" title="Stock issued for services"&gt;2,000&lt;/span&gt; shares of restricted common stock to a consultant for services relating to expansion of the Company
into new markets&lt;span style="background-color: white"&gt;. The shares were valued at $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20241101__20241113__srt--CounterpartyNameAxis__custom--OneConsultantMember_zHbzROlYoNGk" title="Stock issued for valued"&gt;8,000&lt;/span&gt;
based on the &lt;/span&gt;Company&#x2019;s closing price on the NYSE American on the date of grant&lt;span style="background-color: white"&gt;. The
shares&lt;/span&gt; vested upon grant and will be expensed over the six month service period of the consultant beginning
from the grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the stock grants is being recorded
over the term of the service related to each grant. During the six months ended November 30, 2024, the Company expensed $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensation_c20240601__20241130__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p0" title="Stock-based compensation expense"&gt;97,500&lt;/span&gt; related
to restricted stock awards included in General and administrative in the accompanying Consolidated Statements of Operations, and $293,909
related to restricted stock expenses of which $293,054 was included in General and administrative and $855 in Sales and marketing, respectively,
in the accompanying Consolidated Statements of Operations. During the six months ended November 30, 2023, the Company expensed $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20230601__20231130__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p0" title="Stock-based compensation expense"&gt;0&lt;/span&gt; related
to restricted stock awards and restricted stock expense.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000993"
      unitRef="Shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000995"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000997"
      unitRef="Shares">300000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000999"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2024-06-01to2024-11-30" id="Fact001001">1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-06-012023-05-31"
      decimals="INF"
      id="Fact001003"
      unitRef="Shares">250000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-06-012023-05-31"
      decimals="0"
      id="Fact001005"
      unitRef="USD">3100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-03-012024-03-05_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001014"
      unitRef="Shares">207748250</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-03-012024-03-05_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001016"
      unitRef="USD">1246490</us-gaap:StockRepurchasedDuringPeriodValue>
    <axil:RemainingOutstanding
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember105062531"
      decimals="INF"
      id="Fact001018"
      unitRef="Shares">42251750</axil:RemainingOutstanding>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-06-012024-11-30_us-gaap_PreferredStockMember105062531"
      decimals="INF"
      id="Fact001020"
      unitRef="Shares">11118250</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-06-012024-11-30_us-gaap_CommonStockMember105062546"
      decimals="INF"
      id="Fact001022"
      unitRef="Shares">555913</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001024"
      unitRef="Shares">31133500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001026"
      unitRef="Shares">31133500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact001028"
      unitRef="Shares">42251750</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact001030"
      unitRef="Shares">42251750</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001032"
      unitRef="Shares">6466852</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001034"
      unitRef="Shares">6466852</us-gaap:CommonStockSharesOutstanding>
    <axil:NumberOfOptionIssued
      contextRef="AsOf2024-11-13_custom_OneConsultantMember"
      decimals="INF"
      id="Fact001050"
      unitRef="Shares">5000</axil:NumberOfOptionIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-11-13_custom_OneConsultantMember"
      decimals="INF"
      id="Fact001052"
      unitRef="USDPShares">4.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <axil:ValueOfOptionIssued
      contextRef="AsOf2024-11-13_custom_OneConsultantMember"
      decimals="0"
      id="Fact001054"
      unitRef="USD">20000</axil:ValueOfOptionIssued>
    <axil:NumberOfOptionIssued
      contextRef="AsOf2024-10-14_custom_OfficersMember"
      decimals="INF"
      id="Fact001056"
      unitRef="Shares">600000</axil:NumberOfOptionIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-10-14_custom_OfficersMember"
      decimals="INF"
      id="Fact001058"
      unitRef="USDPShares">4.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <axil:ValueOfOptionIssued
      contextRef="AsOf2024-10-14_custom_OfficersMember"
      decimals="0"
      id="Fact001060"
      unitRef="USD">2406000</axil:ValueOfOptionIssued>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001069">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4m0elWfo1i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span id="xdx_8B0_zu3zfXyKET7i" style="display: none"&gt;Schedule of stock option assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;Risk free interest rate&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20240601__20241130_pdd" title="Risk free interest rate"&gt;3.95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;Expected life&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240601__20241130_zeXIQ76XcgFg" title="Expected life"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 82%"&gt;Expected volatility&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: center"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20240601__20241130_pdd" title="Expected volatility"&gt;464%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;Expected dividend&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20240601__20241130_pdd" title="Expected dividend"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1077"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact001071"
      unitRef="Pure">0.0395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2024-06-01to2024-11-30" id="Fact001073">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact001075"
      unitRef="Pure">4.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001079">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcf8H5MW7gj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zO4GfUn4yHef" style="display: none"&gt;Schedule of stock options activities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of Options&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt; Exercise Price&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt; Remaining Term&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 49%"&gt;Outstanding as of May 31, 2024&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240531_zmDANmVyPacd" style="width: 10%; text-align: right" title="Number of Options Outstanding, Beginning"&gt;268,750&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240531_zk70Sqto5p5l" style="width: 10%; text-align: right" title="Weighted Average  Exercise Price, Beginning"&gt;1.84&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220601__20230531_zHQzQR79BUvi" title="Weighted Average  Remaining Term"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240601__20241130_pdd" style="text-align: right" title="Number of Options Outstanding, Granted"&gt;629,000&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240601__20241130_pdd" style="text-align: right" title="Weighted Average  Exercise Price, Granted"&gt;4.17&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240601__20241130_zFC9aO68cFB4" style="text-align: right" title="Number of Options Outstanding, Exercised/Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240601__20241130_z6mNOLm5jdrc" style="text-align: right" title="Weighted Average  Exercise Price, Exercised/Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Less: Unvested at November 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNI_di_c20241130_zrASSeGiVmr5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending"&gt;(650,500&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Ending"&gt;4.11&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240601__20241130_z9TzsyXY4sU2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term"&gt;6.7&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested at November 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding, Vested"&gt;247,250&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20241130_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Exercise Price, Vested"&gt;2.13&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240601__20241130_z2H6GyxahMn7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average  Remaining Term, Vested"&gt;7.6&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact001081"
      unitRef="Shares">268750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-05-31"
      decimals="INF"
      id="Fact001083"
      unitRef="USDPShares">1.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-06-012023-05-31" id="Fact001085">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact001087"
      unitRef="Shares">629000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-06-01to2024-11-30"
      decimals="INF"
      id="Fact001089"
      unitRef="USDPShares">4.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001095"
      unitRef="Shares">650500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001097"
      unitRef="USDPShares">4.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-06-01to2024-11-30" id="Fact001099">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001101"
      unitRef="Shares">247250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001103"
      unitRef="USDPShares">2.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2024-06-01to2024-11-30" id="Fact001105">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001107"
      unitRef="USD">211055</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001109"
      unitRef="USD">102215</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-02-012024-02-14_custom_ThreeBoardMembersMember"
      decimals="INF"
      id="Fact001111"
      unitRef="Shares">5000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-02-012024-02-14_custom_ThreeBoardMembersMember"
      decimals="0"
      id="Fact001113"
      unitRef="USD">195000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-11-012024-11-13_custom_OneConsultantMember"
      decimals="INF"
      id="Fact001115"
      unitRef="Shares">2000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-11-012024-11-13_custom_OneConsultantMember"
      decimals="0"
      id="Fact001117"
      unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-06-012024-11-30_custom_RestrictedStockAwardsMember"
      decimals="0"
      id="Fact001119"
      unitRef="USD">97500</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-06-012023-11-30_custom_RestrictedStockAwardsMember"
      decimals="0"
      id="Fact001121"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001128">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znaBUnwxGuB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 10 &#x2013; &lt;span id="xdx_824_zW8EEHrSqLm9"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As discussed in Note 2 above, the Company adopted
ASU 2016-02, &#x201c;Leases&lt;i&gt;&#x201d; &lt;/i&gt;on June 1, 2019, which require lessees to report on their balance sheets a right-of-use asset
and a lease liability in connection with most lease agreements classified as operating leases.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company treats a contract as a lease when the
contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or if the Company directs
the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (&#x201c;ROU&#x201d;)
assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company&#x2019;s right to
use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company&#x2019;s obligation to make payments
over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of
the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease.
In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services,
which are considered non-lease components for accounting purposes. For our real estate leases, the Company applies a practical expedient
to include these non-lease components in calculating the ROU asset and lease liability. For variable costs that may change during the
lifetime of the lease, the Company expenses as incurred.&#160;Since the interest rate implicit in a lease is generally not readily determinable
for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental
borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease
term to obtain an asset of similar value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company reviews the impairment of ROU assets consistent
with the approach applied for the Company&#x2019;s other long-lived assets. The Company reviews the recoverability of long-lived assets
when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment
of possible impairment is based on the Company&#x2019;s ability to recover the carrying value of the asset from the expected undiscounted
future pre-tax cash flows of the related operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Lease expense is recognized on a straight-line basis
over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring
after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the six months ended November 30, 2024, the
Company entered into two new lease agreements. The Company&#x2019;s lease agreements do not contain any residual value guarantees or restrictive
covenants. The Company&#x2019;s lease agreements do not have an explicit renewal option, and the termination options are available in the
event of material breaches. The expiration dates of the leases are on various dates between December 1, 2024 and January 31, 2029.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company computed an initial lease liability of
$&lt;span id="xdx_90A_ecustom--InitialLeaseLiability_c20241130_pp0p0" title="Initial lease liability"&gt;767,269&lt;/span&gt;&#160;for the two new lease agreements and an initial ROU asset in the same amount which was recorded on the books at the commencement
of the leases. During the three months ended November 30, 2024 and 2023, the Company recorded operating lease costs in the amount of $&lt;span id="xdx_901_eus-gaap--OperatingLeaseCost_c20240901__20241130_pp0p0" title="Operating lease cost"&gt;49,080&lt;/span&gt;&#160;and
$&lt;span id="xdx_908_eus-gaap--OperatingLeaseCost_c20230901__20231130_pp0p0" title="Operating lease cost"&gt;18,659&lt;/span&gt;, respectively. During the six months ended November 30, 2024 and 2023, the Company recorded operating lease costs in the amount
of $&lt;span id="xdx_90B_eus-gaap--OperatingLeaseCost_c20240601__20241130_pp0p0" title="Operating lease cost"&gt;67,739&lt;/span&gt;&#160;and $&lt;span id="xdx_90D_eus-gaap--OperatingLeaseCost_c20230601__20231130_pp0p0" title="Operating lease cost"&gt;37,317&lt;/span&gt;, respectively. Operating lease and short-term lease expenses are included in General and administrative expenses
on the accompanying Consolidated Statements of Operations.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The weighted average remaining term and discount
rate for the Company&#x2019;s operating leases as of November 30, 2024&#160;was&#160;&lt;span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241130_zv7Wkco6HRAe"&gt;3.8&lt;/span&gt;&#160;years
and&#160;&lt;span id="xdx_902_eus-gaap--LesseeOperatingLeaseDiscountRate_c20241130_pdd"&gt;13.0%&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_zAcrHm0htup8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;&lt;span id="xdx_8B2_z15bIRVPzzG" style="display: none"&gt;Schedule of supplemental balance sheet information&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20241130_zdjHzwYHe515" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20240531_z5EzBjvpJgff" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--RightOfUseAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left; padding-left: 9pt"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;899,239&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;131,970&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Accumulated reduction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(161,988&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(95,218&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Operating lease assets, net&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;737,251&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;36,752&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;899,239&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;131,970&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AccumulatedReduction_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Accumulated reduction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(161,081&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(95,218&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total lease liability, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,158&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,752&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OperatingLeaseLiabilityCurrentPortion_iNI_pp0p0_di_zt6NgcuV3QU8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(207,077&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(36,752&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Non-current portion&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;531,081&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1179"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z4tmRNVK2rdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Maturities of operating lease liabilities were as follows as of November
30, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4BZ0rSSOCh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_z4FOsnbl7Pd2" style="display: none"&gt;Schedule of maturities of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20241130_zbzsam2y0Xal" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Operating Lease (fiscal year-end)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz3IL_z87XRggIyeae" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 81%"&gt;2025 (six months remaining)&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;94,651&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz3IL_zEiMUpr53XD6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;258,005&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz3IL_zwm8rKEk30a4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269,437&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz3IL_zWnpCyRufoUb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,420&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz3IL_zg63Cy6ZHG2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2029&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;128,040&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz3IL_zCE6kpDMo5Wi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;968,553&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zOI7bPagT1s4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(230,395&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zN4FhJcJ6L6a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;738,158&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zmCeY9ct0J87" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Accounts Payable&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the three months ended November 30, 2024, the
Company renewed its relationship with an entity, and as a result of the agreement, $&lt;span id="xdx_90E_eus-gaap--AccruedRoyaltiesCurrent_c20241130_pp0p0" title="Due in royalties"&gt;218,699&lt;/span&gt; previously due in relation to royalties, was
forgiven and included in Sales and marketing in the accompanying Consolidated Statements of Operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;From time to time, we become involved in various lawsuits
and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of
the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure
purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and
circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate
and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments
on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent
with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with
certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of
operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings
are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution
of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As
a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular
period, depending upon the size of the loss or our income for that particular period.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <axil:InitialLeaseLiability
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001130"
      unitRef="USD">767269</axil:InitialLeaseLiability>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001132"
      unitRef="USD">49080</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001134"
      unitRef="USD">18659</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001136"
      unitRef="USD">67739</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001138"
      unitRef="USD">37317</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-11-30" id="Fact001139">P3Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001140"
      unitRef="Pure">0.130</us-gaap:LesseeOperatingLeaseDiscountRate>
    <axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001149">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfSupplementalBalanceSheetInformationTableTextBlock_zAcrHm0htup8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;&lt;span id="xdx_8B2_z15bIRVPzzG" style="display: none"&gt;Schedule of supplemental balance sheet information&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20241130_zdjHzwYHe515" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20240531_z5EzBjvpJgff" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;November 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;May 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--RightOfUseAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left; padding-left: 9pt"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;899,239&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;131,970&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Accumulated reduction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(161,988&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(95,218&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Operating lease assets, net&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;737,251&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;36,752&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;899,239&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;131,970&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AccumulatedReduction_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Accumulated reduction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(161,081&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(95,218&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total lease liability, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,158&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,752&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OperatingLeaseLiabilityCurrentPortion_iNI_pp0p0_di_zt6NgcuV3QU8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(207,077&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(36,752&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Non-current portion&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;531,081&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1179"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</axil:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock>
    <axil:RightOfUseAssets
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001154"
      unitRef="USD">899239</axil:RightOfUseAssets>
    <axil:RightOfUseAssets
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001155"
      unitRef="USD">131970</axil:RightOfUseAssets>
    <axil:OperatingLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001157"
      unitRef="USD">-161988</axil:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <axil:OperatingLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001158"
      unitRef="USD">-95218</axil:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001160"
      unitRef="USD">737251</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001161"
      unitRef="USD">36752</us-gaap:OperatingLeaseRightOfUseAsset>
    <axil:LeaseLiability
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001166"
      unitRef="USD">899239</axil:LeaseLiability>
    <axil:LeaseLiability
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001167"
      unitRef="USD">131970</axil:LeaseLiability>
    <axil:AccumulatedReduction
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001169"
      unitRef="USD">-161081</axil:AccumulatedReduction>
    <axil:AccumulatedReduction
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001170"
      unitRef="USD">-95218</axil:AccumulatedReduction>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001172"
      unitRef="USD">738158</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001173"
      unitRef="USD">36752</us-gaap:OperatingLeaseLiability>
    <axil:OperatingLeaseLiabilityCurrentPortion
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001175"
      unitRef="USD">207077</axil:OperatingLeaseLiabilityCurrentPortion>
    <axil:OperatingLeaseLiabilityCurrentPortion
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001176"
      unitRef="USD">36752</axil:OperatingLeaseLiabilityCurrentPortion>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001178"
      unitRef="USD">531081</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001181">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4BZ0rSSOCh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_z4FOsnbl7Pd2" style="display: none"&gt;Schedule of maturities of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20241130_zbzsam2y0Xal" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Operating Lease (fiscal year-end)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz3IL_z87XRggIyeae" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 81%"&gt;2025 (six months remaining)&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;94,651&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz3IL_zEiMUpr53XD6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;258,005&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz3IL_zwm8rKEk30a4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269,437&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz3IL_zWnpCyRufoUb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,420&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz3IL_zg63Cy6ZHG2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2029&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;128,040&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz3IL_zCE6kpDMo5Wi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;968,553&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zOI7bPagT1s4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(230,395&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zN4FhJcJ6L6a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4.5pt double; text-align: right"&gt;738,158&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001183"
      unitRef="USD">94651</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001185"
      unitRef="USD">258005</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001187"
      unitRef="USD">269437</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001189"
      unitRef="USD">218420</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001191"
      unitRef="USD">128040</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001193"
      unitRef="USD">968553</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001195"
      unitRef="USD">230395</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001197"
      unitRef="USD">738158</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001199"
      unitRef="USD">218699</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001206">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zY7tVSnUtwI5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 11 &#x2013; &lt;span id="xdx_820_zDsw2jZNwHch"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s Chairman and Chief Executive
Officer (&#x201c;CEO&#x201d;), Jeff Toghraie, is the managing director of Intrepid Global Advisors (&#x201c;Intrepid&#x201d;). Intrepid
has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the
year. Intrepid was paid approximately $&lt;span id="xdx_900_ecustom--ConsultingFee_c20240601__20241130__srt--CounterpartyNameAxis__custom--IntrepidMember_pp0p0" title="Consulting fee"&gt;127,000&lt;/span&gt;
in consulting fees for the six months ended November 30, 2024. As of November 30, 2024 and May 31, 2024, the Company had amounts
payable to Intrepid of $&lt;span id="xdx_90E_ecustom--PayableToRelatedParty_c20241130__srt--CounterpartyNameAxis__custom--IntrepidMember_pp0p0" title="Payable to related party"&gt;178,520&lt;/span&gt;
and $&lt;span id="xdx_909_ecustom--PayableToRelatedParty_iI_pp0p0_c20240531__srt--CounterpartyNameAxis__custom--IntrepidMember_z6sDuFaoVwxi" title="Payable to related party"&gt;11,798&lt;/span&gt;,
respectively. These advances were short-term in nature and non-interest bearing. The Company's Board Member, Chief Financial Officer
("CFO"), and Chief Operating Officer ("COO") has a controlling interest in BZ Capital Strategies. BZ Capital
Strategies was&#160;paid $&lt;span id="xdx_904_ecustom--ConsultingFee_c20240601__20241130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BZCapitalStrategiesMember_pp0p0" title="Consulting fee"&gt;75,000&lt;/span&gt;
in consulting fees&#160;for the six months ended November 30, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <axil:ConsultingFee
      contextRef="From2024-06-012024-11-30_custom_IntrepidMember"
      decimals="0"
      id="Fact001208"
      unitRef="USD">127000</axil:ConsultingFee>
    <axil:PayableToRelatedParty
      contextRef="AsOf2024-11-30_custom_IntrepidMember"
      decimals="0"
      id="Fact001210"
      unitRef="USD">178520</axil:PayableToRelatedParty>
    <axil:PayableToRelatedParty
      contextRef="AsOf2024-05-31_custom_IntrepidMember"
      decimals="0"
      id="Fact001212"
      unitRef="USD">11798</axil:PayableToRelatedParty>
    <axil:ConsultingFee
      contextRef="From2024-06-012024-11-30_custom_BZCapitalStrategiesMember"
      decimals="0"
      id="Fact001214"
      unitRef="USD">75000</axil:ConsultingFee>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001216">&lt;p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_zCKNLGKmQ1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 12 &#x2013; &lt;span id="xdx_82C_zMt8WgS5RPJ8"&gt;Concentrations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="text-decoration: underline"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the
Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents
instruments. The Company maintains its cash in bank deposits accounts. The Company&#x2019;s account at this institution is insured by the
Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $&lt;span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20241130_pp0p0" title="Cash, FDIC insured amount"&gt;250,000&lt;/span&gt;. At November 30, 2024 and May 31, 2024, the Company held cash
of approximately $&lt;span id="xdx_900_eus-gaap--CashUninsuredAmount_c20241130_pp0p0" title="Cash, uninsured amount"&gt;4,463,897&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--CashUninsuredAmount_c20240531_pp0p0" title="Cash, uninsured amount"&gt;3,003,876&lt;/span&gt;, respectively, in excess of federally insured limits. The Company has not experienced any losses
in such accounts through November 30, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Concentration of Revenue, Accounts Receivable,
Product Line, and Supplier&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company predominantly sells the products direct-to-consumer.
There was no single customer that accounted for greater than 10% of consolidated net sales for the three and six months ended November
30, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the three months ended November 30, 2024, approximately&#160;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"&gt;90.2%&lt;/span&gt;&#160;of
our consolidated net sales were to customers located in the U.S. (based on the customer&#x2019;s shipping address). During the three months
ended November 30, 2023, approximately&#160;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20230901__20231130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"&gt;94.6%&lt;/span&gt;&#160;of our consolidated net sales were to customers located in the U.S. (based on the
customer&#x2019;s shipping address). All Company assets are located in the U.S.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the six months ended November 30, 2024, approximately&#160;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"&gt;91.2%&lt;/span&gt;&#160;of
our consolidated net sales were to customers located in the U.S. (based on the customer&#x2019;s shipping address). During the six months
ended November 30, 2023, approximately&#160;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_c20230601__20231130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration risk, percentage"&gt;93.9%&lt;/span&gt;&#160;of our consolidated net sales were to customers located in the U.S. (based on the
customer&#x2019;s shipping address).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2024, accounts receivable from
customers that accounted for more than&#160;10%&#160;of sales transactions were from one customer amounting to &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_pdd" title="Concentration risk, percentage"&gt;14.5%&lt;/span&gt;. As of May 31, 2024,
no single customer accounted for more than&#160;10%&#160;of accounts receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Manufacturing is outsourced primarily overseas via
a number of third-party vendors. The two largest vendors accounted for&#160;&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"&gt;73.2%&lt;/span&gt;&#160;and&#160;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240901__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorOneMember_pdd" title="Concentration risk, percentage"&gt;15.9%&lt;/span&gt;, respectively,&#160;of all purchases
for the three months ended November 30, 2024. For the three months ended November 30, 2023, the largest vendor accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20230901__20231130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"&gt;82.7%&lt;/span&gt; of
all purchases. For the six months ended November 30, 2024, the two largest vendors accounted for&#160;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"&gt;61.8%&lt;/span&gt;&#160;and&#160;&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20240601__20241130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorOneMember_pdd" title="Concentration risk, percentage"&gt;26.0%&lt;/span&gt;, respectively,&#160;of
all purchases. For the six months ended November 30, 2023, the largest vendor accounted for &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20230601__20231130__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__srt--MajorCustomersAxis__custom--VendorsMember_pdd" title="Concentration risk, percentage"&gt;86.7%&lt;/span&gt; of all purchases.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001218"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001220"
      unitRef="USD">4463897</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001222"
      unitRef="USD">3003876</us-gaap:CashUninsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-09-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001224"
      unitRef="Pure">0.902</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-09-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001226"
      unitRef="Pure">0.946</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001228"
      unitRef="Pure">0.912</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-06-012023-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001230"
      unitRef="Pure">0.939</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-06-012024-11-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember"
      decimals="INF"
      id="Fact001232"
      unitRef="Pure">0.145</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember"
      decimals="INF"
      id="Fact001234"
      unitRef="Pure">0.732</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-09-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember"
      decimals="INF"
      id="Fact001236"
      unitRef="Pure">0.159</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-09-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember"
      decimals="INF"
      id="Fact001238"
      unitRef="Pure">0.827</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember"
      decimals="INF"
      id="Fact001240"
      unitRef="Pure">0.618</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-06-012024-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorOneMember"
      decimals="INF"
      id="Fact001242"
      unitRef="Pure">0.260</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-06-012023-11-30_us-gaap_ProductConcentrationRiskMember_custom_PurchasesMember_custom_VendorsMember"
      decimals="INF"
      id="Fact001244"
      unitRef="Pure">0.867</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001251">&lt;p id="xdx_805_eus-gaap--SegmentReportingDisclosureTextBlock_zmPxQC5GHzWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 13 &#x2013; &lt;span id="xdx_82A_zLtLMcALAsfg"&gt;Business Segment and Geographic Area Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Business Segments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company, directly or through its subsidiaries,
markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing
enhancement and hearing protection business. The Company&#x2019;s determination of its reportable segments is based on how its chief operating
decision makers manage the business.&#160;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The Company&#x2019;s segment information is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_za2t9Oc9lZTg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Segment and Geographic Area Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B2_zdNxLoyJPpM9" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three months ended November 30,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six months ended November 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Sales, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;284,545&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;230,741&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;836,054&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;545,594&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;7,448,029&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;8,190,936&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;12,747,792&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;13,982,352&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Total net sales&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;7,732,574&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;8,421,677&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;13,583,846&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;14,527,946&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating earnings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Segment gross profit:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;173,507&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;172,583&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;429,996&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;394,107&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;5,324,540&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;6,085,356&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;9,221,699&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;10,511,398&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total segment gross profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;5,498,047&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GrossProfit_c20230901__20231130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;6,257,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GrossProfit_c20240601__20241130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;9,651,695&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GrossProfit_c20230601__20231130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;10,905,505&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Selling and Marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SellingAndMarketingExpense_c20240901__20241130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;3,377,760&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SellingAndMarketingExpense_c20230901__20231130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;3,672,780&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SellingAndMarketingExpense_c20240601__20241130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;6,047,231&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SellingAndMarketingExpense_c20230601__20231130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;6,879,621&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;General and Administrative&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240901__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;1,447,416&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230901__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;1,321,247&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240601__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;3,072,295&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230601__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;2,588,215&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated operating income&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ConsolidatedOperatingIncomeLoss_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;672,871&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConsolidatedOperatingIncomeLoss_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;1,263,912&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ConsolidatedOperatingIncomeLoss_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;532,169&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ConsolidatedOperatingIncomeLoss_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;1,437,669&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets"&gt;4,039,069&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets"&gt;5,439,289&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zSd1tXeKzgJb" style="text-align: right" title="Consolidated total assets"&gt;4,039,069&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zgJkAQWpELv2" style="text-align: right" title="Consolidated total assets"&gt;5,439,289&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;9,670,630&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;7,686,720&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z1wRJEG4eV49" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;9,670,630&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z50CV28EbXtj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;7,686,720&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated total assets&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,709,699&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsNet_c20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,126,009&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130_zWjVhJ4qa31b" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,709,699&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20231130_ztQM5MICcI22" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,126,009&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments for property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1364"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;65,783&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;19,885&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;107,623&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;70,845&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated total payments for property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;65,783&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;19,885&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;107,623&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;70,845&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;839&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;1,417&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;1,678&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;2,835&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;33,601&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;26,368&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;45,657&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;53,187&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated total depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;34,440&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;27,785&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;47,335&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;56,022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zrmtTLXO59qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Geographic Area Information&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For geographic area information of sales for the three
and six months ended November 30, 2024, see Note 12 &#x2013; Concentrations.&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001260">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_za2t9Oc9lZTg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Segment and Geographic Area Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B2_zdNxLoyJPpM9" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three months ended November 30,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six months ended November 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Sales, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;284,545&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;230,741&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;836,054&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="width: 10%; text-align: right" title="Total net sales"&gt;545,594&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;7,448,029&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;8,190,936&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;12,747,792&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net sales"&gt;13,982,352&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Total net sales&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;7,732,574&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;8,421,677&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;13,583,846&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Total net sales"&gt;14,527,946&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating earnings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Segment gross profit:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;173,507&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;172,583&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;429,996&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;394,107&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GrossProfit_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;5,324,540&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--GrossProfit_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;6,085,356&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GrossProfit_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;9,221,699&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GrossProfit_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total segment gross profit"&gt;10,511,398&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total segment gross profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GrossProfit_c20240901__20241130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;5,498,047&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GrossProfit_c20230901__20231130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;6,257,939&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GrossProfit_c20240601__20241130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;9,651,695&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GrossProfit_c20230601__20231130_pp0p0" style="text-align: right" title="Total segment gross profit"&gt;10,905,505&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Selling and Marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SellingAndMarketingExpense_c20240901__20241130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;3,377,760&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SellingAndMarketingExpense_c20230901__20231130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;3,672,780&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SellingAndMarketingExpense_c20240601__20241130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;6,047,231&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SellingAndMarketingExpense_c20230601__20231130_pp0p0" style="text-align: right" title="Selling and Marketing"&gt;6,879,621&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;General and Administrative&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240901__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;1,447,416&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230901__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;1,321,247&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OtherGeneralAndAdministrativeExpense_c20240601__20241130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;3,072,295&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherGeneralAndAdministrativeExpense_c20230601__20231130_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and Administrative"&gt;2,588,215&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated operating income&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ConsolidatedOperatingIncomeLoss_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;672,871&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConsolidatedOperatingIncomeLoss_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;1,263,912&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ConsolidatedOperatingIncomeLoss_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;532,169&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ConsolidatedOperatingIncomeLoss_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated operating income (loss)"&gt;1,437,669&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets"&gt;4,039,069&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total assets"&gt;5,439,289&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zSd1tXeKzgJb" style="text-align: right" title="Consolidated total assets"&gt;4,039,069&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_zgJkAQWpELv2" style="text-align: right" title="Consolidated total assets"&gt;5,439,289&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;9,670,630&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsNet_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;7,686,720&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z1wRJEG4eV49" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;9,670,630&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_z50CV28EbXtj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total assets"&gt;7,686,720&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated total assets&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,709,699&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsNet_c20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,126,009&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20241130_zWjVhJ4qa31b" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,709,699&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20231130_ztQM5MICcI22" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total assets"&gt;13,126,009&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments for property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total payments for property and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1364"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;65,783&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;19,885&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;107,623&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total payments for property and equipment"&gt;70,845&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated total payments for property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;65,783&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsToAcquireProductiveAssets_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;19,885&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;107,623&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total payments for property and equipment"&gt;70,845&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 6.75pt"&gt;Hair care and skin care&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;839&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;1,417&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;1,678&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HairCareAndSkinCareMember_pp0p0" style="text-align: right" title="Consolidated total depreciation and amortization"&gt;2,835&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 6.75pt"&gt;Hearing enhancement and protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;33,601&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;26,368&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;45,657&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130__us-gaap--StatementBusinessSegmentsAxis__custom--HearingEnhancementAndProtectionMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consolidated total depreciation and amortization"&gt;53,187&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; text-align: left; padding-bottom: 2.5pt"&gt;Consolidated total depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20240901__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;34,440&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230901__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;27,785&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20240601__20241130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;47,335&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230601__20231130_pp0p0" style="border-bottom: Black 4.5pt double; text-align: right" title="Consolidated total depreciation and amortization"&gt;56,022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 4.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001262"
      unitRef="USD">284545</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001264"
      unitRef="USD">230741</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001266"
      unitRef="USD">836054</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001268"
      unitRef="USD">545594</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001270"
      unitRef="USD">7448029</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001272"
      unitRef="USD">8190936</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001274"
      unitRef="USD">12747792</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001276"
      unitRef="USD">13982352</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001278"
      unitRef="USD">7732574</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001280"
      unitRef="USD">8421677</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001282"
      unitRef="USD">13583846</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001284"
      unitRef="USD">14527946</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001286"
      unitRef="USD">173507</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001288"
      unitRef="USD">172583</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001290"
      unitRef="USD">429996</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001292"
      unitRef="USD">394107</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001294"
      unitRef="USD">5324540</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001296"
      unitRef="USD">6085356</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001298"
      unitRef="USD">9221699</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001300"
      unitRef="USD">10511398</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001302"
      unitRef="USD">5498047</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001304"
      unitRef="USD">6257939</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001306"
      unitRef="USD">9651695</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001308"
      unitRef="USD">10905505</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001310"
      unitRef="USD">3377760</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001312"
      unitRef="USD">3672780</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001314"
      unitRef="USD">6047231</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001316"
      unitRef="USD">6879621</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001318"
      unitRef="USD">1447416</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001320"
      unitRef="USD">1321247</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001322"
      unitRef="USD">3072295</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001324"
      unitRef="USD">2588215</us-gaap:OtherGeneralAndAdministrativeExpense>
    <axil:ConsolidatedOperatingIncomeLoss
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001326"
      unitRef="USD">672871</axil:ConsolidatedOperatingIncomeLoss>
    <axil:ConsolidatedOperatingIncomeLoss
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001328"
      unitRef="USD">1263912</axil:ConsolidatedOperatingIncomeLoss>
    <axil:ConsolidatedOperatingIncomeLoss
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001330"
      unitRef="USD">532169</axil:ConsolidatedOperatingIncomeLoss>
    <axil:ConsolidatedOperatingIncomeLoss
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001332"
      unitRef="USD">1437669</axil:ConsolidatedOperatingIncomeLoss>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001334"
      unitRef="USD">4039069</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001336"
      unitRef="USD">5439289</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001338"
      unitRef="USD">4039069</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001340"
      unitRef="USD">5439289</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001342"
      unitRef="USD">9670630</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001344"
      unitRef="USD">7686720</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001346"
      unitRef="USD">9670630</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001348"
      unitRef="USD">7686720</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001350"
      unitRef="USD">13709699</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact001352"
      unitRef="USD">13126009</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact001354"
      unitRef="USD">13709699</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact001356"
      unitRef="USD">13126009</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001366"
      unitRef="USD">65783</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001368"
      unitRef="USD">19885</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001370"
      unitRef="USD">107623</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001372"
      unitRef="USD">70845</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001374"
      unitRef="USD">65783</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001376"
      unitRef="USD">19885</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001378"
      unitRef="USD">107623</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001380"
      unitRef="USD">70845</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-09-012024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001382"
      unitRef="USD">839</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-09-012023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001384"
      unitRef="USD">1417</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-06-012024-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001386"
      unitRef="USD">1678</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-06-012023-11-30_custom_HairCareAndSkinCareMember"
      decimals="0"
      id="Fact001388"
      unitRef="USD">2835</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-09-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001390"
      unitRef="USD">33601</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-09-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001392"
      unitRef="USD">26368</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-06-012024-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001394"
      unitRef="USD">45657</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-06-012023-11-30_custom_HearingEnhancementAndProtectionMember"
      decimals="0"
      id="Fact001396"
      unitRef="USD">53187</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001398"
      unitRef="USD">34440</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001400"
      unitRef="USD">27785</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001402"
      unitRef="USD">47335</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001404"
      unitRef="USD">56022</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-06-01to2024-11-30" id="Fact001411">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zuG215MeHdzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 14 &#x2013; &lt;span id="xdx_823_zZPYnc6cMxJ6"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We calculated our interim tax provision in accordance
with ASC 270, &#x201c;&lt;i&gt;Interim Reporting&lt;/i&gt;,&#x201d; and ASC 740, &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;.&#x201d; As the end of each
interim quarterly period, we estimate our annual effective tax rate and apply that rate to our ordinary quarterly earnings to calculate
the tax related to ordinary income. The tax effects of other items that are excluded from ordinary income are discretely calculated and
recognized in the period in which they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We recorded an income tax expense of $&lt;span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20240901__20241130_zHVgCTFNkh4" title="Income tax expense"&gt;67,250&lt;/span&gt; for the
three months ended November 30, 2024 and an income tax expense of $&lt;span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230901__20231130_zbV5EC57EQea" title="Income tax expense"&gt;364,393&lt;/span&gt; for the three months ended November 30, 2023. We recorded an
income tax expense of $&lt;span id="xdx_903_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20240601__20241130_zE13RdFSUPu3" title="Income tax expense"&gt;67,250&lt;/span&gt; for the six months ended November 30, 2024 and an income tax expense of $&lt;span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230601__20231130_zVLhqALjhiW2" title="Income tax expense"&gt;430,382&lt;/span&gt; for the six months ended
November 30, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company does not have any uncertain tax positions
or events leading to uncertainty in a tax position. The Company&#x2019;s 2020, 2021, 2022 and 2023 Corporate Income Tax Returns are subject
to IRS examination.&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-09-012024-11-30"
      decimals="0"
      id="Fact001413"
      unitRef="USD">67250</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-09-012023-11-30"
      decimals="0"
      id="Fact001415"
      unitRef="USD">364393</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-06-01to2024-11-30"
      decimals="0"
      id="Fact001417"
      unitRef="USD">67250</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-06-012023-11-30"
      decimals="0"
      id="Fact001419"
      unitRef="USD">430382</us-gaap:IncomeTaxExpenseBenefit>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2024-09-012024-11-30" id="Fact001420">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2024-09-012024-11-30" id="Fact001421">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2024-09-012024-11-30" id="Fact001422">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2024-09-012024-11-30" id="Fact001423">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
